{
  "category": "Anatomic Pathology",
  "subject": {
    "name": "Gynecological",
    "url": "https://app.pathprimer.com/curriculum/68a4e07a-f0ca-46c9-a3d6-7f00e61398c1",
    "lessons": {
      "Cervix: Nonneoplastic Lesions": {
        "name": "Cervix: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/da275ad4-18d5-4e90-be1f-bc369e1b7220",
        "topics": {
          "Tunnel Clusters": {
            "name": "Tunnel Clusters",
            "url": "https://app.pathprimer.com/document/3e3c16ef-2236-4745-92d2-5fdf6d96f5f0/lesson/da275ad4-18d5-4e90-be1f-bc369e1b7220",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign lobular proliferation of cervical glands"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Multiparous > nulliparous"
                  },
                  {
                    "text": "Typically asymptomatic"
                  },
                  {
                    "text": "Possibly more common during pregnancy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Incidental finding"
                  },
                  {
                    "text": "May cause expansion of cervical wall (rare)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Well-demarcated, lobular appearance"
                  },
                  {
                    "text": "Commonly mixture of type A and type B patternsType AElongated, closely packed glandsCuboidal cells with bland, basally located, oval nuclei and apical mucinous cytoplasmMay show mild cytologic atypiaType B (most common)Closely packed, cystically dilated glands filled with inspissated mucinFlattened cells with bland, ovoid nuclei",
                    "sub_points": [
                      "Type AElongated, closely packed glandsCuboidal cells with bland, basally located, oval nuclei and apical mucinous cytoplasmMay show mild cytologic atypia",
                      "Elongated, closely packed glands",
                      "Cuboidal cells with bland, basally located, oval nuclei and apical mucinous cytoplasm",
                      "May show mild cytologic atypia",
                      "Type B (most common)Closely packed, cystically dilated glands filled with inspissated mucinFlattened cells with bland, ovoid nuclei",
                      "Closely packed, cystically dilated glands filled with inspissated mucin",
                      "Flattened cells with bland, ovoid nuclei"
                    ]
                  },
                  {
                    "text": "Lacks stromal response"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAX2 positive"
                  },
                  {
                    "text": "p16 negative or patchy positive"
                  },
                  {
                    "text": "Low Ki-67 index"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Nabothian cysts"
                  },
                  {
                    "text": "HPV-associated in situ and invasive (microcystic) adenocarcinoma"
                  },
                  {
                    "text": "HPV-independent gastric-type endocervical adenocarcinoma"
                  },
                  {
                    "text": "Mesonephric remnants/hyperplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign nonneoplastic lobular proliferation of cervical glands (1st described by Fluhmann in 1961)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unclear": [
                  {
                    "text": "May represent hyperplastic endocervical glands in response to hormonal milieu"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "8% of adult women"
                  },
                  {
                    "text": "Multiparous > nulliparous"
                  },
                  {
                    "text": "Possibly more common during pregnancy"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Typically asymptomatic"
                  },
                  {
                    "text": "Rarely visible on colposcopic examination"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Incidental finding"
                  },
                  {
                    "text": "May cause expansion of cervical wall (rarely)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Well-demarcated, lobular architecture"
                  },
                  {
                    "text": "2 typesType A: Elongated, closely packed glandsType B (most common): Closely packed, cystically dilated glands filled with inspissated mucinIndependent and commonly admixed",
                    "sub_points": [
                      "Type A: Elongated, closely packed glands",
                      "Type B (most common): Closely packed, cystically dilated glands filled with inspissated mucin",
                      "Independent and commonly admixed"
                    ]
                  },
                  {
                    "text": "No stromal response"
                  },
                  {
                    "text": "May be seen in association with nabothian cysts"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Type ACuboidal cells with bland, basally located, oval nuclei and apical mucinous cytoplasmMay show mild cytologic atypia: Nuclear enlargement and small nucleoliGastric metaplasia in up to 15%",
                    "sub_points": [
                      "Cuboidal cells with bland, basally located, oval nuclei and apical mucinous cytoplasm",
                      "May show mild cytologic atypia: Nuclear enlargement and small nucleoli",
                      "Gastric metaplasia in up to 15%"
                    ]
                  },
                  {
                    "text": "Type BFlattened cells with bland, ovoid nuclei",
                    "sub_points": [
                      "Flattened cells with bland, ovoid nuclei"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "PAX2 positive, p16 negative or patchy positive, low Ki-67 index"
                  },
                  {
                    "text": "HIK1083 positive if gastric metaplasia"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Nabothian Cysts": [
                  {
                    "text": "At most, several large, typically macroscopically visible, mucin-filled cysts"
                  },
                  {
                    "text": "No lobular growth"
                  }
                ],
                "Adenocarcinoma In Situ, Usual Type, HPV Associated": [
                  {
                    "text": "Nuclear hyperchromasia, pseudostratification, and atypia"
                  },
                  {
                    "text": "Apical mitoses and apoptotic bodies"
                  },
                  {
                    "text": "p16 diffusely positive"
                  }
                ],
                "Gastric-Type Endocervical Adenocarcinoma": [
                  {
                    "text": "No lobular growth"
                  },
                  {
                    "text": "Irregular branching glands"
                  },
                  {
                    "text": "Often deep extension in cervical wall"
                  },
                  {
                    "text": "At least focal desmoplasia and overt malignant cytologic features"
                  },
                  {
                    "text": "Loss of PAX2 expression"
                  }
                ],
                "Invasive Adenocarcinoma, Microcystic, HPV Associated": [
                  {
                    "text": "Infiltrative growth"
                  },
                  {
                    "text": "May have desmoplasia"
                  },
                  {
                    "text": "Cytologic atypia"
                  },
                  {
                    "text": "Numerous mitoses and apoptoses"
                  },
                  {
                    "text": "p16 diffusely positive"
                  }
                ],
                "Mesonephric Remnants/Hyperplasia": [
                  {
                    "text": "More often deep within cervical wall but occasionally superficial"
                  },
                  {
                    "text": "Cuboidal, nonmucinous cells"
                  },
                  {
                    "text": "Densely eosinophilic intraluminal secretions"
                  },
                  {
                    "text": "GATA3 positive"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Lobulated growth helps distinguish tunnel clusters, even when florid, from invasive carcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Arias-Stella Reaction": {
            "name": "Arias-Stella Reaction",
            "url": "https://app.pathprimer.com/document/529f5d14-feb6-4dba-9a09-e3f21acce9b8/lesson/da275ad4-18d5-4e90-be1f-bc369e1b7220",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign epithelial change characterized by cells with enlarged nuclei but maintained nuclear:cytoplasmic ratio"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "May occur anywhere in female genital tract"
                  },
                  {
                    "text": "Most commonly reproductive age (pregnant) but may be seen in women at any age on oral contraceptive or hormone replacement therapy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Does not typically form mass lesion"
                  },
                  {
                    "text": "May extensively involve polyp(s)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Usually focal but occasionally extensive with micropapillary and cribriform growths"
                  },
                  {
                    "text": "Affected glands show spectrum of nuclear and cytoplasmic changes"
                  },
                  {
                    "text": "Cells often protrude into gland lumen (hobnail appearance)"
                  },
                  {
                    "text": "Enlarged cells with abundant eosinophilic to vacuolated cytoplasmMaintained nuclear:cytoplasmic ratio",
                    "sub_points": [
                      "Maintained nuclear:cytoplasmic ratio"
                    ]
                  },
                  {
                    "text": "Variably enlarged nuclei with irregular nuclear contours and variable appearance of chromatinIntranuclear cytoplasmic pseudoinclusions common",
                    "sub_points": [
                      "Intranuclear cytoplasmic pseudoinclusions common"
                    ]
                  },
                  {
                    "text": "Mitoses typically absent"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Napsin-A, HNF-1-β frequently positive"
                  },
                  {
                    "text": "Reduced or loss of ER expression"
                  },
                  {
                    "text": "Low MIB1 proliferative index"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Adenocarcinoma in situ (cervix)"
                  },
                  {
                    "text": "Clear cell carcinoma (cervix, endometrium, ovary, peritoneum)"
                  },
                  {
                    "text": "Progesterone-related atypia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Arias-Stella phenomenon or change"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign epithelial change characterized by cells with enlarged nuclei but maintained nuclear:cytoplasmic ratio"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hormonal": [
                  {
                    "text": "Secondary to increased gonadotropin stimulation (e.g., pregnancy, gestational trophoblastic disease, or high-dose progestins)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Relatively common"
                  },
                  {
                    "text": "May be seen in up to 50% of gravid hysterectomies"
                  }
                ],
                "Age": [
                  {
                    "text": "May be seen in women of all ages but most commonly reproductive age"
                  }
                ],
                "Site": [
                  {
                    "text": "More common in gestational endometrium"
                  },
                  {
                    "text": "May occur anywhere in female genital tractMore diagnostically problematic in cervix",
                    "sub_points": [
                      "More diagnostically problematic in cervix"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Incidental finding"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Changes regress postpartum"
                  }
                ],
                "Treatment": [
                  {
                    "text": "None"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Does not typically form mass lesion"
                  },
                  {
                    "text": "May extensively involve polyp(s)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Usually focal (involves portion of gland, single gland, or small number of glands)"
                  },
                  {
                    "text": "± confluent micropapillary and cribriform growths"
                  },
                  {
                    "text": "Cells often protrude into gland lumen (hobnail appearance)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Spectrum of nuclear and cytoplasmic changes"
                  },
                  {
                    "text": "Enlarged cells with abundant eosinophilic to vacuolated cytoplasmMaintained nuclear:cytoplasmic ratio",
                    "sub_points": [
                      "Maintained nuclear:cytoplasmic ratio"
                    ]
                  },
                  {
                    "text": "Variably enlarged nucleiIrregular nuclear contoursVariable chromatin patterns (smudgy to dispersed)Intranuclear cytoplasmic pseudoinclusions common",
                    "sub_points": [
                      "Irregular nuclear contours",
                      "Variable chromatin patterns (smudgy to dispersed)",
                      "Intranuclear cytoplasmic pseudoinclusions common"
                    ]
                  },
                  {
                    "text": "Mitoses typically absent"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Napsin-A, HNF-1-β frequently positive"
                  },
                  {
                    "text": "Reduced or loss of ER expression"
                  },
                  {
                    "text": "Low MIB1 proliferative index"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adenocarcinoma In Situ, Usual Type (Cervix)": [
                  {
                    "text": "Common nuclear stratification"
                  },
                  {
                    "text": "Increased nuclear:cytoplasmic ratio"
                  },
                  {
                    "text": "Global nuclear hyperchromasia"
                  },
                  {
                    "text": "Increased apical mitoses"
                  },
                  {
                    "text": "Apoptotic bodies common"
                  },
                  {
                    "text": "Typically no hobnail appearance"
                  }
                ],
                "Clear Cell Carcinoma (Cervix, Endometrium, Ovary, Peritoneum)": [
                  {
                    "text": "Usually forms mass lesion"
                  },
                  {
                    "text": "Mixture of histologic patternsTubulocystic, papillary, solid",
                    "sub_points": [
                      "Tubulocystic, papillary, solid"
                    ]
                  },
                  {
                    "text": "Epithelial cells with malignant cytologic appearanceLack smudgy, degenerative nuclei",
                    "sub_points": [
                      "Lack smudgy, degenerative nuclei"
                    ]
                  },
                  {
                    "text": "Mitoses present"
                  }
                ],
                "Progesterone-Related Atypia": [
                  {
                    "text": "Similar histologic appearance"
                  },
                  {
                    "text": "Alternate explanation if patient is not pregnant"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Arias-Stella reaction typically does not form mass, shows spectrum of nuclear atypia, and lacks mitoses, all features that are key to its recognition and distinction from malignancy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Microglandular Hyperplasia": {
            "name": "Microglandular Hyperplasia",
            "url": "https://app.pathprimer.com/document/b3add0ff-3f67-43c6-9a4f-f758572e01c5/lesson/da275ad4-18d5-4e90-be1f-bc369e1b7220",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign, nonneoplastic endocervical glandular proliferation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Asymptomatic, typically occurs at reproductive age"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Rarely, small polypoid lesion (most microscopic)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Typical architectureTightly packed tubular or cystically dilated glandsIntraluminal mucin with sprinkling of acute inflammationScant intervening stroma with variable amounts of acute and chronic inflammation",
                    "sub_points": [
                      "Tightly packed tubular or cystically dilated glands",
                      "Intraluminal mucin with sprinkling of acute inflammation",
                      "Scant intervening stroma with variable amounts of acute and chronic inflammation"
                    ]
                  },
                  {
                    "text": "Morphologic variants (uncommon)Solid, reticular, or trabecularPseudoinfiltrativeAbundant myxoid or hyalinized stroma",
                    "sub_points": [
                      "Solid, reticular, or trabecular",
                      "Pseudoinfiltrative",
                      "Abundant myxoid or hyalinized stroma"
                    ]
                  },
                  {
                    "text": "Cuboidal to low columnar endocervical cells, often with sub- and supranuclear vacuoles"
                  },
                  {
                    "text": "Immature squamous cells or reserve cells beneath endocervical cells"
                  },
                  {
                    "text": "Bland to at most focal mild cytologic atypia"
                  },
                  {
                    "text": "Mitoses rare or absent"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p16 may be variably positive but not diffuse (block-like)"
                  },
                  {
                    "text": "p63, keratin 17 (reserve cells) positive; PAX2 retained"
                  },
                  {
                    "text": "CEA luminal positivity (endocervical cells) and cytoplasmic positivity (squamous metaplasia)"
                  },
                  {
                    "text": "ER and PR positive; low MIB-1 proliferation index"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Microglandular hyperplasia-like endometrial adenocarcinoma"
                  },
                  {
                    "text": "Clear cell adenocarcinoma"
                  },
                  {
                    "text": "Endocervical adenocarcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Microglandular change"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign, nonneoplastic endocervical glandular proliferation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Hormonal exposure (e.g., pregnancy/postpartum, oral contraceptives, hormone replacement therapy)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Reproductive, rarely postmenopausal"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Rarely, small polypoid lesion"
                  },
                  {
                    "text": "Majority incidental microscopic finding"
                  },
                  {
                    "text": "Surface erosion"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Typically superficial location"
                  },
                  {
                    "text": "Lesions may be solitary or multiple"
                  },
                  {
                    "text": "Often polypoid at low-power magnification"
                  },
                  {
                    "text": "Typical architectureTightly packed tubular or cystically dilated glandsIntraluminal mucin with sprinkling of acute inflammationScant intervening stroma with variable amounts of acute and chronic inflammation",
                    "sub_points": [
                      "Tightly packed tubular or cystically dilated glands",
                      "Intraluminal mucin with sprinkling of acute inflammation",
                      "Scant intervening stroma with variable amounts of acute and chronic inflammation"
                    ]
                  },
                  {
                    "text": "Unusual morphologic variants (uncommon)Solid, reticular, or trabecular growthPseudoinfiltrative growthAbundant myxoid or hyalinized stroma",
                    "sub_points": [
                      "Solid, reticular, or trabecular growth",
                      "Pseudoinfiltrative growth",
                      "Abundant myxoid or hyalinized stroma"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cuboidal to low columnar endocervical cells, often with sub- and supranuclear vacuolesOccasionally, hobnail and signet-ring cells, and paucity of sub- and supranuclear vacuoles",
                    "sub_points": [
                      "Occasionally, hobnail and signet-ring cells, and paucity of sub- and supranuclear vacuoles"
                    ]
                  },
                  {
                    "text": "Typically immature squamous cells or reserve cells beneath endocervical cells (may be flattened or attenuated)"
                  },
                  {
                    "text": "Bland to at most focal mild cytologic atypia"
                  },
                  {
                    "text": "Mitoses rare or absent< 1/10 HPF",
                    "sub_points": [
                      "< 1/10 HPF"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "p16 may be variably positive but not diffuse (block-like)"
                  },
                  {
                    "text": "p63, keratin 17 (reserve cells) positive; PAX2 retained"
                  },
                  {
                    "text": "CEA luminal positivity (endocervical cells) and cytoplasmic positivity (squamous metaplasia)"
                  },
                  {
                    "text": "ER and PR positive; low MIB-1 proliferation index"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Microglandular Hyperplasia-Like Endometrioid Adenocarcinoma": [
                  {
                    "text": "Typically postmenopausal women"
                  },
                  {
                    "text": "Some degree of cytologic atypia and mitotic activity"
                  },
                  {
                    "text": "Presence of stromal foamy macrophages"
                  },
                  {
                    "text": "Loss of PAX2 expression"
                  }
                ],
                "Clear Cell Adenocarcinoma": [
                  {
                    "text": "Typical admixed architectural patterns"
                  },
                  {
                    "text": "Absence of sub- and supranuclear vacuoles"
                  },
                  {
                    "text": "Conspicuous cytologic atypia"
                  },
                  {
                    "text": "Absence of reserve cells or squamous metaplasia"
                  },
                  {
                    "text": "Mitoses usually > 1/10 HPF; HNF-1-β positive"
                  }
                ],
                "Endocervical Adenocarcinoma": [
                  {
                    "text": "Irregular, haphazard growth"
                  },
                  {
                    "text": "Significant cytologic atypia, mitoses, and apoptoses"
                  },
                  {
                    "text": "Absence of sub- and supranuclear vacuoles"
                  },
                  {
                    "text": "p16, ProEx C, HPV positive; high MIB-1 expression"
                  }
                ],
                "Cervical Adenocarcinoma In Situ": [
                  {
                    "text": "Pseudostratified columnar cells"
                  },
                  {
                    "text": "Hyperchromatic crowded nuclei"
                  },
                  {
                    "text": "Mitoses and apoptotic bodies"
                  },
                  {
                    "text": "Absence of reserve cells or squamous metaplasia"
                  },
                  {
                    "text": "p16, ProEx C, cytoplasmic CEA, and HPV positive"
                  },
                  {
                    "text": "ER negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Before considering diagnosis of microglandular hyperplasia in postmenopausal women, endometrial and (less commonly) endocervical adenocarcinoma with microglandular features should be excluded"
                  },
                  {
                    "text": "Presence of any degree of mitotic activity or cytologic atypia in lesion with microglandular architecture strongly suggests diagnosis of adenocarcinoma"
                  },
                  {
                    "text": "Some microglandular hyperplasias may show extensive fibrinous exudate, and this finding should raise possibility of associated plasminogen deficiency"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Cervix: Neoplasms": {
        "name": "Cervix: Neoplasms",
        "url": "https://app.pathprimer.com/lesson/6b975190-2474-4d36-adc4-4da8d00fee37",
        "topics": {
          "Rhabdomyosarcoma": {
            "name": "Rhabdomyosarcoma",
            "url": "https://app.pathprimer.com/document/1bf2b8bb-4e22-4e0c-a7f7-e9a4ed8ed0c5/lesson/6b975190-2474-4d36-adc4-4da8d00fee37",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant mesenchymal neoplasm composed of skeletal muscle with various degrees of differentiation"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: Pulmonary blastoma, cystic nephroma, ovarian Sertoli-Leydig cell tumors (intermediate or poorly differentiated), cervical botryoid embryonal rhabdomyosarcoma (RMS), nodular thyroid hyperplasia or thyroid carcinoma, and others"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Children to young women (embryonal)"
                  },
                  {
                    "text": "Polypoid, grape-like mass (Botryoid embryonal)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Embryonal RMSCellular zone (cambium layer) and hypo- (myxoid &/or edematous) and hypercellular areasMay have focal fascicular growthFetal-type cartilage (up to 50%)Preexisting entrapped glands",
                    "sub_points": [
                      "Cellular zone (cambium layer) and hypo- (myxoid &/or edematous) and hypercellular areasMay have focal fascicular growth",
                      "May have focal fascicular growth",
                      "Fetal-type cartilage (up to 50%)",
                      "Preexisting entrapped glands"
                    ]
                  },
                  {
                    "text": "Alveolar RMS: Nests, alveoli, or solid growth"
                  },
                  {
                    "text": "Small primitive (embryonal) or polygonal (alveolar) cells and rhabdomyoblasts (including strap cells) ± anaplasia"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Myosin, myogenin, myoglobin, PAX7, myoD1 positive"
                  },
                  {
                    "text": "High Ki-67 index, especially in hypercellular areas"
                  },
                  {
                    "text": "PAX3::FOXO1orPAX7::FOXO1(embryonal)"
                  },
                  {
                    "text": "t(2;13)(q35;q14) (in 85%) or t(1;13)(p36;q14) (alveolar)"
                  },
                  {
                    "text": "DICER1germline or somatic mutations"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Müllerian adenosarcoma ± sarcomatous overgrowth"
                  },
                  {
                    "text": "Leiomyosarcoma"
                  },
                  {
                    "text": "Ewing sarcoma"
                  },
                  {
                    "text": "SMARCA4 undifferentiated uterine sarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Rhabdomyosarcoma (RMS)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Sarcoma botryoides (embryonal RMS with grape-like clinical appearance and cambium layer)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant mesenchymal neoplasm composed of skeletal muscle with various degrees of differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "DICER1-pleuropulmonary blastoma familial tumor predisposition syndromePulmonary blastoma, cystic nephroma, nasal chondromesenchymal hamartoma, ovarian Sertoli-Leydig cell tumors (intermediate or poorly differentiated), cervical botryoid embryonal RMS, ciliary body medulloepithelioma, pineoblastoma, pituitary blastoma, nodular thyroid hyperplasia or thyroid carcinoma, others",
                    "sub_points": [
                      "Pulmonary blastoma, cystic nephroma, nasal chondromesenchymal hamartoma, ovarian Sertoli-Leydig cell tumors (intermediate or poorly differentiated), cervical botryoid embryonal RMS, ciliary body medulloepithelioma, pineoblastoma, pituitary blastoma, nodular thyroid hyperplasia or thyroid carcinoma, others"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "8% of pediatric solid tumors"
                  },
                  {
                    "text": "< 1% of soft tissue sarcomas in adults"
                  },
                  {
                    "text": "Embryonal RMS most common histologic subtype"
                  }
                ],
                "Age": [
                  {
                    "text": "Embryonal RMS: Children to young women (but wide age range)"
                  },
                  {
                    "text": "Alveolar RMS: Typically premenopausal (< 50 years)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Vaginal bleeding or mass protruding through os"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Simple hysterectomy or local excision ± chemotherapy (especially if stage I)"
                  },
                  {
                    "text": "Radical surgery and adjuvant therapy (if advanced)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-year overall survival (all histologies): 68.4%Factors associated with better survival: Younger age, no metastases, embryonal histology, negative lymph nodes, surgical resection",
                    "sub_points": [
                      "Factors associated with better survival: Younger age, no metastases, embryonal histology, negative lymph nodes, surgical resection"
                    ]
                  },
                  {
                    "text": "Embryonal RMS in children: 70-90% 5-year survival with chemotherapyRadical surgery does not provide survival benefit over local excision + chemotherapy",
                    "sub_points": [
                      "Radical surgery does not provide survival benefit over local excision + chemotherapy"
                    ]
                  },
                  {
                    "text": "Embryonal RMS in adults: < 20% survival"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Polypoid, grape-like mass (if botryoid RMS)"
                  },
                  {
                    "text": "Homogeneous, fleshy, yellow-tan to gray-pink myxoid cut surface with soft consistency"
                  },
                  {
                    "text": "Usually 3-4 (up to 30) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Embryonal RMSDensely cellular zone (cambium layer) of primitive small blue cells below surface epithelium and surrounding entrapped epithelial structuresAlternating hypo- (with myxoid &/or edematous stroma) and hypercellular areasSome tumors may be extensively hypocellular± long, intersecting fascicles or storiform growth, typically focalVariable numbers of rhabdomyoblastic cellsIslands of fetal-type cartilage (up to 50%)Rare entrapped preexisting endocervical glands± necrosis and hemorrhage",
                    "sub_points": [
                      "Densely cellular zone (cambium layer) of primitive small blue cells below surface epithelium and surrounding entrapped epithelial structures",
                      "Alternating hypo- (with myxoid &/or edematous stroma) and hypercellular areasSome tumors may be extensively hypocellular",
                      "Some tumors may be extensively hypocellular",
                      "± long, intersecting fascicles or storiform growth, typically focal",
                      "Variable numbers of rhabdomyoblastic cells",
                      "Islands of fetal-type cartilage (up to 50%)",
                      "Rare entrapped preexisting endocervical glands",
                      "± necrosis and hemorrhage"
                    ]
                  },
                  {
                    "text": "Alveolar RMSNests and alveoli or solid growthHyalinized septa between nestsMay be admixed with embryonal RMS",
                    "sub_points": [
                      "Nests and alveoli or solid growth",
                      "Hyalinized septa between nests",
                      "May be admixed with embryonal RMS"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Small, round, elongated, or spindled cells with variable skeletal muscle differentiation"
                  },
                  {
                    "text": "Primitive small cells with scant cytoplasm and abundant apoptoses (typically embryonal RMS)Hyperchromatic nuclei with small nucleoliAnaplasia: Hyperchromatic nuclei, > 3x size of adjacent cells with atypical mitoses",
                    "sub_points": [
                      "Hyperchromatic nuclei with small nucleoli",
                      "Anaplasia: Hyperchromatic nuclei, > 3x size of adjacent cells with atypical mitoses"
                    ]
                  },
                  {
                    "text": "Polygonal cells with variable amount of cytoplasm (typically alveolar RMS)"
                  },
                  {
                    "text": "Rhabdomyoblasts with abundant eosinophilic cytoplasm (when elongated, called strap cells) ± cross striations"
                  },
                  {
                    "text": "± multinucleated giant cells"
                  },
                  {
                    "text": "Variable but often brisk mitotic activity"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Desmin, muscle-specific actin, myosin, myogenin, myoglobin, myoD1, PAX7 positiveTypically coexpression of desmin and myogeninExpression of skeletal muscle markers may be focal",
                    "sub_points": [
                      "Typically coexpression of desmin and myogenin",
                      "Expression of skeletal muscle markers may be focal"
                    ]
                  },
                  {
                    "text": "Rarely, CD99, cytokeratin, EMA, S100, ER, PR, or WT1 positive"
                  },
                  {
                    "text": "SATB2 and BCOR typically negative"
                  },
                  {
                    "text": "High Ki-67 index, especially in hypercellular areas"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Embryonal RMSt(2;13) or t(1:13) withPAX3::FOXO1orPAX7::FOXO1",
                    "sub_points": [
                      "t(2;13) or t(1:13) withPAX3::FOXO1orPAX7::FOXO1"
                    ]
                  },
                  {
                    "text": "Alveolar RMSt(2;13)(q35;q14) in 85%t(1;13)(p36;q14)",
                    "sub_points": [
                      "t(2;13)(q35;q14) in 85%",
                      "t(1;13)(p36;q14)"
                    ]
                  },
                  {
                    "text": "DICER1germline or somatic mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Müllerian Adenosarcoma": [
                  {
                    "text": "Phyllodes-like growth with intraglandular polypoid stromal projections"
                  },
                  {
                    "text": "More conspicuous glandular component (part of tumor)"
                  },
                  {
                    "text": "Variety of müllerian-type epithelium"
                  },
                  {
                    "text": "Usually low-grade nuclei and low mitotic activity"
                  }
                ],
                "Müllerian Adenosarcoma With Sarcomatous Overgrowth": [
                  {
                    "text": "Areas of conventional adenosarcoma"
                  }
                ],
                "Leiomyosarcoma": [
                  {
                    "text": "Fascicular growth"
                  },
                  {
                    "text": "Spindle cells with elongated (spindle) or rounded (epithelioid) nuclei"
                  },
                  {
                    "text": "No cross striations or primitive cells"
                  },
                  {
                    "text": "Frequently ER/PR positive; myogenin and myoD1 negative"
                  }
                ],
                "Ewing Sarcoma": [
                  {
                    "text": "No cambium layer or hypo- and hypercellular areas"
                  },
                  {
                    "text": "Intracytoplasmic glycogen but no cross striations"
                  },
                  {
                    "text": "t(11,22)"
                  }
                ],
                "SMARCA4 Undifferentiated Uterine Sarcoma": [
                  {
                    "text": "Cells with rhabdoid morphology and no cambium layer"
                  },
                  {
                    "text": "No primitive-appearing nuclei"
                  },
                  {
                    "text": "SMARCA4 loss"
                  }
                ],
                "Poorly Differentiated Carcinoma": [
                  {
                    "text": "Cohesive cells with focal keratinization or lumina"
                  },
                  {
                    "text": "EMA, keratin, p16 positive; muscle markers negative"
                  }
                ],
                "Alveolar Soft Part Sarcoma": [
                  {
                    "text": "Prominent sinusoidal vascular network"
                  },
                  {
                    "text": "Cells with homogeneous cytology"
                  },
                  {
                    "text": "PAS-diastase-positive rod-like crystals and granules"
                  },
                  {
                    "text": "TFE3 positive and der(17)t(X;17)(p11.2;q25)"
                  }
                ],
                "Carcinosarcoma": [
                  {
                    "text": "Malignant epithelial component; often HPV positive"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Overall good prognosis with conservative management"
                  },
                  {
                    "text": "In patients with tumors confined to cervix, adenosarcoma staging system superior to uterine sarcoma staging system to predict survival"
                  },
                  {
                    "text": "Genetic testing may be indicated in patients with cervical embryonal RMS, as may be associated with germlineDICER1mutations"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Densely cellular zone (cambium layer) of primitive cells under epithelium is characteristic of embryonal RMS"
                  },
                  {
                    "text": "If abundant glandular component, consider müllerian adenosarcoma"
                  },
                  {
                    "text": "In any polypoid lesion with prominent stroma, scrutinize at high magnification for hypercellular areas with primitive cells"
                  },
                  {
                    "text": "Other tumors in lower female genital tract may be positive for skeletal muscle markers (myogenin)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "HPV- and Non-HPV-Associated In Situ Adenocarcinoma": {
            "name": "HPV- and Non-HPV-Associated In Situ Adenocarcinoma",
            "url": "https://app.pathprimer.com/document/1f7f355c-722f-4610-8b9b-cbc2b4485466/lesson/6b975190-2474-4d36-adc4-4da8d00fee37",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Glandular intraepithelial neoplasm ± HPV associated"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "High-risk HPV infection most common cause (80-90%; HPV-18 most common)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Atypical glandular cells on Papanicolaou smear, may be subtle in gastric or ciliated types"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "HPV associatedEnlarged, hyperchromatic, pseudostratified nucleiFrequent mitoses, typically apicalCommon apoptotic bodies",
                    "sub_points": [
                      "Enlarged, hyperchromatic, pseudostratified nuclei",
                      "Frequent mitoses, typically apical",
                      "Common apoptotic bodies"
                    ]
                  },
                  {
                    "text": "HPV-independent gastric/atypical lobular endocervical gland hyperplasia (resembling foveolar-type epithelium)Variable apical eosinophilic to mucinous cytoplasm (> 50% of cells with scant intracytoplasmic mucin)",
                    "sub_points": [
                      "Variable apical eosinophilic to mucinous cytoplasm (> 50% of cells with scant intracytoplasmic mucin)"
                    ]
                  },
                  {
                    "text": "HPV independent tubal/ciliated"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "HPV associatedp16 (diffuse) and ProEx C positive in most variants (intestinal may be p16 negative)Ki-67 proliferative index typically > 75% in usual typeHPV in situ hybridization or PCR most specific",
                    "sub_points": [
                      "p16 (diffuse) and ProEx C positive in most variants (intestinal may be p16 negative)",
                      "Ki-67 proliferative index typically > 75% in usual type",
                      "HPV in situ hybridization or PCR most specific"
                    ]
                  },
                  {
                    "text": "Gastric typeMUC6 (not specific), HIK1083 or TFF2 positivep16 positive often patchy, Ki-67 typically < 50%Often PAX8, CDX2, CK7 > CK20 positive",
                    "sub_points": [
                      "MUC6 (not specific), HIK1083 or TFF2 positive",
                      "p16 positive often patchy, Ki-67 typically < 50%",
                      "Often PAX8, CDX2, CK7 > CK20 positive"
                    ]
                  },
                  {
                    "text": "Ciliated/Tubal: PAX8, CK7, ER, and PR positive, p16 patchy"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Invasive endocervical adenocarcinoma"
                  },
                  {
                    "text": "Reactive endocervix"
                  },
                  {
                    "text": "Tubal metaplasia/endometriosis/Arias-Stella reaction"
                  },
                  {
                    "text": "Squamous cell carcinoma in situ (vs. SMILE)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Adenocarcinoma in situ (AIS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Glandular intraepithelial neoplasm ± human papillomavirus (HPV) associated"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "High-risk HPV (80-90%; HPV-16 and 18 most common) if HPV associated"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "HPV associatedGeographic variationApparent decline in USA incidence rate in 21- to 24-year age group with HPV vaccineCoexistent squamous intraepithelial lesion (50-70%)",
                    "sub_points": [
                      "Geographic variationApparent decline in USA incidence rate in 21- to 24-year age group with HPV vaccine",
                      "Apparent decline in USA incidence rate in 21- to 24-year age group with HPV vaccine",
                      "Coexistent squamous intraepithelial lesion (50-70%)"
                    ]
                  },
                  {
                    "text": "HPV independentRare",
                    "sub_points": [
                      "Rare"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Young, if HPV associatedMean: 38 years younger than invasive counterpart",
                    "sub_points": [
                      "Mean: 38 years younger than invasive counterpart"
                    ]
                  },
                  {
                    "text": "Wide range, if HPV independent"
                  }
                ],
                "Site": [
                  {
                    "text": "At or near transformation zone, if HPV associated"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic; rarely, vaginal bleeding"
                  },
                  {
                    "text": "Atypical glandular cells on Papanicolaou smear"
                  },
                  {
                    "text": "Watery discharge, if gastric type/atypical lobular endocervical gland hyperplasia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Excision (cold knife cone), hysterectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  },
                  {
                    "text": "Pagetoid spread to endometrium &/or ovary with secondary invasion rare"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically incidental finding"
                  },
                  {
                    "text": "± erythema"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "HPV associatedPreservation of normal glandular architectureAbrupt transition from normal; frequent \"skip\" lesions± partial gland or only surface involvementLimited cribriform or papillary intraglandular growthNo desmoplastic stromal response and minimal periglandular inflammationVariable amounts of intracytoplasmic mucinStratified mucin-producing intraepithelial lesion (SMILE)Variably pseudostratified epitheliumPeripheral cuff of basaloid/reserve cells",
                    "sub_points": [
                      "Preservation of normal glandular architecture",
                      "Abrupt transition from normal; frequent \"skip\" lesions",
                      "± partial gland or only surface involvement",
                      "Limited cribriform or papillary intraglandular growth",
                      "No desmoplastic stromal response and minimal periglandular inflammation",
                      "Variable amounts of intracytoplasmic mucinStratified mucin-producing intraepithelial lesion (SMILE)Variably pseudostratified epitheliumPeripheral cuff of basaloid/reserve cells",
                      "Stratified mucin-producing intraepithelial lesion (SMILE)Variably pseudostratified epitheliumPeripheral cuff of basaloid/reserve cells",
                      "Variably pseudostratified epithelium",
                      "Peripheral cuff of basaloid/reserve cells"
                    ]
                  },
                  {
                    "text": "Coexistence of different HPV-related in situ/adenocarcinoma(s) types"
                  },
                  {
                    "text": "± squamous cell carcinoma in situ [juxtaposed or intimately admixed (adenosquamous cell carcinoma in situ)] if HPV related"
                  },
                  {
                    "text": "HPV independent, gastric typePreservation of normal glandular architectureAbrupt transition from normalSlight glandular complexityNo desmoplastic stromal response and minimal inflammatory component",
                    "sub_points": [
                      "Preservation of normal glandular architecture",
                      "Abrupt transition from normal",
                      "Slight glandular complexity",
                      "No desmoplastic stromal response and minimal inflammatory component"
                    ]
                  },
                  {
                    "text": "HPV-independent atypical lobular endocervical gland hyperplasiaConfined to inner 1/3 of cervical wallProminent to vague lobular architecture± mild epithelial tuftingMay have some surrounding stromal reaction with chronic inflammation± typical lobular endocervical gland hyperplasia",
                    "sub_points": [
                      "Confined to inner 1/3 of cervical wall",
                      "Prominent to vague lobular architecture",
                      "± mild epithelial tufting",
                      "May have some surrounding stromal reaction with chronic inflammation",
                      "± typical lobular endocervical gland hyperplasia"
                    ]
                  },
                  {
                    "text": "HPV independent, tubal/ciliatedPreservation of normal glandular architectureAbrupt transition from normal± minor glandular complexity± endometriosis",
                    "sub_points": [
                      "Preservation of normal glandular architecture",
                      "Abrupt transition from normal",
                      "± minor glandular complexity",
                      "± endometriosis"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "HPV associated> 50% cells with mucin depleted cytoplasm (usual type)Enlarged, hyperchromatic, pseudostratified nucleiFrequent mitoses, more common apicalCommon apoptotic bodiesIf only on surfaceYounger women (mean: 27 years)Less nuclear stratification and enlargement; fewer apoptotic bodies± varying degrees of intestinal differentiation with Paneth and enteroendocrine cellsTypically less nuclear pseudostratification, fewer mitoses and apoptotic bodies if extensive mucinous differentiationSMILE (HPV associated)Multilayered polyhedral to columnar cells with abundant eosinophilic, mucinous, or vacuolated cytoplasmHyperchromatic and atypical nuclei, may not be strikingMitoses often not conspicuous",
                    "sub_points": [
                      "> 50% cells with mucin depleted cytoplasm (usual type)Enlarged, hyperchromatic, pseudostratified nucleiFrequent mitoses, more common apicalCommon apoptotic bodiesIf only on surfaceYounger women (mean: 27 years)Less nuclear stratification and enlargement; fewer apoptotic bodies",
                      "Enlarged, hyperchromatic, pseudostratified nuclei",
                      "Frequent mitoses, more common apical",
                      "Common apoptotic bodies",
                      "If only on surfaceYounger women (mean: 27 years)Less nuclear stratification and enlargement; fewer apoptotic bodies",
                      "Younger women (mean: 27 years)",
                      "Less nuclear stratification and enlargement; fewer apoptotic bodies",
                      "± varying degrees of intestinal differentiation with Paneth and enteroendocrine cellsTypically less nuclear pseudostratification, fewer mitoses and apoptotic bodies if extensive mucinous differentiation",
                      "Typically less nuclear pseudostratification, fewer mitoses and apoptotic bodies if extensive mucinous differentiation",
                      "SMILE (HPV associated)Multilayered polyhedral to columnar cells with abundant eosinophilic, mucinous, or vacuolated cytoplasmHyperchromatic and atypical nuclei, may not be strikingMitoses often not conspicuous",
                      "Multilayered polyhedral to columnar cells with abundant eosinophilic, mucinous, or vacuolated cytoplasm",
                      "Hyperchromatic and atypical nuclei, may not be striking",
                      "Mitoses often not conspicuous"
                    ]
                  },
                  {
                    "text": "HPV independent gastric typeColumnar cells with pale foamy to eosinophilic cytoplasm (reminiscent of foveolar gastric epithelium), prominent cytoplasmic borders, basal nucleiGoblet cells may be presentCytologic atypia often not strikingMitoses and apoptoses present but fewer than in HPV associated usual type",
                    "sub_points": [
                      "Columnar cells with pale foamy to eosinophilic cytoplasm (reminiscent of foveolar gastric epithelium), prominent cytoplasmic borders, basal nuclei",
                      "Goblet cells may be present",
                      "Cytologic atypia often not striking",
                      "Mitoses and apoptoses present but fewer than in HPV associated usual type"
                    ]
                  },
                  {
                    "text": "HPV-independent atypical lobular endocervical gland hyperplasiaMild nuclear stratificationNuclear rounding with nucleoli and mitoses",
                    "sub_points": [
                      "Mild nuclear stratification",
                      "Nuclear rounding with nucleoli and mitoses"
                    ]
                  },
                  {
                    "text": "HPV independent tubal/ciliatedApical bar and ciliaSparse, densely eosinophilic cytoplasm with absent mucinSome nuclear pseudostratification± cytologic atypia and mitoses",
                    "sub_points": [
                      "Apical bar and cilia",
                      "Sparse, densely eosinophilic cytoplasm with absent mucin",
                      "Some nuclear pseudostratification",
                      "± cytologic atypia and mitoses"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Findings on Papanicolaou smearHPV associatedHyperchromatic nuclei in crowded groups (overlapping nuclei)± \"feathering\" of neoplastic cellsMay form rosette-like structuresHPV-independent gastric-type/atypical lobular endocervical gland hyperplasiaIntracytoplasmic golden mucin",
                    "sub_points": [
                      "HPV associatedHyperchromatic nuclei in crowded groups (overlapping nuclei)± \"feathering\" of neoplastic cellsMay form rosette-like structures",
                      "Hyperchromatic nuclei in crowded groups (overlapping nuclei)",
                      "± \"feathering\" of neoplastic cells",
                      "May form rosette-like structures",
                      "HPV-independent gastric-type/atypical lobular endocervical gland hyperplasiaIntracytoplasmic golden mucin",
                      "Intracytoplasmic golden mucin"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "If HPV associatedp16 (diffuse) and ProEx C positive in most variantsIntestinal type may be p16 negative or patchy positiveCDX2 positive if intestinalPAX8 (less often in SMILE) positivep63/p40 positive if adenosquamous (most extensive in squamous); p63 largely negative if SMILEVimentin, ER, and PR usually negativePAX2 and BCL2 negativeKi-67 proliferative indexTypically high (> 75%) in usual type (mucin depleted)Variable in others",
                    "sub_points": [
                      "p16 (diffuse) and ProEx C positive in most variants",
                      "Intestinal type may be p16 negative or patchy positive",
                      "CDX2 positive if intestinal",
                      "PAX8 (less often in SMILE) positive",
                      "p63/p40 positive if adenosquamous (most extensive in squamous); p63 largely negative if SMILE",
                      "Vimentin, ER, and PR usually negative",
                      "PAX2 and BCL2 negative",
                      "Ki-67 proliferative indexTypically high (> 75%) in usual type (mucin depleted)Variable in others",
                      "Typically high (> 75%) in usual type (mucin depleted)",
                      "Variable in others"
                    ]
                  },
                  {
                    "text": "HPV-independent gastric-type and atypical lobular endocervical gland hyperplasiaVariable p16 positivity (often patchy but may be diffuse)MUC6 (not specific), HIK1083 or TFF2 positiveOften PAX8, CDX2, CK7 > CK20 positiveKi-67 typically < 50%± p53-mutant patternCEA may be positiveER/PR usually negativeDecreased expression in gastric gland mucin-specific O-glycans atypical lobular endocervical gland hyperplasia",
                    "sub_points": [
                      "Variable p16 positivity (often patchy but may be diffuse)",
                      "MUC6 (not specific), HIK1083 or TFF2 positive",
                      "Often PAX8, CDX2, CK7 > CK20 positive",
                      "Ki-67 typically < 50%",
                      "± p53-mutant pattern",
                      "CEA may be positive",
                      "ER/PR usually negative",
                      "Decreased expression in gastric gland mucin-specific O-glycans atypical lobular endocervical gland hyperplasia"
                    ]
                  },
                  {
                    "text": "HPV independent tubal/ciliatedPAX8, CK7, ER, and PR positivep16 positivity at most patchyBCL2 and vimentin often positive",
                    "sub_points": [
                      "PAX8, CK7, ER, and PR positive",
                      "p16 positivity at most patchy",
                      "BCL2 and vimentin often positive"
                    ]
                  }
                ],
                "HPV Detection": [
                  {
                    "text": "PCR or in situ hybridizationHPV associated positiveGastric/atypical lobular endocervical gland hyperplasia and ciliated/tubal types negative",
                    "sub_points": [
                      "HPV associated positive",
                      "Gastric/atypical lobular endocervical gland hyperplasia and ciliated/tubal types negative"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Invasive Endocervical Adenocarcinoma": [
                  {
                    "text": "Irregular, haphazard, confluent, &/or deep growth"
                  },
                  {
                    "text": "± desmoplastic stromal reaction"
                  }
                ],
                "Reactive Endocervical Glands (vs. Usual AIS)": [
                  {
                    "text": "May be associated with ulceration"
                  },
                  {
                    "text": "Lack abrupt transition to normal endocervical cells"
                  },
                  {
                    "text": "Marked inflammation common"
                  },
                  {
                    "text": "Usually dispersed chromatin with prominent nucleoli"
                  },
                  {
                    "text": "p16 negative to focally positive"
                  }
                ],
                "Tubal Metaplasia (vs. Usual AIS)": [
                  {
                    "text": "± history of previous cervical conization/LEEP"
                  },
                  {
                    "text": "Ciliated cells lacking cytologic atypia or mitoses"
                  },
                  {
                    "text": "Edematous stroma ± calcifications"
                  },
                  {
                    "text": "BCL2, PAX2, vimentin, ER, and PR positive"
                  }
                ],
                "Endometriosis (vs. Usual AIS)": [
                  {
                    "text": "Endometrial stroma (may be scant)"
                  },
                  {
                    "text": "Evidence of recent or remote hemorrhage"
                  },
                  {
                    "text": "Epithelium: BCL2, PAX2, vimentin, ER, and PR positive"
                  },
                  {
                    "text": "Stroma: CD10 positive"
                  }
                ],
                "High-Grade Squamous Dysplasia Involving Glands (vs. Usual AIS)": [
                  {
                    "text": "No feathery appearance of nuclei with no overlap"
                  },
                  {
                    "text": "No apical mitoses or apoptoses"
                  },
                  {
                    "text": "No intracytoplasmic mucin"
                  }
                ],
                "Secondary Involvement by Endometrioid/Serous Carcinoma (vs. Usual AIS)": [
                  {
                    "text": "High-grade pleomorphic cytologic features (if serous)WT1 positivity (if serous carcinoma from upper gynecologic tract)",
                    "sub_points": [
                      "WT1 positivity (if serous carcinoma from upper gynecologic tract)"
                    ]
                  },
                  {
                    "text": "Coexistent endometrioid carcinoma of uterine corpusER and Vimentin positive",
                    "sub_points": [
                      "ER and Vimentin positive"
                    ]
                  }
                ],
                "Mesonephric Remnants/Hyperplasia (vs. Usual AIS)": [
                  {
                    "text": "Typically deep in cervical wall without superficial component"
                  },
                  {
                    "text": "Lacks conspicuous cytologic atypia and mitoses"
                  },
                  {
                    "text": "Dense intraluminal eosinophilic secretions"
                  },
                  {
                    "text": "p16 negative or patchy positive"
                  },
                  {
                    "text": "GATA3 (diffuse) and PAX2 (nuclear) positive"
                  }
                ],
                "Squamous Cell Carcinoma In Situ (vs. SMILE)": [
                  {
                    "text": "Abundant dense eosinophilic cytoplasm with round nuclei and intercellular bridges"
                  },
                  {
                    "text": "p40/p63 extensively positive"
                  }
                ],
                "Immature Squamous Metaplasia (vs. SMILE)": [
                  {
                    "text": "Mucinous cells only present on surface"
                  },
                  {
                    "text": "Rounded and uniform nuclei without cytologic atypia"
                  },
                  {
                    "text": "Patchy p16 staining at most"
                  }
                ],
                "Arias-Stella Reaction (vs. Gastric Type)": [
                  {
                    "text": "History of pregnancy or hormonal therapy"
                  },
                  {
                    "text": "Abundant eosinophilic to vacuolated cytoplasm with preserved N:C ratio ± nuclear pseudoinclusions and smudgy chromatin"
                  },
                  {
                    "text": "No mitoses or apoptotic bodies"
                  },
                  {
                    "text": "ER, PR positive, MIB1 low; p16 negative"
                  }
                ],
                "Typical Lobular Endocervical Gland Hyperplasia (vs. Atypical Lobular Endocervical Gland Hyperplasia)": [
                  {
                    "text": "No epithelial tufting or nuclear stratification"
                  },
                  {
                    "text": "Small nuclei with no nucleoli or mitotic activity"
                  }
                ],
                "Radiation-Induced Atypia": [
                  {
                    "text": "Prior history of radiation"
                  },
                  {
                    "text": "Preserved nuclear:cytoplasmic ratio"
                  },
                  {
                    "text": "No nuclear pseudostratification, apical mitoses, or apoptoses"
                  },
                  {
                    "text": "Smudgy appearance of chromatin"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Low-power morphologic surrogate features of HPV-associated AIS include abundant apical mitoses and apoptotic bodies"
                  },
                  {
                    "text": "Normal endocervical glands in reproductive-aged women may have scattered mitoses but do not show nuclear pseudostratification, hyperchromasia or apoptotic bodies, as seen in AIS"
                  },
                  {
                    "text": "AIS should always be considered when there is intestinal differentiation, as intestinal metaplasia is exceedingly rare in normal endocervical glands"
                  },
                  {
                    "text": "Focal glandular involvement by high-grade squamous dysplasia/carcinoma in situ should be favored over AIS when nuclei do not overlap and are rounded with no associated intracytoplasmic mucin"
                  },
                  {
                    "text": "SMILE should not be confused with squamous cell carcinoma in situ; even though at low power both show nuclear \"stratification,\" cells display cytoplasmic variably sized vacuoles with mucin in former"
                  },
                  {
                    "text": "Comparison of architecture of neoplastic glands to preexisting glandular architecture helpful in distinguishing in situ from invasive adenocarcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Squamous Cell Carcinoma": {
            "name": "Squamous Cell Carcinoma",
            "url": "https://app.pathprimer.com/document/ac187e75-7d66-4b72-94b9-1d62cfdd540b/lesson/6b975190-2474-4d36-adc4-4da8d00fee37",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant neoplasm originating in or near cervical transformation zone showing squamous differentiation, most human papillomavirus (HPV) associated"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "High-risk HPV (types 16, 18) most common"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Abnormal Papanicolaou smear or vaginal bleeding"
                  },
                  {
                    "text": "> 50% of fatalities lack adequate cytologic screening"
                  },
                  {
                    "text": "Majority between 40-55 years"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Indurated, ulcerated, or elevated granular area (if early)"
                  },
                  {
                    "text": "Papillary, polypoid, nodular, ulcerated mass, or barrel-shaped cervix (if advanced)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Patterns: Nonkeratinizing, keratinizing, basaloid, warty, papillary, lymphoepithelial-like, spindled/sarcomatoid"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, p63, p16 positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Tangentially sectioned, high-grade squamous intraepithelial lesion with extensive endocervical gland involvement"
                  },
                  {
                    "text": "Adenoid basal carcinoma"
                  },
                  {
                    "text": "Small cell neuroendocrine carcinoma"
                  },
                  {
                    "text": "Epithelioid trophoblastic tumor"
                  },
                  {
                    "text": "Placental implantation site/placental site nodule"
                  },
                  {
                    "text": "Clear cell carcinoma [vs. squamous cell carcinoma (SCC) with abundant cytoplasmic glycogen]"
                  },
                  {
                    "text": "Carcinosarcoma (vs. spindled SCC)"
                  },
                  {
                    "text": "Neuroendocrine carcinoma (vs. basaloid SCC)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Squamous cell carcinoma (SCC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant neoplasm originating in or near cervical transformation zone showing squamous differentiation, most human papillomavirus (HPV) associated"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "High-risk HPV (types 16, 18) most commonViral proteins E6 and E7 produced after integration of high-risk HPV DNA into host genome (viral DNA remains extrachromosomal in ~ 15%)Inactivation of cell cycle progression with cellular immortalizationIncreased risk of carcinoma associated with persistent infectionOther factors associated with increased risk of HPV acquisition: Immunosuppression (HIV or posttransplant patients), smoking, high parity, sexually promiscuous partners, increased numbers of lifetime partners",
                    "sub_points": [
                      "Viral proteins E6 and E7 produced after integration of high-risk HPV DNA into host genome (viral DNA remains extrachromosomal in ~ 15%)",
                      "Inactivation of cell cycle progression with cellular immortalization",
                      "Increased risk of carcinoma associated with persistent infection",
                      "Other factors associated with increased risk of HPV acquisition: Immunosuppression (HIV or posttransplant patients), smoking, high parity, sexually promiscuous partners, increased numbers of lifetime partners"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "3.97/100,000 person-years (2006-2007) in USA~ 11,000 new cases/year and 4,000 fatalities/year in USA75% decrease over preceding 50 years due to improved Papanicolaou smear screening in developed countries",
                    "sub_points": [
                      "~ 11,000 new cases/year and 4,000 fatalities/year in USA",
                      "75% decrease over preceding 50 years due to improved Papanicolaou smear screening in developed countries"
                    ]
                  },
                  {
                    "text": "2nd most common type of cancer (17.8 per 100,000 women) and cause of cancer deaths (9.8 per 100,000 women) globally"
                  }
                ],
                "Age": [
                  {
                    "text": "Majority between 40-55 years"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Higher incidence in Blacks"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abnormal Papanicolaou smear"
                  },
                  {
                    "text": "Vaginal bleeding"
                  },
                  {
                    "text": "Occasionally, pain and vaginal discharge"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Spreads primarily through lymphatics to regional (i.e., iliac, obturator, hypogastric, sacral) lymph nodes"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Loop electrosurgical excision procedure or conization, if superficially invasive (stage IA)< 3 mm of invasion, < 7-mm horizontal extent, margins uninvolved, no lymphovascular invasion",
                    "sub_points": [
                      "< 3 mm of invasion, < 7-mm horizontal extent, margins uninvolved, no lymphovascular invasion"
                    ]
                  },
                  {
                    "text": "Radical hysterectomy with sentinel lymph node mapping &/or pelvic lymph node dissection ± radiotherapy, if frankly invasive"
                  },
                  {
                    "text": "Radiotherapy and cisplatin-based chemotherapy, if high stage"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "95% (stage IA); 70-85% (stages IB1 and IIA); 50-70% (stages IB2 and IIB); 30-50% (stage III); 5-15% (stage IV) overall 5-year disease-free survival> 50% of fatalities lacked adequate cytologic screening (older women, lower socioeconomic status, recent immigrants from underdeveloped countries)",
                    "sub_points": [
                      "> 50% of fatalities lacked adequate cytologic screening (older women, lower socioeconomic status, recent immigrants from underdeveloped countries)"
                    ]
                  },
                  {
                    "text": "If lymphoepithelial or verrucous variant, better prognosis"
                  },
                  {
                    "text": "If HIV seropositive, worse prognosis with lower CD4 counts"
                  },
                  {
                    "text": "If carcinoma > 3 mm in depth with lymphovascular invasion, worse prognosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Indurated, ulcerated, or elevated granular area (if early)"
                  },
                  {
                    "text": "Papillary, polypoid, nodular, ulcerated mass, or barrel-shaped cervix (if advanced)"
                  }
                ],
                "Size": [
                  {
                    "text": "Variable"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "PatternsLarge cell nonkeratinizing (moderately differentiated)Round to irregular-shaped and variably sized nests, cords, sheets with less conspicuous keratinizationLarge to medium-sized, generally uniform cells with indistinct cell bordersNumerous mitosesLarge cell keratinizing (well to moderately differentiated)Irregularly shaped and sized nests with abundant keratin pearls ± central necrosisLarge cells with abundant eosinophilic cytoplasm and intercellular bridgesSmall cell nonkeratinizing (poorly differentiated)Nests, cords, sheets ± single cells with at most focal keratinizationVariable but generally small-sized cells with hyperchromatic nucleiBrisk mitotic activityBasaloidSmall nests of cells with peripheral nuclear palisading of nucleiCords and single cells may be seenOccasional nests with keratinizationCells with scant cytoplasm and hyperchromatic nucleiFrequent mitosesCondylomatous (\"warty\")Exophytic, often frond-like acanthotic squamous epitheliumWell-differentiated polygonal cells with conspicuous atypia of basal layer and superficial koilocytotic atypiaPapillaryPapillae with fibrovascular cores lined by multilayered epithelium with variable degree of squamous &/or transitional differentiation (\"squamotransitional\")Cells with relatively abundant eosinophilic cytoplasm, hyperchromatic nuclei with nucleoliMitoses presentSpindled/sarcomatoidNests of well- to moderately differentiated carcinoma with transition to spindled cellsCells with hyperchromatic nuclei and prominent nucleoliUsually numerous mitosesOccasional osteoclast-like giant cells± geographic and single cell necrosisLymphoepithelial-likeNests of dyscohesive squamous cells with vesicular nuclei and nucleoli, indistinct cell borders associated with prominent lymphocytic infiltrateNo keratinization or intercellular bridges",
                    "sub_points": [
                      "Large cell nonkeratinizing (moderately differentiated)Round to irregular-shaped and variably sized nests, cords, sheets with less conspicuous keratinizationLarge to medium-sized, generally uniform cells with indistinct cell bordersNumerous mitoses",
                      "Round to irregular-shaped and variably sized nests, cords, sheets with less conspicuous keratinization",
                      "Large to medium-sized, generally uniform cells with indistinct cell borders",
                      "Numerous mitoses",
                      "Large cell keratinizing (well to moderately differentiated)Irregularly shaped and sized nests with abundant keratin pearls ± central necrosisLarge cells with abundant eosinophilic cytoplasm and intercellular bridges",
                      "Irregularly shaped and sized nests with abundant keratin pearls ± central necrosis",
                      "Large cells with abundant eosinophilic cytoplasm and intercellular bridges",
                      "Small cell nonkeratinizing (poorly differentiated)Nests, cords, sheets ± single cells with at most focal keratinizationVariable but generally small-sized cells with hyperchromatic nucleiBrisk mitotic activity",
                      "Nests, cords, sheets ± single cells with at most focal keratinization",
                      "Variable but generally small-sized cells with hyperchromatic nuclei",
                      "Brisk mitotic activity",
                      "BasaloidSmall nests of cells with peripheral nuclear palisading of nucleiCords and single cells may be seenOccasional nests with keratinizationCells with scant cytoplasm and hyperchromatic nucleiFrequent mitoses",
                      "Small nests of cells with peripheral nuclear palisading of nuclei",
                      "Cords and single cells may be seen",
                      "Occasional nests with keratinization",
                      "Cells with scant cytoplasm and hyperchromatic nuclei",
                      "Frequent mitoses",
                      "Condylomatous (\"warty\")Exophytic, often frond-like acanthotic squamous epitheliumWell-differentiated polygonal cells with conspicuous atypia of basal layer and superficial koilocytotic atypia",
                      "Exophytic, often frond-like acanthotic squamous epithelium",
                      "Well-differentiated polygonal cells with conspicuous atypia of basal layer and superficial koilocytotic atypia",
                      "PapillaryPapillae with fibrovascular cores lined by multilayered epithelium with variable degree of squamous &/or transitional differentiation (\"squamotransitional\")Cells with relatively abundant eosinophilic cytoplasm, hyperchromatic nuclei with nucleoliMitoses present",
                      "Papillae with fibrovascular cores lined by multilayered epithelium with variable degree of squamous &/or transitional differentiation (\"squamotransitional\")",
                      "Cells with relatively abundant eosinophilic cytoplasm, hyperchromatic nuclei with nucleoli",
                      "Mitoses present",
                      "Spindled/sarcomatoidNests of well- to moderately differentiated carcinoma with transition to spindled cellsCells with hyperchromatic nuclei and prominent nucleoliUsually numerous mitosesOccasional osteoclast-like giant cells± geographic and single cell necrosis",
                      "Nests of well- to moderately differentiated carcinoma with transition to spindled cells",
                      "Cells with hyperchromatic nuclei and prominent nucleoli",
                      "Usually numerous mitoses",
                      "Occasional osteoclast-like giant cells",
                      "± geographic and single cell necrosis",
                      "Lymphoepithelial-likeNests of dyscohesive squamous cells with vesicular nuclei and nucleoli, indistinct cell borders associated with prominent lymphocytic infiltrateNo keratinization or intercellular bridges",
                      "Nests of dyscohesive squamous cells with vesicular nuclei and nucleoli, indistinct cell borders associated with prominent lymphocytic infiltrate",
                      "No keratinization or intercellular bridges"
                    ]
                  },
                  {
                    "text": "Focal mucinous differentiation may occur"
                  },
                  {
                    "text": "Desmoplastic stromal response"
                  },
                  {
                    "text": "± lymphovascular invasion"
                  },
                  {
                    "text": "Depth of invasion measured from most superficial epithelial-stromal interface to deepest extent"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7, p63, p16 positive"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Tangentially Sectioned High-Grade Squamous Intraepithelial Lesion With Extensive Endocervical Gland Involvement": [
                  {
                    "text": "Rounded nests with smooth borders"
                  },
                  {
                    "text": "Polarity of basal epithelial cells maintained"
                  },
                  {
                    "text": "No abrupt maturation at interface"
                  }
                ],
                "Adenoid Basal Carcinoma": [
                  {
                    "text": "Deeply located nests of basaloid squamous cells with nuclear palisading, some with lumina"
                  },
                  {
                    "text": "No desmoplastic stromal response"
                  }
                ],
                "Giant Cell Condyloma": [
                  {
                    "text": "Maturation and koilocytotic atypia; no invasion"
                  },
                  {
                    "text": "Low-risk HPV"
                  }
                ],
                "Small Cell Neuroendocrine Carcinoma": [
                  {
                    "text": "Nests, thin cords, and trabeculae of small cells"
                  },
                  {
                    "text": "± nuclear molding with crush artifact often present"
                  },
                  {
                    "text": "Salt and pepper chromatin ± cytoplasmic granules"
                  },
                  {
                    "text": "Brisk mitoses, apoptoses, geographic necrosis common"
                  },
                  {
                    "text": "p63(+); chromogranin, synaptophysin and CD56 often (+)"
                  }
                ],
                "Epithelioid Trophoblastic Tumor": [
                  {
                    "text": "Often well circumscribed"
                  },
                  {
                    "text": "Neoplastic cells arranged around vessels, juxtaposed to geographic areas of hyaline necrosis without keratinization"
                  },
                  {
                    "text": "Inhibin, hPL, CK18 positive"
                  }
                ],
                "Placental Site Nodule": [
                  {
                    "text": "Rounded smooth contours"
                  },
                  {
                    "text": "No keratinization; rare to absent mitoses"
                  },
                  {
                    "text": "Inhibin positive"
                  }
                ],
                "Clear Cell Carcinoma (vs. SCC With Abundant Cytoplasmic Glycogen)": [
                  {
                    "text": "Characteristic architectural patterns"
                  },
                  {
                    "text": "HNF-1-β, napsin A positive; p63 negative"
                  }
                ],
                "Carcinosarcoma (vs. Spindled SCC)": [
                  {
                    "text": "Malignant mesenchymal component"
                  },
                  {
                    "text": "Heterologous elements"
                  }
                ],
                "Displacement Artifact (vs. Lymphovascular Invasion)": [
                  {
                    "text": "Associated with injection of local anesthetic"
                  },
                  {
                    "text": "Adjacent vascular ectasia"
                  },
                  {
                    "text": "± cleft-like space with hemorrhage (needle tract)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Most cervical SCC are HPV associated; however, minor percentage is HPV independent; before making latter diagnosis, all modalities to exclude HPV-related tumor recommended"
                  },
                  {
                    "text": "Be aware of spectrum of morphologies of SCC before making diagnosis of more unusual carcinomas"
                  },
                  {
                    "text": "In contrast to other organs, lymphoepithelial-like SCC of cervix are not EBV related"
                  },
                  {
                    "text": "Tumors with squamotransitional morphology have been reported to be more often associated with low-risk HPV"
                  },
                  {
                    "text": "Lymphovascular invasion is best evaluated at periphery of tumor; be cautious in diagnosing lymphovascular invasion in absence of tissue invasion"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Squamous Intraepithelial Lesion/Dysplasia": {
            "name": "Squamous Intraepithelial Lesion/Dysplasia",
            "url": "https://app.pathprimer.com/document/12cf865e-032e-4eda-846d-8f1587005af3/lesson/6b975190-2474-4d36-adc4-4da8d00fee37",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Squamous cell proliferation in cervical transformation zone showing maturation abnormalities &/or viral cytopathic changes attributable to high-risk human papillomavirus (HR-HPV) infection"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Majority of low-grade squamous intraepithelial lesion (LSIL) regress spontaneously"
                  },
                  {
                    "text": "Minority of high-grade squamous intraepithelial lesion (HSIL) may progress to carcinoma"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Low-grade squamous intraepithelial lesion (LSIL)Acanthosis, hyperkeratosis, parakeratosis, ± papillomatosisIncreased nuclear density in upper layers; preserved polarity at baseIncreased nuclear size, irregular contours, and hyperchromasia in upper layersKoilocytotic atypia in upper layers but minimal atypia in basal layersMitoses typically in lower 1/3",
                    "sub_points": [
                      "Acanthosis, hyperkeratosis, parakeratosis, ± papillomatosis",
                      "Increased nuclear density in upper layers; preserved polarity at base",
                      "Increased nuclear size, irregular contours, and hyperchromasia in upper layers",
                      "Koilocytotic atypia in upper layers but minimal atypia in basal layers",
                      "Mitoses typically in lower 1/3"
                    ]
                  },
                  {
                    "text": "High-grade squamous intraepithelial lesion (HSIL)Acanthosis with increased cellular density ± atypical parakeratosis ± koilocytotic atypiaIncreased nuclear size and hyperchromasia in all layersCrowded, enlarged nuclei with irregular contoursMitoses ± atypical forms in all levels of epitheliumApoptoses may be prominent",
                    "sub_points": [
                      "Acanthosis with increased cellular density ± atypical parakeratosis ± koilocytotic atypia",
                      "Increased nuclear size and hyperchromasia in all layers",
                      "Crowded, enlarged nuclei with irregular contours",
                      "Mitoses ± atypical forms in all levels of epithelium",
                      "Apoptoses may be prominent"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p16: Block (+) in all HSIL and some LSIL"
                  },
                  {
                    "text": "Type-specific HR-HPV testing"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Reactive squamous changes"
                  },
                  {
                    "text": "Immature squamous metaplasia and atrophy"
                  },
                  {
                    "text": "Stratified mucin-producing intraepithelial lesion"
                  },
                  {
                    "text": "Adenosquamous carcinoma in situ"
                  },
                  {
                    "text": "Placental implantation site/plaque"
                  },
                  {
                    "text": "Early invasive squamous cell carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Low-grade squamous intraepithelial lesion (LSIL)"
                  },
                  {
                    "text": "High-grade squamous intraepithelial lesion (HSIL)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Bethesda system SIL terminology for cytology &/or cervical biopsy diagnosis"
                  },
                  {
                    "text": "Cervical intraepithelial neoplasia (CIN) terminology for cervical biopsy diagnosisLSIL = CIN 1 and flat/exophytic condylomaHSIL = CIN 2 and CIN 3",
                    "sub_points": [
                      "LSIL = CIN 1 and flat/exophytic condyloma",
                      "HSIL = CIN 2 and CIN 3"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Squamous cell proliferation in cervical transformation zone showing maturation abnormalities &/or viral cytopathic changes attributable to high-risk human papillomavirus (HR-HPV) infection"
                  },
                  {
                    "text": "Biology reflected in terminology for preinvasive cervical squamous lesionsLSIL considered to represent productive viral infection likely to self-resolveWhen measured, viral load often higher in LSIL than HSIL; therefore, not useful predictor of progressionHSIL considered to represent persistent viral infection associated with higher risk of progression to invasion",
                    "sub_points": [
                      "LSIL considered to represent productive viral infection likely to self-resolveWhen measured, viral load often higher in LSIL than HSIL; therefore, not useful predictor of progression",
                      "When measured, viral load often higher in LSIL than HSIL; therefore, not useful predictor of progression",
                      "HSIL considered to represent persistent viral infection associated with higher risk of progression to invasion"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "HPV": [
                  {
                    "text": "Low-risk (LR-) and HR-HPVLR-HPV types 6 and 11 not associated with HSIL or carcinoma~ 15 HR-HPV genotypes associated with carcinogenic potentialHPV genotypes 16, 18, 45, and 31 confer highest risk",
                    "sub_points": [
                      "LR-HPV types 6 and 11 not associated with HSIL or carcinoma",
                      "~ 15 HR-HPV genotypes associated with carcinogenic potentialHPV genotypes 16, 18, 45, and 31 confer highest risk",
                      "HPV genotypes 16, 18, 45, and 31 confer highest risk"
                    ]
                  },
                  {
                    "text": "Sexual transmission of HR-HPVAssociated with young age, early age at coitarche, multiple and promiscuous sexual partners",
                    "sub_points": [
                      "Associated with young age, early age at coitarche, multiple and promiscuous sexual partners"
                    ]
                  },
                  {
                    "text": "Persistent infection leading to intercalation of viral genomePossibly potentiated by impaired host local immunity (e.g., smoking), inflammation, and certain viral factors",
                    "sub_points": [
                      "Possibly potentiated by impaired host local immunity (e.g., smoking), inflammation, and certain viral factors"
                    ]
                  },
                  {
                    "text": "Expression of viral genes E6 and E7Inhibition of tumor suppressor geneTP53, leading to cell proliferation through effects on retinoblastoma proteinE6: Upregulation of telomerase and loss of replicative senescence, centrosome instabilityE7: Additional potentiating effects on cell proliferation and immortalization",
                    "sub_points": [
                      "Inhibition of tumor suppressor geneTP53, leading to cell proliferation through effects on retinoblastoma protein",
                      "E6: Upregulation of telomerase and loss of replicative senescence, centrosome instability",
                      "E7: Additional potentiating effects on cell proliferation and immortalization"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Usually < 40 years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic, detected on screening Pap smear"
                  }
                ],
                "Natural History": [
                  {
                    "text": "In most women, HPV infection self-resolves within 5 yearsMost of LSIL regress with resolution of infection< 15% of LSIL may progress to HSIL",
                    "sub_points": [
                      "Most of LSIL regress with resolution of infection",
                      "< 15% of LSIL may progress to HSIL"
                    ]
                  },
                  {
                    "text": "Persistent infection with HR-HPV genotype associated with increased risk of HSIL10-20% of HSIL estimated to progress to invasive cancer if untreated",
                    "sub_points": [
                      "10-20% of HSIL estimated to progress to invasive cancer if untreated"
                    ]
                  },
                  {
                    "text": "Course may be more aggressive in HIV(+) patients"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Excision (LEEP or cold knife cone) or ablation (cryotherapy) recommended forHSIL in women > 21 years oldLSIL persistent for > 2 years or alternatively continued observation",
                    "sub_points": [
                      "HSIL in women > 21 years old",
                      "LSIL persistent for > 2 years or alternatively continued observation"
                    ]
                  },
                  {
                    "text": "ObservationGenerally recommended for all 1st-time LSIL Pap smearsMay subsequently offer shorter follow-up interval and interval HPV testingRecommended for 1st-time HSIL in adolescents or young adultsRepeat HSIL or greater at 12 months referred for colposcopyRepeat sampling 6 weeks postpartum for SIL detected during pregnancy",
                    "sub_points": [
                      "Generally recommended for all 1st-time LSIL Pap smearsMay subsequently offer shorter follow-up interval and interval HPV testing",
                      "May subsequently offer shorter follow-up interval and interval HPV testing",
                      "Recommended for 1st-time HSIL in adolescents or young adultsRepeat HSIL or greater at 12 months referred for colposcopy",
                      "Repeat HSIL or greater at 12 months referred for colposcopy",
                      "Repeat sampling 6 weeks postpartum for SIL detected during pregnancy"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "LSIL: Excellent; majority spontaneously regress"
                  },
                  {
                    "text": "HSIL: Excellent, even when untreated (few progress to invasive cancer)"
                  }
                ],
                "Screening Recommendations": [
                  {
                    "text": "< 21 years: No screening"
                  },
                  {
                    "text": "21-29 years: Pap smear screening every 3 years"
                  },
                  {
                    "text": "30-65 years: Pap smear screening with HPV testing every 3-5 years"
                  },
                  {
                    "text": "> 65 years: No screening if history of adequate prior screening and not otherwise at high risk"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Colposcopic findingsExophytic lesion(s), erosion(s)Abnormal blood vesselsLeukoplakiaHSIL appears duller and less reflective of lightWhite change in color of epithelium with application of acetic acid (acetowhite change)Iodine solution to delineate borders of lesionHSIL strongly nonstaining with iodine application",
                    "sub_points": [
                      "Exophytic lesion(s), erosion(s)",
                      "Abnormal blood vessels",
                      "LeukoplakiaHSIL appears duller and less reflective of light",
                      "HSIL appears duller and less reflective of light",
                      "White change in color of epithelium with application of acetic acid (acetowhite change)",
                      "Iodine solution to delineate borders of lesionHSIL strongly nonstaining with iodine application",
                      "HSIL strongly nonstaining with iodine application"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "LSILAcanthosis, hyperkeratosis, parakeratosis ± papillomatosis (exophytic condyloma)Extensive exophytic LSIL (giant condyloma): PapillomatosisImmature exophytic LSIL/papillary immature squamous metaplasia (from reserve cells of transformation zone): Slender, filiform papillaeGenerally well-preserved polarity at baseSurface endocervical epithelium, particularly in immature lesions",
                    "sub_points": [
                      "Acanthosis, hyperkeratosis, parakeratosis ± papillomatosis (exophytic condyloma)Extensive exophytic LSIL (giant condyloma): PapillomatosisImmature exophytic LSIL/papillary immature squamous metaplasia (from reserve cells of transformation zone): Slender, filiform papillae",
                      "Extensive exophytic LSIL (giant condyloma): Papillomatosis",
                      "Immature exophytic LSIL/papillary immature squamous metaplasia (from reserve cells of transformation zone): Slender, filiform papillae",
                      "Generally well-preserved polarity at base",
                      "Surface endocervical epithelium, particularly in immature lesions"
                    ]
                  },
                  {
                    "text": "HSILAcanthosis ± atypical parakeratosisIncreased nuclear density in upper layersHigh nuclear density throughout epithelium with minimal surface maturationThin variantMost 5 layers thickOften associated with typical HSILEosinophilic variantRelatively abundant eosinophilic cytoplasm and distinct cell bordersMay be associated with adenocarcinoma in situ",
                    "sub_points": [
                      "Acanthosis ± atypical parakeratosis",
                      "Increased nuclear density in upper layersHigh nuclear density throughout epithelium with minimal surface maturation",
                      "High nuclear density throughout epithelium with minimal surface maturation",
                      "Thin variantMost 5 layers thickOften associated with typical HSIL",
                      "Most 5 layers thick",
                      "Often associated with typical HSIL",
                      "Eosinophilic variantRelatively abundant eosinophilic cytoplasm and distinct cell borders",
                      "Relatively abundant eosinophilic cytoplasm and distinct cell borders",
                      "May be associated with adenocarcinoma in situ"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "LSILIncreased nuclear size, nuclear contour irregularities, and hyperchromasia in upper epithelial layersBinucleated or multinucleated cells with distinct perinuclear halos (koilocytotic atypia)Minimal in immature lesions (flat and exophytic)Little to no atypia in basal layerMitoses typically confined to lower 1/3 of epithelium",
                    "sub_points": [
                      "Increased nuclear size, nuclear contour irregularities, and hyperchromasia in upper epithelial layers",
                      "Binucleated or multinucleated cells with distinct perinuclear halos (koilocytotic atypia)Minimal in immature lesions (flat and exophytic)",
                      "Minimal in immature lesions (flat and exophytic)",
                      "Little to no atypia in basal layer",
                      "Mitoses typically confined to lower 1/3 of epithelium"
                    ]
                  },
                  {
                    "text": "HSILIncreased nuclear size and hyperchromasia in all epithelial layersCrowded, often uniformly enlarged nuclei with irregular nuclear contoursIncreased mitoses, including atypical forms, at all levels of epitheliumApoptoses may be prominentEosinophilic variantSome typical dysplastic nuclei with enlargement, hyperchromasia, ± membrane irregularities",
                    "sub_points": [
                      "Increased nuclear size and hyperchromasia in all epithelial layers",
                      "Crowded, often uniformly enlarged nuclei with irregular nuclear contours",
                      "Increased mitoses, including atypical forms, at all levels of epithelium",
                      "Apoptoses may be prominent",
                      "Eosinophilic variantSome typical dysplastic nuclei with enlargement, hyperchromasia, ± membrane irregularities",
                      "Some typical dysplastic nuclei with enlargement, hyperchromasia, ± membrane irregularities"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "p16: Block (+) staining useful to confirm SILExtent and intensity of staining should not be used to distinguish LSIL from HSIL",
                    "sub_points": [
                      "Extent and intensity of staining should not be used to distinguish LSIL from HSIL"
                    ]
                  },
                  {
                    "text": "MIB1: Limited utility, most useful to distinguish atrophy (low proliferation) from HSIL (high proliferation)"
                  },
                  {
                    "text": "Stathmin1: High specificity for CIN 3 and squamous cell carcinoma"
                  },
                  {
                    "text": "CK7: In LSIL, potential prognostic marker of risk of progression to CIN 2+ (odds ratio: 2.8)"
                  }
                ],
                "HPV Testing": [
                  {
                    "text": "Cotesting between 30-65 yearsType-specific HR-HPV testing performed concurrent to Pap smear",
                    "sub_points": [
                      "Type-specific HR-HPV testing performed concurrent to Pap smear"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Reactive Squamous Changes": [
                  {
                    "text": "Spongiosis and intraepithelial neutrophils"
                  },
                  {
                    "text": "± binucleated cells with round, uniform nuclei and smooth chromatin with nucleoli"
                  },
                  {
                    "text": "± subtle nuclear enlargement without hyperchromasia or increased density"
                  }
                ],
                "Immature Squamous Metaplasia": [
                  {
                    "text": "Surface columnar cells and mucin droplets"
                  },
                  {
                    "text": "Uniform nuclear spacing with minimal variation in nuclear size and chromasia"
                  },
                  {
                    "text": "No atypia in parabasal or basal cells"
                  }
                ],
                "Stratified Mucin-Producing Intraepithelial Lesion": [
                  {
                    "text": "Stratified epithelial cells with abundant pale cytoplasm affecting full thickness"
                  },
                  {
                    "text": "Minimal p63 and p40 expression"
                  }
                ],
                "Adenosquamous Carcinoma In Situ": [
                  {
                    "text": "Admixture or juxtaposition of squamous and glandular cells"
                  },
                  {
                    "text": "p63 highlights squamous component"
                  }
                ],
                "Atrophy": [
                  {
                    "text": "Lacks appreciable atypia"
                  },
                  {
                    "text": "Bland elongated, sometimes grooved, nuclei (transitional cell metaplasia) with streaming and no mitoses"
                  }
                ],
                "Radiation Change": [
                  {
                    "text": "Cells with uniformly spaced, enlarged nuclei, smudged chromatin, abundant cytoplasm and no mitoses"
                  }
                ],
                "Placental Implantation Site/Plaque": [
                  {
                    "text": "Interface with stroma not well defined"
                  },
                  {
                    "text": "Cells with abundant eosinophilic cytoplasm and indistinct cell borders"
                  },
                  {
                    "text": "Degenerative-type atypia with nuclear pseudoinclusions"
                  },
                  {
                    "text": "Prominent intercellular eosinophilic cellular matrix"
                  },
                  {
                    "text": "Inhibin, PLAP, HLA-G (+)"
                  }
                ],
                "Early Invasive Squamous Cell Carcinoma": [
                  {
                    "text": "Irregular epithelial-stromal interface"
                  },
                  {
                    "text": "Buds of cells with paradoxical maturation and loss of polarity"
                  }
                ],
                "Adenoid Basal Carcinoma (vs. HSIL With Gland Involvement)": [
                  {
                    "text": "Small nests of basaloid cells usually present below level of normal endocervical glands"
                  },
                  {
                    "text": "Cells with scant cytoplasm, oval nuclei with uniform chromatin and minimal atypia, sometimes with lumina"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Different p16 clones may have different sensitivity and specificity as well as predictive value"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diffuse p16 positivity indicative of HR-HPV infection; however, as it can be diffusely (+) in both LSIL and HSIL, it should not be used for grading"
                  },
                  {
                    "text": "p16 may be used to separate HSIL > > LSIL from reactive cytologic changes"
                  },
                  {
                    "text": "p16 positivity in isolation is not diagnostic of HPV-related process; thus, morphology is key to diagnosis"
                  },
                  {
                    "text": "Prominent cytologic atypia or atypical mitoses in basal layers is diagnostic of HSIL"
                  },
                  {
                    "text": "Striking underlying stromal inflammation may be seen in HSIL and not necessarily be indicative of invasion; however, close examination of these areas required"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Vulva and Vagina: Nonneoplastic Lesions": {
        "name": "Vulva and Vagina: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
        "topics": {
          "Schistosomiasis": {
            "name": "Schistosomiasis",
            "url": "https://app.pathprimer.com/document/7b3f8d29-7e54-4ec4-9426-b30df8e206fd/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "Key Facts": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Parasitic trematode worms (flukes) of genusSchistosoma"
                  },
                  {
                    "text": "3 major species causing human infections:Schistosoma mansoni,Schistosoma haematobium,Schistosoma japonicum"
                  },
                  {
                    "text": "Pathology is caused by host tissue reactions against antigens ofSchistosomaeggs, which induce predominantly Th-2 immune responses"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Worldwide distribution; prevalence is highest in sub-Saharan Africa"
                  },
                  {
                    "text": "Mortality related to schistosomiasis is low"
                  },
                  {
                    "text": "Likelihood of complications and morbidity correlate with parasite burden, duration of infection, site(s) of infection"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Inflammatory granulomatous reaction and eosinophilic infiltration, which result in local tissue destruction and fibrosis"
                  },
                  {
                    "text": "S. mansoni(average: 140 x 66 µm): Elongated/oval egg with a lateral spine"
                  },
                  {
                    "text": "S. haematobium(average: 143 x 60 µm): Elongated/oval egg with a terminal spine"
                  },
                  {
                    "text": "S. japonicum(average: 90 x 70 µm): Oval egg with a small lateral spine/knob"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Strongyloidiasis"
                  },
                  {
                    "text": "Tuberculosis"
                  },
                  {
                    "text": "Coccidioidomycosis"
                  },
                  {
                    "text": "Neoplasms, sarcoidosis"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Bilharziasis, snail fever, Katayama fever"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Greek: \"Skhistos\" (divided, cloven) + \"soma\" (body)"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Infectious Agents": [
                  {
                    "text": "Parasitic trematode worms (flukes) ofSchistosomagenus"
                  },
                  {
                    "text": "Species reported to cause infections in humans3 major species:Schistosoma mansoni,Schistosoma haematobium,Schistosoma japonicumLess common species: e.g.,Schistosoma mekongi,Schistosoma intercalatum",
                    "sub_points": [
                      "3 major species:Schistosoma mansoni,Schistosoma haematobium,Schistosoma japonicum",
                      "Less common species: e.g.,Schistosoma mekongi,Schistosoma intercalatum"
                    ]
                  },
                  {
                    "text": "Association ofSchistosomaspp. with diseases of organ systemsS. mansoniandS. japonicum: Diseases in intestines and liverS. haematobium: Diseases in genitourinary tractLess common species: e.g.,S. mekongiandS. intercalatumcan cause diseases in intestines and liver",
                    "sub_points": [
                      "S. mansoniandS. japonicum: Diseases in intestines and liver",
                      "S. haematobium: Diseases in genitourinary tract",
                      "Less common species: e.g.,S. mekongiandS. intercalatumcan cause diseases in intestines and liver"
                    ]
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Life cycleSchistosomaeggs are seeded into fresh water through urine or feces from infected humans or animalsEggs release miracidia, which penetrate into snailsEachSchistosomasp. is associated with a specific snail species, distribution of which determines geographic distributions of individualSchistosomaspp.Cercariae (infectious larvae form) are produced inside snail host, which are then released into waterHumans/animals become infected when skin is penetrated by cercariae in contaminated waterCercariae penetrate human skin, become schistosomula, and migrate through circulation until they reach the liver, where they mature into adult wormsWorms stay in bowel/rectum venules (S. mansoni and S. japonicum) or venous plexus in bladder (S. haematobium)Eggs are deposited in the tissueEggs then move toward lumen of intestine, or bladder and ureters, and are then eliminated in feces or urine, respectively",
                    "sub_points": [
                      "Schistosomaeggs are seeded into fresh water through urine or feces from infected humans or animals",
                      "Eggs release miracidia, which penetrate into snailsEachSchistosomasp. is associated with a specific snail species, distribution of which determines geographic distributions of individualSchistosomaspp.",
                      "EachSchistosomasp. is associated with a specific snail species, distribution of which determines geographic distributions of individualSchistosomaspp.",
                      "Cercariae (infectious larvae form) are produced inside snail host, which are then released into water",
                      "Humans/animals become infected when skin is penetrated by cercariae in contaminated water",
                      "Cercariae penetrate human skin, become schistosomula, and migrate through circulation until they reach the liver, where they mature into adult wormsWorms stay in bowel/rectum venules (S. mansoni and S. japonicum) or venous plexus in bladder (S. haematobium)",
                      "Worms stay in bowel/rectum venules (S. mansoni and S. japonicum) or venous plexus in bladder (S. haematobium)",
                      "Eggs are deposited in the tissueEggs then move toward lumen of intestine, or bladder and ureters, and are then eliminated in feces or urine, respectively",
                      "Eggs then move toward lumen of intestine, or bladder and ureters, and are then eliminated in feces or urine, respectively"
                    ]
                  },
                  {
                    "text": "Pathology is caused by host responses against antigens ofSchistosomaeggs, which induce predominantly Th-2 immune response, resulting in an eosinophilic granulomatous reaction"
                  },
                  {
                    "text": "Eggs may embolize to liver, spleen, lungs, brain, or spinal cord, and less commonly skin and peritoneal surfaces"
                  },
                  {
                    "text": "Extent of pathology depends on worm burden, host genetic background, and parasite strains"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [
                  {
                    "text": "Worldwide distribution"
                  },
                  {
                    "text": "Prevalence is highest in sub-Saharan Africa, where 85% of total burden is found"
                  },
                  {
                    "text": "Endemic distributions of differentSchistosomaspp.S. mansoni: Mostly in Africa and South AmericaS. haematobium: Mostly in Africa and Middle EastS. japonicum: Mostly in East AsiaS. mekongi: Mostly in Laos, CambodiaS. intercalatum: Mostly in West and Central Africa",
                    "sub_points": [
                      "S. mansoni: Mostly in Africa and South America",
                      "S. haematobium: Mostly in Africa and Middle East",
                      "S. japonicum: Mostly in East Asia",
                      "S. mekongi: Mostly in Laos, Cambodia",
                      "S. intercalatum: Mostly in West and Central Africa"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Migratory infection or immediate manifestationsMaculopapular eruption at site of cercarial penetrationCercarial dermatitis (\"swimmer's itch\")Maculopapular skin eruption with pruritus after repeated contacts with parasites; mostly associated with larvae of bird schistosomes ofTrichobilharziaspp.",
                    "sub_points": [
                      "Maculopapular eruption at site of cercarial penetration",
                      "Cercarial dermatitis (\"swimmer's itch\")Maculopapular skin eruption with pruritus after repeated contacts with parasites; mostly associated with larvae of bird schistosomes ofTrichobilharziaspp.",
                      "Maculopapular skin eruption with pruritus after repeated contacts with parasites; mostly associated with larvae of bird schistosomes ofTrichobilharziaspp."
                    ]
                  },
                  {
                    "text": "Acute infection (Katayama fever)Hypersensitivity reaction to schistosome antigens and circulating immune complexes; occurs 3-8 weeks after exposureAssociated with eosinophiliaSymptoms are variable, e.g., fever, urticaria and angioedema, arthralgias, diarrhea, abdominal pain",
                    "sub_points": [
                      "Hypersensitivity reaction to schistosome antigens and circulating immune complexes; occurs 3-8 weeks after exposure",
                      "Associated with eosinophilia",
                      "Symptoms are variable, e.g., fever, urticaria and angioedema, arthralgias, diarrhea, abdominal pain"
                    ]
                  },
                  {
                    "text": "Chronic infectionOccurs in response to cumulative deposition of eggs in tissues, and the resulting host reactionsIntestinal infectionMost common symptoms: Abdominal pain, diarrheaHeavy infections: Intestinal bleeding and iron deficiency anemiaHepatosplenic infectionIn adults, chronic infection leads to periportal fibrosis, resulting in portal hypertension, splenomegaly, portocaval shunting, and gastrointestinal varicesCoinfection of hepatitis B/hepatitis C and schistosomiasis is reported to cause more severe disease and worse prognosis than those infected with either of the pathogens aloneUrinary tract infectionEarly infection: Hematuria with eggs excreted in urineEarly chronic infection: Granulomatous inflammation and ulcerations result in development of pseudopolyps, which may mimic malignancyLongstanding infection: Fibrosis and calcification of bladder wall, bladder neck obstruction; associated with bacterial superinfection, acute renal failure, and development of bladder cancerGenital tract infectionWomen: Hypertrophic &/or ulcerative lesions of cervix, vagina, or vulva; involvement of ovaries or fallopian tubes may lead to infertilityMen: Infection may involve epididymis, testicles, spermatic cord, or prostateReported to be a risk factor for HIV infection in endemic areasPulmonary infectionOccurs mostly as complications in patients with hepatosplenic infection, which leads to embolization ofSchistosomaeggs into pulmonary circulationProgression of disease can result in granulomatous pulmonary endarteritis, pulmonary hypertension, and cor pulmonaleCentral nervous system infectionResults from embolization of eggs/egg-laying worms to spinal cord or cerebral microcirculationMyelopathy is more common than cerebral diseaseBrain involvement may present as single or multiple intracerebral lesions",
                    "sub_points": [
                      "Occurs in response to cumulative deposition of eggs in tissues, and the resulting host reactions",
                      "Intestinal infectionMost common symptoms: Abdominal pain, diarrheaHeavy infections: Intestinal bleeding and iron deficiency anemia",
                      "Most common symptoms: Abdominal pain, diarrhea",
                      "Heavy infections: Intestinal bleeding and iron deficiency anemia",
                      "Hepatosplenic infectionIn adults, chronic infection leads to periportal fibrosis, resulting in portal hypertension, splenomegaly, portocaval shunting, and gastrointestinal varicesCoinfection of hepatitis B/hepatitis C and schistosomiasis is reported to cause more severe disease and worse prognosis than those infected with either of the pathogens alone",
                      "In adults, chronic infection leads to periportal fibrosis, resulting in portal hypertension, splenomegaly, portocaval shunting, and gastrointestinal varices",
                      "Coinfection of hepatitis B/hepatitis C and schistosomiasis is reported to cause more severe disease and worse prognosis than those infected with either of the pathogens alone",
                      "Urinary tract infectionEarly infection: Hematuria with eggs excreted in urineEarly chronic infection: Granulomatous inflammation and ulcerations result in development of pseudopolyps, which may mimic malignancyLongstanding infection: Fibrosis and calcification of bladder wall, bladder neck obstruction; associated with bacterial superinfection, acute renal failure, and development of bladder cancer",
                      "Early infection: Hematuria with eggs excreted in urine",
                      "Early chronic infection: Granulomatous inflammation and ulcerations result in development of pseudopolyps, which may mimic malignancy",
                      "Longstanding infection: Fibrosis and calcification of bladder wall, bladder neck obstruction; associated with bacterial superinfection, acute renal failure, and development of bladder cancer",
                      "Genital tract infectionWomen: Hypertrophic &/or ulcerative lesions of cervix, vagina, or vulva; involvement of ovaries or fallopian tubes may lead to infertilityMen: Infection may involve epididymis, testicles, spermatic cord, or prostateReported to be a risk factor for HIV infection in endemic areas",
                      "Women: Hypertrophic &/or ulcerative lesions of cervix, vagina, or vulva; involvement of ovaries or fallopian tubes may lead to infertility",
                      "Men: Infection may involve epididymis, testicles, spermatic cord, or prostate",
                      "Reported to be a risk factor for HIV infection in endemic areas",
                      "Pulmonary infectionOccurs mostly as complications in patients with hepatosplenic infection, which leads to embolization ofSchistosomaeggs into pulmonary circulationProgression of disease can result in granulomatous pulmonary endarteritis, pulmonary hypertension, and cor pulmonale",
                      "Occurs mostly as complications in patients with hepatosplenic infection, which leads to embolization ofSchistosomaeggs into pulmonary circulation",
                      "Progression of disease can result in granulomatous pulmonary endarteritis, pulmonary hypertension, and cor pulmonale",
                      "Central nervous system infectionResults from embolization of eggs/egg-laying worms to spinal cord or cerebral microcirculationMyelopathy is more common than cerebral diseaseBrain involvement may present as single or multiple intracerebral lesions",
                      "Results from embolization of eggs/egg-laying worms to spinal cord or cerebral microcirculation",
                      "Myelopathy is more common than cerebral disease",
                      "Brain involvement may present as single or multiple intracerebral lesions"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Generally treated with praziquantel"
                  },
                  {
                    "text": "Reexamination of feces or urine after treatment is recommended to assess efficacy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality related to schistosomiasis is low"
                  },
                  {
                    "text": "Likelihood of complications and morbidity correlate with parasite burden, duration of infection, sites of infection"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Chest: Fine miliary nodules corresponding to granulomatous reactions toSchistosomaeggs"
                  },
                  {
                    "text": "Bladder: Eggshell calcification in submucosa of bladder and ureteral wall in longstanding infection"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Liver: Septal calcifications aligned perpendicularly to liver capsule produce characteristic \"turtle back\" appearance of hepatic schistosomiasis"
                  }
                ]
              },
              "Macroscopic Features": {
                "Gross Examination": [
                  {
                    "text": "Liver: Symmer clay pipestem fibrosis: Enlarged fibrotic portal tracts with severe portal fibrosis due to schistosomiasis"
                  },
                  {
                    "text": "Bladder/intestines\"Sandy patches\": Masses of calcified ova in mucosaPolyps or masses: Arise due to granulomatous inflammation and subsequent fibrosis surrounding eggs",
                    "sub_points": [
                      "\"Sandy patches\": Masses of calcified ova in mucosa",
                      "Polyps or masses: Arise due to granulomatous inflammation and subsequent fibrosis surrounding eggs"
                    ]
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Tissue reactionsInflammatory granulomatous reaction and eosinophilic infiltration, which result in local tissue destruction and fibrosis; entrapped ova eventually die and calcifyRecently laid eggs can cause acute inflammation",
                    "sub_points": [
                      "Inflammatory granulomatous reaction and eosinophilic infiltration, which result in local tissue destruction and fibrosis; entrapped ova eventually die and calcify",
                      "Recently laid eggs can cause acute inflammation"
                    ]
                  },
                  {
                    "text": "Morphology ofSchistosomaeggsS. mansoni(average:140 x 66 µm): Elongated/oval egg with a lateral spineS. haematobium(average: 143 x 60 µm): Elongated/oval egg with a terminal spineS. japonicum(average: 90 x 70 µm): Oval egg with a small lateral spine/knobS. intercalatum(average: 175 x 60 µm): ResemblesS. haematobiumegg but it is longer, thinner, and has a longer terminal spineS. mekongi(average: 69 x 56 µm): Spherical egg with small lateral spine that is not always visible",
                    "sub_points": [
                      "S. mansoni(average:140 x 66 µm): Elongated/oval egg with a lateral spine",
                      "S. haematobium(average: 143 x 60 µm): Elongated/oval egg with a terminal spine",
                      "S. japonicum(average: 90 x 70 µm): Oval egg with a small lateral spine/knob",
                      "S. intercalatum(average: 175 x 60 µm): ResemblesS. haematobiumegg but it is longer, thinner, and has a longer terminal spine",
                      "S. mekongi(average: 69 x 56 µm): Spherical egg with small lateral spine that is not always visible"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Ova Detection in Clinical Specimens": [
                  {
                    "text": "Eggs can be detected in urine and stool specimens by microscopy"
                  },
                  {
                    "text": "Extent of egg shedding may vary widely; multiple specimens may be needed for diagnosis"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "Commercial assays are available against various schistosome antigens, e.g., ELISA, radioimmunoassay, Western blot, complement fixation"
                  },
                  {
                    "text": "Sensitivity and specificity depend on serologic technique, antigen used, and intensity of infection"
                  },
                  {
                    "text": "Tests are generally negative during acute infection and turn positive 6-12 weeks after exposure"
                  },
                  {
                    "text": "Cannot distinguish between prior infection and active disease"
                  }
                ],
                "Antigen Testing": [
                  {
                    "text": "Qualitative assays that measure parasite antigens in blood, stool, &/or urine have been developed"
                  },
                  {
                    "text": "Sensitivity and specificity vary with assay techniques and targeted antigens but are reported to be as good as or better than stool or urine concentration methods for egg detection"
                  }
                ],
                "Molecular Diagnostics": [
                  {
                    "text": "PCR assays for stool, urine, and serum have been developed but largely remain as research tools"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Strongyloidiasis": [
                  {
                    "text": "Strongyloidesworms and larvae are seen in intestinal crypts &/or mucosa, often associated with exuberant eosinophilic infiltration"
                  },
                  {
                    "text": "In intestinal infection, egg-layingSchistosomaworms are present in microvasculature, while ova are mainly in submucosa associated with granulomatous reactionEosinophilic infiltrate is less intense than that seen in strongyloidiasis",
                    "sub_points": [
                      "Eosinophilic infiltrate is less intense than that seen in strongyloidiasis"
                    ]
                  }
                ],
                "Coccidioidomycosis": [
                  {
                    "text": "Lacks ova and shows spherules with endospores"
                  }
                ],
                "Tuberculosis": [
                  {
                    "text": "Positive for acid-fast stain and lacks ova and eosinophilic inflammation"
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Lacks presence of ova and eosinophilic inflammation"
                  }
                ],
                "Neoplasms": [
                  {
                    "text": "Lack ova and exhibit histologic morphologies consistent with malignant or benign neoplasms"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Inflammatory granulomatous reaction and eosinophilic infiltration associated withSchistosomaova deposition"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adenosis": {
            "name": "Adenosis",
            "url": "https://app.pathprimer.com/document/cae0e874-453b-41f9-b0a8-871b13c98e86/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Ectopic müllerian-type epithelium replacing squamous epithelium or as glands in lamina propria"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Prenatal exposure to diethylstilbestrol (DES) in uteroIf < 8-weeks gestation, 100% develop adenosisIf > 15-weeks gestation, 6% develop adenosis",
                    "sub_points": [
                      "If < 8-weeks gestation, 100% develop adenosis",
                      "If > 15-weeks gestation, 6% develop adenosis"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Median: 44 years"
                  },
                  {
                    "text": "Typically asymptomatic"
                  },
                  {
                    "text": "DES related (90%); non-DES related (10%)"
                  },
                  {
                    "text": "May be associated with malignancy (clear cell carcinoma in 1 per 1,000 DES-exposed women)"
                  },
                  {
                    "text": "Increased risk for vaginal squamous intraepithelial neoplasia"
                  },
                  {
                    "text": "Excellent prognosis (except if malignant transformation)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically not visible"
                  },
                  {
                    "text": "May be red and granular, nodular, or cystic"
                  },
                  {
                    "text": "Usually involves upper 1/3 of vagina"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Surface epithelium or superficial lamina propria"
                  },
                  {
                    "text": "Simple or cystic glands ± papillary infoldings"
                  },
                  {
                    "text": "Endocervical > tuboendometrioid > \"embryonic\" (low columnar to cuboidal cells) epithelium"
                  },
                  {
                    "text": "Rarely, intestinal (goblet cells) or gastric differentiation (may be admixed with other types) ± neuroendocrine cells"
                  },
                  {
                    "text": "± squamous metaplasia, microglandular hyperplasia"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Endometriosis"
                  },
                  {
                    "text": "Clear cell carcinoma"
                  },
                  {
                    "text": "Metastatic endometrial carcinoma"
                  },
                  {
                    "text": "Mesonephric remnants"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Presence of ectopic müllerian-type glandular epithelium replacing squamous mucosa or as glands in lamina propria"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Spontaneous (Developmental Anomaly)": [
                  {
                    "text": "Postembryonic persistence of müllerian-type epithelium"
                  }
                ],
                "Environmental Exposure": [
                  {
                    "text": "Prenatal exposure to diethylstilbestrol (DES) in uteroIf < 8-weeks gestation, 100% develop adenosisIf > 15-weeks gestation, 6% develop adenosis",
                    "sub_points": [
                      "If < 8-weeks gestation, 100% develop adenosis",
                      "If > 15-weeks gestation, 6% develop adenosis"
                    ]
                  },
                  {
                    "text": "DES alters p63 expression, potentially resulting in persistence of müllerian-type epithelium into adulthood"
                  },
                  {
                    "text": "DES may induce adenosis via dysregulation of SMAD-/RUNX1-mediated cell fate of müllerian epithelium"
                  }
                ],
                "Potentially Related To": [
                  {
                    "text": "CO₂ laser vaporization, 5-fluorouracil therapy, prior surgery"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "10% spontaneous, 90% DES related"
                  }
                ],
                "Age": [
                  {
                    "text": "Median: 44 years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Typically asymptomatic"
                  },
                  {
                    "text": "Vaginal bleeding, pain, or mucoid discharge may occur"
                  }
                ],
                "Natural History": [
                  {
                    "text": "May be associated with clear cell carcinoma (1 per 1,000 DES-exposed women), HPV-associated or -independent (gastric-type) vaginal adenocarcinoma"
                  },
                  {
                    "text": "Increased risk for vaginal squamous in situ neoplasia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Close observation, cautery, surgical excision (if florid)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent (except if malignant transformation)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "If visible, red and granular, nodular, or cystic"
                  },
                  {
                    "text": "Usually involves upper 1/3 of vagina"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Similar appearance in DES and non-DES-associated adenosis"
                  },
                  {
                    "text": "Typically located at surface epithelium (\"surface adenosis\") or superficial lamina propria"
                  },
                  {
                    "text": "Ranges from minimal to extensive"
                  },
                  {
                    "text": "Simple or cystic glands ± papillary infoldings"
                  },
                  {
                    "text": "Endocervical > tuboendometrioid > \"embryonic\" (low columnar to cuboidal cells) epithelium"
                  },
                  {
                    "text": "Rarely, intestinal (goblet cells) or gastric differentiation (may be admixed with other types) ± neuroendocrine cells"
                  },
                  {
                    "text": "± squamous metaplasia (increases with age)"
                  },
                  {
                    "text": "± microglandular hyperplasia (± oral contraceptive use)"
                  },
                  {
                    "text": "Chronic inflammation may be present"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Bland, oval to round nuclei; mitoses rare"
                  }
                ],
                "Atypical Adenosis": [
                  {
                    "text": "Smoothly contoured glands lined by single layer of cells with enlarged, atypical nuclei with prominent nucleoli"
                  },
                  {
                    "text": "Adjacent to ~ 75% of vaginal clear cell carcinomas; may be adjacent to gastric type adenocarcinomas"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "If gastric type: MUC6 positive; ER, CDX2 may be positive"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endometriosis": [
                  {
                    "text": "Endometrial-type stroma ± recent/remote hemorrhage"
                  }
                ],
                "Clear Cell Carcinoma": [
                  {
                    "text": "Tubulocystic, papillary, solid growths"
                  },
                  {
                    "text": "Moderate to marked nuclear atypia"
                  },
                  {
                    "text": "Cytoplasmic glycogen (PAS positive, diastase sensitive)"
                  }
                ],
                "Metastatic Endometrioid Endometrial Carcinoma": [
                  {
                    "text": "Prior or concurrent history"
                  },
                  {
                    "text": "Complex glandular growth; mitoses common"
                  }
                ],
                "Mesonephric Remnants": [
                  {
                    "text": "Located deep in vaginal wall, lacks cilia and mucin"
                  },
                  {
                    "text": "Dense intraluminal PAS-positive eosinophilic material"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Gastric-type vaginal adenosis not associated with DES"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Presence of metaplastic (e.g., microglandular hyperplasia, Arias-Stella) or hyperplastic (papillary architecture) changes in adenosis should not be misconstrued as malignant"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Molluscum Contagiosum": {
            "name": "Molluscum Contagiosum",
            "url": "https://app.pathprimer.com/document/fadf8b85-db27-41a9-aa85-b68dae530a1a/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Viral skin infection (Poxviridae family) causing raised, pearl-like papules or nodules"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Transmission through direct contact"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1-2% of world population infected"
                  },
                  {
                    "text": "More common in children and adolescents (< 8 years)"
                  },
                  {
                    "text": "Extragenital location most commonAnogenital area, mons, and upper thighs also frequently affected but rarely mucosa",
                    "sub_points": [
                      "Anogenital area, mons, and upper thighs also frequently affected but rarely mucosa"
                    ]
                  },
                  {
                    "text": "Painless papules (14-30 days post inoculation)"
                  },
                  {
                    "text": "Self-limited, usually within 6-12 months"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "5- to 8-mm, firm, pearly, skin-colored to whitish papules with central depressionMultiple and larger lesions, if immunosuppressed",
                    "sub_points": [
                      "Multiple and larger lesions, if immunosuppressed"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cup-shaped indentation of epidermis filled with keratin and with downward proliferation into dermis"
                  },
                  {
                    "text": "Prominent acanthosis with loss of stratum corneum"
                  },
                  {
                    "text": "Keratinocytes with homogeneous, purplish-red, cytoplasmic inclusion bodies (Henderson-Patterson)"
                  },
                  {
                    "text": "Viral cytopathic effect more common in superficial layers"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Oval to cylindrical, 150 x 300 nm, cytoplasmic viral particles with electron-dense core"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Condyloma acuminatum"
                  },
                  {
                    "text": "Fox-Fordyce disease"
                  },
                  {
                    "text": "Orf (ecthyma contagiosum)"
                  },
                  {
                    "text": "Milker nodule"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Molluscum contagiosum (MC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "\"Water warts\""
                  }
                ],
                "Definitions": [
                  {
                    "text": "Viral skin infection (Poxviridae family) causing raised, pearl-like papules or nodules"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Double-stranded DNA virus"
                  },
                  {
                    "text": "Transmission through direct contact (skin to skin or with contaminated object)"
                  },
                  {
                    "text": "MC159 and MC160 proteins facilitate immune evasion"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1-2% of world population infected"
                  },
                  {
                    "text": "Clinical manifestations in < 5% of children in USA"
                  },
                  {
                    "text": "Increasing in USA via sexual transmission"
                  }
                ],
                "Age": [
                  {
                    "text": "More common in children and adolescents (< 8 years)"
                  }
                ],
                "Site": [
                  {
                    "text": "Trunk, axilla, antecubital and popliteal fossa common"
                  },
                  {
                    "text": "Anogenital area, mons, and upper thighs also frequently affected"
                  },
                  {
                    "text": "Mucosa rarely involved"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Painless papules (14-30 days post inoculation)Extensive involvement if immunocompromised",
                    "sub_points": [
                      "Extensive involvement if immunocompromised"
                    ]
                  },
                  {
                    "text": "Inflammatory lesions not uncommonMolluscum dermatitis (eczema surrounding MC)Gianotti-Crosti-like reactions (eruption of numerous edematous and erythematous papules or papulovesicles separate from MC)",
                    "sub_points": [
                      "Molluscum dermatitis (eczema surrounding MC)",
                      "Gianotti-Crosti-like reactions (eruption of numerous edematous and erythematous papules or papulovesicles separate from MC)"
                    ]
                  },
                  {
                    "text": "Multiple lesions and molluscum dermatitis more common with history of atopic dermatitis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical removal"
                  },
                  {
                    "text": "Other: Curettage, liquid nitrogen, topical keratolytics, antivirals, intralesional injections, laser, immunomodulators (e.g., imiquimod), and cantharidin"
                  },
                  {
                    "text": "Treatment may prevent autoinoculation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Self-limited, usually within 6-12 months but up to 4 years (if immunocompromised)"
                  },
                  {
                    "text": "Scarring may occur with scratching (< 10%)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "5- to 8-mm, firm, pearly, skin-colored to whitish papules with central depression"
                  },
                  {
                    "text": "Multiple and larger lesions, if immunosuppressed"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cup-shaped indentation of epidermis filled with keratin with downward proliferation into dermis"
                  },
                  {
                    "text": "Prominent acanthosis with loss of stratum corneum"
                  },
                  {
                    "text": "Keratinocytes with homogeneous, purplish-red, cytoplasmic inclusion bodies (Henderson-Patterson)"
                  },
                  {
                    "text": "Viral cytopathic effect more common in superficial epithelial layers"
                  },
                  {
                    "text": "Rarely associated with inflammation unless ruptured"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Epidermal cell cytoplasm increases from base to surface due to increase in size of cytoplasmic viral particlesOften produces crescentic nuclear shape",
                    "sub_points": [
                      "Often produces crescentic nuclear shape"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "Oval to cylindrical 150 x 300 nm cytoplasmic viral particles with electron-dense core"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Condyloma Acuminatum": [
                  {
                    "text": "HPV related"
                  },
                  {
                    "text": "Exophytic verrucopapillary architecture"
                  },
                  {
                    "text": "Hyperkeratosis and hypergranulosis"
                  },
                  {
                    "text": "Superficial koilocytosis"
                  },
                  {
                    "text": "Basal hyperplasia with scattered mitoses"
                  }
                ],
                "Fox-Fordyce Disease": [
                  {
                    "text": "Cystically dilated follicle filled with keratin"
                  },
                  {
                    "text": "No viral inclusions"
                  }
                ],
                "Orf (Ecthyma Contagiosum)": [
                  {
                    "text": "Almost exclusively on fingers, hands, forearms"
                  },
                  {
                    "text": "Marked spongiosis common"
                  },
                  {
                    "text": "Lacks cup-shaped architecture and viral inclusions"
                  }
                ],
                "Milker Nodule": [
                  {
                    "text": "Almost always on fingers and hands"
                  },
                  {
                    "text": "Lacks cup-shaped architecture"
                  },
                  {
                    "text": "Prominent vascularity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Keratinocytes with purplish-red cytoplasmic inclusions are pathognomonic of MC"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Herpes Simplex Virus": {
            "name": "Herpes Simplex Virus",
            "url": "https://app.pathprimer.com/document/d15a8e3d-1417-4b6e-a0b2-d0d5ff923298/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Sexually or congenitally transmitted infection by herpes simplex virus (HSV) 1 or 2"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "HSV2 responsible for 70-90% of genital herpes"
                  },
                  {
                    "text": "Symptoms 3-7 days after inoculationPainful burning and stinging ± constitutional symptomsGrouped vesicles 12-48 hours later, lasting 10-12 daysDisrupted vesicles form ulcers lasting 1-2 weeks",
                    "sub_points": [
                      "Painful burning and stinging ± constitutional symptoms",
                      "Grouped vesicles 12-48 hours later, lasting 10-12 days",
                      "Disrupted vesicles form ulcers lasting 1-2 weeks"
                    ]
                  },
                  {
                    "text": "Primary infection during pregnancy may lead to abortion, premature delivery, or neonatal herpes"
                  },
                  {
                    "text": "Reactivation with stress, menses, extensive ultraviolet light exposure, or immunosuppression"
                  },
                  {
                    "text": "Highest risk of neonatal herpes with vaginal delivery, prolonged ruptured membranes before cesarean section, or if cervical involvement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Ulcerated epidermis or intraepidermal blister"
                  },
                  {
                    "text": "Intracellular ballooning and reticular degeneration of keratinocytes"
                  },
                  {
                    "text": "Acantholytic keratinocytes with multinucleation, nuclear molding, and chromatin margination (ground glass), most common cytopathic effect"
                  },
                  {
                    "text": "Marked pseudoepitheliomatous hyperplasia can occur, next to ulcer, especially in immunocompromised patients"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "HSV1 and HSV2 immunohistochemistry"
                  },
                  {
                    "text": "PCR, cultures or serology"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Reparative changes adjacent to ulcer"
                  },
                  {
                    "text": "Squamous cell carcinoma"
                  },
                  {
                    "text": "Syphilis, granuloma inguinale, and chancroid"
                  },
                  {
                    "text": "Lymphoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Herpes simplex virus (HSV)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Sexually or congenitally transmitted infection by HSV"
                  },
                  {
                    "text": "Primary: Initial manifestation in individuals without preexisting antibodies"
                  },
                  {
                    "text": "Latency: Time period after initial infection before and between reactivation periods"
                  },
                  {
                    "text": "Recurrent: Reactivation of HSV after latency"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "HSV1 and HSV2: Double-stranded, enveloped DNA viruses"
                  },
                  {
                    "text": "After initial infection, virus transported to (sacral) sensory and autonomic ganglia (latent reservoir)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "28% HSV2 seropositivity prevalence if pregnant"
                  }
                ],
                "Incidence": [
                  {
                    "text": "70-90% of genital herpes caused by HSV2, though HSV1 increasing in incidence"
                  },
                  {
                    "text": "Increased risk with number of sexual partners, poverty, lower education, homosexuality"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms 3-7 days after inoculationPainful burning/stinging ± constitutional symptomsVesicles 12-48 hours later, lasting 10-12 daysDisrupted vesicles form ulcers (in immunocompromised patients) or erosions lasting 1-2 weeks",
                    "sub_points": [
                      "Painful burning/stinging ± constitutional symptoms",
                      "Vesicles 12-48 hours later, lasting 10-12 days",
                      "Disrupted vesicles form ulcers (in immunocompromised patients) or erosions lasting 1-2 weeks"
                    ]
                  },
                  {
                    "text": "Ulcerative, nodular or vegetans lesions (when chronic) may simulate carcinoma in immunosuppressed patients"
                  },
                  {
                    "text": "Lymphadenopathy may be present"
                  },
                  {
                    "text": "Acquired lymphangioma circumscriptum in severe lesions"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Primary infection during pregnancy may lead to abortion, premature delivery, or neonatal herpes"
                  },
                  {
                    "text": "Reactivation with stress, menses, extensive ultraviolet light exposure, or immunosuppression"
                  },
                  {
                    "text": "Highest risk of neonatal herpes with vaginal delivery, prolonged ruptured membranes before cesarean section, or if cervical involvement"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Drugs: Acyclovir and other antivirals"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "~ 80% recurrence rate"
                  },
                  {
                    "text": "Up to 4 recurrences/year common as virus harbors indefinitely in ganglia (HSV2 > HSV1 reactivation)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Small (1- to 3-mm) grouped vesicles may be present on mucosa, possibly extending to skin"
                  },
                  {
                    "text": "More commonly, vesicles rupture leaving erosions or ulcers (immunocompromised patients)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Intracellular ballooning and reticular degeneration of keratinocytes in early phase"
                  },
                  {
                    "text": "Ulcerated epidermis or intraepidermal blister"
                  },
                  {
                    "text": "Usually prominent lymphocytic inflammatory infiltrate"
                  },
                  {
                    "text": "Follicular or eccrine involvement associated with marked inflammation and secondary necrosis"
                  },
                  {
                    "text": "± marked pseudoepitheliomatous hyperplasia next to ulcer, especially in immunocompromised patients"
                  },
                  {
                    "text": "Lichenoid lymphocytic vasculitis may occur in skin adjacent to viral cytopathic effect"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Acantholytic keratinocytes with multinucleation, nuclear molding, and chromatin margination (ground glass), most common cytopathic effect"
                  },
                  {
                    "text": "Cowdry A cytopathic effect with large eosinophilic nuclear inclusions and clear halo, less common"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "HSV1/2 (highlight cells without classic cytopathic effect)"
                  }
                ],
                "PCR": [
                  {
                    "text": "On fresh or formalin-fixed paraffin-embedded tissue"
                  }
                ],
                "Cultures": [
                  {
                    "text": "Sensitivity: 100% (blister) to 33% (ulcerative phase)"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "To provide evidence of past infection"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Reparative Changes Adjacent to Ulcer": [
                  {
                    "text": "No chromatin margination, nuclear molding, or viral inclusions in squamous cells"
                  }
                ],
                "Squamous Cell Carcinoma": [
                  {
                    "text": "Infiltrative, irregular nests of atypical squamous epithelial cells with desmoplastic stromal reaction"
                  },
                  {
                    "text": "No viral cytopathic effect"
                  }
                ],
                "Syphilis, Granuloma Inguinale, and Chancroid": [
                  {
                    "text": "Absence of characteristic viral cytopathic effect"
                  }
                ],
                "Lymphoma": [
                  {
                    "text": "Dense, monotonous infiltrate of atypical lymphocytes but no viral cytopathic effect"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Discrete ulcer or extensive inflammation, especially around adnexa, should always raise possibility of HSV infection"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Bartholin Cyst": {
            "name": "Bartholin Cyst",
            "url": "https://app.pathprimer.com/document/b7e37070-3b23-420e-b31e-5c1e3461789a/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Cystic dilatation of Bartholin gland (major vestibular gland) or tributary duct"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most commonly due to blockage of duct with retention of secretions and secondary cyst formation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Reproductive age (3rd decade most common)"
                  },
                  {
                    "text": "Labia minora (at 4 or 8 o'clock position)"
                  },
                  {
                    "text": "Typically unilateral"
                  },
                  {
                    "text": "Usually painless swelling"
                  },
                  {
                    "text": "Often mobile and fluctuant"
                  },
                  {
                    "text": "Tenderness if infected; local discomfort if large"
                  },
                  {
                    "text": "May recur, requiring complete excision"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually < 5 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cyst lined by transitional, low cuboidal, or mucinous epitheliumMay be flattened or denuded",
                    "sub_points": [
                      "May be flattened or denuded"
                    ]
                  },
                  {
                    "text": "Normal (residual) mucus glands often adjacent to cyst"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Mucinous cells: NKX3.1 frequently positive, PSA often positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Mucinous (mucous) cyst"
                  },
                  {
                    "text": "Ciliated cyst"
                  },
                  {
                    "text": "Paraurethral (Skene) gland cyst"
                  },
                  {
                    "text": "Epidermal inclusion (keratinous or sebaceous) cyst"
                  },
                  {
                    "text": "Mesonephric (wolffian)-like cyst"
                  },
                  {
                    "text": "Cyst of canal of Nuck (mesothelial cyst)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Bartholin gland cyst"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Cystic dilatation of Bartholin gland (major vestibular gland) or tributary duct"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Acquired Lesion": [
                  {
                    "text": "Most commonly due to blockage of duct with retention of secretions and secondary cyst formation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common vulvar cyst"
                  }
                ],
                "Age": [
                  {
                    "text": "Reproductive age (3rd decade most common)"
                  }
                ],
                "Site": [
                  {
                    "text": "Labia minora (at 4 or 8 o'clock position)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Typically unilateral, usually painless swelling"
                  },
                  {
                    "text": "Often mobile and fluctuant"
                  },
                  {
                    "text": "Tenderness if infected; local discomfort if large"
                  }
                ],
                "Natural History": [
                  {
                    "text": "May resolve without treatment, unless symptomatic or large"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Marsupialization or complete excision"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "May recur, requiring complete excision"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Round, well-defined unilocular cyst located posterolateral to vaginal introitus"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Size": [
                  {
                    "text": "Usually < 5 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cyst lined by transitional, low cuboidal, or mucinous epitheliumMay be flattened (attenuated) secondary to increased intracystic pressureMay exhibit focal squamous metaplasiaMay be extensively denuded",
                    "sub_points": [
                      "May be flattened (attenuated) secondary to increased intracystic pressure",
                      "May exhibit focal squamous metaplasia",
                      "May be extensively denuded"
                    ]
                  },
                  {
                    "text": "Normal (residual) mucus glands often adjacent to cyst"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Mucinous cells: Bland, round to oval, basally located nuclei"
                  },
                  {
                    "text": "Transitional cells: Bland, ovoid to flattened, centrally located nuclei"
                  },
                  {
                    "text": "± reactive epithelial changes"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Mucinous cells: NKX3.1 frequently positive, PSA often positive"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Mucinous (Mucous) Cyst": [
                  {
                    "text": "Most commonly in vulvar vestibule (secondary to cystic dilatation of minor vestibular gland or duct)"
                  },
                  {
                    "text": "Considered of urogenital sinus origin"
                  }
                ],
                "Ciliated Cyst": [
                  {
                    "text": "Cyst partially or completely lined by ciliated (tuboendometrioid) epithelium"
                  },
                  {
                    "text": "Thought to represent ciliated metaplasia of mucinous or Bartholin cyst"
                  }
                ],
                "Paraurethral (Skene) Gland Cyst": [
                  {
                    "text": "Cystic dilatation of paraurethral gland or its ductParaurethral glands are female homologue of male prostate glandPaired glands located on either side of urethral meatusMost commonly secondary to infection with formation of retention cyst",
                    "sub_points": [
                      "Paraurethral glands are female homologue of male prostate gland",
                      "Paired glands located on either side of urethral meatus",
                      "Most commonly secondary to infection with formation of retention cyst"
                    ]
                  },
                  {
                    "text": "May be asymptomatic, cause urinary obstruction, or dyspareunia"
                  },
                  {
                    "text": "Usually < 2 cm"
                  },
                  {
                    "text": "Transitional or squamous epithelium"
                  }
                ],
                "Epidermal Inclusion (Keratinous or Sebaceous) Cyst": [
                  {
                    "text": "Labia majora most common location"
                  },
                  {
                    "text": "White, cheesy/grumous cyst contents (on gross)"
                  },
                  {
                    "text": "Stratified squamous epithelium and keratinaceous debris"
                  }
                ],
                "Mesonephric (Wolffian)-Like Cyst": [
                  {
                    "text": "More common in vagina (Gartner duct cyst)"
                  },
                  {
                    "text": "Presumably arises from mesonephric duct remnants"
                  },
                  {
                    "text": "Often located in lateral aspect of vagina and vulva"
                  },
                  {
                    "text": "Cuboidal to low columnar nonmucinous epithelium"
                  }
                ],
                "Cyst of Canal of Nuck (Mesothelial Cyst)": [
                  {
                    "text": "Most commonly located in superolateral portion of labia majora or inguinal canal"
                  },
                  {
                    "text": "Analogous to spermatic cord hydrocele"
                  },
                  {
                    "text": "Flattened mesothelial cells"
                  },
                  {
                    "text": "Arises from remnant of processus vaginalis peritonei a.k.a. canal of NuckFormed when round ligament passes through inguinal canal and inserts into labium majusNormally obliterates during fetal development but may persist into adulthood",
                    "sub_points": [
                      "Formed when round ligament passes through inguinal canal and inserts into labium majus",
                      "Normally obliterates during fetal development but may persist into adulthood"
                    ]
                  },
                  {
                    "text": "May be associated with inguinal hernia"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Majority of soft tissue tumors often mistaken as Bartholin cyst on clinical examination"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Presence of residual mucinous glands around cyst is clue to diagnosis of Bartholin gland cyst"
                  },
                  {
                    "text": "Location of cyst is essential to correct classification"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lichen Sclerosus": {
            "name": "Lichen Sclerosus",
            "url": "https://app.pathprimer.com/document/56a71752-7a5c-4eb5-a113-d18964b9fba6/lesson/f0725965-42f8-4a7f-aa2d-cf95905178c1",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Chronic pruritic fibrosing dermatosis preferentially affecting anogenital skin and mucosa (postmenopausal)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Variably pruritic"
                  },
                  {
                    "text": "Sharply demarcated \"porcelain white\" to light pink plaques in classic figure of 8 distribution"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Irregularly shaped, white to erythematous plaques"
                  },
                  {
                    "text": "Tissue paper-like appearance"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Early lesionsPsoriasiform epidermal hyperplasia with hyperkeratosisSuperficial dermal band-like chronic inflammationVacuolization of basal epidermal layerLymphocytic exocytosis into lower epidermisPapillary dermal fibrosis",
                    "sub_points": [
                      "Psoriasiform epidermal hyperplasia with hyperkeratosis",
                      "Superficial dermal band-like chronic inflammation",
                      "Vacuolization of basal epidermal layer",
                      "Lymphocytic exocytosis into lower epidermis",
                      "Papillary dermal fibrosis"
                    ]
                  },
                  {
                    "text": "Established lesionsEpidermal atrophy with rete effacementPapillary dermal eosinophilic homogenizationVascular \"drop-out\"Deeper location of chronic inflammatory infiltrate",
                    "sub_points": [
                      "Epidermal atrophy with rete effacement",
                      "Papillary dermal eosinophilic homogenization",
                      "Vascular \"drop-out\"",
                      "Deeper location of chronic inflammatory infiltrate"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p53 wild-type or equivocal staining patterns"
                  },
                  {
                    "text": "p16 negative or patchy positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Vulvar intraepithelial neoplasia, differentiated type, HPV independent"
                  },
                  {
                    "text": "Lichen planus"
                  },
                  {
                    "text": "Late-stage radiation dermatitis"
                  },
                  {
                    "text": "Psoriasis"
                  },
                  {
                    "text": "Scleroderma"
                  },
                  {
                    "text": "Vulvovestibular sclerosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Juvenile vulvar lichen sclerosus (in children)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Chronic pruritic fibrosing dermatosis preferentially affecting anogenital skin and mucosa of postmenopausal women"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Different Proposed Mechanisms": [
                  {
                    "text": "Dysregulation of Sonic Hedgehog receptor may be associated with increased risk of local recurrence in patients with squamous cell carcinoma that arose in background of lichen sclerosus"
                  },
                  {
                    "text": "Hormonal factors (e.g., low estrogen levels)"
                  },
                  {
                    "text": "Autoimmune (± coexistence with other autoimmune diseases)"
                  },
                  {
                    "text": "Genetic factors (familial)"
                  },
                  {
                    "text": "Local factors (e.g., trauma or friction)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Bimodal peak incidence (premenstrual girls and postmenopausal women)"
                  },
                  {
                    "text": "Prevalence: 1:70 to 1:1,000 in women, 1:900 in children"
                  },
                  {
                    "text": "2-3% of women presenting to gynecologist"
                  },
                  {
                    "text": "F:M ratio = 6:1"
                  },
                  {
                    "text": "Higher frequency in patients with morphea, alopecia areata, and pernicious anemia"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically 5th decade but can occur in childhood"
                  }
                ],
                "Site": [
                  {
                    "text": "Anogenital region, extragenital involvement rare (< 10%)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Sharply demarcated \"porcelain white\" to light pink plaques in classic figure of 8 distribution (involving vulva, perineum and perianal skin)Involvement can be more limited",
                    "sub_points": [
                      "Involvement can be more limited"
                    ]
                  },
                  {
                    "text": "Variably pruritic but often painful"
                  },
                  {
                    "text": "± dyspareunia"
                  },
                  {
                    "text": "Skin wrinkling (tissue paper appearance), if longstanding"
                  },
                  {
                    "text": "Follicular plugging, telangiectasias, and purpura with bullae, if late stage"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Lesions seldom resolve completely"
                  },
                  {
                    "text": "If persistent and severe, attenuation of labia minora and clitoral hood with adhesions and urethral stricture may occur"
                  },
                  {
                    "text": "Squamous dysplasia and squamous cell carcinoma, HPV independent (1.6% and 2.2%, respectively) may develop"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Topical corticosteroids, if pruritic"
                  },
                  {
                    "text": "Calcineurin inhibitors as steroid-sparing therapy"
                  },
                  {
                    "text": "Surgery to prevent stricture"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall good outcome, except if malignant transformation (< 5%)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Irregularly shaped, white to erythematous plaques"
                  },
                  {
                    "text": "Tissue paper-like appearance"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Early lesionsPsoriasiform epidermal hyperplasia with hyperkeratosis and hypergranulosisColumnar parakeratosis associated with focal grouping of epidermal dyskeratotic cellsLymphocytes lining basal layer and peppering throughout squamous epitheliumVacuolization of basal layer with scattered dyskeratotic cellsPerivascular lymphocytic infiltrate evolving to band-like distribution\"Wiry fibrosis\" with linear entrapment of lymphocytesThicker vascular wall of dermal capillaries± papillary dermal edema and erythrocyte extravasation",
                    "sub_points": [
                      "Psoriasiform epidermal hyperplasia with hyperkeratosis and hypergranulosis",
                      "Columnar parakeratosis associated with focal grouping of epidermal dyskeratotic cells",
                      "Lymphocytes lining basal layer and peppering throughout squamous epithelium",
                      "Vacuolization of basal layer with scattered dyskeratotic cells",
                      "Perivascular lymphocytic infiltrate evolving to band-like distribution",
                      "\"Wiry fibrosis\" with linear entrapment of lymphocytes",
                      "Thicker vascular wall of dermal capillaries",
                      "± papillary dermal edema and erythrocyte extravasation"
                    ]
                  },
                  {
                    "text": "Established lesionsEpidermal atrophy with rete effacementSquamatization of basal cell layerFollicular pluggingPapillary dermal eosinophilic homogenizationDilation &/or loss of vasculatureDeeper location of chronic inflammatory infiltrate",
                    "sub_points": [
                      "Epidermal atrophy with rete effacement",
                      "Squamatization of basal cell layer",
                      "Follicular plugging",
                      "Papillary dermal eosinophilic homogenization",
                      "Dilation &/or loss of vasculature",
                      "Deeper location of chronic inflammatory infiltrate"
                    ]
                  },
                  {
                    "text": "± non-HPV-related squamous neoplasia (intraepithelial or invasive), HPV independent"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Elastic van Gieson: Decreased elastic fibers in areas of papillary dermal hyalinization"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "p53 either wild-type or equivocal staining patterns"
                  },
                  {
                    "text": "CK17 often positive"
                  },
                  {
                    "text": "p16 negative"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Vulvar Intraepithelial Neoplasia, Differentiated Type, HPV Independent": [
                  {
                    "text": "Prominent atypia of basal epidermal layer"
                  },
                  {
                    "text": "Abnormal epithelial differentiation with cells with abundant brightly eosinophilic cytoplasm common"
                  },
                  {
                    "text": "Diffuse p53 positivity in basal parabasal layers"
                  }
                ],
                "Lichen Planus": [
                  {
                    "text": "Hyperkeratosis and wedge-shaped hypergranulosis with acanthosis with \"saw-tooth\" rete ridges"
                  },
                  {
                    "text": "Civatte/colloid bodies"
                  },
                  {
                    "text": "Lymphocytic lichenoid infiltrate obscuring dermal-epidermal junction with basal layer squamatization"
                  },
                  {
                    "text": "No zone of papillary dermal hyalinization or loss of superficial elastic tissue"
                  }
                ],
                "Late-Stage Radiation Dermatitis": [
                  {
                    "text": "Prior clinical history"
                  },
                  {
                    "text": "Thick-walled blood vessels"
                  },
                  {
                    "text": "Atypical endothelial cells and fibroblasts"
                  },
                  {
                    "text": "Perivascular fibrin deposition"
                  },
                  {
                    "text": "Sclerosis of collagen with admixed elastotic material"
                  }
                ],
                "Psoriasis": [
                  {
                    "text": "Epidermal spongiosis with vesicles"
                  },
                  {
                    "text": "Munro microabscesses"
                  },
                  {
                    "text": "No band-like inflammatory infiltrate (but superficial mixed inflammatory infiltrate)"
                  },
                  {
                    "text": "Lacks dermal homogenization"
                  }
                ],
                "Scleroderma": [
                  {
                    "text": "Generally no \"tissue paper\" atrophy of skin"
                  },
                  {
                    "text": "Thickened collagen bundles typically involve entire reticular dermis with sparing of superficial dermis and epidermis"
                  },
                  {
                    "text": "Spared inflammatory infiltrate typically seen around deep vessels and adnexal structures"
                  }
                ],
                "Vulvovestibular Sclerosis": [
                  {
                    "text": "No abnormalities in other areas of vulva"
                  },
                  {
                    "text": "No basal epidermal alterations (no vacuolization) or lymphocytic infiltrate"
                  }
                ],
                "Mycosis Fungoides": [
                  {
                    "text": "Typical clinical presentation/prior history"
                  },
                  {
                    "text": "Atypical lymphoid infiltrate"
                  }
                ],
                "Vitiligo (Gross Differential Diagnosis)": [
                  {
                    "text": "Whitened area usually flat and symmetrical"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Lichen sclerosus not uncommonly occurs in pediatric population but has similar presentation and histologic features as seen in postmenopausal women"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Follicular involvement may be early histologic manifestations of lichen sclerosus"
                  },
                  {
                    "text": "Close evaluation of basal layer in lichen sclerosus should be undertaken to exclude non-HPV-related vulvar intraepithelial neoplasia, HPV independent, differentiated type (not infrequent association)"
                  },
                  {
                    "text": "p53 may be overexpressed in lichen sclerosus and other inflammatory disorders of vulva; thus, distinction from vulvar intraepithelial neoplasia should include morphologic features"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Vulva and Vagina: Neoplasms": {
        "name": "Vulva and Vagina: Neoplasms",
        "url": "https://app.pathprimer.com/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
        "topics": {
          "Extramammary Paget Disease": {
            "name": "Extramammary Paget Disease",
            "url": "https://app.pathprimer.com/document/141d8db5-d433-4705-9d03-eb85f1f6f5ea/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Intraepidermal adenocarcinoma (primary or secondary) with frequent extension into adnexal structures; rarely invasive"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Often clinically misdiagnosed as inflammatory process (dermatitis)"
                  },
                  {
                    "text": "Moist, red, eczematous-appearing plaque"
                  },
                  {
                    "text": "Worse prognosis if nodules visible, elevated CEA levels, > 1-mm dermal invasion, lymph node metastases, underlying malignancy"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Nests &/or single cells and, less commonly, glands confined to basal and parabasal or higher layersCells with abundant pale cytoplasm and large vesicular nuclei with prominent nucleoliMelanin pigment may be seen occasionally",
                    "sub_points": [
                      "Cells with abundant pale cytoplasm and large vesicular nuclei with prominent nucleoli",
                      "Melanin pigment may be seen occasionally"
                    ]
                  },
                  {
                    "text": "Associated proliferative epidermal lesions in 1/3"
                  },
                  {
                    "text": "Invasive component in up to 48% of primary extramammary Paget disease (EMPD)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Primary and secondary EMPD: CAM5.2, CEA, EMA positive; ER, PR, MART-1/melan-A, tyrosinase, MITF, and HMB-45 negative; rarely S100 positive"
                  },
                  {
                    "text": "Primary: CK7, GCDFP-15, MUC1, MUC5, GATA3 positive"
                  },
                  {
                    "text": "Secondary anorectal: CK20, CDX2, MUC2 positive"
                  },
                  {
                    "text": "Secondary urothelial: CK7, CK20, GATA3, p63, uroplakin-3 positive"
                  },
                  {
                    "text": "Secondary cervical: p16 positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Squamous cell carcinoma"
                  },
                  {
                    "text": "Melanoma"
                  },
                  {
                    "text": "Sebaceous carcinoma"
                  },
                  {
                    "text": "Clear cell papulosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Extramammary Paget disease (EMPD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Primary (85%)Intraepidermal adenocarcinoma with frequent extension into adnexal structures; rarely invasiveNo underlying malignancy",
                    "sub_points": [
                      "Intraepidermal adenocarcinoma with frequent extension into adnexal structures; rarely invasive",
                      "No underlying malignancy"
                    ]
                  },
                  {
                    "text": "Secondary (15%)Intraepidermal adenocarcinoma associated with underlying (extracutaneous) malignancy (anorectal, urinary, cervical)",
                    "sub_points": [
                      "Intraepidermal adenocarcinoma associated with underlying (extracutaneous) malignancy (anorectal, urinary, cervical)"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Theories Regarding Cell of Origin": [
                  {
                    "text": "Pluripotential epidermal or adnexal stem cells"
                  },
                  {
                    "text": "Clear cells of TokerRecently identified as CK7-positive/CK20-negative normal constituent of vulvar, perineal, and perianal skin at ostia/opening of anogenital mammary-like glandsGreater frequency of Toker cells in areas of EMPD",
                    "sub_points": [
                      "Recently identified as CK7-positive/CK20-negative normal constituent of vulvar, perineal, and perianal skin at ostia/opening of anogenital mammary-like glands",
                      "Greater frequency of Toker cells in areas of EMPD"
                    ]
                  },
                  {
                    "text": "Apocrine glands"
                  },
                  {
                    "text": "Anogenital mammary-like glands"
                  }
                ],
                "Molecular findings": [
                  {
                    "text": "PIK3CA (35%), ERBB2 (27%), and TP53 (27%) alterations"
                  },
                  {
                    "text": "Hypermethylation ofCDH1also described"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare (~ 2% of vulvar neoplasms)"
                  },
                  {
                    "text": "Most common vulvar adnexal malignancy (primary EMPD)"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically after 4th decade; peak at ~ 65 years"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Whites"
                  }
                ],
                "Site": [
                  {
                    "text": "Anogenital skin"
                  },
                  {
                    "text": "Labia majora > labia minora > clitoris"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Moist, red, eczematous-appearing plaque(s)Raised white areas of hyperkeratosis on erythematous background resulting in characteristic cake-icing or strawberries and cream appearance",
                    "sub_points": [
                      "Raised white areas of hyperkeratosis on erythematous background resulting in characteristic cake-icing or strawberries and cream appearance"
                    ]
                  },
                  {
                    "text": "Often pruritic"
                  },
                  {
                    "text": "Rarely hyperpigmented or hypopigmented"
                  },
                  {
                    "text": "May be ulcerated"
                  },
                  {
                    "text": "May mimic inflammatory process (dermatitis), seborrheic keratosis, pigmented condyloma, or pigmented vulvar intraepithelial neoplasia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Wide local excision"
                  },
                  {
                    "text": "Lymph node dissection, if invasive component > 1 mm"
                  },
                  {
                    "text": "Surgical treatment challenging due toMisleading visual assessment of margins, ~ 30% of grossly negative margins will be pathologically positiveCommon deceptive appearance on frozen sectionMargin status not predictive of recurrence, as tumor commonly multifocal (skip lesions)",
                    "sub_points": [
                      "Misleading visual assessment of margins, ~ 30% of grossly negative margins will be pathologically positive",
                      "Common deceptive appearance on frozen section",
                      "Margin status not predictive of recurrence, as tumor commonly multifocal (skip lesions)"
                    ]
                  },
                  {
                    "text": "Topical bleomycin, 5-fluorouracil, carbon dioxide laser, imiquimod, or systemic retinoids if recurrent in situ disease"
                  },
                  {
                    "text": "Treatment of underlying malignancy if secondary EMPD"
                  },
                  {
                    "text": "Distant metastatic disease treated by multiple chemotherapy agents and targeted therapy based on next-generation sequencing (e.g., against HER2/neu amplification,TP53andPIK3CAmutations)"
                  },
                  {
                    "text": "Mohs micrographic surgery may be associated with lower recurrence risk (limited experience)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Favorable outcome if localized and noninvasive (~ 80% cases)"
                  },
                  {
                    "text": "Disease-specific survival for microinvasive (≤ 1 mm) similar to noninvasive disease (88-100%)"
                  },
                  {
                    "text": "Factors associated with worse prognosisNodules on clinical examinationElevated CEA levelsDermal invasion (> 1 mm)Lymph node metastases (66% mortality)Underlying malignancy (secondary EMPD)",
                    "sub_points": [
                      "Nodules on clinical examination",
                      "Elevated CEA levels",
                      "Dermal invasion (> 1 mm)",
                      "Lymph node metastases (66% mortality)",
                      "Underlying malignancy (secondary EMPD)"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Often ill-defined, raised red scaly plaque(s)"
                  }
                ],
                "Size": [
                  {
                    "text": "Few mm to cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Nests &/or single cells and, less commonly, glands confined to basal or parabasal layers of squamous epithelium"
                  },
                  {
                    "text": "± extension to upper layers of squamous epithelium may occur"
                  },
                  {
                    "text": "Preserved but compressed, basal keratinocytes"
                  },
                  {
                    "text": "± acantholysis"
                  },
                  {
                    "text": "± adnexal extension, most commonly hair follicles and eccrine ducts"
                  },
                  {
                    "text": "Associated proliferative epidermal lesions (in 1/3)Squamous hyperplasiaFibroepithelioma-like hyperplasiaPapillomatous hyperplasia",
                    "sub_points": [
                      "Squamous hyperplasia",
                      "Fibroepithelioma-like hyperplasia",
                      "Papillomatous hyperplasia"
                    ]
                  },
                  {
                    "text": "Invasive componentSingle cells within upper dermis (most common) often obscured by dense chronic inflammatory infiltrateConfluent nests and glands (rare)",
                    "sub_points": [
                      "Single cells within upper dermis (most common) often obscured by dense chronic inflammatory infiltrate",
                      "Confluent nests and glands (rare)"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Abundant pale cytoplasm and large vesicular nuclei with prominent nucleoli"
                  },
                  {
                    "text": "Intracytoplasmic vacuoles and compressed nuclei"
                  },
                  {
                    "text": "Melanin pigment may be seen occasionally (due to transfer of pigment from melanocytes)"
                  },
                  {
                    "text": "Variable mitotic activity but often low"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Primary and secondary EMPDCAM5.2, CEA, EMA positiveER and PR negativeS100 rarely positiveMART-1/melan-A, tyrosinase, MITF, and HMB-45 negativeRarely aberrant expression of melan-A",
                    "sub_points": [
                      "CAM5.2, CEA, EMA positive",
                      "ER and PR negative",
                      "S100 rarely positive",
                      "MART-1/melan-A, tyrosinase, MITF, and HMB-45 negativeRarely aberrant expression of melan-A",
                      "Rarely aberrant expression of melan-A"
                    ]
                  },
                  {
                    "text": "Primary EMPDCK7, GCDFP-15, GATA3, MUC1, MUC5 positiveAndrogen receptor positive (50%)± CDX2CK20, MUC2 negative",
                    "sub_points": [
                      "CK7, GCDFP-15, GATA3, MUC1, MUC5 positive",
                      "Androgen receptor positive (50%)",
                      "± CDX2",
                      "CK20, MUC2 negative"
                    ]
                  },
                  {
                    "text": "Secondary EMPD, anorectalCK20, CDX2, MUC2 positiveCK7, MUC1, and GCDFP-15 negative",
                    "sub_points": [
                      "CK20, CDX2, MUC2 positive",
                      "CK7, MUC1, and GCDFP-15 negative"
                    ]
                  },
                  {
                    "text": "Secondary EMPD, urothelialCK7, CK20, GATA3, p63, and uroplakin-3 positiveGCDFP-15 negative",
                    "sub_points": [
                      "CK7, CK20, GATA3, p63, and uroplakin-3 positive",
                      "GCDFP-15 negative"
                    ]
                  },
                  {
                    "text": "Secondary EMPD, cervicalp16 positiveGCDFP-15, ER negative",
                    "sub_points": [
                      "p16 positive",
                      "GCDFP-15, ER negative"
                    ]
                  },
                  {
                    "text": "Staining profiles associated with aggressive behaviorLoss of MUC5AC in primary EMPDHER2 neu overexpression (30-50% of primary EMPD)D2-40 expression (related to increased lymphangiogenesis)",
                    "sub_points": [
                      "Loss of MUC5AC in primary EMPD",
                      "HER2 neu overexpression (30-50% of primary EMPD)",
                      "D2-40 expression (related to increased lymphangiogenesis)"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "In Situ and Invasive Squamous Cell Carcinoma With Intraepidermal Spread": [
                  {
                    "text": "No glandular differentiation or intracytoplasmic mucin"
                  },
                  {
                    "text": "CEA and GCDFP-15 negative; CK5/6, CK34βE12 positive"
                  }
                ],
                "Superficial Spreading Melanoma and Melanoma In Situ": [
                  {
                    "text": "Involvement of basal layer of epidermis without compression of basal keratinocytes"
                  },
                  {
                    "text": "MART-1/melan-A, tyrosinase, MITF, &/or HMB-45 positive"
                  },
                  {
                    "text": "Keratin, EMA, GCDFP-15 negative"
                  }
                ],
                "Sebaceous Carcinoma": [
                  {
                    "text": "Often prominent, infiltrative dermal component"
                  },
                  {
                    "text": "Cells with multiple cytoplasmic vacuoles and indentation of hyperchromatic nuclei (due to lipid)"
                  },
                  {
                    "text": "Lacks CEA, GCDFP-15 expression"
                  },
                  {
                    "text": "Positive for adipophilin and perilipin"
                  }
                ],
                "Clear Cell Papulosis": [
                  {
                    "text": "Typically young children"
                  },
                  {
                    "text": "No cytologic atypia or mitoses"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "As often confused with inflammatory process, there can be median of 2 years in delay of diagnosis"
                  },
                  {
                    "text": "Oozing, crusted, steroid-resistant, &/or growing plaques/nodules on vulva should prompt biopsyClose follow-up essential with low threshold for biopsy of any suspicious area",
                    "sub_points": [
                      "Close follow-up essential with low threshold for biopsy of any suspicious area"
                    ]
                  },
                  {
                    "text": "Location may be hint to originVulvar-based favors cutaneous originPerianal-based favors anorectal originVestibular and periurethral locations favor urothelial origin",
                    "sub_points": [
                      "Vulvar-based favors cutaneous origin",
                      "Perianal-based favors anorectal origin",
                      "Vestibular and periurethral locations favor urothelial origin"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Adnexal extension should not be confused with invasive disease; levels may be helpful in this distinction"
                  },
                  {
                    "text": "Immunohistochemistry often required, as routine histologic findings alone insufficient to distinguish primary from secondary EMPD"
                  },
                  {
                    "text": "Finding of melanin within neoplastic cells in epidermis does not exclude EMPDAs aberrant expression of melan-A has been reported, > 1 melanocytic marker is recommended",
                    "sub_points": [
                      "As aberrant expression of melan-A has been reported, > 1 melanocytic marker is recommended"
                    ]
                  },
                  {
                    "text": "Primary (cutaneous) EMPD typically CK7 positive/CK20 negative, and secondary EMPD typically CK7 negative/CK20 positive (except if urothelial)If both markers negative, other entities should be considered, including melanoma",
                    "sub_points": [
                      "If both markers negative, other entities should be considered, including melanoma"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Granular Cell Tumor": {
            "name": "Granular Cell Tumor",
            "url": "https://app.pathprimer.com/document/b764f30f-0629-4ec3-9b40-e8e012295d5b/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Neoplasm with neuroectodermal differentiation composed of epithelioid to polygonal cells with abundant eosinophilic and granular cytoplasm"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "5-15% of granular cell tumors"
                  },
                  {
                    "text": "May be multifocal within vulva or coexisting with other locations (Noonan syndrome)"
                  },
                  {
                    "text": "Solitary, mobile, slow-growing, nontender nodule"
                  },
                  {
                    "text": "Labium major most common site"
                  },
                  {
                    "text": "Uncommon local recurrences (2-5%) and rare malignant behavior (1-2%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Nonencapsulated but often well-defined subcutaneous or dermal < 5-cm nodule with white and firm cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Pushing, nodular, or infiltrative growth"
                  },
                  {
                    "text": "Diffuse, nested, or corded growth of polygonal cells"
                  },
                  {
                    "text": "Abundant granular cytoplasm with PAS-D-resistant bodies"
                  },
                  {
                    "text": "Associated pseudoepitheliomatous hyperplasia ~ 30%"
                  },
                  {
                    "text": "Malignant if ≥ 3 of following features: Necrosis, cell spindling, vesicular nuclei with large nucleoli, > 2 mitoses/10 HPF at 200x, high nuclear:cytoplasmic ratio, and pleomorphism"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "S100, SOX10, nestin, calretinin, and inhibin positive"
                  },
                  {
                    "text": "NSE, CD68, CD63, CD56, TFF3, and MITF often positive"
                  },
                  {
                    "text": "Loss-of-function mutations in ATP6AP1 or ATP6AP2"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Squamous cell carcinoma (if superficial biopsy)"
                  },
                  {
                    "text": "Smooth muscle tumor with granular change"
                  },
                  {
                    "text": "Reactive changes with abundant histiocytes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Granular cell tumor (GCT)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Granular cell myoblastoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Neoplasm with neuroectodermal differentiation composed of epithelioid to polygonal cells with abundant eosinophilic, granular cytoplasm, with low risk of recurrence"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 10% of GCTs"
                  },
                  {
                    "text": "May be multifocal within vulva or coexisting with other locations (Noonan syndrome)"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 52 (range: 6-76) years"
                  }
                ],
                "Site": [
                  {
                    "text": "Vulva > > > > vagina, cervix, ovary"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Solitary, mobile, slow-growing, nontender noduleLabium majus > > clitoris or mon pubis",
                    "sub_points": [
                      "Labium majus > > clitoris or mon pubis"
                    ]
                  },
                  {
                    "text": "Pruritus and pain if symptomatic"
                  },
                  {
                    "text": "10-15% multifocal"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Local excision with negative margins to avoid recurrence"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent outcome for most patients"
                  },
                  {
                    "text": "2-5% local recurrences and 1-2% malignant behavior"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Nonencapsulated but often well-defined, subcutaneous or dermal nodule"
                  },
                  {
                    "text": "White, firm cut surface with rare ulceration"
                  }
                ],
                "Size": [
                  {
                    "text": "Generally < 5 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Pushing, nodular, or infiltrative margins"
                  },
                  {
                    "text": "Diffuse, nested, or corded patterns of loosely cohesive cells"
                  },
                  {
                    "text": "Collagen bands often present between nests"
                  },
                  {
                    "text": "Entrapment of adnexal structures (if in labium major)"
                  },
                  {
                    "text": "Common perineural involvement"
                  },
                  {
                    "text": "Associated epidermal hyperplasia; striking, pseudoepitheliomatous hyperplasia in ~ 30%"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Polygonal to spindle (latter if malignant) cells"
                  },
                  {
                    "text": "Abundant granular cytoplasm with PAS-D-resistant bodies (phagolysosomes)"
                  },
                  {
                    "text": "Small, dark (benign) to vesicular nuclei with nucleoli (malignant)"
                  },
                  {
                    "text": "Malignant if ≥ 3 of following features: Necrosis, cell spindling, vesicular nuclei with large nucleoli, > 2 mitoses/10 HPF at 200x, high nuclear:cytoplasmic ratio, and pleomorphismIf 1-2 features: Atypical GCT",
                    "sub_points": [
                      "If 1-2 features: Atypical GCT"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "S100, SOX10, nestin, calretinin, and inhibin positive"
                  },
                  {
                    "text": "NSE, CD68, CD63, CD56, TFF3, and MITF often positive; HMB-45 negative"
                  },
                  {
                    "text": "p53 expression > 10% of cells if malignant"
                  },
                  {
                    "text": "Ki-67 positive < 1% of cells; but often in > 30% if malignant"
                  },
                  {
                    "text": "Neurofilaments, GFAP, desmin negative"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Intracellular granules containing myelin figures and fragmented rough endoplasmic reticulum"
                  }
                ],
                "Molecular Findings": [
                  {
                    "text": "Loss-of-function mutations in ATP6AP1 or ATP6AP2"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Squamous Cell Carcinoma (If Superficial Biopsy)": [
                  {
                    "text": "Lack of maturation of squamous epithelium ± koilocytosis"
                  },
                  {
                    "text": "Greater degree of nuclear pleomorphism"
                  },
                  {
                    "text": "Brisk mitoses, including atypical forms"
                  }
                ],
                "Smooth Muscle Tumor With Granular Change": [
                  {
                    "text": "Fascicles or sheets (if epithelioid) of cohesive cells without intervening collagenous stroma"
                  },
                  {
                    "text": "May have myxoid background"
                  },
                  {
                    "text": "Desmin and caldesmon positive"
                  }
                ],
                "Reactive Changes With Abundant Histiocytes": [
                  {
                    "text": "History of infection, trauma, or cesarean section"
                  },
                  {
                    "text": "Foamy macrophages admixed with inflammatory cells"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Before making diagnosis of invasive squamous cell carcinoma, consider pseudoepitheliomatous hyperplasia associated with underlying GCT"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Vulvar Intraepithelial Neoplasia": {
            "name": "Vulvar Intraepithelial Neoplasia",
            "url": "https://app.pathprimer.com/document/6d9143d7-fd2d-4014-953c-8128277c2b55/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Squamous cell precursor lesion showing abnormalities in maturation driven by either HPV infection, p53, or other mechanismHPV-associated vulvar intraepithelial neoplasia (VIN)HPV-independent VIN, p53 aberrant or p53 wild type",
                    "sub_points": [
                      "HPV-associated vulvar intraepithelial neoplasia (VIN)",
                      "HPV-independent VIN, p53 aberrant or p53 wild type"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "HPV associated > > HPV independent, p53 mutated > > HPV independent, p53 wild type"
                  },
                  {
                    "text": "HPV associated: 4th-5th decades vs. HPV independent 7th-8th decades"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "HPV associatedLoss of maturation (with common crowding) of cells within epidermisAtypical parakeratosis ± koilocytotic atypia (typically in warty type)Nuclear enlargement with hyperchromasia and multinucleationBrisk mitotic activity often with abnormal forms and apoptoses",
                    "sub_points": [
                      "Loss of maturation (with common crowding) of cells within epidermis",
                      "Atypical parakeratosis ± koilocytotic atypia (typically in warty type)",
                      "Nuclear enlargement with hyperchromasia and multinucleation",
                      "Brisk mitotic activity often with abnormal forms and apoptoses"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant typeProminent parakeratosisAtrophic or acanthotic epidermis with elongation and anastomosis of rete ridgesProminent basal ± parabasal cytologic atypia with upward maturationEnlarged, hypereosinophilic keratinocytes with prominent intercellular bridgesPremature keratinization with squamous eddies and keratin pearls",
                    "sub_points": [
                      "Prominent parakeratosis",
                      "Atrophic or acanthotic epidermis with elongation and anastomosis of rete ridges",
                      "Prominent basal ± parabasal cytologic atypia with upward maturation",
                      "Enlarged, hypereosinophilic keratinocytes with prominent intercellular bridges",
                      "Premature keratinization with squamous eddies and keratin pearls"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typeAcanthotic &/or verruciform architectureRetained maturation with altered squamous differentiation (parakeratosis, hypogranulosis, cytoplasmic pallor)No cytologic atypia, rare mitoses confined to basal and parabasal layers",
                    "sub_points": [
                      "Acanthotic &/or verruciform architecture",
                      "Retained maturation with altered squamous differentiation (parakeratosis, hypogranulosis, cytoplasmic pallor)",
                      "No cytologic atypia, rare mitoses confined to basal and parabasal layers"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "HPV associated: p16 block staining"
                  },
                  {
                    "text": "HPV independent: p53-mutant or wild-type pattern"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "HPV-associated vulvar intraepithelial neoplasia (VIN)"
                  },
                  {
                    "text": "HPV-independent VINp53 mutantp53 wild type",
                    "sub_points": [
                      "p53 mutant",
                      "p53 wild type"
                    ]
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Other terminology (accepted by WHO)/new recommended terminologyUsual-type VIN/HPV-associated VINDifferentiated-type VIN/HPV-independent VIN, p53 aberrantDifferentiated exophytic vulvar intraepithelial lesion, vulvar acanthosis with altered differentiation, vulvar-altered maturation/HPV independent, p53 wild type",
                    "sub_points": [
                      "Usual-type VIN/HPV-associated VIN",
                      "Differentiated-type VIN/HPV-independent VIN, p53 aberrant",
                      "Differentiated exophytic vulvar intraepithelial lesion, vulvar acanthosis with altered differentiation, vulvar-altered maturation/HPV independent, p53 wild type"
                    ]
                  },
                  {
                    "text": "Other terminology (not recommended by WHO)Mild, moderate, and severe dysplasia; carcinoma in situ; Bowenoid papulosis; Bowen disease; vulva carcinoma in situ, usual type",
                    "sub_points": [
                      "Mild, moderate, and severe dysplasia; carcinoma in situ; Bowenoid papulosis; Bowen disease; vulva carcinoma in situ, usual type"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Squamous cell precursor lesion showing abnormalities in maturation driven by either HPV infection, p53, or other mechanism"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "HPV Associated": [
                  {
                    "text": "High-risk HPV"
                  }
                ],
                "HPV Independent, p53 Mutant Type": [
                  {
                    "text": "Association with inflammatory lesions [lichen sclerosus (LS) and lichen planus (LP)]"
                  }
                ],
                "HPV Independent, p53 Wild Type": [
                  {
                    "text": "HRASmutations, among others"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "HPV associated > > HPV independent, p53 mutant > > HPV independent, p53 wild type"
                  },
                  {
                    "text": "HPV associated more common in smokers or immunocompromised"
                  },
                  {
                    "text": "HPV independent, p53 mutant: ~ 10%"
                  },
                  {
                    "text": "HPV independent, p53 wild type: Uncertain"
                  }
                ],
                "Age": [
                  {
                    "text": "HPV associated: Commonly 4th-5th decades"
                  },
                  {
                    "text": "HPV independent, p53 mutant and wild types: Typically 7th-8th decades"
                  }
                ],
                "Presentation": [
                  {
                    "text": "HPV associatedPruritus common; asymptomatic 20%Pain, dyspareunia, and sexual dysfunction (particularly if in fourchette or multifocal)",
                    "sub_points": [
                      "Pruritus common; asymptomatic 20%",
                      "Pain, dyspareunia, and sexual dysfunction (particularly if in fourchette or multifocal)"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant typeLong history of itching, burning due to associated inflammatory processOften incidental finding2-5% progression from LS or LP",
                    "sub_points": [
                      "Long history of itching, burning due to associated inflammatory process",
                      "Often incidental finding",
                      "2-5% progression from LS or LP"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typeRaised, white or erythematous lesion with irregular cauliflower-like or plaque-like exophytic surfacePruritus or pain less common",
                    "sub_points": [
                      "Raised, white or erythematous lesion with irregular cauliflower-like or plaque-like exophytic surface",
                      "Pruritus or pain less common"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "American College of Obstetrics and Gynecology recommendationsChemical or surgical ablation/excision",
                    "sub_points": [
                      "Chemical or surgical ablation/excision"
                    ]
                  },
                  {
                    "text": "HPV vaccine optional"
                  },
                  {
                    "text": "Other modalitiesImmunomodulatory drugs, retinoids, 5-FUSmoking cessationWithdrawal of systemic corticosteroids (if applicable)",
                    "sub_points": [
                      "Immunomodulatory drugs, retinoids, 5-FU",
                      "Smoking cessation",
                      "Withdrawal of systemic corticosteroids (if applicable)"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "HPV associatedMay regress spontaneously~ 15% recurrence rate despite negative margins3-9% rate of progression to squamous cell carcinoma (median: 41 months)",
                    "sub_points": [
                      "May regress spontaneously",
                      "~ 15% recurrence rate despite negative margins",
                      "3-9% rate of progression to squamous cell carcinoma (median: 41 months)"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant type> 80% progression to squamous cell carcinoma (median: 22.8 months)",
                    "sub_points": [
                      "> 80% progression to squamous cell carcinoma (median: 22.8 months)"
                    ]
                  },
                  {
                    "text": "Both HPV associated and HPV independent; p53 mutant type worse prognosis ifImmunocompromised state (e.g., HIV positive)Current smoking historyAge > 40 yearsHistory of other lower genital tract neoplasia (e.g., cervical, vaginal, anal)Proximity to squamocolumnar junction of anal vergeDelay in diagnosis",
                    "sub_points": [
                      "Immunocompromised state (e.g., HIV positive)",
                      "Current smoking history",
                      "Age > 40 years",
                      "History of other lower genital tract neoplasia (e.g., cervical, vaginal, anal)",
                      "Proximity to squamocolumnar junction of anal verge",
                      "Delay in diagnosis"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typeExcellent if completely excisedRisk of coexisting or subsequent squamous cell carcinoma",
                    "sub_points": [
                      "Excellent if completely excised",
                      "Risk of coexisting or subsequent squamous cell carcinoma"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "HPV associatedMultifocal (over 50%)White, erythematous, or hyperpigmented, flat or raised (papules and plaques), may coalesce",
                    "sub_points": [
                      "Multifocal (over 50%)",
                      "White, erythematous, or hyperpigmented, flat or raised (papules and plaques), may coalesce"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant typeUsually solitary, raised or flatSymmetrical or irregular borders with flesh coloredHypopigmented papules and plaquesUlceration not uncommonOften in background of LS and, less commonly, LP",
                    "sub_points": [
                      "Usually solitary, raised or flat",
                      "Symmetrical or irregular borders with flesh colored",
                      "Hypopigmented papules and plaques",
                      "Ulceration not uncommon",
                      "Often in background of LS and, less commonly, LP"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typeTypically solitaryVerruciform growth or thick plaque",
                    "sub_points": [
                      "Typically solitary",
                      "Verruciform growth or thick plaque"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "HPV associatedLoss of maturation (with common crowding) of cells within epidermisOften full- or near full-thickness epithelial involvement2 main patternsBasaloid: Small cells with high nuclear:cytoplasmic ratioWarty: Epithelial thickening and common papillomatosisAtypical parakeratosis ± koilocytotic atypia (typically in warty type)Nuclear enlargement with hyperchromasia and multinucleationBrisk mitotic activity above basal layer often with abnormal forms and apoptosesExtension into adnexae common; ± pagetoid spreadMucinous differentiation (rare)± melanin pigment within keratinocytes± vulvar condyloma &/or cervical HPV-related lesions",
                    "sub_points": [
                      "Loss of maturation (with common crowding) of cells within epidermisOften full- or near full-thickness epithelial involvement",
                      "Often full- or near full-thickness epithelial involvement",
                      "2 main patternsBasaloid: Small cells with high nuclear:cytoplasmic ratioWarty: Epithelial thickening and common papillomatosis",
                      "Basaloid: Small cells with high nuclear:cytoplasmic ratio",
                      "Warty: Epithelial thickening and common papillomatosis",
                      "Atypical parakeratosis ± koilocytotic atypia (typically in warty type)",
                      "Nuclear enlargement with hyperchromasia and multinucleation",
                      "Brisk mitotic activity above basal layer often with abnormal forms and apoptoses",
                      "Extension into adnexae common; ± pagetoid spread",
                      "Mucinous differentiation (rare)",
                      "± melanin pigment within keratinocytes",
                      "± vulvar condyloma &/or cervical HPV-related lesions"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant typeProminent parakeratosisAtrophic or acanthotic epidermis with elongation and anastomosis of rete ridgesProminent basal ± parabasal cytologic atypia with upward maturationLarge vesicular nuclei with prominent nucleoli ± hyperchromasiaMitoses ± atypical formsEnlarged, hypereosinophilic keratinocytes with prominent intercellular bridgesPremature keratinization with squamous eddies and keratin pearlsAcantholysis and spongiosis commonExtension to adnexal structures rare± LS; rarely, LP or squamous hyperplasiaRarely, basaloid or warty morphology (mimics HPV associated)",
                    "sub_points": [
                      "Prominent parakeratosis",
                      "Atrophic or acanthotic epidermis with elongation and anastomosis of rete ridges",
                      "Prominent basal ± parabasal cytologic atypia with upward maturationLarge vesicular nuclei with prominent nucleoli ± hyperchromasiaMitoses ± atypical forms",
                      "Large vesicular nuclei with prominent nucleoli ± hyperchromasia",
                      "Mitoses ± atypical forms",
                      "Enlarged, hypereosinophilic keratinocytes with prominent intercellular bridges",
                      "Premature keratinization with squamous eddies and keratin pearls",
                      "Acantholysis and spongiosis common",
                      "Extension to adnexal structures rare",
                      "± LS; rarely, LP or squamous hyperplasia",
                      "Rarely, basaloid or warty morphology (mimics HPV associated)"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typeAcanthotic &/or verruciform architectureRetained maturation with altered squamous differentiationHyper- and parakeratosisPartial or complete hypogranulosis or, rarely, hypergranulosisCytoplasmic pallor in mid- and superficial layersNo cytologic atypia; rare mitoses confined to basal and parabasal layers",
                    "sub_points": [
                      "Acanthotic &/or verruciform architecture",
                      "Retained maturation with altered squamous differentiationHyper- and parakeratosisPartial or complete hypogranulosis or, rarely, hypergranulosisCytoplasmic pallor in mid- and superficial layers",
                      "Hyper- and parakeratosis",
                      "Partial or complete hypogranulosis or, rarely, hypergranulosis",
                      "Cytoplasmic pallor in mid- and superficial layers",
                      "No cytologic atypia; rare mitoses confined to basal and parabasal layers"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "HPV associatedp16 block and strong positivityKi-67 positive in upper layersp53 typically wild type (with exceptions)",
                    "sub_points": [
                      "p16 block and strong positivity",
                      "Ki-67 positive in upper layers",
                      "p53 typically wild type (with exceptions)"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 mutant typep53-mutant pattern (overexpression in basal ± parabasal cells, null or cytoplasmic)p16 typically negative (with exceptions if superimposed HPV)",
                    "sub_points": [
                      "p53-mutant pattern (overexpression in basal ± parabasal cells, null or cytoplasmic)",
                      "p16 typically negative (with exceptions if superimposed HPV)"
                    ]
                  },
                  {
                    "text": "HPV independent, p53 wild typep16 negative or patchy, p53 wild type",
                    "sub_points": [
                      "p16 negative or patchy, p53 wild type"
                    ]
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "HPV associated: High-risk HPV types"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Condyloma (vs. HPV Associated)": [
                  {
                    "text": "Koilocytotic atypia confined to upper layers with maturation"
                  },
                  {
                    "text": "Lacks block positive p16"
                  },
                  {
                    "text": "Low proliferative Ki-67 index"
                  }
                ],
                "Early Invasive Squamous Cell Carcinoma (vs. HPV Associated)": [
                  {
                    "text": "Disruption of dermal-epidermal junction with detached nests with paradoxical maturation"
                  },
                  {
                    "text": "Desmoplastic stromal reaction"
                  }
                ],
                "Sebaceous Carcinoma (vs. HPV Associated)": [
                  {
                    "text": "Vacuolated cytoplasm at least focally"
                  },
                  {
                    "text": "AR and adipophilin positive"
                  }
                ],
                "Multinucleated Atypia (vs. HPV Associated)": [
                  {
                    "text": "Multinucleated cells limited to lower epidermis"
                  },
                  {
                    "text": "No HPV-related cytologic features"
                  }
                ],
                "Paget Disease (vs. HPV Associated)": [
                  {
                    "text": "Atypical intraepidermal cells, some forming nests or acini, with abundant pale cytoplasm"
                  },
                  {
                    "text": "CEA, GCDFP-15, TRPS1, GATA3 positive"
                  }
                ],
                "Lichen Simplex Chronicus (vs. HPV Independent, p53 Mutant and Wild Types)": [
                  {
                    "text": "Thickened scaly skin without verrucous growth in younger patients (if differential p53 wild type)"
                  },
                  {
                    "text": "Lacks prominent basal atypia or features of aberrant maturation (if differential p53 mutant)"
                  },
                  {
                    "text": "p53 wild type (if differential p53 mutant)"
                  }
                ],
                "Lichen Sclerosus (vs. HPV Independent, p53 Mutant)": [
                  {
                    "text": "Vacuolization of basal epidermal layer"
                  },
                  {
                    "text": "If wild-type p53 pattern, helpful"
                  }
                ],
                "Pseudoepitheliomatous Hyperplasia (vs. HPV Independent, p53 Mutant and Wild Types)": [
                  {
                    "text": "± associated ulcer or underlying (granular cell) tumor"
                  },
                  {
                    "text": "Maturation of epidermis maintained (including preservation of granular layer)"
                  },
                  {
                    "text": "Mild focal atypia limited to lower epidermis"
                  }
                ],
                "Hypertrophic Lichen Planus (vs. HPV Independent, p53 Mutant Type)": [
                  {
                    "text": "Associated with extragenital lesions (e.g., oral mucosa, medial wrists, areas of trauma/koebnerization)"
                  },
                  {
                    "text": "Accentuation of granular layer (often wedge-shaped)"
                  },
                  {
                    "text": "Sawtooth pattern in lower epidermis (i.e., jagged and pointy)"
                  },
                  {
                    "text": "Dyskeratotic cells and hydropic change along dermal-epidermal junction"
                  },
                  {
                    "text": "Acantholysis or spongiosis absent"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Presence of LS should prompt careful surveillance (lifetime) for HPV-independent, p53-mutant VIN"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Tangential sectioning of HPV-associated VIN involving skin appendages should not be overinterpreted as invasion"
                  },
                  {
                    "text": "HPV-associated low-grade VIN other than condyloma is exceedingly rare; thus, consider possibility of HPV-independent, p53-mutated VIN"
                  },
                  {
                    "text": "Rare morphologic overlap between HPV-associated and -independent VIN; thus, use of p16, HPV ISH/PCR, and p53 helpful"
                  },
                  {
                    "text": "Nonspecific dermatosis may mimic HPV-independent, p53-mutant VIN; thus, criteria for establishing diagnosis should be strict"
                  },
                  {
                    "text": "HPV-associated VIN with superimposed lichen simplex chronicus can show parabasal staining for p53 and should not be misinterpreted as HPV-independent, p53-mutant VIN; diffuse p16 stain will help distinguish between these entities"
                  },
                  {
                    "text": "If markedly atypical basal layer, p53 wild-type staining favors nonneoplastic process, but do not confuse lack of staining as reassuring"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Clear Cell Carcinoma": {
            "name": "Clear Cell Carcinoma",
            "url": "https://app.pathprimer.com/document/fc7cfecd-d8a3-4506-9fb4-afd624a05826/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Müllerian-type adenocarcinoma characterized by tubulocystic, solid, and papillary growths ± clear or hobnail cells"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "In utero exposure to diethylstilbestrol (DES) (to prevent early pregnancy loss in 1950-1960s)Associated with extensive adenosis of upper vagina (presumed precursor)",
                    "sub_points": [
                      "Associated with extensive adenosis of upper vagina (presumed precursor)"
                    ]
                  },
                  {
                    "text": "No DES exposure in older women (instead association with adenosis or endometriosis)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare; if exposed to DES, absolute risk 1:1,000 (but overall incidence decreasing)"
                  },
                  {
                    "text": "2 peaks: Children/young (majority) (DES related) or postmenopausal"
                  },
                  {
                    "text": "Anterior wall, upper 1/3 of vagina"
                  },
                  {
                    "text": "Vaginal bleeding or discharge, hypercalcemia, abnormal Papanicolaou smear"
                  },
                  {
                    "text": "Stage most important prognostic factor"
                  },
                  {
                    "text": "More favorable outcome if DES related"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tubulocystic > > papillary, solid, or mixed patterns"
                  },
                  {
                    "text": "Moderate to marked nuclear atypia"
                  },
                  {
                    "text": "Mitotic activity usually < 10/10 HPF"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, EMA, PAX8, napsin A, HNF-1-β (+)"
                  },
                  {
                    "text": "PAX2 and CA125 often (+)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Atypical adenosis"
                  },
                  {
                    "text": "Arias-Stella reaction in adenosis or endometriosis"
                  },
                  {
                    "text": "Gastric-type adenocarcinoma"
                  },
                  {
                    "text": "Metastatic clear cell carcinoma (endometrium/kidney)"
                  },
                  {
                    "text": "Yolk sac tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Müllerian-type adenocarcinoma characterized by tubulocystic, solid, papillary growths ± clear or hobnail cells"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "In utero exposure to diethylstilbestrol (DES) (to prevent early pregnancy loss in 1950-1960s) in most children/young women with clear cell carcinoma"
                  },
                  {
                    "text": "DES exposure associated with extensive adenosis of upper vagina (presumed precursor of some clear cell carcinoma)"
                  },
                  {
                    "text": "No history of DES exposure in older women, instead association with adenosis or endometriosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare; if exposed to DES, absolute risk 1:1,000 (but overall incidence decreasing)"
                  },
                  {
                    "text": "2 peaks: Children/young (majority); postmenopausal (DES unrelated)"
                  }
                ],
                "Site": [
                  {
                    "text": "Anterior wall, upper 1/3 of vagina"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Vaginal bleeding or discharge"
                  },
                  {
                    "text": "Abnormal Papanicolaou smear"
                  },
                  {
                    "text": "Hypercalcemia"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Propensity for early (non-DES) or late (DES) recurrences and metastases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery (if adolescents/young) or chemoradiation (if older)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Stage most important prognostic factor> 90% survival for stage I tumors vs. ~ 30% if metastatic",
                    "sub_points": [
                      "> 90% survival for stage I tumors vs. ~ 30% if metastatic"
                    ]
                  },
                  {
                    "text": "Recurrence rate: ~ 25% within 3 years of diagnosis"
                  },
                  {
                    "text": "More favorable outcome if DES related"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Polypoid or flat ± ulcerated; ≤ 10 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Tubulocystic > > papillary, solid, or mixed patterns"
                  },
                  {
                    "text": "Hyaline globules and psammoma bodies may be seen"
                  },
                  {
                    "text": "May be associated with adenosis or endometriosis"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Clear or eosinophilic cytoplasm &/or hobnail cells"
                  },
                  {
                    "text": "Moderate to marked nuclear atypia"
                  },
                  {
                    "text": "Mitotic activity usually < 10/10 HPF"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7, EMA, PAX8, napsin A, HNF-1-β (+); PAX2, CA125 often (+)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Atypical Adenosis": [
                  {
                    "text": "Lacks severe atypia and stromal invasion"
                  }
                ],
                "Arias-Stella Reaction in Adenosis or Endometriosis": [
                  {
                    "text": "Preserved architecture and partial gland involvement"
                  },
                  {
                    "text": "Degenerative-type atypia and rare mitoses"
                  }
                ],
                "Gastric-Type Adenocarcinoma": [
                  {
                    "text": "No background adenosis or endometriosis"
                  },
                  {
                    "text": "No tubulocystic or papillary patterns"
                  },
                  {
                    "text": "Abundant pale cytoplasm and well-defined membranes"
                  },
                  {
                    "text": "MUC6/HIK1083 (+); CK20/CDX2 (+) ~ 50%; p53 often mutant"
                  }
                ],
                "Metastatic Clear Cell Carcinoma (Endometrium/Kidney)": [
                  {
                    "text": "Prior history or concomitant mass"
                  },
                  {
                    "text": "Nested growth, sinusoidal vasculature, CD10 (+) (if renal)"
                  }
                ],
                "Yolk Sac Tumor": [
                  {
                    "text": "Young age (< 3 years) with elevated serum α-fetoprotein"
                  },
                  {
                    "text": "Reticular growth and Schiller-Duval bodies"
                  },
                  {
                    "text": "α-fetoprotein and SALL4 (+); CK7 and EMA typically (-)"
                  }
                ],
                "HPV-Related Adenocarcinoma With Clear Cells": [
                  {
                    "text": "Villiform or papillary architecture"
                  },
                  {
                    "text": "Apical mitoses, apoptotic bodies, p16 diffusely (+)"
                  }
                ],
                "Nephrogenic Adenoma in Diverticulum (in Vagina)": [
                  {
                    "text": "No cytologic atypia or mitoses"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Exclude endometrial primary, especially in older patients"
                  },
                  {
                    "text": "Immunohistochemical overlap between gastric-type and clear cell carcinoma (HNF-1-β > > > napsin)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neuroendocrine Tumors": {
            "name": "Neuroendocrine Tumors",
            "url": "https://app.pathprimer.com/document/7c1fc412-6e78-4b1e-a1b3-c3e8b8966601/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Epithelial neoplasms composed of neuroendocrine cells with variable prognosis"
                  },
                  {
                    "text": "Low-grade neuroendocrine tumors (NET) grade 1 (carcinoid) and grade 2 (atypical carcinoid)"
                  },
                  {
                    "text": "Small cell neuroendocrine carcinoma (SCNEC) and large cell neuroendocrine carcinoma (LGNEC)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "High-risk HPV, mostly types 16 and 18"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Common featuresDiffuse, organoid, insular, nested, and trabecularSalt and pepper chromatin (except LCNEC)",
                    "sub_points": [
                      "Diffuse, organoid, insular, nested, and trabecular",
                      "Salt and pepper chromatin (except LCNEC)"
                    ]
                  },
                  {
                    "text": "NET grade 1 (carcinoid)Bland morphology and rare mitoses with no necrosis",
                    "sub_points": [
                      "Bland morphology and rare mitoses with no necrosis"
                    ]
                  },
                  {
                    "text": "NET grade 2 (atypical carcinoid)Moderate atypia, 5-10 mitoses/10 HPF, focal necrosis",
                    "sub_points": [
                      "Moderate atypia, 5-10 mitoses/10 HPF, focal necrosis"
                    ]
                  },
                  {
                    "text": "SCNECDensely cellularHyperchromatic cells and brisk mitotic activityNuclear molding, crush artifact, and necrosis",
                    "sub_points": [
                      "Densely cellular",
                      "Hyperchromatic cells and brisk mitotic activity",
                      "Nuclear molding, crush artifact, and necrosis"
                    ]
                  },
                  {
                    "text": "LGNECCells with abundant eosinophilic cytoplasm and large nuclei with prominent nucleoliOften peripheral palisadingBrisk mitotic activity (> 10/10 HPF)",
                    "sub_points": [
                      "Cells with abundant eosinophilic cytoplasm and large nuclei with prominent nucleoli",
                      "Often peripheral palisading",
                      "Brisk mitotic activity (> 10/10 HPF)"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Synaptophysin, chromogranin, NSE, CD56, Leu-7 variably positive; required for diagnosis of LCNEC but not for SCNEC"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Metastatic small cell carcinoma (vs. SCNEC)"
                  },
                  {
                    "text": "HPV-associated squamous cell carcinoma (vs. SCNEC)"
                  },
                  {
                    "text": "Lymphoma/leukemia (vs. SCNEC, LCNEC)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Small cell neuroendocrine carcinoma (SCNEC)"
                  },
                  {
                    "text": "Large cell neuroendocrine carcinoma (LCNEC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Low-grade neuroendocrine tumor (NET), carcinoid and atypical carcinoid tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Epithelial neoplasms composed of neuroendocrine cells with variable prognosis, including low-grade NETs (carcinoid, atypical carcinoid), and high-grade NETs (SCNEC and LCNEC)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "High-risk HPV"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 2% of all cervical neoplasms"
                  },
                  {
                    "text": "SCNEC most frequent; low-grade NET almost nonexistent"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 21-87 (average: 36-42) years"
                  },
                  {
                    "text": "Cervical SCNEC and LCNEC typically premenopausal"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Vaginal bleeding; cervical mass; abnormal Pap smear"
                  },
                  {
                    "text": "Paraneoplastic manifestations: Cushing syndrome (ACTH), syndrome of inappropriate antidiuretic hormone (SIADH), carcinoid syndrome (serotonin), hypoglycemia (insulin)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Radical hysterectomy if early stage"
                  },
                  {
                    "text": "Chemotherapy/chemoradiation if advanced stage"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Neuroendocrine tumor grade 1: Better prognosis but metastatic potential"
                  },
                  {
                    "text": "Neuroendocrine tumor grade 2: Prognosis closer to high-grade neuroendocrine carcinomas (very limited experience)"
                  },
                  {
                    "text": "SCNEC and LCNEC: Poor outcome for all stages with high recurrence rate even when initial high response to neoadjuvant chemotherapy"
                  },
                  {
                    "text": "Conventional carcinomas with minor neuroendocrine component may have similar poor prognosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "From small and inconspicuous to large, barrel-shaped, ulcerating mass with variable size; ± polypoid"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Low-grade NETNET grade 1 (carcinoid)Organoid nested growth most commonTrabecular, insular, ribbon- and follicle-like patternsRosette-like structures (perivascular) commonNo necrosisNET grade 2 (atypical carcinoid)Organoid nested pattern most commonTrabecular, insular, spindle, ribbon- and follicle-like patterns, and rosette-like structuresFoci of necrosis",
                    "sub_points": [
                      "NET grade 1 (carcinoid)Organoid nested growth most commonTrabecular, insular, ribbon- and follicle-like patternsRosette-like structures (perivascular) commonNo necrosis",
                      "Organoid nested growth most common",
                      "Trabecular, insular, ribbon- and follicle-like patterns",
                      "Rosette-like structures (perivascular) common",
                      "No necrosis",
                      "NET grade 2 (atypical carcinoid)Organoid nested pattern most commonTrabecular, insular, spindle, ribbon- and follicle-like patterns, and rosette-like structuresFoci of necrosis",
                      "Organoid nested pattern most common",
                      "Trabecular, insular, spindle, ribbon- and follicle-like patterns, and rosette-like structures",
                      "Foci of necrosis"
                    ]
                  },
                  {
                    "text": "SCNECDiffuse, insular, corded, trabecular, or nested growthOccasionally rosette-like or acinar formationSquamous/glandular differentiation may be presentProminent necrosis and lymphovascular invasion± invasive or in situ adenocarcinoma > > > in situ or invasive squamous cell carcinoma; rarely, mesonephric carcinoma",
                    "sub_points": [
                      "Diffuse, insular, corded, trabecular, or nested growth",
                      "Occasionally rosette-like or acinar formation",
                      "Squamous/glandular differentiation may be present",
                      "Prominent necrosis and lymphovascular invasion",
                      "± invasive or in situ adenocarcinoma > > > in situ or invasive squamous cell carcinoma; rarely, mesonephric carcinoma"
                    ]
                  },
                  {
                    "text": "LCNECDiffuse, insular, organoid, trabecular, or cord-likeOften prominent peripheral palisadingFocal glandular differentiationExtensive geographic necrosis and lymphovascular invasionFrequently associated with invasive or in situ adenocarcinoma &/or squamous cell carcinoma",
                    "sub_points": [
                      "Diffuse, insular, organoid, trabecular, or cord-like",
                      "Often prominent peripheral palisading",
                      "Focal glandular differentiation",
                      "Extensive geographic necrosis and lymphovascular invasion",
                      "Frequently associated with invasive or in situ adenocarcinoma &/or squamous cell carcinoma"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Low-grade NETNET grade 1 (carcinoid)Abundant, finely granular, argyrophilic cytoplasmRound to oval nuclei with conspicuous nucleoli and salt and pepper chromatinNo to mild cytologic atypia; exceedingly rare mitosesNET grade 2 (atypical carcinoid)Salt and pepper chromatin and finely granular cytoplasmMild to moderate cytologic atypiaIncreased mitotic activity: 5-10 mitoses/10 HPF",
                    "sub_points": [
                      "NET grade 1 (carcinoid)Abundant, finely granular, argyrophilic cytoplasmRound to oval nuclei with conspicuous nucleoli and salt and pepper chromatinNo to mild cytologic atypia; exceedingly rare mitoses",
                      "Abundant, finely granular, argyrophilic cytoplasm",
                      "Round to oval nuclei with conspicuous nucleoli and salt and pepper chromatin",
                      "No to mild cytologic atypia; exceedingly rare mitoses",
                      "NET grade 2 (atypical carcinoid)Salt and pepper chromatin and finely granular cytoplasmMild to moderate cytologic atypiaIncreased mitotic activity: 5-10 mitoses/10 HPF",
                      "Salt and pepper chromatin and finely granular cytoplasm",
                      "Mild to moderate cytologic atypia",
                      "Increased mitotic activity: 5-10 mitoses/10 HPF"
                    ]
                  },
                  {
                    "text": "SCNECSmall, round, oval to spindle, monotonous cells with scant cytoplasm (increased nuclear:cytoplasmic ratio)Nuclei with finely dispersed chromatin or hyperchromasia and inconspicuous nucleoli (salt and pepper chromatin)Nuclear molding and crush artifact commonBrisk mitotic activity (> 10 mitoses/10 HPF)Numerous apoptotic bodiesOccasionally, intermediate-type cells with larger, more uniform nuclei and coarse chromatin",
                    "sub_points": [
                      "Small, round, oval to spindle, monotonous cells with scant cytoplasm (increased nuclear:cytoplasmic ratio)",
                      "Nuclei with finely dispersed chromatin or hyperchromasia and inconspicuous nucleoli (salt and pepper chromatin)",
                      "Nuclear molding and crush artifact common",
                      "Brisk mitotic activity (> 10 mitoses/10 HPF)",
                      "Numerous apoptotic bodies",
                      "Occasionally, intermediate-type cells with larger, more uniform nuclei and coarse chromatin"
                    ]
                  },
                  {
                    "text": "LCNECMedium to large cells with abundant eosinophilic/argyrophilic cytoplasmOften eosinophilic cytoplasmic granulesLarge vesicular nuclei with prominent nucleoliBrisk mitotic activity (> 10 mitoses/10 HPF)",
                    "sub_points": [
                      "Medium to large cells with abundant eosinophilic/argyrophilic cytoplasm",
                      "Often eosinophilic cytoplasmic granules",
                      "Large vesicular nuclei with prominent nucleoli",
                      "Brisk mitotic activity (> 10 mitoses/10 HPF)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Low molecular weight cytokeratin (punctate staining), EMA, CEA, p16, and p53 variably positive"
                  },
                  {
                    "text": "Neuroendocrine markers (synaptophysin, chromogranin, NSE, CD56, Leu-7) often positive"
                  },
                  {
                    "text": "TTF-1 positive in up to 40%"
                  },
                  {
                    "text": "Insulinoma-associated protein 1 often positive (high-grade neuroendocrine carcinoma)"
                  },
                  {
                    "text": "Polypeptide and amine hormones (somatostatin, serotonin, calcitonin, insulin, or glucagon) occasionally positive"
                  }
                ],
                "PCR": [
                  {
                    "text": "HPV positive, often type 16 or 18"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Metastatic Small Cell Carcinoma (vs. SCNEC)": [
                  {
                    "text": "Prior relevant clinical history and radiologic findings"
                  },
                  {
                    "text": "Often widely metastatic at diagnosis"
                  },
                  {
                    "text": "HPV negative"
                  }
                ],
                "HPV-Associated Squamous Cell Carcinoma With Small &/or Basaloid Cells (vs. SCNEC)": [
                  {
                    "text": "Lack of trabecular or cord-like growths"
                  },
                  {
                    "text": "No nuclear molding or crush artifact"
                  },
                  {
                    "text": "p63 positivity; neuroendocrine markers negative or only focally positive"
                  }
                ],
                "Lymphoma/Leukemia (vs. SCNEC, LCNEC)": [
                  {
                    "text": "Known prior history"
                  },
                  {
                    "text": "Noncohesive cells without insular or nested patterns"
                  },
                  {
                    "text": "Variable stages of myelocytic differentiation (leukemia)"
                  },
                  {
                    "text": "Marked associated sclerosis (B-cell lymphoma)"
                  },
                  {
                    "text": "B- or T-cell lineage markers (lymphomas)"
                  },
                  {
                    "text": "CD43, myeloperoxidase, lysozyme, and chloroacetate esterase (leukemia) positive"
                  },
                  {
                    "text": "Neuroendocrine markers negative"
                  }
                ],
                "Adenoid Basal Carcinoma (vs. SCNEC)": [
                  {
                    "text": "Typically incidental finding"
                  },
                  {
                    "text": "Small nests with frequent peripheral palisading present below high-grade squamous dysplasia"
                  },
                  {
                    "text": "Low-grade cytologic features"
                  },
                  {
                    "text": "p63 positive"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Association with paraneoplastic manifestations: Cushing syndrome, SIADH, carcinoid syndrome, or hypoglycemia"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Minor components of SCNEC and LCNEC can occur in each of 2; in some instances, distinction is difficult, and designation as NEC is most important"
                  },
                  {
                    "text": "If NEC admixed with other histologic subtypes, advisable to provide percentage of each component"
                  },
                  {
                    "text": "SCNEC may be negative for all neuroendocrine markers; synaptophysin and CD56 most sensitive markers, although CD56 nonspecific"
                  },
                  {
                    "text": "To establish diagnosis of LCNEC, positivity for at least 1 neuroendocrine marker is required"
                  },
                  {
                    "text": "Scattered positivity for neuroendocrine markers within nonneuroendocrine carcinomas may be seen due to presence of isolated neuroendocrine cells but should not be interpreted as neuroendocrine neoplastic component"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Deep (Aggressive) Angiomyxoma": {
            "name": "Deep (Aggressive) Angiomyxoma",
            "url": "https://app.pathprimer.com/document/3de9b9da-902d-4a0e-b373-ad22d2312e63/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infiltrative, nonmetastasizing, hypocellular myxoid neoplasm of vulvovaginal and pelvic regions"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Reproductive age"
                  },
                  {
                    "text": "Vulvovaginal region, perineum, and pelvic soft tissue most common sites"
                  },
                  {
                    "text": "30-40% risk of local, destructive recurrence if incompletely excised"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually large (> 10 cm)"
                  },
                  {
                    "text": "Poorly demarcated"
                  },
                  {
                    "text": "Soft, gelatinous consistency"
                  },
                  {
                    "text": "Clear to opaque cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Uniformly hypocellular with infiltrative margins"
                  },
                  {
                    "text": "Copious myxoid matrix"
                  },
                  {
                    "text": "Bland, spindle-shaped stromal cells with eosinophilic bipolar cytoplasmic processes"
                  },
                  {
                    "text": "Uniformly distributed medium to large-sized vessels, often with hyalinized walls"
                  },
                  {
                    "text": "Collections of smooth muscle (\"myoid bundles\") often close to vessels"
                  },
                  {
                    "text": "Mitoses rare"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Desmin, SMA, HMGA2, ER, PR usually positive"
                  },
                  {
                    "text": "CD 34 variably positive"
                  },
                  {
                    "text": "S100 negative"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Superficial angiomyxoma"
                  },
                  {
                    "text": "Angiomyofibroblastoma"
                  },
                  {
                    "text": "Fibroepithelial stromal polyp (edematous)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Aggressive angiomyxoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infiltrative, nonmetastasizing, hypocellular myxoid neoplasm of vulvovaginal and pelvic region with potential for local, destructive recurrence(s)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "HMGA2Rearrangement in 1/3": [
                  {
                    "text": "Encodes DNA architectural factor important in transcriptional regulation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon"
                  }
                ],
                "Age": [
                  {
                    "text": "Reproductive age: 4th-5th decades most common"
                  }
                ],
                "Sex": [
                  {
                    "text": "Females and males (in analogous sites)"
                  }
                ],
                "Site": [
                  {
                    "text": "Vulvovaginal region"
                  },
                  {
                    "text": "Perineum"
                  },
                  {
                    "text": "Pelvic soft tissues"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often thought to represent Bartholin gland cyst; occasionally lipoma or hernia"
                  },
                  {
                    "text": "± abdominal fullness, urinary frequency, dyspareunia, dyschezia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Wide local excision with 1-cm margins, if possible"
                  },
                  {
                    "text": "GnRH agonist therapy, if unresectable or recurrent"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "30-40% risk of local, destructive recurrence if incompletely excised"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Poorly demarcated from surrounding soft tissues"
                  },
                  {
                    "text": "Soft, gelatinous consistency; clear to opaque cut surface"
                  }
                ],
                "Size": [
                  {
                    "text": "Variable, usually > 10 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Typically uniformly hypocellular"
                  },
                  {
                    "text": "Copious myxoid matrix"
                  },
                  {
                    "text": "Spindle-shaped stromal cells with eosinophilic bipolar cytoplasmic processes"
                  },
                  {
                    "text": "Medium to large-sized vesselsUniformly distributed throughoutOften with hyalinized wallsConcentric condensation of collagen fibers",
                    "sub_points": [
                      "Uniformly distributed throughout",
                      "Often with hyalinized walls",
                      "Concentric condensation of collagen fibers"
                    ]
                  },
                  {
                    "text": "Collections of smooth muscle bundles (\"myoid bundles\")Commonly near vessels",
                    "sub_points": [
                      "Commonly near vessels"
                    ]
                  },
                  {
                    "text": "Often extravasated red blood cells"
                  },
                  {
                    "text": "Recurrences may show increased cellularity, stromal collagen, &/or vascularity (with hyalinization of vessel walls)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Spindle cells with bland cytologic appearanceRound to ovoid nucleiUniform nuclear contoursDelicate dispersed chromatin",
                    "sub_points": [
                      "Round to ovoid nuclei",
                      "Uniform nuclear contours",
                      "Delicate dispersed chromatin"
                    ]
                  },
                  {
                    "text": "Rare mitoses"
                  }
                ],
                "Margins": [
                  {
                    "text": "Poorly defined"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Desmin, SMA, HMGA2, ER, PR usually positive"
                  },
                  {
                    "text": "CD 34 variably positive (up to 50%)"
                  },
                  {
                    "text": "S100 negative"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Superficial Angiomyxoma": [
                  {
                    "text": "No involvement of deep soft tissues"
                  },
                  {
                    "text": "Lobulated growth with well-demarcated borders"
                  },
                  {
                    "text": "Lacks medium to large-sized vessels"
                  },
                  {
                    "text": "Typically associated with stromal acute inflammatory cells"
                  }
                ],
                "Angiomyofibroblastoma": [
                  {
                    "text": "Subcutis (not deep soft tissues); well circumscribed"
                  },
                  {
                    "text": "More vascular; contains small capillaries"
                  },
                  {
                    "text": "Alternating zones of cellularity"
                  }
                ],
                "Fibroepithelial Stromal Polyp (Edematous)": [
                  {
                    "text": "Polypoid and superficially located"
                  },
                  {
                    "text": "Often central vascular core"
                  },
                  {
                    "text": "Stellate and multinucleate cells characteristicTypically near epithelial-stromal interfaceMay be present around central vascular core",
                    "sub_points": [
                      "Typically near epithelial-stromal interface",
                      "May be present around central vascular core"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Gross appearance"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "If recurrent, may have more collagenous appearance"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Malignant Melanoma": {
            "name": "Malignant Melanoma",
            "url": "https://app.pathprimer.com/document/04291706-3a43-4964-a276-86d39c0eb68d/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant neoplasm composed of cells showing melanocytic differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "< 0.3% of all malignant melanomas"
                  },
                  {
                    "text": "< 3% of malignant tumors of vagina"
                  },
                  {
                    "text": "Peri- and postmenopausal (mean: 57 years)"
                  },
                  {
                    "text": "Distal 1/3 (anterior) of vagina most common site"
                  },
                  {
                    "text": "Frequent local recurrences"
                  },
                  {
                    "text": "Poor outcome; median survival: < 2 years"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Often pigmented (< 10% nonpigmented)"
                  },
                  {
                    "text": "Single or multiple (\"satellite\") lesions"
                  },
                  {
                    "text": "Polypoid most common with frequent ulceration"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse, nested, trabecular, &/or fascicular patterns"
                  },
                  {
                    "text": "Epithelioid ± spindled cells"
                  },
                  {
                    "text": "In situ component may be present at lateral margins (radial growth phase)"
                  },
                  {
                    "text": "Frequently reniform or horseshoe-shaped nuclei with variable nuclear atypia and prominent nucleoli"
                  },
                  {
                    "text": "± multinucleated cells"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "S100 > melan-A > microphthalmia transcription factor (MITF) > HMB-45 typically (+) (most to least sensitive)"
                  },
                  {
                    "text": "InfrequentBRAForKIT(c-Kit) mutations"
                  },
                  {
                    "text": "TP53andATRXmutations relatively common"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Squamous cell carcinoma"
                  },
                  {
                    "text": "Leiomyosarcoma"
                  },
                  {
                    "text": "Paget disease"
                  },
                  {
                    "text": "Metastatic malignant melanoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant neoplasm composed of cells showing melanocytic differentiation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "< 0.3% of all malignant melanomas"
                  },
                  {
                    "text": "< 3% of malignant tumors of vagina"
                  }
                ],
                "Age": [
                  {
                    "text": "Peri- and postmenopausal (mean: 57 years)"
                  }
                ],
                "Site": [
                  {
                    "text": "Distal 1/3 (anterior) of vagina most common"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Vaginal bleeding or discharge"
                  },
                  {
                    "text": "Palpable mass (may be pigmented)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery (may require exenteration if locally advanced)"
                  },
                  {
                    "text": "Lymphadenectomy vs. sentinel node sampling (latter not well validated)"
                  },
                  {
                    "text": "Radiation if tumor incompletely excised or close margin"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor outcome5-year survival rate: 14%; median survival: < 2 years",
                    "sub_points": [
                      "5-year survival rate: 14%; median survival: < 2 years"
                    ]
                  },
                  {
                    "text": "Worse prognosis than cutaneous or vulvar melanomas"
                  },
                  {
                    "text": "Frequent local recurrences"
                  },
                  {
                    "text": "Lung most common metastatic site"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Single or multiple (\"satellite\") lesions"
                  },
                  {
                    "text": "Polypoid most common with frequent ulceration"
                  },
                  {
                    "text": "Macular, if early lesion"
                  },
                  {
                    "text": "Often pigmented (< 10% nonpigmented)"
                  }
                ],
                "Size": [
                  {
                    "text": "Mean: 3 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diffuse, nested, trabecular, &/or fascicular patterns"
                  },
                  {
                    "text": "Epithelioid (most frequent) ± spindled cells"
                  },
                  {
                    "text": "Rarely, cells with plasmacytoid or signet-ring morphology"
                  },
                  {
                    "text": "Intracytoplasmic melanin common, at least focally"
                  },
                  {
                    "text": "± in situ component at lateral margins (radial growth phase)"
                  },
                  {
                    "text": "May arise from preexisting nevus"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Frequently reniform or horseshoe-shaped nuclei with variable nuclear atypia and prominent nucleoli"
                  },
                  {
                    "text": "± multinucleated cells"
                  },
                  {
                    "text": "Brisk mitotic activity"
                  }
                ],
                "Staging System (Chung Level)": [
                  {
                    "text": "Level I: Tumor confined to surface epithelium"
                  },
                  {
                    "text": "Level II: Invasion ≤ 1 mm"
                  },
                  {
                    "text": "Level III: Invasion ≤ 2 mm"
                  },
                  {
                    "text": "Level IV: Invasion > 2 mm"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "S100 > melan-A > microphthalmia transcription factor (MITF) > HMB-45 typically (+) (most to least sensitive)"
                  },
                  {
                    "text": "InfrequentBRAForKIT(c-Kit) mutations, relatively commonTP53andATRXmutations"
                  },
                  {
                    "text": "PRAME expressed in most; ± PDL1 expression"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Squamous Cell Carcinoma, Poorly Differentiated": [
                  {
                    "text": "Focal keratin formation and intercellular bridges"
                  },
                  {
                    "text": "Vaginal intraepithelial neoplasia may be present"
                  },
                  {
                    "text": "Keratin (+); HMB-45, melan-A, S100 (-)"
                  }
                ],
                "Leiomyosarcoma": [
                  {
                    "text": "No intracellular pigment"
                  },
                  {
                    "text": "Desmin, caldesmon (+); HMB-45, melan-A, S100 (-)"
                  }
                ],
                "Paget Disease": [
                  {
                    "text": "Focal glandular formation"
                  },
                  {
                    "text": "Often cells with intracellular mucin (signet-ring cells)"
                  },
                  {
                    "text": "CK7, GATA 3 (+); HMB-45, melan-A (-)"
                  }
                ],
                "Metastatic Malignant Melanoma": [
                  {
                    "text": "Prior history (usually cutaneous), which may be remote"
                  },
                  {
                    "text": "No in situ component"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "No clinical implications if vaginal or vulvar origin cannot be determined"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "For any poorly differentiated vaginal tumor, consider melanoma; > 1 marker improves diagnostic accuracy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "HPV-Associated Adenocarcinomas": {
            "name": "HPV-Associated Adenocarcinomas",
            "url": "https://app.pathprimer.com/document/3b2b270a-da70-42f0-b681-a1cb997b6abe/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Invasive glandular neoplasm of cervix with variable mucin associated with high-risk human papillomavirus (HR-HPV) infection"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "HR-HPV infection (90-95%)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "~ 75-80% of all cervical adenocarcinomas"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Apical mitoses and apoptotic bodies (surrogate markers of HPV infection) at 40-100x magnification"
                  },
                  {
                    "text": "Usual type (includes villoglandular and micropapillary) with columnar cells with eosinophilic cytoplasm and > 50% of cell-depleted mucin"
                  },
                  {
                    "text": "Mucinous, NOS: ≥ 50% of cells with abundant intracytoplasmic mucin in background of usual type"
                  },
                  {
                    "text": "Intestinal: ≥ 50% of goblet cells in background of usual type"
                  },
                  {
                    "text": "Signet-ring cell: ≥ 50% of cells with intracytoplasmic vacuoles in background of usual type"
                  },
                  {
                    "text": "Invasive stratified mucinous: Nested, insular, trabecular, papillary, micropapillary, single cell patterns of stratified cells with variable amounts of intracytoplasmic mucin"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Typically p16 (strong diffuse), ProEx C, CEA positive"
                  },
                  {
                    "text": "PAX8 < < < positive than upper genital tract tumors"
                  },
                  {
                    "text": "Vimentin, ER, PR typically negative"
                  },
                  {
                    "text": "CK20 and CDX2 may be positive in intestinal type"
                  },
                  {
                    "text": "MUC6 often positive and p53 often mutant pattern in invasive stratified mucinous carcinoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Endocervical adenocarcinoma in situ"
                  },
                  {
                    "text": "HPV-independent adenocarcinomas"
                  },
                  {
                    "text": "Secondary involvement by endometrial adenocarcinoma"
                  },
                  {
                    "text": "Squamous/adenosquamous adenocarcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Invasive glandular neoplasm of cervix with variable amounts of mucin associated with high-risk human papillomavirus (HR-HPV) infection"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "HR-HPV infection (90-95%)HPV-18 > HPV-16 > other HR-HPVHPV types 16, 18, and 45",
                    "sub_points": [
                      "HPV-18 > HPV-16 > other HR-HPV",
                      "HPV types 16, 18, and 45"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 25% of all cervical carcinomas"
                  },
                  {
                    "text": "~ 75-80%% of all cervical adenocarcinomas"
                  }
                ],
                "Age": [
                  {
                    "text": "4th-5th decades most common"
                  },
                  {
                    "text": "Range: 23-55 (average: 35) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Cervical mass or abnormality visualized on exam (85%)"
                  },
                  {
                    "text": "Abnormal vaginal bleeding (50-75%)"
                  },
                  {
                    "text": "Asymptomatic"
                  },
                  {
                    "text": "Atypical glandular cells on Papanicolaou smear"
                  },
                  {
                    "text": "Metastatic disease may be initial presentation, most commonly involving ovary"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Radical hysterectomy with pelvic lymph node dissection"
                  },
                  {
                    "text": "Trachelectomy ± pelvic lymph node dissection, if preservation of fertility desired"
                  },
                  {
                    "text": "Radiation &/or chemotherapy if inoperable, advanced stage"
                  },
                  {
                    "text": "Potential role of mTOR inhibitors"
                  },
                  {
                    "text": "Immune checkpoint (PD-1) inhibition for advanced stage or recurrent disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall 5-year survival: 50-65%93-100% stage IA; 85-90% stage IB",
                    "sub_points": [
                      "93-100% stage IA; 85-90% stage IB"
                    ]
                  },
                  {
                    "text": "Micropapillary and mucinous subtypes, especially invasive stratified, associated with more aggressive behaviorMicropapillary carcinoma associated with Silva pattern C, high frequency of lymphovascular invasion, higher FIGO stage, and metastasesInvasive stratified mucinous carcinoma associated with higher frequency of Silva pattern C, higher FIGO stage, lymph node metastases, local and distant recurrences",
                    "sub_points": [
                      "Micropapillary carcinoma associated with Silva pattern C, high frequency of lymphovascular invasion, higher FIGO stage, and metastases",
                      "Invasive stratified mucinous carcinoma associated with higher frequency of Silva pattern C, higher FIGO stage, lymph node metastases, local and distant recurrences"
                    ]
                  },
                  {
                    "text": "Size, extend of invasion, and lymphovascular invasion most important parameters"
                  },
                  {
                    "text": "Silva pattern of invasion important prognostic factorSilva pattern A: Excellent prognosis (no lymphovascular invasion)Silva pattern B: Good prognosis (lymphovascular invasion in ~ 20% of tumors)Silva pattern C: Poor prognosis (overt destructive invasion and lymphovascular invasion in > 50% of tumors)",
                    "sub_points": [
                      "Silva pattern A: Excellent prognosis (no lymphovascular invasion)",
                      "Silva pattern B: Good prognosis (lymphovascular invasion in ~ 20% of tumors)",
                      "Silva pattern C: Poor prognosis (overt destructive invasion and lymphovascular invasion in > 50% of tumors)"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Polypoid, ulcerated, or granular mass"
                  },
                  {
                    "text": "Barrel-shaped cervix"
                  },
                  {
                    "text": "No gross abnormality (~ 20%)"
                  },
                  {
                    "text": "Exophytic, friable mass (rare)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Closely packed or irregularly spaced glands ± cribriforming, macrocystic, microcystic, microglandular or solid growth(s)"
                  },
                  {
                    "text": "Papillary (broad (usual), thin and elongated (villoglandular), micropapillae (small papillae free floating in spaces) growths"
                  },
                  {
                    "text": "Nested, insular, trabecular, papillary, micropapillary, single cell patterns of stratified cells (invasive stratified mucinous carcinoma)"
                  },
                  {
                    "text": "Clusters, cords, or single cells (uncommon)"
                  },
                  {
                    "text": "Mucin pools occasionally"
                  },
                  {
                    "text": "± variable degree of invasion with desmoplastic stromaIf villoglandular variant invasion may be minimalIf present, seen as usual-type or branching tubular glands or papillae ± associated desmoplastic reactionNo desmoplastic reaction if Silva pattern A of invasion",
                    "sub_points": [
                      "If villoglandular variant invasion may be minimalIf present, seen as usual-type or branching tubular glands or papillae ± associated desmoplastic reaction",
                      "If present, seen as usual-type or branching tubular glands or papillae ± associated desmoplastic reaction",
                      "No desmoplastic reaction if Silva pattern A of invasion"
                    ]
                  },
                  {
                    "text": "± lymphovascular invasion"
                  },
                  {
                    "text": "± > 1 HPV-related adenocarcinoma subtypes"
                  },
                  {
                    "text": "± adenocarcinoma in situ (usual, intestinal, stratified mucin-producing subtypes)"
                  },
                  {
                    "text": "± squamous intraepithelial lesion or invasive carcinoma (~ 60%)"
                  },
                  {
                    "text": "Rare association with neuroendocrine, choriocarcinomatous, and hepatoid differentiation"
                  },
                  {
                    "text": "± secondary involvement of endometrial glands (may mimic endometrial primary), fallopian tube, or ovary (may mimic ovarian primary)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Diagnosis based on finding apical mitoses and apoptotic bodies (surrogate markers of HPV infection) at 40-100x magnification on routine-stained slides"
                  },
                  {
                    "text": "Usual type (includes villoglandular and micropapillary)Columnar cells with eosinophilic cytoplasm and > 50% of cell-depleted mucinEnlarged, crowded, frequently pseudostratified hyperchromatic nuclei (pseudoendometrioid appearance) with variable cytologic atypiaLow-grade nuclear atypia may be seen if villoglandularHigh-grade nuclear atypia if micropapillaryBrisk mitoses and apoptotic bodies",
                    "sub_points": [
                      "Columnar cells with eosinophilic cytoplasm and > 50% of cell-depleted mucin",
                      "Enlarged, crowded, frequently pseudostratified hyperchromatic nuclei (pseudoendometrioid appearance) with variable cytologic atypiaLow-grade nuclear atypia may be seen if villoglandularHigh-grade nuclear atypia if micropapillary",
                      "Low-grade nuclear atypia may be seen if villoglandular",
                      "High-grade nuclear atypia if micropapillary",
                      "Brisk mitoses and apoptotic bodies"
                    ]
                  },
                  {
                    "text": "Mucinous typesMucinous, not otherwise specified≥ 50% of cells have abundant intracytoplasmic mucin in background of usual typeNuclear pseudostratification may be less prominent in areas of overt mucinous cytoplasmIntestinal≥ 50% of goblet cells in a background of usual type± Paneth cellsNuclei basally located with less pseudostratification and less mitoses in this componentSignet-ring cellNoncohesive growth with ≥ 50% of cells with intracytoplasmic vacuoles and peripheral nuclei in background of usual typeApical mitoses &/or basal apoptoses may not be seen in this componentInvasive stratified mucinousVariable amounts of intracytoplasmic mucinMay have histiocytoid, glassy cell-like, or squamoid morphologyVariable degree of nuclear atypia but at least moderateCommon mitoses and apoptotic bodies",
                    "sub_points": [
                      "Mucinous, not otherwise specified≥ 50% of cells have abundant intracytoplasmic mucin in background of usual typeNuclear pseudostratification may be less prominent in areas of overt mucinous cytoplasm",
                      "≥ 50% of cells have abundant intracytoplasmic mucin in background of usual type",
                      "Nuclear pseudostratification may be less prominent in areas of overt mucinous cytoplasm",
                      "Intestinal≥ 50% of goblet cells in a background of usual type± Paneth cellsNuclei basally located with less pseudostratification and less mitoses in this component",
                      "≥ 50% of goblet cells in a background of usual type",
                      "± Paneth cells",
                      "Nuclei basally located with less pseudostratification and less mitoses in this component",
                      "Signet-ring cellNoncohesive growth with ≥ 50% of cells with intracytoplasmic vacuoles and peripheral nuclei in background of usual typeApical mitoses &/or basal apoptoses may not be seen in this component",
                      "Noncohesive growth with ≥ 50% of cells with intracytoplasmic vacuoles and peripheral nuclei in background of usual type",
                      "Apical mitoses &/or basal apoptoses may not be seen in this component",
                      "Invasive stratified mucinousVariable amounts of intracytoplasmic mucinMay have histiocytoid, glassy cell-like, or squamoid morphologyVariable degree of nuclear atypia but at least moderateCommon mitoses and apoptotic bodies",
                      "Variable amounts of intracytoplasmic mucinMay have histiocytoid, glassy cell-like, or squamoid morphology",
                      "May have histiocytoid, glassy cell-like, or squamoid morphology",
                      "Variable degree of nuclear atypia but at least moderate",
                      "Common mitoses and apoptotic bodies"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Usual typep16 (strong diffuse block type) and ProEx C positiveCEA and CK7 positiveEMA positiveInside out pattern if micropapillaryPAX8 less frequently positive than upper genital tractTypically, ER, PR, and vimentin negative (with some exceptions)AR, MUC6, HNF-1-β, napsin A, GATA3, CD10, WT1, and HER2 negativeMMR protein expression preservedp53 wild type",
                    "sub_points": [
                      "p16 (strong diffuse block type) and ProEx C positive",
                      "CEA and CK7 positive",
                      "EMA positiveInside out pattern if micropapillary",
                      "Inside out pattern if micropapillary",
                      "PAX8 less frequently positive than upper genital tract",
                      "Typically, ER, PR, and vimentin negative (with some exceptions)",
                      "AR, MUC6, HNF-1-β, napsin A, GATA3, CD10, WT1, and HER2 negative",
                      "MMR protein expression preserved",
                      "p53 wild type"
                    ]
                  },
                  {
                    "text": "Mucinous typesp16 (strong diffuse block type), CEA, and CK7 positiveER, PR, vimentin, MUC6, GATA3, and CK20 usually negativeCK20 and CDX2 may be positive in intestinal typeMUC6 often positive in invasive stratified mucinous carcinomaCAIX, HNF-1-β, and napsin A may be positivep40/p63 may be positive at periphery of nests of invasive stratified mucinous carcinomaPAX8 less frequently positive than upper genital tract, especially invasive stratified mucinous carcinomap53 often mutant pattern in invasive stratified mucinous carcinoma",
                    "sub_points": [
                      "p16 (strong diffuse block type), CEA, and CK7 positive",
                      "ER, PR, vimentin, MUC6, GATA3, and CK20 usually negativeCK20 and CDX2 may be positive in intestinal typeMUC6 often positive in invasive stratified mucinous carcinoma",
                      "CK20 and CDX2 may be positive in intestinal type",
                      "MUC6 often positive in invasive stratified mucinous carcinoma",
                      "CAIX, HNF-1-β, and napsin A may be positive",
                      "p40/p63 may be positive at periphery of nests of invasive stratified mucinous carcinoma",
                      "PAX8 less frequently positive than upper genital tract, especially invasive stratified mucinous carcinoma",
                      "p53 often mutant pattern in invasive stratified mucinous carcinoma"
                    ]
                  }
                ],
                "PCR": [
                  {
                    "text": "HR-HPV positive"
                  }
                ],
                "Molecular Alterations": [
                  {
                    "text": "Usual typePIK3CA,KRAS, andPTENmutationsOther abnormalities in PI3K/Akt/mTOR cascade",
                    "sub_points": [
                      "PIK3CA,KRAS, andPTENmutations",
                      "Other abnormalities in PI3K/Akt/mTOR cascade"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endocervical Adenocarcinoma In Situ": [
                  {
                    "text": "No extension below level of normal glands"
                  },
                  {
                    "text": "Normal cervical glandular architecture preserved"
                  },
                  {
                    "text": "Minimal to no cribriform architecture"
                  }
                ],
                "Secondary Involvement by Endometrial Endometrioid Adenocarcinoma": [
                  {
                    "text": "Known endometrial primary"
                  },
                  {
                    "text": "Coexisting endometrial intraepithelial neoplasia/atypical hyperplasia"
                  },
                  {
                    "text": "Scant intervening stroma, foamy histiocytes"
                  },
                  {
                    "text": "ER, PR, and vimentin typically positive"
                  },
                  {
                    "text": "ProEx C, CEA, p16 negative (latter sometimes patchy positive)"
                  },
                  {
                    "text": "HPV negative"
                  }
                ],
                "HPV-Independent or Metastatic Adenocarcinomas": [
                  {
                    "text": "If clear cell carcinoma, typical architectural features"
                  },
                  {
                    "text": "If serous carcinoma, high-grade nuclear features and prominent budding of tumor cells and typically not cervical primary with WT1 positivity and p53-mutant pattern"
                  }
                ],
                "Mesonephric Hyperplasia/Carcinoma (vs. Usual-Type Adenocarcinoma)": [
                  {
                    "text": "Endometrioid-like appearance with eosinophilic intraluminal secretions"
                  },
                  {
                    "text": "Mucin-free cuboidal epithelium"
                  },
                  {
                    "text": "GATA3 and CD10 (luminal) positive"
                  },
                  {
                    "text": "HPV negative"
                  }
                ],
                "Adenosquamous /Squamous Cell Carcinoma (vs. Invasive Stratified Mucinous Carcinoma)": [
                  {
                    "text": "Intercellular bridges and keratin formation"
                  },
                  {
                    "text": "Extensive p40/p63 positivity if squamous cell carcinoma"
                  }
                ],
                "Primary Endometrioid Adenocarcinoma (vs. Usual-Type Adenocarcinoma)": [
                  {
                    "text": "Associated precursor lesion (endometriosis ± hyperplasia)"
                  },
                  {
                    "text": "ER, PR, and vimentin often positive"
                  },
                  {
                    "text": "p16 typically patchy positive"
                  },
                  {
                    "text": "HPV negative"
                  }
                ],
                "Metastatic Adenocarcinoma (± Signet-Ring Cells)": [
                  {
                    "text": "Clinical history"
                  },
                  {
                    "text": "Prominent lymphovascular or outer cervical wall involvement"
                  },
                  {
                    "text": "Appropriate immunohistochemical panel"
                  }
                ],
                "Microglandular Hyperplasia": [
                  {
                    "text": "Sub- and supranuclear vacuoles"
                  },
                  {
                    "text": "Preservation of reserve cell layer"
                  },
                  {
                    "text": "Typically no mitoses or cytologic atypia"
                  },
                  {
                    "text": "p16 usually negative (with exceptions)"
                  }
                ],
                "Papillary Endocervicitis, Müllerian Papilloma, Villoglandular Adenoma (If Villoglandular Morphology)": [
                  {
                    "text": "No complex architecture, no cytologic atypia, and no stromal invasion"
                  }
                ],
                "Deep Glands": [
                  {
                    "text": "Typically no mass forming"
                  },
                  {
                    "text": "Scattered glands lacking haphazard growth"
                  },
                  {
                    "text": "No cytologic atypia or stromal reaction"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Depth of invasion should be measured from surface to deepest point of invasion; however, this information may not always be relevant when dealing with adenocarcinomas with Silva pattern A of invasion"
                  },
                  {
                    "text": "Before making diagnosis of separate endometrial and endocervical primaries, extensive sampling may help identify transition between 2 tumors"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Apical mitoses and basally located apoptotic bodies seen at 40-100x magnification represent morphologic surrogates of HPV-associated adenocarcinoma"
                  },
                  {
                    "text": "Before making diagnosis of primary endometrioid adenocarcinoma of cervix in absence of precursor lesion, exclude mucin-depleted HPV-associated adenocarcinoma, as it shows nuclear pseudostratification and may mimic morphology of endometrioid adenocarcinoma"
                  },
                  {
                    "text": "Villoglandular adenocarcinoma is now included within category of usual-type HPV-associated adenocarcinoma, as it is often seen with usual-type endocervical adenocarcinoma displaying apical mitoses and apoptotic bodies; however, it should be noted in report, as often exophytic and invasion may be absent"
                  },
                  {
                    "text": "Close attention should be paid to exclude component of micropapillary carcinoma in HPV-associated adenocarcinoma, as it has an with aggressive behavior; this pattern should be noted in pathology report for prognostic purposes"
                  },
                  {
                    "text": "Goblet cells and Paneth cells may be seen in intestinal-type HPV-associated adenocarcinoma and HPV-independent gastric-type adenocarcinoma, and p16 may be diffusely positive in latter; thus, diagnosis should be made based on morphologic appearance of nongoblet cells, associated precursor lesions, as well as HPV status"
                  },
                  {
                    "text": "Before establishing diagnosis of primary signet-ring cell carcinoma of the cervix, metastases should always be excluded, especially when no usual-type adenocarcinoma is seen"
                  },
                  {
                    "text": "Invasive stratified mucinous adenocarcinoma should be included in differential diagnosis of adenosquamous and squamous carcinoma, and these tumors were likely misdiagnosed as such in past; at higher power, stratified cells have abundant intracytoplasmic vacuoles, and no intercellular bridges are identified"
                  },
                  {
                    "text": "HNF-1-β and napsin can be positive in mucinous carcinomas of cervix; thus, relay on morphologic features, p16, and, if necessary, HPV status"
                  },
                  {
                    "text": "Some HPV-associated adenocarcinomas lack typical morphologic features of different categories of HPV-associated adenocarcinomas but still have brisk mitotic activity and abundant apoptosis and are diffusely p16 positive and HPV positive"
                  },
                  {
                    "text": "HPV-associated adenocarcinomas can display Silva pattern A, B, or C (latter more frequent in micropapillary and invasive stratified mucinous carcinomas), in contrast to all HPV-independent adenocarcinomas that are associated with a Silva pattern C of invasion"
                  }
                ]
              },
              "REPORTING": {
                "Staging": [
                  {
                    "text": "Stage should be based on parameters available from pathologic material"
                  },
                  {
                    "text": "It is important not to provide different gross and microscopic measurements for tumor size"
                  },
                  {
                    "text": "Horizontal tumor extension has little prognostic value in stage I tumors (microscopic disease)"
                  },
                  {
                    "text": "If different specimens, deepest point of invasion in 1 single specimen should be noted"
                  },
                  {
                    "text": "Term \"microinvasive\" carcinoma should not be used in reporting invasive adenocarcinoma"
                  },
                  {
                    "text": "Although Silva patterns have not been fully adopted, it is important at least mention it in comment"
                  },
                  {
                    "text": "Quantification of lymphovascular invasion may be important, as it has been found in endometrial carcinomas, correlating with risk of lymph node metastases"
                  },
                  {
                    "text": "Lymphovascular invasion does not upstage tumor even when outside uterus"
                  },
                  {
                    "text": "Endometrial and adnexal involvement by adenocarcinoma does not change FIGO stage but should be reported"
                  },
                  {
                    "text": "Multiple isolated or aggregates of tumor cells within lymph nodes should not be aggregated as single measurement but should be reported"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Squamous Cell Carcinoma": {
            "name": "Squamous Cell Carcinoma",
            "url": "https://app.pathprimer.com/document/8d70c2d4-901b-4a4e-9b70-056c239a810f/lesson/1040e4f4-281e-4303-86a9-0d6948b0e12e",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant squamous tumor associated with stromal invasion ± HPV"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "90% of all invasive carcinomas; 5% of female genital cancers"
                  },
                  {
                    "text": "HPV associated (30%): 35-65 years"
                  },
                  {
                    "text": "HPV independent (70%): 55-85 years"
                  },
                  {
                    "text": "80% in labia; often multiple, if HPV associated"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Endophytic or exophytic (warty)"
                  },
                  {
                    "text": "White, firm mass with raised borders"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Warty type (HPV associated)"
                  },
                  {
                    "text": "Basaloid type (HPV associated)"
                  },
                  {
                    "text": "Keratinizing (more commonly HPV independent)"
                  },
                  {
                    "text": "Sarcomatoid type"
                  },
                  {
                    "text": "± acantholytic"
                  },
                  {
                    "text": "Adjacent vulvar intraepithelial neoplasia (VIN) in 30-70%; preexisting inflammatory dermatoses common if HPV-independent, p53 mutant type VIN"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Cytokeratins, p63, and p40, GATA3 (+)"
                  },
                  {
                    "text": "HPV associated: p16 strong (+); p53 typically wild type"
                  },
                  {
                    "text": "HPV independent, p53 mutant type: p53(+) or \"null\"; p16 typically (-)"
                  },
                  {
                    "text": "HPV independent, p53 wild type: p53 wild type; p16 typically (-) or patchy"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pseudoepitheliomatous hyperplasia"
                  },
                  {
                    "text": "Tangentially sectioned VIN"
                  },
                  {
                    "text": "Leiomyosarcoma, melanoma"
                  },
                  {
                    "text": "Angiosarcoma (vs. acantholytic squamous cell carcinoma)"
                  },
                  {
                    "text": "Proximal-type epithelioid sarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Epidermoid carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant squamous tumor associated with stromal invasion ± HPV"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "HPV Associated (30%)": [
                  {
                    "text": "HPV types 16 > 33 >18; background HPV-associated VIN"
                  }
                ],
                "HPV Independent (70%)": [
                  {
                    "text": "Background p53 mutant type or p53 wild-type VIN"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Represents 90% of all invasive carcinomas5% of female genital cancers",
                    "sub_points": [
                      "5% of female genital cancers"
                    ]
                  },
                  {
                    "text": "Increased in young patients in recent years, if HPV related"
                  },
                  {
                    "text": "Increased in immunocompromised patients and smokers, if HPV related"
                  }
                ],
                "Age": [
                  {
                    "text": "35-65 years (HPV) vs. 55-85 years (non-HPV)"
                  }
                ],
                "Site": [
                  {
                    "text": "80% labia > > clitoris, introitus, perineum, urethral meatus"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Slow-growing papule, nodule, or plaque ± ulceration"
                  },
                  {
                    "text": "Pruritus, pain, &/or bleeding or asymptomatic"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Vulvectomy or complete excision (latter with > 1-cm margins; similar outcome with less complications) ± sentinel lymph node biopsy/lymphadenectomy"
                  },
                  {
                    "text": "Chemotherapy ± radiation if advanced disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "HPV associated5-year survival rate for FIGO stage I: > 80%5-year survival rate for FIGO stage IV: 10-20%Factors associated with recurrence: Positive or < 3-mm margins, tumor size, depth of invasion, lymphovascular and perineural invasionInfiltrative growth and fibromyxoid stroma associated with adverse prognosis",
                    "sub_points": [
                      "5-year survival rate for FIGO stage I: > 80%",
                      "5-year survival rate for FIGO stage IV: 10-20%",
                      "Factors associated with recurrence: Positive or < 3-mm margins, tumor size, depth of invasion, lymphovascular and perineural invasion",
                      "Infiltrative growth and fibromyxoid stroma associated with adverse prognosis"
                    ]
                  },
                  {
                    "text": "HPV independentWorse prognosis than HPV relatedStage and lymph node involvement most important prognostic factorsRecurrence rate: 12-37%Multiple local recurrences, rapid progression common",
                    "sub_points": [
                      "Worse prognosis than HPV related",
                      "Stage and lymph node involvement most important prognostic factors",
                      "Recurrence rate: 12-37%",
                      "Multiple local recurrences, rapid progression common"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "White, firm mass with raised borders"
                  },
                  {
                    "text": "Endophytic or exophytic (warty)"
                  },
                  {
                    "text": "May be flat or ulcerated"
                  },
                  {
                    "text": "Fleshy cut surface if sarcomatoid"
                  },
                  {
                    "text": "Multiple synchronous tumors may occur (if HPV associated)"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "WartyComplex verruciform (condyloma-like) architectureInvasion as irregularly shaped, jagged nestsSquamous pearls and large keratin whorls within nestsIndividual cell keratinization (common)Desmoplastic stroma",
                    "sub_points": [
                      "Complex verruciform (condyloma-like) architecture",
                      "Invasion as irregularly shaped, jagged nests",
                      "Squamous pearls and large keratin whorls within nests",
                      "Individual cell keratinization (common)",
                      "Desmoplastic stroma"
                    ]
                  },
                  {
                    "text": "BasaloidVariably sized sheets of cellsBroad, anastomosing trabeculae and nestsNests are less cellular centrallySmall clusters and cords (less common)± abrupt maturation with keratinization within nestsCentral necrosis within nests (common)Often densely hyalinized or desmoplastic stroma",
                    "sub_points": [
                      "Variably sized sheets of cells",
                      "Broad, anastomosing trabeculae and nestsNests are less cellular centrally",
                      "Nests are less cellular centrally",
                      "Small clusters and cords (less common)",
                      "± abrupt maturation with keratinization within nests",
                      "Central necrosis within nests (common)",
                      "Often densely hyalinized or desmoplastic stroma"
                    ]
                  },
                  {
                    "text": "Mixed warty and basaloid"
                  },
                  {
                    "text": "Keratinizing (more commonly HPV independent)Sheets and irregularly shaped and sized islands, cords, nests, trabeculae ± desmoplastic stroma",
                    "sub_points": [
                      "Sheets and irregularly shaped and sized islands, cords, nests, trabeculae ± desmoplastic stroma"
                    ]
                  },
                  {
                    "text": "SarcomatoidFascicular growth",
                    "sub_points": [
                      "Fascicular growth"
                    ]
                  },
                  {
                    "text": "± acantholytic appearance"
                  },
                  {
                    "text": "Perineural and lymphovascular invasion not uncommon"
                  },
                  {
                    "text": "± prominent mixed inflammation, including eosinophils"
                  },
                  {
                    "text": "Adjacent VIN in 30-70%; preexisting inflammatory dermatoses common if HPV independent"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "WartyCytoplasmic halos and koilocytotic atypiaIrregularly clumped and dispersed chromatinProminent nucleoli, multinucleation commonVariable mitotic activity",
                    "sub_points": [
                      "Cytoplasmic halos and koilocytotic atypia",
                      "Irregularly clumped and dispersed chromatin",
                      "Prominent nucleoli, multinucleation common",
                      "Variable mitotic activity"
                    ]
                  },
                  {
                    "text": "BasaloidRelatively uniform cells with scant cytoplasm (undifferentiated appearance); rarely, clear cytoplasmOvoid nuclei with coarsely granular chromatin and indistinct nucleoli; brisk mitoses",
                    "sub_points": [
                      "Relatively uniform cells with scant cytoplasm (undifferentiated appearance); rarely, clear cytoplasm",
                      "Ovoid nuclei with coarsely granular chromatin and indistinct nucleoli; brisk mitoses"
                    ]
                  },
                  {
                    "text": "KeratinizingCells with abundant eosinophilic cytoplasm and variable degrees of keratin formationVariable cytologic atypia and mitotic activity",
                    "sub_points": [
                      "Cells with abundant eosinophilic cytoplasm and variable degrees of keratin formation",
                      "Variable cytologic atypia and mitotic activity"
                    ]
                  },
                  {
                    "text": "SarcomatoidTapering hyperchromatic nuclei and variable eosinophilic cytoplasm ± rhabdoid cells",
                    "sub_points": [
                      "Tapering hyperchromatic nuclei and variable eosinophilic cytoplasm ± rhabdoid cells"
                    ]
                  }
                ],
                "Reporting": [
                  {
                    "text": "HPV associated vs. HPV independent"
                  },
                  {
                    "text": "Depth of InvasionConventional: Measurement from epithelial-stromal junction of adjacent most superficial dermal papilla to deepest point of invasionAlternative: Measurement from nearest dysplastic rete peg to deepest point of invasion (accepted by FIGO)Tumor thickness, if no landmarks",
                    "sub_points": [
                      "Conventional: Measurement from epithelial-stromal junction of adjacent most superficial dermal papilla to deepest point of invasion",
                      "Alternative: Measurement from nearest dysplastic rete peg to deepest point of invasion (accepted by FIGO)",
                      "Tumor thickness, if no landmarks"
                    ]
                  },
                  {
                    "text": "Distance to closest margins (in situ and invasive)"
                  },
                  {
                    "text": "Lymphovascular invasion"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Cytokeratins, p63 and p40, GATA3 (+)"
                  },
                  {
                    "text": "HPV associated: p16 strong (+); p53 typically (-)"
                  },
                  {
                    "text": "HPV independentp53 mutant type: p53(+) or \"null\"; p16 typically (-)p53 wild type: p53 heterogeneous; p16 typically (-)",
                    "sub_points": [
                      "p53 mutant type: p53(+) or \"null\"; p16 typically (-)",
                      "p53 wild type: p53 heterogeneous; p16 typically (-)"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Tangentially Sectioned Vulvar Intraepithelial Neoplasia": [
                  {
                    "text": "Uniform, puzzle-like nests with smooth contours"
                  },
                  {
                    "text": "No desmoplastic reaction"
                  }
                ],
                "Pseudoepitheliomatous Hyperplasia": [
                  {
                    "text": "May be associated with underlying granular cell tumor"
                  },
                  {
                    "text": "Uniform nuclear morphology"
                  },
                  {
                    "text": "Nuclear:cytoplasmic ratio maintained"
                  }
                ],
                "Leiomyosarcoma (vs. Spindled Squamous Cell Carcinoma)": [
                  {
                    "text": "Cigar-shaped nuclei with paranuclear vacuoles"
                  },
                  {
                    "text": "SMA, desmin, and caldesmon (+)"
                  }
                ],
                "Melanoma": [
                  {
                    "text": "In situ component"
                  },
                  {
                    "text": "± nuclear pseudoinclusions and melanin pigment"
                  },
                  {
                    "text": "S100, HMB-45, SOX10, and melan-A (+); PRAME often (+)"
                  }
                ],
                "Angiosarcoma (vs. Acantholytic Squamous Cell Carcinoma)": [
                  {
                    "text": "Spaces or intracytoplasmic vacuoles with erythrocytes"
                  },
                  {
                    "text": "CD31, CD34, and ERG (+)"
                  }
                ],
                "Proximal-Type Epithelioid Sarcoma": [
                  {
                    "text": "No in situ component or keratinization"
                  },
                  {
                    "text": "p63, cytokeratin 5/6 (-); CD34(+)"
                  }
                ],
                "Basal Cell Carcinoma": [
                  {
                    "text": "No in situ component; fairly uniform cytologic features"
                  },
                  {
                    "text": "Characteristic retraction artifact \"clefting\" around tumor"
                  },
                  {
                    "text": "BER-EP4(+)"
                  }
                ],
                "Sebaceous Carcinoma": [
                  {
                    "text": "Lacks in situ component"
                  },
                  {
                    "text": "Small cytoplasmic vacuoles and nuclear indentation"
                  },
                  {
                    "text": "PAS and p63 (-); AR, CK7, and adipophilin (+)"
                  }
                ],
                "Verrucous Carcinoma": [
                  {
                    "text": "Exophytic verruciform growth"
                  },
                  {
                    "text": "Lower border of tumor \"pushing\" rather than infiltrative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Exophytic component of tumor should not be used for depth of invasion measurement"
                  },
                  {
                    "text": "In poorly differentiated tumors, keratinization and desmosomes provide clues to diagnosis"
                  },
                  {
                    "text": "Tangential sectioning of adnexal structures involved by VIN should not be misinterpreted as invasion"
                  },
                  {
                    "text": "Before considering diagnosis of sarcoma, possibility of spindle squamous cell carcinoma should be excluded"
                  },
                  {
                    "text": "As significant morphologic overlap between HPV-related and -independent squamous cell carcinoma occurs, immunohistochemistry useful in subclassification"
                  },
                  {
                    "text": "Early stromal invasion may be difficult to diagnose in superficial biopsies; presence of paradoxical maturation and loss of basal membrane and cell polarity helpful in distinction from in situ disease"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Fallopian Tube: Nonneoplastic Lesions": {
        "name": "Fallopian Tube: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/7f36a342-b07f-462c-985c-990526a035e7",
        "topics": {
          "Fallopian Tube: Diagnosis": {
            "name": "Fallopian Tube: Diagnosis",
            "url": "https://app.pathprimer.com/document/69caa949-9dfd-473d-bd80-982d8366d5ab/lesson/7f36a342-b07f-462c-985c-990526a035e7",
            "content": {
              "SURGICAL/CLINICAL CONSIDERATIONS": {
                "Goal of Consultation": [
                  {
                    "text": "Determine if a mass-forming lesion of fallopian tube is benign or malignant"
                  },
                  {
                    "text": "Diagnose suspected tubal pregnancies by identifying products of conception"
                  }
                ],
                "Change in Patient Management": [
                  {
                    "text": "Additional biopsies may be taken for staging if carcinoma is present"
                  },
                  {
                    "text": "If ectopic pregnancy is present, salpingectomy or salpingotomy is performedAdditional surgical exploration is not necessary to identify alternative sites",
                    "sub_points": [
                      "Additional surgical exploration is not necessary to identify alternative sites"
                    ]
                  }
                ],
                "Clinical Setting": [
                  {
                    "text": "Majority of serous carcinomas are thought to arise in fimbriae of fallopian tubesWomen withBRCA1orBRCA2orP53(Li-Fraumeni syndrome) germline mutations are at high risk~ 10% will be diagnosed with an occult carcinomaTubal carcinoma is difficult to diagnose preoperativelyInflammatory conditions are more common than malignancy",
                    "sub_points": [
                      "Women withBRCA1orBRCA2orP53(Li-Fraumeni syndrome) germline mutations are at high risk~ 10% will be diagnosed with an occult carcinoma",
                      "~ 10% will be diagnosed with an occult carcinoma",
                      "Tubal carcinoma is difficult to diagnose preoperativelyInflammatory conditions are more common than malignancy",
                      "Inflammatory conditions are more common than malignancy"
                    ]
                  },
                  {
                    "text": "Women with elevated hCG levels but without documented intrauterine pregnancy may have ectopic pregnancyRupture and hemorrhage can be life threateningMajority of cases are diagnosed by ultrasound and managed conservativelyIn rare cases, clinical evaluation is inconclusive and intraoperative examination may be helpful",
                    "sub_points": [
                      "Rupture and hemorrhage can be life threatening",
                      "Majority of cases are diagnosed by ultrasound and managed conservatively",
                      "In rare cases, clinical evaluation is inconclusive and intraoperative examination may be helpful"
                    ]
                  }
                ]
              },
              "SPECIMEN EVALUATION": {
                "Gross": [
                  {
                    "text": "Describe size (length and diameter) and presence or absence of fimbriated endTubal carcinomas typically arise within fimbriaClose inspection for adhesions, discoloration, or masses is critical",
                    "sub_points": [
                      "Tubal carcinomas typically arise within fimbriaClose inspection for adhesions, discoloration, or masses is critical",
                      "Close inspection for adhesions, discoloration, or masses is critical"
                    ]
                  },
                  {
                    "text": "Patency of lumen is determined with probePlastic ring may be present if there has been prior tubal ligation",
                    "sub_points": [
                      "Plastic ring may be present if there has been prior tubal ligation"
                    ]
                  },
                  {
                    "text": "Serosal surface is describedNormal: Smooth and glisteningAdhesions: Rough surface and attached tissueParatubal cystsPurulent or fibrinous exudatesRupture",
                    "sub_points": [
                      "Normal: Smooth and glistening",
                      "Adhesions: Rough surface and attached tissue",
                      "Paratubal cysts",
                      "Purulent or fibrinous exudates",
                      "Rupture"
                    ]
                  },
                  {
                    "text": "For tubes removed as part of prophylactic salpingectomyIf grossly normal or if only cysts are present, fixation without sectioning is recommendedLikelihood of diagnosing carcinoma is very smallDetection of precursor lesions and small carcinomas may be compromised unless specimen is optimally fixed and processedIf a solid nodule > 0.5 cm is present and only a portion can be frozen, a frozen section may be appropriateFrozen section should only be performed if surgeon will perform additional staging procedures if carcinoma is diagnosed",
                    "sub_points": [
                      "If grossly normal or if only cysts are present, fixation without sectioning is recommendedLikelihood of diagnosing carcinoma is very smallDetection of precursor lesions and small carcinomas may be compromised unless specimen is optimally fixed and processed",
                      "Likelihood of diagnosing carcinoma is very small",
                      "Detection of precursor lesions and small carcinomas may be compromised unless specimen is optimally fixed and processed",
                      "If a solid nodule > 0.5 cm is present and only a portion can be frozen, a frozen section may be appropriateFrozen section should only be performed if surgeon will perform additional staging procedures if carcinoma is diagnosed",
                      "Frozen section should only be performed if surgeon will perform additional staging procedures if carcinoma is diagnosed"
                    ]
                  },
                  {
                    "text": "If a mass is present in tubeMake serial cross sections of tube; note any tubal contentsPurulent exudateHemorrhagePlacental or fetal tissue with membranesMassesAreas of firmness or discoloration",
                    "sub_points": [
                      "Make serial cross sections of tube; note any tubal contentsPurulent exudateHemorrhagePlacental or fetal tissue with membranesMassesAreas of firmness or discoloration",
                      "Purulent exudate",
                      "Hemorrhage",
                      "Placental or fetal tissue with membranes",
                      "Masses",
                      "Areas of firmness or discoloration"
                    ]
                  }
                ],
                "Frozen Section": [
                  {
                    "text": "If solid mass is present, a portion may be frozen to determine if carcinoma is presentIn absence of a mass, frozen section should not be undertakenTubes without solid gross lesions are best evaluated on permanent sectionsCysts and grossly normal tissue are highly unlikely to yield sufficient findings for a diagnosis of malignancy",
                    "sub_points": [
                      "In absence of a mass, frozen section should not be undertaken",
                      "Tubes without solid gross lesions are best evaluated on permanent sections",
                      "Cysts and grossly normal tissue are highly unlikely to yield sufficient findings for a diagnosis of malignancy"
                    ]
                  },
                  {
                    "text": "In setting of suspected ectopic pregnancies, areas of hemorrhage and blood clot often contain products of conception if they are not readily evident"
                  }
                ]
              },
              "MOST COMMON DIAGNOSES": {
                "Serous Lesions": [
                  {
                    "text": "Serous tubal intraepithelial carcinoma (STIC)Lacks invasion into underlying stromaMay be seen in areas adjacent to invasive carcinomaSupports a primary tubal carcinoma vs. carcinoma arising in ovary, peritoneum, or endometriumIdentified at low power by irregular epithelial thickness with exfoliation of tumor cellsHigh nuclear to cytoplasmic ratio and loss of ciliaNuclei show marked pleomorphismEnlarged nuclei with prominent nucleoliLoss of nuclear polarityFrequent mitosesHyperchromasiaApoptotic bodies commonHistologic features should recapitulate those seen in invasive serous carcinomaMay require supportive immunohistochemical studies for p53 and Ki-67 for diagnosis",
                    "sub_points": [
                      "Lacks invasion into underlying stroma",
                      "May be seen in areas adjacent to invasive carcinomaSupports a primary tubal carcinoma vs. carcinoma arising in ovary, peritoneum, or endometrium",
                      "Supports a primary tubal carcinoma vs. carcinoma arising in ovary, peritoneum, or endometrium",
                      "Identified at low power by irregular epithelial thickness with exfoliation of tumor cellsHigh nuclear to cytoplasmic ratio and loss of cilia",
                      "High nuclear to cytoplasmic ratio and loss of cilia",
                      "Nuclei show marked pleomorphismEnlarged nuclei with prominent nucleoliLoss of nuclear polarityFrequent mitosesHyperchromasiaApoptotic bodies common",
                      "Enlarged nuclei with prominent nucleoli",
                      "Loss of nuclear polarity",
                      "Frequent mitoses",
                      "Hyperchromasia",
                      "Apoptotic bodies common",
                      "Histologic features should recapitulate those seen in invasive serous carcinoma",
                      "May require supportive immunohistochemical studies for p53 and Ki-67 for diagnosis"
                    ]
                  },
                  {
                    "text": "Invasive serous carcinoma90% of fallopian tube carcinomas3-20% are bilateralMost common in women aged 40s-60sSimilar histologic features as mentioned above with invasion into underlying stromaFrequently associated with lymphovascular invasion, which may be identified on frozen sections",
                    "sub_points": [
                      "90% of fallopian tube carcinomas3-20% are bilateralMost common in women aged 40s-60s",
                      "3-20% are bilateral",
                      "Most common in women aged 40s-60s",
                      "Similar histologic features as mentioned above with invasion into underlying stroma",
                      "Frequently associated with lymphovascular invasion, which may be identified on frozen sections"
                    ]
                  }
                ],
                "Ectopic Pregnancy": [
                  {
                    "text": "Most common implantation site for ectopic pregnancy is fallopian tubeUnusual sites are ovary, abdomen, cervix, or caesarean section scarIncreased risk is associated with endometriosis, pelvic inflammatory disease, and prior surgery",
                    "sub_points": [
                      "Unusual sites are ovary, abdomen, cervix, or caesarean section scar",
                      "Increased risk is associated with endometriosis, pelvic inflammatory disease, and prior surgery"
                    ]
                  },
                  {
                    "text": "87-99% of tubal pregnancies can be diagnosed by transvaginal ultrasoundOnly rare women have a positive pregnancy test and inconclusive ultrasound examinationsTermed \"pregnancy of unknown location\" (PUL)",
                    "sub_points": [
                      "Only rare women have a positive pregnancy test and inconclusive ultrasound examinations",
                      "Termed \"pregnancy of unknown location\" (PUL)"
                    ]
                  },
                  {
                    "text": "Many women are treated medically with methotrexate"
                  },
                  {
                    "text": "Surgical treatment can be by salpingotomy or salpingectomyIntraoperative evaluation may be useful for cases with unclear clinical and imaging characteristicsPresence of fetal villi, gestational sac, implantation site, or embryonic parts is diagnostic",
                    "sub_points": [
                      "Intraoperative evaluation may be useful for cases with unclear clinical and imaging characteristics",
                      "Presence of fetal villi, gestational sac, implantation site, or embryonic parts is diagnostic"
                    ]
                  }
                ],
                "Infarction": [
                  {
                    "text": "Edematous, hemorrhagic tube grossly"
                  },
                  {
                    "text": "Widespread hemorrhagic necrosis commonly present microscopically"
                  }
                ],
                "Transitional Cell Lesions": [
                  {
                    "text": "Transitional cell metaplasiaAlso termed Walthard nestsCommon benign finding; not proven to be a precursor lesion",
                    "sub_points": [
                      "Also termed Walthard nests",
                      "Common benign finding; not proven to be a precursor lesion"
                    ]
                  },
                  {
                    "text": "Transitional cell carcinoma10% of primary fallopian tube carcinomasMost common in women in 40s-50sIncreased risk in women withBRCA1orBRCA2mutationsHistologic appearance is similar to urinary tract transitional carcinomasSolid and papillary sheet-like growthHigh-grade nucleiFrequent mitoses",
                    "sub_points": [
                      "10% of primary fallopian tube carcinomas",
                      "Most common in women in 40s-50s",
                      "Increased risk in women withBRCA1orBRCA2mutations",
                      "Histologic appearance is similar to urinary tract transitional carcinomasSolid and papillary sheet-like growthHigh-grade nucleiFrequent mitoses",
                      "Solid and papillary sheet-like growth",
                      "High-grade nuclei",
                      "Frequent mitoses"
                    ]
                  }
                ],
                "Inflammatory Conditions": [
                  {
                    "text": "Can be associated with endometriosis, pelvic inflammatory disease, and chronic endometritisRisk factor for ectopic pregnancyUsually bilateralSome cancers are associated with inflammation and abscess formation",
                    "sub_points": [
                      "Risk factor for ectopic pregnancy",
                      "Usually bilateral",
                      "Some cancers are associated with inflammation and abscess formation"
                    ]
                  },
                  {
                    "text": "May be caused by tuberculosis, actinomycosis, coccidioidomycosis, Crohn disease, or sarcoidosis"
                  },
                  {
                    "text": "Can result in a tubal mass &/or distension and thickening of tubal plicae"
                  },
                  {
                    "text": "Chronic active salpingitis can result in salpingitis follicularisFused plicae due to fibrin deposition result in follicle-like structures",
                    "sub_points": [
                      "Fused plicae due to fibrin deposition result in follicle-like structures"
                    ]
                  }
                ],
                "Salpingitis Isthmica Nodosa": [
                  {
                    "text": "Diverticular disease of tubesSurrounded by smooth muscleOnly mild inflammation",
                    "sub_points": [
                      "Surrounded by smooth muscle",
                      "Only mild inflammation"
                    ]
                  },
                  {
                    "text": "Grossly appears as yellow-white nodules near isthmus"
                  }
                ],
                "Mesonephric Remnant of Broad Ligament": [
                  {
                    "text": "May form a nodule in wall of tube"
                  },
                  {
                    "text": "Composed of small tubules with low columnar to cuboidal cellsLack cilia",
                    "sub_points": [
                      "Lack cilia"
                    ]
                  },
                  {
                    "text": "Surrounded by prominent smooth muscle"
                  },
                  {
                    "text": "May have a cystic component"
                  }
                ],
                "Leiomyoma": [
                  {
                    "text": "Can form nodules in wall of fallopian tube"
                  },
                  {
                    "text": "Formed of bland spindle-shaped smooth muscle cells"
                  }
                ]
              },
              "REPORTING": {
                "Gross Evaluation": [
                  {
                    "text": "Grossly normal tubes or tubes with only small cystic or solid nodules (< 5 mm) may be reported as suchFurther processing and diagnosis should be deferred to permanent sections",
                    "sub_points": [
                      "Further processing and diagnosis should be deferred to permanent sections"
                    ]
                  }
                ],
                "Frozen Section": [
                  {
                    "text": "Report \"invasive serous carcinoma, high grade\" when serous carcinoma is identified"
                  },
                  {
                    "text": "Serous tubal intraepithelial carcinoma is difficult if not impossible to diagnose by frozen sectionReport \"severe tubal atypia\" with explanation of the features that are present and defer final diagnosis to permanent sections",
                    "sub_points": [
                      "Report \"severe tubal atypia\" with explanation of the features that are present and defer final diagnosis to permanent sections"
                    ]
                  },
                  {
                    "text": "Report \"tubal ectopic pregnancy\" when identifiable products of conception are present"
                  }
                ]
              },
              "PITFALLS": {
                "Transitional Cell Metaplasia": [
                  {
                    "text": "May mimic tubal intraepithelial carcinoma due to increased epithelial thickness and increased nuclear density"
                  },
                  {
                    "text": "Lesions consist of bland cells with streaming nuclei oriented perpendicularly to epithelial base"
                  },
                  {
                    "text": "Pleomorphism and mitotic activity should be absent"
                  }
                ],
                "Endometriosis": [
                  {
                    "text": "Endometrial glands and stroma present in lumen or within tubal wall"
                  },
                  {
                    "text": "Endometriosis may form a mass or areas of extensive hemorrhage mimicking a neoplasm or possible ectopic pregnancy"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Fallopian Tube: Neoplasms": {
        "name": "Fallopian Tube: Neoplasms",
        "url": "https://app.pathprimer.com/lesson/42d0799c-47ca-4616-95fb-c077d13d2f8a",
        "topics": {
          "Adenomatoid Tumor": {
            "name": "Adenomatoid Tumor",
            "url": "https://app.pathprimer.com/document/edb6965b-ddc8-4bcf-9e4f-fe02ad5f1cb6/lesson/42d0799c-47ca-4616-95fb-c077d13d2f8a",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign tumor of mesothelial origin"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common benign tumor of fallopian tube"
                  },
                  {
                    "text": "Typically incidental finding"
                  },
                  {
                    "text": "4th-5th decades"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Small, generally < 2 cm"
                  },
                  {
                    "text": "Well-circumscribed, subserosal or intramural, solid, gray to yellow-white noduleIf associated with renal transplant, less well circumscribed and often multiple",
                    "sub_points": [
                      "If associated with renal transplant, less well circumscribed and often multiple"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Numerous variably sized but usually small cysts, tubular gland-like structures, and signet-ring-like cells"
                  },
                  {
                    "text": "Variable amounts of cytoplasm, bland nuclear features, no mitoses± degenerative (bizarre) atypia",
                    "sub_points": [
                      "± degenerative (bizarre) atypia"
                    ]
                  },
                  {
                    "text": "Loose collagenous or fibromuscular stroma"
                  },
                  {
                    "text": "Lymphoid infiltrate ± lymphoid aggregates"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "AE1/AE3, CK7, CAM5.2, CK18/19, EMA positive"
                  },
                  {
                    "text": "Calretinin, D2-40, WT1, ER, PR positive; BAP1 retained"
                  },
                  {
                    "text": "PAX8 may be positive"
                  },
                  {
                    "text": "CK5/6, caldesmon typically negative"
                  },
                  {
                    "text": "TRAF7mutations"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Malignant mesothelioma"
                  },
                  {
                    "text": "Salpingitis isthmica nodosa"
                  },
                  {
                    "text": "Signet-ring cell carcinoma"
                  },
                  {
                    "text": "Lymphangioma"
                  },
                  {
                    "text": "Lipoleiomyoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign tumor of mesothelial origin"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common benign tumor of fallopian tube"
                  }
                ],
                "Age": [
                  {
                    "text": "4th-5th decades"
                  }
                ],
                "Site": [
                  {
                    "text": "Uterus > fallopian tube/mesosalpinx"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic, incidental finding"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Excision, if symptomatic"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well-circumscribed, subserosal or intramural noduleIf associated with renal transplant, less well circumscribed and often multiple",
                    "sub_points": [
                      "If associated with renal transplant, less well circumscribed and often multiple"
                    ]
                  },
                  {
                    "text": "Solid, gray to tan to yellow-white cut surface"
                  }
                ],
                "Size": [
                  {
                    "text": "Small, generally < 2 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Circumscribed but unencapsulated"
                  },
                  {
                    "text": "Numerous variably sized but usually small cysts, tubular gland-like structures, and signet-ring-like cells"
                  },
                  {
                    "text": "Loose collagenous or fibromuscular stroma"
                  },
                  {
                    "text": "Lymphoid infiltrate ± lymphoid aggregates, often at peripheryLess prominent in females than in males",
                    "sub_points": [
                      "Less prominent in females than in males"
                    ]
                  },
                  {
                    "text": "Extensive infarction may occur"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cuboidal to flat to hobnail cells"
                  },
                  {
                    "text": "Intracytoplasmic vacuoles (signet-ring-like cells)"
                  },
                  {
                    "text": "Variable amounts of cytoplasm and typically bland nuclei± degenerative (bizarre) atypia",
                    "sub_points": [
                      "± degenerative (bizarre) atypia"
                    ]
                  },
                  {
                    "text": "Mitoses absent"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "Surface microvilli"
                  }
                ],
                "Histochemistry and Immunohistochemistry": [
                  {
                    "text": "Alcian blue positive vacuoles (hyaluronidase sensitive)"
                  },
                  {
                    "text": "AE1/AE3, CK7, CAM5.2, CK18/19, EMA positiveKeratin paranuclear and cytoplasmic positive",
                    "sub_points": [
                      "Keratin paranuclear and cytoplasmic positive"
                    ]
                  },
                  {
                    "text": "Calretinin, D2-40, WT1, ER, PR positive; BAP1 retained"
                  },
                  {
                    "text": "PAX8 may be positive"
                  },
                  {
                    "text": "CK5/6, caldesmon typically negative"
                  }
                ],
                "Molecular Features": [
                  {
                    "text": "TRAF7mutations resulting in activation of NF-kB pathway"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Malignant Mesothelioma": [
                  {
                    "text": "Clinically symptomatic and grossly visible"
                  },
                  {
                    "text": "Poorly circumscribed margins"
                  },
                  {
                    "text": "Invasion of underlying tissues"
                  },
                  {
                    "text": "Solid and complex architectural growth"
                  },
                  {
                    "text": "Uniform cytologic atypia and mitotic activity"
                  },
                  {
                    "text": "Loss of BAP1 (~ 50%)"
                  }
                ],
                "Salpingitis Isthmica Nodosa": [
                  {
                    "text": "Connection with fallopian tube lumen"
                  },
                  {
                    "text": "Tubal-type epithelium"
                  },
                  {
                    "text": "D2-40 negative"
                  }
                ],
                "Signet-Ring Cell Carcinoma": [
                  {
                    "text": "Prior clinical history"
                  },
                  {
                    "text": "Poorly circumscribed"
                  },
                  {
                    "text": "Cells with intracytoplasmic mucin"
                  },
                  {
                    "text": "BER-EP4, CEA, B72.3 typically positive"
                  },
                  {
                    "text": "Calretinin, D2-40, WT1 negative"
                  }
                ],
                "Lymphangioma": [
                  {
                    "text": "Small cysts &/or variably sized channels with eosinophilic intraluminal fluid"
                  },
                  {
                    "text": "CD31, CD34, D2-40 positive; WT1 and keratin negative"
                  }
                ],
                "Lipoleiomyoma": [
                  {
                    "text": "Predominant smooth muscle component"
                  },
                  {
                    "text": "D2-40, calretinin negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Any sizable mesothelial lesion thought to be adenomatoid tumor should be entirely examined to exclude malignant mesothelioma with adenomatoid morphology"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Serous Borderline Tumor": {
            "name": "Serous Borderline Tumor",
            "url": "https://app.pathprimer.com/document/bd0305c4-bc60-4419-8955-2867121cb693/lesson/42d0799c-47ca-4616-95fb-c077d13d2f8a",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Low-grade proliferative serous neoplasm without invasion"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare"
                  },
                  {
                    "text": "22-83 (mean: 42) years"
                  },
                  {
                    "text": "Presentation: Incidental; pelvic pain ± ascites; abdominal fullness"
                  },
                  {
                    "text": "Fimbriated end more common"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Multiple soft, papillary, or nodular excrescences within lumen"
                  },
                  {
                    "text": "Wide size range"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hierarchical papillary architecture with detached, small papillae, micropapillae, tufting or budding"
                  },
                  {
                    "text": "Columnar/cuboidal and eosinophilic cells, latter with terminal bar and ciliaLow nuclear gradeMitotic figures rare",
                    "sub_points": [
                      "Low nuclear grade",
                      "Mitotic figures rare"
                    ]
                  },
                  {
                    "text": "No stromal invasion"
                  },
                  {
                    "text": "Luminal and mucosal salpingoliths (psammomatous calcifications) common"
                  },
                  {
                    "text": "Hydrosalpinx (~ 40%)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAX8, WT1, ER, PR positive"
                  },
                  {
                    "text": "Calretinin, p16 patchy positive; D2-40 negative"
                  },
                  {
                    "text": "p53 wild type"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Malignant mesothelioma, epithelial type"
                  },
                  {
                    "text": "Low-grade serous carcinoma"
                  },
                  {
                    "text": "Epithelial hyperplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Serous borderline tumor (SBT)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Serous tumor of uncertain malignant potential (not recommended)"
                  },
                  {
                    "text": "Atypical proliferative serous tumor (not recommended)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Low-grade proliferative serous neoplasm without invasion"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neoplastic Transformation": [
                  {
                    "text": "May arise from papillary hyperplasia of fallopian tube"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  }
                ],
                "Age": [
                  {
                    "text": "22-83 (mean: 42) years"
                  }
                ],
                "Site": [
                  {
                    "text": "Fimbriated end more common"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Incidental"
                  },
                  {
                    "text": "Abdominal fullness or pelvic pain ± ascites"
                  },
                  {
                    "text": "Abnormal Papanicolaou smear"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Salpingectomy ± oophorectomy (if fertility desired) ± staging biopsies"
                  },
                  {
                    "text": "Bilateral salpingo-oophorectomy + hysterectomy + staging biopsies"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Stage dependent"
                  },
                  {
                    "text": "Implant type dependent (invasive implants associated with poor prognosis)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Multiple soft, papillary, or nodular excrescences within lumen"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range: 2-23 (mean: 4.5) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hierarchical papillary architecture"
                  },
                  {
                    "text": "Detached, small papillae, micropapillae, tufting or budding"
                  },
                  {
                    "text": "No stromal invasion"
                  },
                  {
                    "text": "Luminal and mucosal salpingoliths (psammomatous calcifications) common"
                  },
                  {
                    "text": "± papillary tufting of uninvolved tubal epithelium"
                  },
                  {
                    "text": "Hydrosalpinx (~ 40%)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Columnar/cuboidal and eosinophilic cells, latter with terminal bar and cilia"
                  },
                  {
                    "text": "Low nuclear grade and rare mitoses"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "PAX8, WT1, ER, PR positive"
                  },
                  {
                    "text": "Calretinin, p16 patchy positive"
                  },
                  {
                    "text": "D2-40 negative"
                  },
                  {
                    "text": "p53 wild type"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Malignant Mesothelioma, Epithelial Type": [
                  {
                    "text": "Extensive peritoneal involvement"
                  },
                  {
                    "text": "Lacks prominent cellular budding"
                  },
                  {
                    "text": "D2-40 positive; ER negative"
                  },
                  {
                    "text": "Loss of BAP1 (~ 50%)"
                  },
                  {
                    "text": "Microvilli by electron microscopy"
                  }
                ],
                "Low-Grade Serous Carcinoma": [
                  {
                    "text": "Confluent papillary growth"
                  },
                  {
                    "text": "Stromal invasion"
                  },
                  {
                    "text": "More pronounced cytologic atypia and prominent nucleoli"
                  }
                ],
                "Epithelial Hyperplasia": [
                  {
                    "text": "Not mass forming"
                  },
                  {
                    "text": "Lacks fibrovascular cores"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "May represent source of peritoneal or ovarian low-grade serous neoplasms, but stage, not source of tumor, clinically significant"
                  },
                  {
                    "text": "Finding of psammoma bodies with low-grade serous-type epithelium in Papanicolaou smear should prompt evaluation of upper genital tract, including fallopian tube, to exclude SBT"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Ovary: Nonneoplastic Lesions": {
        "name": "Ovary: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/fe17c9eb-92da-42fc-92f7-2d34ef8a63d0",
        "topics": {
          "Endometriosis and Deciduosis": {
            "name": "Endometriosis and Deciduosis",
            "url": "https://app.pathprimer.com/document/c27541db-fbb0-47a3-bdd9-36abeb23a9c0/lesson/fe17c9eb-92da-42fc-92f7-2d34ef8a63d0",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Endometriosis: Ectopic endometrial tissue"
                  },
                  {
                    "text": "Deciduosis: Ectopic tissue resembling endometrial tissue during pregnancy"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Asymptomatic, infertility, pain"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Red, brown, white plaques ± adhesions (endometriosis)"
                  },
                  {
                    "text": "Blood-filled \"chocolate\" cysts or cysts with roughened, granular, tan to brown lining with variably thick wall (endometrioma)"
                  },
                  {
                    "text": "Tan to pale brown or gray to white, soft or gelatinous nodules (deciduosis)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "EndometriosisEndometrial-type glands and stroma ± recent hemorrhage, hemosiderin, histiocytes, fibrosisSingle layer of müllerian-type epithelium to appearance of cycling endometriumDegenerative epithelial atypia or metaplasiaStroma may be myxoid, show smooth muscle metaplasia, or hyalinization/fibrosis",
                    "sub_points": [
                      "Endometrial-type glands and stroma ± recent hemorrhage, hemosiderin, histiocytes, fibrosis",
                      "Single layer of müllerian-type epithelium to appearance of cycling endometrium",
                      "Degenerative epithelial atypia or metaplasia",
                      "Stroma may be myxoid, show smooth muscle metaplasia, or hyalinization/fibrosis"
                    ]
                  },
                  {
                    "text": "DeciduosisNodular aggregates and clusters of cells with abundant, dense (glassy) eosinophilic to vacuolated (bubbly) cytoplasm and distinct cell borders, usually involving superficial ovarian cortexRound/oval nuclei with prominent nucleoli or indented nucleiStroma with myxoid change (pregnancy) or hyalinization/fibrosis (longstanding lesions)",
                    "sub_points": [
                      "Nodular aggregates and clusters of cells with abundant, dense (glassy) eosinophilic to vacuolated (bubbly) cytoplasm and distinct cell borders, usually involving superficial ovarian cortex",
                      "Round/oval nuclei with prominent nucleoli or indented nuclei",
                      "Stroma with myxoid change (pregnancy) or hyalinization/fibrosis (longstanding lesions)"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hemorrhagic follicular cyst"
                  },
                  {
                    "text": "Cystadenoma"
                  },
                  {
                    "text": "Deciduoid mesothelioma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Endometriosis: Ectopic endometrial tissue"
                  },
                  {
                    "text": "Deciduosis: Ectopic tissue resembling endometrial tissue during pregnancy"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Endometriosis": [
                  {
                    "text": "Metaplastic vs. implantation (retrograde menstruation)"
                  }
                ],
                "Deciduosis": [
                  {
                    "text": "Secondary to high levels of chorionic gonadotropin (pregnancy or gestational trophoblastic disease) or progestin"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Endometriosis: Common (15% of reproductive women)"
                  },
                  {
                    "text": "Deciduosis: Involves almost all ovaries at term"
                  }
                ],
                "Site": [
                  {
                    "text": "Ovary (most common), peritoneal surfaces"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic (if microscopic)"
                  },
                  {
                    "text": "Endometriosis: Infertility, pain (depending on extent)"
                  },
                  {
                    "text": "Deciduosis: Incidental at cesarean section (~ 10%)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "If limited: Analgesics"
                  },
                  {
                    "text": "If significant: Androgens, progestins, GnRH agonists, &/or aromatase inhibitors"
                  },
                  {
                    "text": "If severe: Laser ablation or excision"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent except if secondary malignancy"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Frequently bilateral"
                  },
                  {
                    "text": "Red, brown, or white plaques often associated with adhesions (endometriosis)"
                  },
                  {
                    "text": "Blood-filled \"chocolate\" cysts or cysts with roughened, granular, tan to brown lining ± thick wall (endometrioma) to polypoid/nodular (polypoid endometriosis)"
                  },
                  {
                    "text": "Tan to pale brown or gray to white, soft or gelatinous nodules (deciduosis)"
                  }
                ],
                "Size": [
                  {
                    "text": "Endometriosis: Microscopic to cystic (≤ 15 cm)"
                  },
                  {
                    "text": "Deciduosis: Microscopic to small (usually < 5 mm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "EndometriosisEndometrial-type glands and stroma ± recent hemorrhage, hemosiderin ± histiocytesEpithelial component: Müllerian-type epithelium ranging from atrophic to cycling endometriumMay show degenerative atypia (enlarged nuclei with smudgy chromatin) or metaplastic changesStroma may be myxoid (particularly during pregnancy), show smooth muscle metaplasia, elastosis, or hyalinization/fibrosis (longstanding lesions)Atrophic endometriosis: Absent or minimal endometrial/nonspecific stromaStromal endometriosis: Stroma onlyPolypoid endometriosis: Similar to endometrial polypNecrotic pseudoxanthomatous nodules rare (central necrosis surrounded by pseudoxanthoma cells, surrounded by fibrosis)Secondary hyperplastic changes, endometrioid or clear cell carcinoma, other",
                    "sub_points": [
                      "Endometrial-type glands and stroma ± recent hemorrhage, hemosiderin ± histiocytes",
                      "Epithelial component: Müllerian-type epithelium ranging from atrophic to cycling endometriumMay show degenerative atypia (enlarged nuclei with smudgy chromatin) or metaplastic changes",
                      "May show degenerative atypia (enlarged nuclei with smudgy chromatin) or metaplastic changes",
                      "Stroma may be myxoid (particularly during pregnancy), show smooth muscle metaplasia, elastosis, or hyalinization/fibrosis (longstanding lesions)Atrophic endometriosis: Absent or minimal endometrial/nonspecific stromaStromal endometriosis: Stroma only",
                      "Atrophic endometriosis: Absent or minimal endometrial/nonspecific stroma",
                      "Stromal endometriosis: Stroma only",
                      "Polypoid endometriosis: Similar to endometrial polyp",
                      "Necrotic pseudoxanthomatous nodules rare (central necrosis surrounded by pseudoxanthoma cells, surrounded by fibrosis)",
                      "Secondary hyperplastic changes, endometrioid or clear cell carcinoma, other"
                    ]
                  },
                  {
                    "text": "DeciduosisNodular aggregates/clusters of cells with abundant, dense (glassy) eosinophilic to vacuolated cytoplasm and distinct cell borders, usually on superficial ovarian cortexRound/oval nuclei with prominent nucleoli or indented nuclei (more often if cytoplasmic vacuolization)± degenerative, pyknotic nuclei± rich vascular network and sprinkling of lymphocytesNo mitotic activity",
                    "sub_points": [
                      "Nodular aggregates/clusters of cells with abundant, dense (glassy) eosinophilic to vacuolated cytoplasm and distinct cell borders, usually on superficial ovarian cortex",
                      "Round/oval nuclei with prominent nucleoli or indented nuclei (more often if cytoplasmic vacuolization)",
                      "± degenerative, pyknotic nuclei",
                      "± rich vascular network and sprinkling of lymphocytes",
                      "No mitotic activity"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Epithelium: ER, PR, CK7 (+), ± ARID1A loss"
                  },
                  {
                    "text": "Stroma: ER, PR, CD10 (+)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hemorrhagic Follicular Cyst (vs. Endometrioma)": [
                  {
                    "text": "Granulosa-theca lining"
                  },
                  {
                    "text": "No endometrial-type stroma or müllerian epithelium"
                  }
                ],
                "Cystadenoma (vs. Endometrioma)": [
                  {
                    "text": "Lacks endometrial-type stroma"
                  },
                  {
                    "text": "Hemosiderin uncommon or very focal"
                  }
                ],
                "Deciduoid Mesothelioma (vs. Deciduosis)": [
                  {
                    "text": "Invasion of underlying tissues"
                  },
                  {
                    "text": "Keratin, calretinin, and D2-40 (+), ± BAP1 loss"
                  }
                ],
                "Carcinomatosis (vs. Deciduosis)": [
                  {
                    "text": "Invasion of underlying tissue, malignant cytologic features"
                  },
                  {
                    "text": "Keratin diffusely (+)"
                  }
                ],
                "Peritoneal Tuberculosis (vs. Deciduosis)": [
                  {
                    "text": "Caseating granulomas, lacks myxoid appearance; CD56(+)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Endometriomas are often lined by attenuated endometrioid epithelium and lack obvious endometrial stromal component"
                  },
                  {
                    "text": "Cysts with marked epithelial atypia should be carefully examined and extensively sampled to exclude malignancy"
                  },
                  {
                    "text": "Before making diagnosis of signet-ring cell carcinoma in pregnant patient, consider possibility of deciduosis"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Ovary: Neoplasms": {
        "name": "Ovary: Neoplasms",
        "url": "https://app.pathprimer.com/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
        "topics": {
          "Benign Serous Tumors": {
            "name": "Benign Serous Tumors",
            "url": "https://app.pathprimer.com/document/7f321a1a-8eba-4dcb-a245-b92c1a5aef1f/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Tumor composed of varying amounts of ovarian-type stroma and benign tubal-type epitheliumSerous cystadenoma: Predominantly cystic (> 1 cm) with minimal stromal componentSerous cystadenofibroma: Prominent cyst(s) with abundant stromal componentSerous adenofibroma: Predominant stromal component admixed with small glandsSurface papilloma: Adenofibroma variant with prominent papillae involving ovarian surface",
                    "sub_points": [
                      "Serous cystadenoma: Predominantly cystic (> 1 cm) with minimal stromal component",
                      "Serous cystadenofibroma: Prominent cyst(s) with abundant stromal component",
                      "Serous adenofibroma: Predominant stromal component admixed with small glands",
                      "Surface papilloma: Adenofibroma variant with prominent papillae involving ovarian surface"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Wide range (mean: 4th decade)"
                  },
                  {
                    "text": "Pelvic pressure or pain, or asymptomatic"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically unilateral and usually < 10 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cysts, glands, papillae lined by single layer of bland cuboidal, columnar, or flattened cells with variable amounts of cilia"
                  },
                  {
                    "text": "Variably cellular bland fibromatous stroma (± edema, hyalinization), if (cyst)adenofibroma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAX8, WT1, ER positive (epithelial component)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Serous borderline tumor"
                  },
                  {
                    "text": "Seromucinous cystadenoma/fibroma"
                  },
                  {
                    "text": "Endometriosis"
                  },
                  {
                    "text": "Peritoneal inclusion cyst(s)"
                  },
                  {
                    "text": "Hydrosalpinx"
                  },
                  {
                    "text": "Cystic struma ovarii"
                  },
                  {
                    "text": "Rete cystadenoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Tumor composed of varying amounts of ovarian-type stroma and benign tubal-type epitheliumSerous cystadenoma: Predominantly cystic (> 1 cm) with minimal stromal componentSerous cystadenofibroma: Prominent cyst(s) with abundant stromal componentSerous adenofibroma: Predominant stromal component admixed with small glandsSurface papilloma: Adenofibroma variant with prominent papillae involving ovarian surface",
                    "sub_points": [
                      "Serous cystadenoma: Predominantly cystic (> 1 cm) with minimal stromal component",
                      "Serous cystadenofibroma: Prominent cyst(s) with abundant stromal component",
                      "Serous adenofibroma: Predominant stromal component admixed with small glands",
                      "Surface papilloma: Adenofibroma variant with prominent papillae involving ovarian surface"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Wide range (mean: 4th decade)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Pelvic pressure or pain or asymptomatic"
                  },
                  {
                    "text": "Urinary bladder symptoms or change in bowel habits (due to secondary compression)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cystectomy or oophorectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Simple or complex \"cysts,\" 8- to 9-cm diameter"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically unilateral"
                  },
                  {
                    "text": "CystadenomaUni- or rarely multilocular with clear fluidSmooth outer and inner surfaces",
                    "sub_points": [
                      "Uni- or rarely multilocular with clear fluid",
                      "Smooth outer and inner surfaces"
                    ]
                  },
                  {
                    "text": "CystadenofibromaVariably sized cysts usually containing clear fluidIntermixed white-to-gray, firm, solid areasFirm papillary excrescences may be seen",
                    "sub_points": [
                      "Variably sized cysts usually containing clear fluid",
                      "Intermixed white-to-gray, firm, solid areas",
                      "Firm papillary excrescences may be seen"
                    ]
                  },
                  {
                    "text": "AdenofibromaPredominantly solid, firm, white-to-gray cut surfaceScattered small cysts",
                    "sub_points": [
                      "Predominantly solid, firm, white-to-gray cut surface",
                      "Scattered small cysts"
                    ]
                  },
                  {
                    "text": "Surface papillomaFirm, \"nubby\" papillary excrescences",
                    "sub_points": [
                      "Firm, \"nubby\" papillary excrescences"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Mean: 8-9 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cysts, glands, or papillae lined by single layer of serous-type epithelium"
                  },
                  {
                    "text": "Variably cellular fibromatous stroma (± edema, hyalinization), if (cyst)adenofibroma"
                  },
                  {
                    "text": "Rarely, psammoma bodies, minor sex cord-like elements, signet-ring-stromal cells, ulceration with histiocytes"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cuboidal, columnar, or flattened cells with variable amounts of cilia"
                  },
                  {
                    "text": "Epithelium and stroma with bland nuclei and rare to no mitoses"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "PAX8, WT1, ER positive (epithelial component)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Copy number changes (trisomy 12) in stromal cells"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Serous Borderline Tumor": [
                  {
                    "text": "Soft, friable papillary excrescences (gross)"
                  },
                  {
                    "text": "Hierarchical branching of papillae with irregular contours"
                  },
                  {
                    "text": "Epithelial component with pseudostratification, detached cell clusters (\"budding\"), and some cytologic atypia"
                  },
                  {
                    "text": "If borderline areas < 10% of tumor, diagnosis of \"serous cystadenoma with focal proliferation\" or \"serous cystadenoma with focal atypia\" appropriate"
                  }
                ],
                "Seromucinous Cystadenoma/Fibroma": [
                  {
                    "text": "Mixture of ciliated and mucinous (endocervical-type) epithelium"
                  }
                ],
                "Endometriosis": [
                  {
                    "text": "Endometrial-type stroma (CD10 positive)"
                  },
                  {
                    "text": "Recent &/or old hemorrhage, fibrosis"
                  }
                ],
                "Peritoneal Inclusion Cyst(s)": [
                  {
                    "text": "Mesothelial cells (no cilia); surface adhesions common"
                  },
                  {
                    "text": "± squamous or transitional metaplasia"
                  }
                ],
                "Hydrosalpinx": [
                  {
                    "text": "Residual plicae within cyst, tuboovarian adhesions"
                  }
                ],
                "Cystic Struma Ovarii": [
                  {
                    "text": "Focal colloid containing follicles adjacent to main cyst"
                  },
                  {
                    "text": "Thyroglobulin, TTF-1 positive"
                  }
                ],
                "Rete Cystadenoma": [
                  {
                    "text": "Centered in ovarian hilum; no cilia"
                  },
                  {
                    "text": "Smooth muscle ± Leydig cells in cyst wall"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Ciliated epithelium, which may be only focally present, essential for diagnosis; if cilia not identified, consider entities in differential diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Benign Brenner Tumor": {
            "name": "Benign Brenner Tumor",
            "url": "https://app.pathprimer.com/document/42970a16-6e20-4919-bea0-8b59ca46cd53/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign epithelial-stromal tumor with nests of transitional-type epithelium embedded in fibromatous stroma"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Potential derivation from Walthard nests"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "< 5% of benign ovarian epithelial-stromal tumors"
                  },
                  {
                    "text": "Rarely, hormonal manifestations (functioning stroma)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Well circumscribed and typically < 2 cm"
                  },
                  {
                    "text": "Solid, firm, white to pale yellow cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Round to oval, evenly distributed nests or (less commonly) trabeculae of transitional-type epithelium"
                  },
                  {
                    "text": "Abundant pale amphophilic, eosinophilic, and, less commonly, clear cytoplasm"
                  },
                  {
                    "text": "± signet ring-like cells within nests"
                  },
                  {
                    "text": "Oval to elongated nuclei often with central longitudinal grooves (\"coffee bean\")"
                  },
                  {
                    "text": "Small nucleoli and rare or absent mitoses"
                  },
                  {
                    "text": "Fibroma-like stroma that may show luteinization"
                  },
                  {
                    "text": "Dystrophic stromal calcifications in ~ 1/3"
                  },
                  {
                    "text": "Associated mucinous tumor > > serous cystadenoma or mature cystic teratoma in 25%"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, EMA, p63, uroplakin-3, thrombomodulin, and GATA3 positive"
                  },
                  {
                    "text": "KRASmutations or 12q14-21 amplification"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Endometrioid adenofibroma with squamous morules"
                  },
                  {
                    "text": "Adult granulosa cell tumor (insular)"
                  },
                  {
                    "text": "Insular carcinoid (primary or metastatic)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign epithelial-stromal tumor with nests of transitional-type epithelium embedded in fibromatous stroma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Postulated Origin": [
                  {
                    "text": "Derivation from Walthard nests"
                  },
                  {
                    "text": "Possible surface epithelial or germ cell origin"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "< 5% of benign ovarian epithelial-stromal tumors"
                  }
                ],
                "Age": [
                  {
                    "text": "22-90 (mean: 56) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Typically incidental finding"
                  },
                  {
                    "text": "Pelvic/abdominal symptoms or signs if large"
                  },
                  {
                    "text": "Rarely, hormonal manifestations (if functioning stroma)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "IMAGING": {
                "CT and MR Findings": [
                  {
                    "text": "Solid ovarian mass containing punctate calcifications often associated with a multilocular cyst"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically solitary; rarely multiple or bilateral (< 10%)"
                  },
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "Solid, firm, white to pale yellow cut surface"
                  },
                  {
                    "text": "Small (occasionally large) cysts may be seenLarge cysts may indicate associated mucinous tumor",
                    "sub_points": [
                      "Large cysts may indicate associated mucinous tumor"
                    ]
                  },
                  {
                    "text": "Gritty texture if extensively calcified"
                  }
                ],
                "Size": [
                  {
                    "text": "Typically < 2 cm (often incidental finding)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Round to variably shaped solid nestsIf cystic, may be lined by mucinous (most common), ciliated, cuboidal, or flat epithelium and contain eosinophilic or mucinous secretionsSquamous differentiation may be present",
                    "sub_points": [
                      "If cystic, may be lined by mucinous (most common), ciliated, cuboidal, or flat epithelium and contain eosinophilic or mucinous secretions",
                      "Squamous differentiation may be present"
                    ]
                  },
                  {
                    "text": "Prominent fibromatous stroma, normocellular, cellular, collagenous, or thecomatous (less frequent)Stromal luteinization common (but variable in extent)",
                    "sub_points": [
                      "Stromal luteinization common (but variable in extent)"
                    ]
                  },
                  {
                    "text": "Dystrophic calcifications in ~ 1/3"
                  },
                  {
                    "text": "Association in ~ 25% with: Mucinous tumor (clonal relation) > > serous cystadenoma, mature cystic teratoma"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Abundant pale amphophilic, eosinophilic > > clear cytoplasm with perinuclear halo"
                  },
                  {
                    "text": "± signet ring-like cells within nests"
                  },
                  {
                    "text": "Oval to elongated nuclei often with longitudinal grooves (\"coffee bean\")"
                  },
                  {
                    "text": "Small nucleoli and rare/absent mitoses"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Transitional-type cellsCK7, EMA, p63, uroplakin-3, thrombomodulin, GATA3, AR, S100 positiveChromogranin, serotonin, WT1 rarely focally positiveCK20, PAX8, WT1, ER, PR, PAX2 negative",
                    "sub_points": [
                      "CK7, EMA, p63, uroplakin-3, thrombomodulin, GATA3, AR, S100 positive",
                      "Chromogranin, serotonin, WT1 rarely focally positive",
                      "CK20, PAX8, WT1, ER, PR, PAX2 negative"
                    ]
                  },
                  {
                    "text": "Luteinized cells: Inhibin/calretinin positive"
                  }
                ],
                "Genetic Abnormalities": [
                  {
                    "text": "KRASmutations or 12q14-21 amplification; MYC amplification rarely"
                  },
                  {
                    "text": "Absence ofTERTpromoter mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endometrioid Adenofibroma With Squamous Morules": [
                  {
                    "text": "More prominent epithelial component"
                  },
                  {
                    "text": "Well-formed glands but not multilayered epithelium"
                  },
                  {
                    "text": "Squamous but not transitional-type epithelium"
                  },
                  {
                    "text": "PAX8 positive; urothelial markers, p63 negative in glands"
                  }
                ],
                "Adult Granulosa Cell Tumor (Insular)": [
                  {
                    "text": "Other typical growths and Call-Exner bodies"
                  },
                  {
                    "text": "Typically less prominent fibromatous stroma and no epithelial elements"
                  },
                  {
                    "text": "EMA, p63 negative; inhibin, calretinin, FOXL2 positive"
                  }
                ],
                "Insular Carcinoid, Primary or Metastatic": [
                  {
                    "text": "Often carcinoid syndrome"
                  },
                  {
                    "text": "Multinodular and extraovarian spread, if metastatic"
                  },
                  {
                    "text": "Argentaffin granules ± other carcinoid patterns"
                  },
                  {
                    "text": "\"Salt and pepper\" chromatin"
                  },
                  {
                    "text": "Neuroendocrine markers diffusely and CDX-2 often positive"
                  },
                  {
                    "text": "Thrombomodulin, uroplakin-3, p63, GATA3 negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In tumors with prominent fibromatous stroma and epithelial nests, consider Brenner and carcinoid tumor"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Colorectal Carcinoma": {
            "name": "Colorectal Carcinoma",
            "url": "https://app.pathprimer.com/document/bff30e49-f2d2-4b17-8e11-7985103ce40f/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Secondary involvement by colorectal carcinoma either by lymphovascular spread or, less commonly, direct extension"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common metastatic carcinoma to ovary (up to 75% have primary in rectum or sigmoid colon)"
                  },
                  {
                    "text": "Ovary initial site of presentation (3-30%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Bilateral (60-70%)"
                  },
                  {
                    "text": "± surface involvement"
                  },
                  {
                    "text": "Multinodular, solid and cystic, friable cut surface"
                  },
                  {
                    "text": "Cysts with yellowish, hemorrhagic, gelatinous material"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Poorly defined nodules with different morphologies"
                  },
                  {
                    "text": "Simple, small, medium, or, most commonly, large glands that may be dilated"
                  },
                  {
                    "text": "Cribriform garland-like pattern with central necrosis"
                  },
                  {
                    "text": "Segmental and \"dirty\" necrosis of glands"
                  },
                  {
                    "text": "Associated desmoplastic stroma, if infiltrative growth"
                  },
                  {
                    "text": "± pools of extracellular mucin"
                  },
                  {
                    "text": "Periglandular stromal condensation/luteinization common"
                  },
                  {
                    "text": "Cells with variable degree of mucinous differentiation"
                  },
                  {
                    "text": "Pseudoendometrioid morphology not uncommon"
                  },
                  {
                    "text": "Signet ring cells (if > 10% Krukenberg tumor)"
                  },
                  {
                    "text": "High-grade nuclear features and brisk mitotic activity"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK20, CDX-2, CEA, P504S, SATB2 typically diffusely positive"
                  },
                  {
                    "text": "CK7 and CA125 typically negativeCK7 positive, if right side or high grade",
                    "sub_points": [
                      "CK7 positive, if right side or high grade"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary endometrioid carcinoma"
                  },
                  {
                    "text": "Primary mucinous carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Secondary involvement by colorectal carcinoma either by lymphovascular spread or, less commonly, direct extension"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common metastatic carcinoma to ovary (up to 75% have primary in rectum or sigmoid colon)~ 40% of all metastatic ovarian tumors",
                    "sub_points": [
                      "~ 40% of all metastatic ovarian tumors"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 19-85 (mean: 55) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Ovary initial site of presentation (3-30%)"
                  },
                  {
                    "text": "Abdominal or pelvic pain (most common)"
                  },
                  {
                    "text": "Signs or symptoms secondary to colonic obstruction"
                  },
                  {
                    "text": "Vaginal bleeding or incidental finding (rare)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Bilateral salpingo-oophorectomy ± hysterectomy, resection of primary tumor (if synchronous) ± chemoradiation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dismal"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Bilateral (60-70%)"
                  },
                  {
                    "text": "± surface involvement"
                  },
                  {
                    "text": "Multinodular, solid and cystic, friable cut surfaceMostly solid cut surface, if small",
                    "sub_points": [
                      "Mostly solid cut surface, if small"
                    ]
                  },
                  {
                    "text": "Cysts with yellowish, hemorrhagic, gelatinous material"
                  },
                  {
                    "text": "Extensive areas of necrosis"
                  }
                ],
                "Size": [
                  {
                    "text": "Microscopic to > 25 (mean: 10) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Poorly defined nodules with different morphologies"
                  },
                  {
                    "text": "Simple, small, medium, or, most commonly, large glands that may be dilated"
                  },
                  {
                    "text": "Papillary architecture also common"
                  },
                  {
                    "text": "Cribriform garland-like pattern with central necrosis"
                  },
                  {
                    "text": "Segmental and \"dirty\" necrosis of glands (eosinophilic with karyorrhectic debris)"
                  },
                  {
                    "text": "Associated desmoplastic stroma, if infiltrative growth"
                  },
                  {
                    "text": "± pools of extracellular mucin"
                  },
                  {
                    "text": "Periglandular stromal condensation/luteinization common"
                  },
                  {
                    "text": "Lymphovascular invasion at hilus frequent"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Eosinophilic or (rarely) clear cytoplasm"
                  },
                  {
                    "text": "Variable degree of mucinous differentiationPseudoendometrioid or mucinousSignet-ring cells (if > 10% Krukenberg tumor)",
                    "sub_points": [
                      "Pseudoendometrioid or mucinous",
                      "Signet-ring cells (if > 10% Krukenberg tumor)"
                    ]
                  },
                  {
                    "text": "High-grade nuclear features and brisk mitotic activity"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK20, CDX-2, CEA, P504S, SATB2 diffusely positive"
                  },
                  {
                    "text": "β-catenin positive (1/3)"
                  },
                  {
                    "text": "CK7 and CA125 typically negativeCK7 positive, if right-sided or high-grade",
                    "sub_points": [
                      "CK7 positive, if right-sided or high-grade"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Endometrioid Carcinoma": [
                  {
                    "text": "Associated endometriosis or adenofibroma component"
                  },
                  {
                    "text": "Squamous differentiation"
                  },
                  {
                    "text": "Low-grade cytologic atypia"
                  },
                  {
                    "text": "CK7, ER, and PAX8 positive"
                  }
                ],
                "Primary Mucinous Carcinoma": [
                  {
                    "text": "Multinodularity and infiltrative growth rare"
                  },
                  {
                    "text": "Typically no segmental or \"dirty\" necrosis"
                  },
                  {
                    "text": "± teratoma; PAX8 positive in 40% (but may be weak)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "45% of large intestinal metastases to ovary thought clinically to be primary tumors"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Bilateral ovarian tumors with relatively well-formed glands lined by high-grade neoplastic cells and with \"dirty\" necrosis should raise high suspicion for metastatic colon carcinoma"
                  },
                  {
                    "text": "Note there is some immunohistochemical overlap between colonic and ovarian carcinomas with CDX2 > SATB2; thus, molecular studies may occasionally help distinguish ovarian from metastatic colon carcinoma in patient with history of colon cancer and new ovarian mass"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Endometrioid Adenocarcinoma": {
            "name": "Endometrioid Adenocarcinoma",
            "url": "https://app.pathprimer.com/document/dcbea637-90ca-4652-87e0-08e27bd77568/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm composed of endometrial-type cells morphologically identical to endometrial endometrioid carcinoma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Late reproductive to postmenopausal (mean: 52 years)"
                  },
                  {
                    "text": "Unilateral > bilateral (20%)"
                  },
                  {
                    "text": "Overall favorable outcome as most low stage (80-90%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "May arise in endometriotic cyst or adenofibroma"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Major architectural patterns: Glandular, papillary, solid"
                  },
                  {
                    "text": "Variants: With squamous differentiation, spindled, sex cord-like, with cording and stromal hyalinization, clear cell change, mucin rich, transitional-like morphology, ciliated, oxyphilic, with basaloid cells, dedifferentiated, with yolk sac tumor"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, EMA, PAX8 (+); PR (> 65%), ER (> 75%) (+)"
                  },
                  {
                    "text": "p16 patchy expression and p53 wild-type but may be mutant; HNF-1-β > napsin A (+)"
                  },
                  {
                    "text": "± WT1, CD99, calretinin, glypican-3"
                  },
                  {
                    "text": "Mismatch repair deficiency (~ 13%),POLEmutations (~ 5%);TP53mutated (~ 9-13%); nonspecific profile (~ 69-73%)"
                  },
                  {
                    "text": "CTNNB1(~ 55%) andARID1A(~ 30%) mutations"
                  },
                  {
                    "text": "PIK3CA(~ 40%),KRAS(~ 35%), andPTEN(~ 20%) mutations"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Adult granulosa, Sertoli cell and Sertoli-Leydig cell tumors"
                  },
                  {
                    "text": "Metastatic colonic/breast adenocarcinoma"
                  },
                  {
                    "text": "Metastatic endometrioid adenocarcinoma"
                  },
                  {
                    "text": "Mesonephric-like carcinoma"
                  },
                  {
                    "text": "High-grade serous/clear cell carcinoma"
                  },
                  {
                    "text": "Female adnexal tumor of probable wolffian origin"
                  },
                  {
                    "text": "Carcinoid tumor, insular or trabecular"
                  },
                  {
                    "text": "Carcinosarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Endometrioid carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasm composed of endometrial-type cells morphologically identical to endometrial endometrioid carcinoma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unopposed Estrogen": [
                  {
                    "text": "Association with independent endometrial endometrioid carcinoma or atypical hyperplasia/endometrial intraepithelial neoplasia"
                  }
                ],
                "Precursor Lesions": [
                  {
                    "text": "Endometriosis"
                  },
                  {
                    "text": "Endometrioid adenofibroma or borderline tumor"
                  }
                ],
                "Risk Factors, Inherited and Noninherited": [
                  {
                    "text": "Similar to endometrial endometrioid carcinoma"
                  },
                  {
                    "text": "Lynch syndrome (up to 3%)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "15% of all ovarian carcinomas"
                  }
                ],
                "Age": [
                  {
                    "text": "Late reproductive to postmenopausal (mean: 52 years)Typically occurs 5-10 years earlier if endometriosis associated",
                    "sub_points": [
                      "Typically occurs 5-10 years earlier if endometriosis associated"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Unilateral > bilateral (20%)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal swelling, pain"
                  },
                  {
                    "text": "Hormonal manifestationsVaginal bleedingSynchronous endometrial endometrioid carcinoma (up to 20%)",
                    "sub_points": [
                      "Vaginal bleeding",
                      "Synchronous endometrial endometrioid carcinoma (up to 20%)"
                    ]
                  },
                  {
                    "text": "Signs and symptoms related to endometriosis"
                  },
                  {
                    "text": "Asymptomatic"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Salpingo-oophorectomy + staging biopsies (if fertility desired)"
                  },
                  {
                    "text": "Bilateral salpingo-oophorectomy + hysterectomy + staging biopsiesComprehensive surgical staging in stage I tumors may not be necessary",
                    "sub_points": [
                      "Comprehensive surgical staging in stage I tumors may not be necessary"
                    ]
                  },
                  {
                    "text": "Chemotherapy, radiation therapy, if advanced stage or recurrent"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall favorable as most are low stage (stage I or II; 80-90%)"
                  },
                  {
                    "text": "Stage most important factorStage IA: > 95% 10-year survival rateStage IC: > 80% 10-year survival rateStage III: ~ 30% 10-year survival rate",
                    "sub_points": [
                      "Stage IA: > 95% 10-year survival rate",
                      "Stage IC: > 80% 10-year survival rate",
                      "Stage III: ~ 30% 10-year survival rate"
                    ]
                  },
                  {
                    "text": "If associated yolk sac tumor, typically high stage at presentation and poor prognosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Variably solid and cystic with smooth surface"
                  },
                  {
                    "text": "Solid or solid with small cysts if arising in adenofibroma"
                  },
                  {
                    "text": "Protruding nodule from wall if arising in endometriotic cyst"
                  },
                  {
                    "text": "White to tan cut surface with variable hemorrhage and necrosis"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range (mean: 11 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Major architectural patternsGlandularSmall to large, simple to labyrinthine branching glandsCribriformMicroglandular-like appearancePapillaryVilloglandular-likeSolid glandular",
                    "sub_points": [
                      "GlandularSmall to large, simple to labyrinthine branching glandsCribriformMicroglandular-like appearance",
                      "Small to large, simple to labyrinthine branching glands",
                      "Cribriform",
                      "Microglandular-like appearance",
                      "PapillaryVilloglandular-like",
                      "Villoglandular-like",
                      "Solid glandular"
                    ]
                  },
                  {
                    "text": "Variant patterns (may be admixed)With squamous differentiationMorular (nonkeratinizing) (more common)Keratin whorls/pearlsGlycogenated squamous epitheliumKeratin granulomas may be seen on ovarian or peritoneal surfaces (contains keratin debris and ghost squamous cells but no viable tumor cells)With spindled areasMerges imperceptibly with glandsTypically low gradeAbrupt keratinization within spindled areasSex cord-likeCords, trabeculae (possibly in hyalinized stroma), microfollicular, insular, or sertoliform patterns (resemble adult granulosa cell > Sertoli cell > Sertoli-Leydig cell tumor)Prominent stromal luteinizationClear cell changeGlycogenated squamous epitheliumSecretory change (sub- and supranuclear vacuoles)Clear cells, not otherwise specifiedWith cording and stromal hyalinization (much less common than its endometrial counterpart)Merging of low-grade, cord-like areas with endometrioid glandsSmall nonvillous papillae (much less common than its endometrial counterpart)Small buds of cells with eosinophilic &/or focally mucinous cytoplasmMucin rich (typically endocervical-type cells but rarely may have small component of intestinal-type cells)CiliatedOxyphilicWith basaloid epithelial cellsTransitional-like morphology (low-grade cytologic features)Microglandular hyperplasia-like (rare)Subnuclear vacuoles and associated acute and chronic inflammatory infiltrateDedifferentiatedDiffuse or vaguely nested growth of noncohesive cells with abrupt transition to low-grade endometrioid carcinoma± myxoid background stroma± rhabdoid or multinucleated pleomorphic cellsAssociation with yolk sac tumor and less commonly other germ cell tumorsTypical patterns of yolk sac neoplasiaTrophoblastic elements",
                    "sub_points": [
                      "With squamous differentiationMorular (nonkeratinizing) (more common)Keratin whorls/pearlsGlycogenated squamous epitheliumKeratin granulomas may be seen on ovarian or peritoneal surfaces (contains keratin debris and ghost squamous cells but no viable tumor cells)",
                      "Morular (nonkeratinizing) (more common)",
                      "Keratin whorls/pearls",
                      "Glycogenated squamous epithelium",
                      "Keratin granulomas may be seen on ovarian or peritoneal surfaces (contains keratin debris and ghost squamous cells but no viable tumor cells)",
                      "With spindled areasMerges imperceptibly with glandsTypically low gradeAbrupt keratinization within spindled areas",
                      "Merges imperceptibly with glands",
                      "Typically low grade",
                      "Abrupt keratinization within spindled areas",
                      "Sex cord-likeCords, trabeculae (possibly in hyalinized stroma), microfollicular, insular, or sertoliform patterns (resemble adult granulosa cell > Sertoli cell > Sertoli-Leydig cell tumor)Prominent stromal luteinization",
                      "Cords, trabeculae (possibly in hyalinized stroma), microfollicular, insular, or sertoliform patterns (resemble adult granulosa cell > Sertoli cell > Sertoli-Leydig cell tumor)",
                      "Prominent stromal luteinization",
                      "Clear cell changeGlycogenated squamous epitheliumSecretory change (sub- and supranuclear vacuoles)Clear cells, not otherwise specified",
                      "Glycogenated squamous epithelium",
                      "Secretory change (sub- and supranuclear vacuoles)",
                      "Clear cells, not otherwise specified",
                      "With cording and stromal hyalinization (much less common than its endometrial counterpart)Merging of low-grade, cord-like areas with endometrioid glands",
                      "Merging of low-grade, cord-like areas with endometrioid glands",
                      "Small nonvillous papillae (much less common than its endometrial counterpart)Small buds of cells with eosinophilic &/or focally mucinous cytoplasm",
                      "Small buds of cells with eosinophilic &/or focally mucinous cytoplasm",
                      "Mucin rich (typically endocervical-type cells but rarely may have small component of intestinal-type cells)",
                      "Ciliated",
                      "Oxyphilic",
                      "With basaloid epithelial cells",
                      "Transitional-like morphology (low-grade cytologic features)",
                      "Microglandular hyperplasia-like (rare)Subnuclear vacuoles and associated acute and chronic inflammatory infiltrate",
                      "Subnuclear vacuoles and associated acute and chronic inflammatory infiltrate",
                      "DedifferentiatedDiffuse or vaguely nested growth of noncohesive cells with abrupt transition to low-grade endometrioid carcinoma± myxoid background stroma± rhabdoid or multinucleated pleomorphic cells",
                      "Diffuse or vaguely nested growth of noncohesive cells with abrupt transition to low-grade endometrioid carcinoma",
                      "± myxoid background stroma",
                      "± rhabdoid or multinucleated pleomorphic cells",
                      "Association with yolk sac tumor and less commonly other germ cell tumorsTypical patterns of yolk sac neoplasiaTrophoblastic elements",
                      "Typical patterns of yolk sac neoplasia",
                      "Trophoblastic elements"
                    ]
                  },
                  {
                    "text": "Stromal luteinization may be extensive"
                  },
                  {
                    "text": "Metaplastic stromal changes, including osseous"
                  },
                  {
                    "text": "Associated endometriosis (40%)"
                  },
                  {
                    "text": "± endometrioid adenofibroma or endometrioid borderline tumor"
                  },
                  {
                    "text": "± seromucinous borderline tumor"
                  },
                  {
                    "text": "May be admixed with clear cell carcinoma or neuroendocrine carcinoma"
                  },
                  {
                    "text": "± synchronous endometrial endometrioid carcinoma"
                  },
                  {
                    "text": "± association with mesodermal adenosarcoma"
                  },
                  {
                    "text": "Geographic or segmental necrosis can be seen"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Columnar cells with pseudostratified nuclei and variable but usually moderate, cytologic atypia"
                  },
                  {
                    "text": "± nuclear grooves"
                  },
                  {
                    "text": "Mitotic activity typically often low, as most tumors low grade"
                  },
                  {
                    "text": "Arias-Stella reaction (rare)"
                  }
                ],
                "Grading": [
                  {
                    "text": "FIGO gradingGrade 1: < 5% nonsquamous solid growthGrade 2: 5-50% nonsquamous solid growthGrade 3: > 50% nonsquamous solid growthSevere nuclear atypia raises grade by 1",
                    "sub_points": [
                      "Grade 1: < 5% nonsquamous solid growth",
                      "Grade 2: 5-50% nonsquamous solid growth",
                      "Grade 3: > 50% nonsquamous solid growth",
                      "Severe nuclear atypia raises grade by 1"
                    ]
                  },
                  {
                    "text": "Most endometrioid carcinoma grade 1 or 2 (< 10% grade 3)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7, EMA, PAX8 (+)Expression varies in high-grade and dedifferentiated carcinoma",
                    "sub_points": [
                      "Expression varies in high-grade and dedifferentiated carcinoma"
                    ]
                  },
                  {
                    "text": "PR (> 65%), ER (> 75%) (+)Expression varies in high-grade carcinoma and typically (-) in dedifferentiated carcinoma",
                    "sub_points": [
                      "Expression varies in high-grade carcinoma and typically (-) in dedifferentiated carcinoma"
                    ]
                  },
                  {
                    "text": "p16 patchy expression, rarely block (+), especially in high-grade tumors"
                  },
                  {
                    "text": "p53 may show either wild- or mutant-type pattern of expression (latter more often if high grade)"
                  },
                  {
                    "text": "HNF-1-β > napsin A (+) but racemase (-) (latter 2 more common if secretory variant)"
                  },
                  {
                    "text": "WT1 (not diffuse with exceptions), calretinin, and glypican-3 may be (+)"
                  },
                  {
                    "text": "CD99, CD56, chromogranin, and synaptophysin may be focally (+)"
                  },
                  {
                    "text": "CDX-2 and CK20 rarely (+) [former (+) in morules]"
                  },
                  {
                    "text": "SF1, inhibin, and SALL4 (-)"
                  },
                  {
                    "text": "GATA3 and TTF-1 typically (-) with exceptions"
                  },
                  {
                    "text": "Glypican-3 and SALL4 (+) if yolk sac tumor"
                  }
                ],
                "Molecular Alterations": [
                  {
                    "text": "Mismatch repair deficiency (~ 13%),POLEmutations (~ 5%);TP53mutated (~ 9-13%); no specific molecular profile (~ 69-73%)"
                  },
                  {
                    "text": "CTNNB1(~ 55%) andARID1Amutations (~ 30%)"
                  },
                  {
                    "text": "PIK3CA(~ 40%),KRAS(~ 35%), andPTEN(~ 20%) mutations"
                  },
                  {
                    "text": "Common inactivation ofSMARCA4,SMARCA2,ARID1A, andARID1Bin dedifferentiated carcinomas"
                  },
                  {
                    "text": "Lack of i(12p) in somatically derived yolk sac tumor"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adult Granulosa Cell Tumor": [
                  {
                    "text": "Unilateral"
                  },
                  {
                    "text": "Other characteristic architectural patterns"
                  },
                  {
                    "text": "No squamous or mucinous differentiation; no endometriosis"
                  },
                  {
                    "text": "Inhibin, SF1, and FOXL2 (+)"
                  },
                  {
                    "text": "FOXL2mutations"
                  }
                ],
                "Sertoli-Leydig Cell Tumor": [
                  {
                    "text": "Unilateral; if hormonal manifestations, commonly virilizing"
                  },
                  {
                    "text": "No squamous or mucinous differentiation; no endometriosis"
                  },
                  {
                    "text": "Inhibin and SF1 (+);DICER1mutations"
                  }
                ],
                "Metastatic Colonic Adenocarcinoma": [
                  {
                    "text": "Prior history and often bilateral with extraovarian disease"
                  },
                  {
                    "text": "Multinodular growth"
                  },
                  {
                    "text": "\"Dirty\" and segmental necrosis with garland pattern"
                  },
                  {
                    "text": "Disconnect between well-differentiated architecture and high-grade cytology"
                  },
                  {
                    "text": "Typically CK20, CDX-2, SATB2 diffusely (+); CK7(-) (unless high grade or right sided)"
                  }
                ],
                "Metastatic Endometrioid Endometrial Adenocarcinoma": [
                  {
                    "text": "Bulky tumor in endometrium"
                  },
                  {
                    "text": "Bilateral ovarian (± ovarian surface) involvement may occur"
                  },
                  {
                    "text": "Deep myometrial or lymphovascular invasion"
                  }
                ],
                "Metastatic Breast Carcinoma": [
                  {
                    "text": "Prior history and common bilateral involvement"
                  },
                  {
                    "text": "Variety of architectural patterns, including single-file and signet ring-like cells"
                  },
                  {
                    "text": "GCDFP-15, TRPS1, GATA3 (+)"
                  },
                  {
                    "text": "PAX8 and WT1 (-) (with rare exceptions for latter)"
                  }
                ],
                "Mesonephric-Like Carcinoma": [
                  {
                    "text": "Vesicular, often overlapping nuclei"
                  },
                  {
                    "text": "ER and PR typically (-)"
                  },
                  {
                    "text": "TTF-1 and GATA3 positivity"
                  },
                  {
                    "text": "KRASmutations and lack ofPTENmutations"
                  },
                  {
                    "text": "± gain of 1q and gains of chromosomes 10 and 12"
                  }
                ],
                "High-Grade Serous Carcinoma (vs. Grade 3 Endometrioid Carcinoma)": [
                  {
                    "text": "More often advanced stage"
                  },
                  {
                    "text": "Prominent cleft-like spaces"
                  },
                  {
                    "text": "Irregular complex papillae with cell tufting and budding"
                  },
                  {
                    "text": "Poorly formed glands without nuclear polarity, lacking apical border"
                  },
                  {
                    "text": "High-grade nuclear atypia"
                  },
                  {
                    "text": "Endometriosis, adenofibroma typically absent"
                  },
                  {
                    "text": "WT1 diffusely (+)"
                  }
                ],
                "Serous Carcinoma With Transitional Cell Morphology (vs. Endometrioid Carcinoma With Transitional Cell Features)": [
                  {
                    "text": "High-grade nuclear features"
                  },
                  {
                    "text": "Transition to high-grade serous carcinoma"
                  }
                ],
                "Clear Cell Carcinoma (vs. Endometrioid Carcinoma With Clear Cells)": [
                  {
                    "text": "Paraneoplastic syndromes may occur"
                  },
                  {
                    "text": "Typical architectural patterns"
                  },
                  {
                    "text": "Napsin A and racemase extensively (+)"
                  },
                  {
                    "text": "ER(-) [can be (+)]"
                  }
                ],
                "Female Adnexal Tumor of Probable Wolffian Origin": [
                  {
                    "text": "More extensive sieve-like pattern"
                  },
                  {
                    "text": "Poorly formed glands without well-defined luminal borders"
                  },
                  {
                    "text": "CK7 and EMA (80%) (-) [if (+), only focal]"
                  },
                  {
                    "text": "PAX8 typically (-)"
                  }
                ],
                "Insular or Trabecular Carcinoid Tumor": [
                  {
                    "text": "Carcinoid syndrome, if insular type ~ 33%"
                  },
                  {
                    "text": "Salt and pepper chromatin"
                  },
                  {
                    "text": "Orangeophilic cytoplasmic granules"
                  },
                  {
                    "text": "No squamous or mucinous differentiation"
                  },
                  {
                    "text": "Chromogranin, synaptophysin, and CD56 (+)"
                  }
                ],
                "Metastatic Endocervical Adenocarcinoma": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Disconnect between well-differentiated architecture and high-grade cytology"
                  },
                  {
                    "text": "Apical mitoses and apoptotic bodies"
                  },
                  {
                    "text": "p16 strong and diffusely (+); HPV(+)"
                  }
                ],
                "Carcinosarcoma (vs. Grade 3 Endometrioid Carcinoma)": [
                  {
                    "text": "Malignant mesenchymal component"
                  },
                  {
                    "text": "Often heterologous elements"
                  }
                ],
                "Grade 3 Endometrioid Carcinoma (vs. Dedifferentiated Carcinoma)": [
                  {
                    "text": "Cohesive cells in nests and islands"
                  },
                  {
                    "text": "Keratin, EMA, ER, and PR more extensively (+)"
                  }
                ],
                "Glandular Yolk Sac Tumor (vs. Endometrioid Carcinoma, Secretory Variant)": [
                  {
                    "text": "Young age and elevated serum AFP"
                  },
                  {
                    "text": "Disconnect between low-grade architecture and high-grade (primitive-appearing) nuclei"
                  },
                  {
                    "text": "No squamous differentiation or endometriosis"
                  },
                  {
                    "text": "SALL4(+)"
                  }
                ],
                "Primary Mucinous Carcinoma": [
                  {
                    "text": "Different architectural patterns"
                  },
                  {
                    "text": "Extensive intestinal-type differentiation"
                  },
                  {
                    "text": "Lack of PR and typically less often PAX8(+)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Possibility of Lynch syndrome should be considered in setting of ovarian endometrioid adenocarcinoma"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Consider possibility of synchronous or metachronous extraovarian endometrioid carcinoma before making diagnosis of metastatic endometrial carcinoma"
                  },
                  {
                    "text": "Some endometrioid carcinomas can show extensive WT1 positivity, and as they also can haveTP53mutations, morphology and other molecular tests may be required to separate high-grade endometrioid from high-grade serous carcinomas; high-grade serous carcinomas typically show high-grade nuclear atypia with poorly formed glands, absent nuclear polarity, and no luminal border"
                  },
                  {
                    "text": "Even though synchronous endometrial and ovarian endometrioid carcinomas are almost always clonally related, they mostly behave as independent tumors when applying typical morphologic criteria (depth of invasion of endometrial tumor, lymphovascular invasion and size of endometrial tumor, presence of precursor in ovary)"
                  },
                  {
                    "text": "Do not mistake endometrioid carcinoma with stromal lutein cells, which can be calretinin (+), as Leydig cells in Sertoli-Leydig cell tumor"
                  },
                  {
                    "text": "Before making diagnosis of primary mucinous carcinoma of ovary, consider possibility of endometrioid carcinoma with mucinous differentiation (look for typical patterns of endometrioid carcinoma)"
                  },
                  {
                    "text": "Seromucinous carcinoma currently included within category of endometrioid carcinoma as there is poor diagnostic reproducibility, it often displays endometrioid areas &/or squamous differentiation, and it shows similar immunohistochemical and molecular profile to endometrioid carcinoma"
                  },
                  {
                    "text": "If endometrioid carcinoma associated with adenosarcoma, which may show high-grade features or stromal overgrowth, prognosis related to latter, as endometrioid carcinoma typically low grade"
                  },
                  {
                    "text": "Inhibin, SF1, and FOXL2 best sex cord markers in separating sex cord-stromal tumor from endometrioid carcinoma"
                  },
                  {
                    "text": "Glypican-3 should not be used to distinguish yolk sac tumor from endometrioid carcinoma, as it is (+) in both; furthermore, yolk sac tumors may be PAX8(+)"
                  },
                  {
                    "text": "In separating breast from endometrioid carcinoma, GCDFP-15 [when (+)] and TRPS1 are most helpful; GATA3 does not exclude possibility of metastatic breast carcinoma if negative; remember, mammaglobin can be (+) in gynecologic epithelial malignancies"
                  },
                  {
                    "text": "TTF-1, GATA3, ER, and PR are most helpful in distinction of mesonephric-like carcinoma from endometrioid carcinoma (with exceptions)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Thecoma": {
            "name": "Thecoma",
            "url": "https://app.pathprimer.com/document/e4355a94-c5e2-4f4c-9231-73d1871a4b5a/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Stromal tumor composed of cells resembling thecal component of ovarian follicles"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Peri- and postmenopausal most common"
                  },
                  {
                    "text": "Estrogenic manifestations (1/2)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Firm, yellow to tan, vaguely nodular cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse > > lobulated growth"
                  },
                  {
                    "text": "Hyaline plaques/bands"
                  },
                  {
                    "text": "Keloid-type sclerosis or myxoid background less common"
                  },
                  {
                    "text": "Fibroma-like areas"
                  },
                  {
                    "text": "Sex cord-like differentiation (< 10%) may be seen"
                  },
                  {
                    "text": "Foci of calcification (more extensive in pregnancy) > adipose metaplasia may occur"
                  },
                  {
                    "text": "Syncytial appearance as membranes poorly defined"
                  },
                  {
                    "text": "Moderate amounts of pale, amphophilic, \"gray\" cytoplasm; oval nuclei; indistinct nucleoli"
                  },
                  {
                    "text": "Less commonly vacuolated cytoplasm"
                  },
                  {
                    "text": "Occasional grooves can be seen"
                  },
                  {
                    "text": "Banal cytologic features and ≤ 4 mitoses/10 HPF"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Reticulin stain: Fibers around individual cells"
                  },
                  {
                    "text": "Calretinin, inhibin, WT1, CD56, SF1 (+)"
                  },
                  {
                    "text": "ER, PR, CD10, FOXL2 frequently (+)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Fibroma"
                  },
                  {
                    "text": "Microcystic stromal tumor"
                  },
                  {
                    "text": "Adult granulosa cell tumor"
                  },
                  {
                    "text": "Sclerosing stromal tumor"
                  },
                  {
                    "text": "Luteinized thecoma with sclerosing peritonitis"
                  },
                  {
                    "text": "Steroid cell tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Stromal tumor composed of cells resembling thecal component of ovarian follicles"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, if pure (~ 5% of all sex cord-stromal tumors)"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically peri- and postmenopausal (mean: 59 years)On average, 10 years older than patients with fibroma",
                    "sub_points": [
                      "On average, 10 years older than patients with fibroma"
                    ]
                  },
                  {
                    "text": "~ 20% in young (20-30 years)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Estrogenic manifestations (1/2; e.g., vaginal bleeding)"
                  },
                  {
                    "text": "Androgenic manifestations in ~ 10%"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Unilateral salpingo-oophorectomy ± hysterectomySampling of endometrium to exclude neoplasia",
                    "sub_points": [
                      "Sampling of endometrium to exclude neoplasia"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent depending on endometrial pathologyEndometrial adenocarcinoma in ~ 20%",
                    "sub_points": [
                      "Endometrial adenocarcinoma in ~ 20%"
                    ]
                  },
                  {
                    "text": "Local recurrence rare"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unilateral in > 98%"
                  },
                  {
                    "text": "Well-circumscribed, solid mass"
                  },
                  {
                    "text": "Firm, yellow to tan, vaguely nodular cut surface"
                  },
                  {
                    "text": "± cystic degeneration, hemorrhage, focal calcification (may be extensive in pregnancy), or necrosis"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range (average: 5-10 cm, ~ 65% < 5 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diffuse > > lobulated growth"
                  },
                  {
                    "text": "Hyaline plaques/bands"
                  },
                  {
                    "text": "Keloid-type sclerosis or myxoid background less common"
                  },
                  {
                    "text": "Fibroma-like areas (40%)"
                  },
                  {
                    "text": "Sex cord-like differentiation (< 10%) may be seen"
                  },
                  {
                    "text": "Foci of calcification > adipose metaplasia may occur"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Moderate amounts of pale, amphophilic, \"gray\" cytoplasm; oval nuclei indistinct nucleoliSyncytial appearance as membranes poorly definedLess commonly vacuolated cytoplasmOccasional grooves can be seenMultinucleated (bizarre nuclei) rare",
                    "sub_points": [
                      "Syncytial appearance as membranes poorly defined",
                      "Less commonly vacuolated cytoplasm",
                      "Occasional grooves can be seen",
                      "Multinucleated (bizarre nuclei) rare"
                    ]
                  },
                  {
                    "text": "Banal cytologic features and ≤ 4 mitoses/10 HPF"
                  },
                  {
                    "text": "Potential malignant potential (Clement and Young criteria)≥ 4 mitoses/10 HPF with 1 or more worrisome features: Adhesions, rupture, necrosis, cytologic atypia",
                    "sub_points": [
                      "≥ 4 mitoses/10 HPF with 1 or more worrisome features: Adhesions, rupture, necrosis, cytologic atypia"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Reticulin stain: Fibers around individual cells"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Calretinin, inhibin, WT1, CD56, SF1 (+)"
                  },
                  {
                    "text": "ER, PR, CD10, FOXL2 frequently (+)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Fibroma": [
                  {
                    "text": "Storiform or fascicular growth; no luteinized cells"
                  },
                  {
                    "text": "CD10(-), inhibin, calretinin weak/patchy (+) or (-)"
                  }
                ],
                "Microcystic Stromal Tumor": [
                  {
                    "text": "No endocrine manifestations"
                  },
                  {
                    "text": "Prominent microcysts; cyclin-D1, β-catenin (+)"
                  },
                  {
                    "text": "Inhibin, calretinin, CD56, FOXL2, ER, and PR (-)"
                  }
                ],
                "Adult Granulosa Cell Tumor": [
                  {
                    "text": "Sex cord patterns > 10% of neoplasm"
                  },
                  {
                    "text": "Clusters of cells highlighted by reticulin stain"
                  }
                ],
                "Sclerosing Stromal Tumor": [
                  {
                    "text": "Young women (< 30 years)"
                  },
                  {
                    "text": "Irregular hemangiopericytoma-like vessels"
                  },
                  {
                    "text": "Alternating hypo- and hypercellular areas"
                  }
                ],
                "Luteinized Thecoma With Sclerosing Peritonitis": [
                  {
                    "text": "Younger age (< 30 years)"
                  },
                  {
                    "text": "Not typically mass forming, typically bilateral"
                  },
                  {
                    "text": "Luteinized cells typically smaller and brisk mitotic activity"
                  },
                  {
                    "text": "Sclerosing peritonitis with adhesions"
                  }
                ],
                "Steroid Cell Tumor": [
                  {
                    "text": "Cells with multiple, small, lipid vacuoles"
                  },
                  {
                    "text": "Melan-A (+); FOXL2 typically (-)"
                  }
                ],
                "Smooth Muscle Neoplasm": [
                  {
                    "text": "Fascicular growth"
                  },
                  {
                    "text": "Cigar-shaped nuclei, brightly eosinophilic cytoplasm"
                  },
                  {
                    "text": "SMA, desmin, caldesmon (+); inhibin (-)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Endometrial sampling is important in patients with thecoma, as they are commonly estrogenic"
                  },
                  {
                    "text": "May have significant fibromatous component or hybrid appearance; thus, term fibrothecoma also appropriate"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sertoli Cell Tumor": {
            "name": "Sertoli Cell Tumor",
            "url": "https://app.pathprimer.com/document/a47eef4d-a23f-438c-a62a-932034aabaf2/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Sex cord-stromal tumor composed of Sertoli cells with rare, if any, Leydig cells"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Peutz-Jeghers syndrome (autosomal dominant)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare (< 4% of Sertoli-stromal tumors)"
                  },
                  {
                    "text": "Age range: 2-76 (mean: 30) years"
                  },
                  {
                    "text": "Estrogenic (menstrual abnormalities) > androgenic manifestations (~ 50% of tumors functional)"
                  },
                  {
                    "text": "Malignant behavior in ~ 10% of stage I tumors, especially if severe cytologic atypia, > 5 mitoses/10 HPF, necrosis"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Unilateral, typically solid mass with tan to yellow cut surface"
                  },
                  {
                    "text": "Range: 1-30 (mean: 8) cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Typically diffuse or nodular growth at low power"
                  },
                  {
                    "text": "Variable admixture of tubules (hollow or solid, rarely endometrioid-like or retiform), cords/trabeculae, and sheets of cells"
                  },
                  {
                    "text": "Cuboidal or columnar cells with pale, deeply eosinophilic, or vacuolated cytoplasm"
                  },
                  {
                    "text": "Variable mitotic activity but typically < 5/10 HPF"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Inhibin, SF1, and calretinin (+)"
                  },
                  {
                    "text": "AE1/AE3, CAM5.2, vimentin, CD99, WT1, NSE, and CD56 frequently (+)"
                  },
                  {
                    "text": "EMA, PAX8, CK7, GATA3, and chromogranin typically (-)"
                  },
                  {
                    "text": "DICER1mutations"
                  },
                  {
                    "text": "STK11(LKB1) mutation if Peutz-Jeghers syndrome"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Sertoli-Leydig cell tumor"
                  },
                  {
                    "text": "Endometrioid carcinoma"
                  },
                  {
                    "text": "Carcinoid tumor"
                  },
                  {
                    "text": "Female adnexal tumor of probable wolffian origin"
                  },
                  {
                    "text": "Hilar Sertoli cell proliferation"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Folliculome lipidique (lipid rich)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Sex cord-stromal tumor composed of Sertoli cells with rare, if any, Leydig cells with variety of morphologic patterns"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "Peutz-Jeghers syndrome (PJS) (autosomal dominant)Mucocutaneous pigmentation and intestinal (and other) hamartomatous polypsF > M cancer risk, including gastrointestinal, pancreatic, lung, breast, and other cancersGastric type adenocarcinoma of cervix, Sertoli cell tumor (oxyphilic), and sex cord tumor with annular tubules in ovary",
                    "sub_points": [
                      "Mucocutaneous pigmentation and intestinal (and other) hamartomatous polyps",
                      "F > M cancer risk, including gastrointestinal, pancreatic, lung, breast, and other cancers",
                      "Gastric type adenocarcinoma of cervix, Sertoli cell tumor (oxyphilic), and sex cord tumor with annular tubules in ovary"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare (< 4% of Sertoli-stromal tumors)"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 2-76 (mean: 30) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal swelling &/or pain"
                  },
                  {
                    "text": "Estrogenic (menstrual abnormalities) > androgenic manifestations (~ 50% of tumors functional)"
                  },
                  {
                    "text": "Manifestations due to progesterone, renin, or aldosterone production rare"
                  },
                  {
                    "text": "Isosexual precocity"
                  },
                  {
                    "text": "Incidental finding"
                  },
                  {
                    "text": "CA-125 elevated serum levels rarely"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Salpingo-oophorectomy or hysterectomy and bilateral salpingo-oophorectomy"
                  },
                  {
                    "text": "Chemotherapy &/or radiation therapy if malignant"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent in majority of patients (especially if stage I)"
                  },
                  {
                    "text": "Malignant behavior in ~ 10% of stage I tumorsSevere cytologic atypia, > 5 mitoses/10 HPF, and necrosis associated with adverse outcome",
                    "sub_points": [
                      "Severe cytologic atypia, > 5 mitoses/10 HPF, and necrosis associated with adverse outcome"
                    ]
                  },
                  {
                    "text": "Recurrences and metastases can occur"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unilateral"
                  },
                  {
                    "text": "Typically solid; less frequently solid and cysticRarely, mostly cystic with small mural nodules",
                    "sub_points": [
                      "Rarely, mostly cystic with small mural nodules"
                    ]
                  },
                  {
                    "text": "Tan to yellow cut surface (solid component)"
                  },
                  {
                    "text": "Rarely necrosis &/or hemorrhage"
                  }
                ],
                "Size": [
                  {
                    "text": "Range: 1-30 (mean: 8) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Well demarcated"
                  },
                  {
                    "text": "Typically diffuse or nodular growth"
                  },
                  {
                    "text": "Variable admixture ofTightly packed tubules (most common pattern)Solid &/or hollow (in variable proportions)Complex branchingEndometrioid-like (uncommon, usually focal)Anastomosing cords and trabeculae 1-3 layers thickSheets of cellsPseudopapillae, likely artifactual (uncommon)Islands (uncommon)Retiform tubules (rare)Spindle cells (rare)",
                    "sub_points": [
                      "Tightly packed tubules (most common pattern)Solid &/or hollow (in variable proportions)Complex branchingEndometrioid-like (uncommon, usually focal)",
                      "Solid &/or hollow (in variable proportions)",
                      "Complex branching",
                      "Endometrioid-like (uncommon, usually focal)",
                      "Anastomosing cords and trabeculae 1-3 layers thick",
                      "Sheets of cells",
                      "Pseudopapillae, likely artifactual (uncommon)",
                      "Islands (uncommon)",
                      "Retiform tubules (rare)",
                      "Spindle cells (rare)"
                    ]
                  },
                  {
                    "text": "± eosinophilic secretions within lumina"
                  },
                  {
                    "text": "Rare luteinized or Leydig cells occasionally"
                  },
                  {
                    "text": "Delicate septa to abundant and hyalinized stroma"
                  },
                  {
                    "text": "Calcification and tumor cell necrosis rare"
                  },
                  {
                    "text": "Other components (very minor)Granulosa elementsAnnular tubules",
                    "sub_points": [
                      "Granulosa elements",
                      "Annular tubules"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cuboidal or columnar cells withModerately pale cytoplasm (most often)Deeply eosinophilic cytoplasm (may be associated with PJS)Vacuolated cytoplasm [lipid rich (folliculome lipidique)] (may be associated with PJS)",
                    "sub_points": [
                      "Moderately pale cytoplasm (most often)",
                      "Deeply eosinophilic cytoplasm (may be associated with PJS)",
                      "Vacuolated cytoplasm [lipid rich (folliculome lipidique)] (may be associated with PJS)"
                    ]
                  },
                  {
                    "text": "Round to oval, uniform nuclei; inconspicuous nucleoliNuclear grooves not uncommonBizarre nuclei may be seen",
                    "sub_points": [
                      "Nuclear grooves not uncommon",
                      "Bizarre nuclei may be seen"
                    ]
                  },
                  {
                    "text": "Cytologic atypia may occur"
                  },
                  {
                    "text": "Variable mitotic activity most commonly < 5/10 HPF"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Inhibin, SF1, and calretinin (+)"
                  },
                  {
                    "text": "AE1/AE3, CAM5.2 (cytoplasmic or dot-like), vimentin, CD99, WT1, NSE, and CD56 frequently (+)"
                  },
                  {
                    "text": "Aromatase (+)"
                  },
                  {
                    "text": "NKX3.1 may be (+)"
                  },
                  {
                    "text": "S100 and SMA can be (+) (minority)"
                  },
                  {
                    "text": "EMA, CK7, PAX8, GATA3, and chromogranin typically (-)"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "DICER1somatic mutations"
                  },
                  {
                    "text": "NoFOXL2mutations"
                  },
                  {
                    "text": "STK11(LKB1) mutation if PJS"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sertoli-Leydig Cell Tumor": [
                  {
                    "text": "Abundant Leydig cells"
                  },
                  {
                    "text": "Extensive retiform pattern or heterologous elements (if intermediate differentiation)"
                  },
                  {
                    "text": "Melan-A (+) (Leydig cells mostly)"
                  }
                ],
                "Endometrioid Carcinoma": [
                  {
                    "text": "Intraluminal or intracytoplasmic mucin"
                  },
                  {
                    "text": "Squamous differentiation"
                  },
                  {
                    "text": "Associated adenofibroma or endometriosis"
                  },
                  {
                    "text": "EMA and PAX8 (+)"
                  },
                  {
                    "text": "Inhibin and SF1 (-)"
                  },
                  {
                    "text": "± MMR, INI1, BRG1, BRM, ARID1-A; p53 may be abnormal"
                  }
                ],
                "Carcinoid Tumor": [
                  {
                    "text": "Associated teratoma or mucinous tumor common"
                  },
                  {
                    "text": "Acini with brush border"
                  },
                  {
                    "text": "Cells with neuroendocrine granules"
                  },
                  {
                    "text": "Salt and pepper chromatin"
                  },
                  {
                    "text": "Chromogranin and other neuroendocrine markers (+); inhibin and SF1 (-)"
                  }
                ],
                "Female Adnexal Tumor of Probable Wolffian Origin": [
                  {
                    "text": "Admixture of cysts with sieve-like pattern"
                  },
                  {
                    "text": "Only weakly and focally inhibin (+)"
                  },
                  {
                    "text": "GATA3, inhibin, calretinin, and SF1 may be (+)"
                  }
                ],
                "Steroid Cell Tumor": [
                  {
                    "text": "No tubular differentiation"
                  },
                  {
                    "text": "Lipochrome pigment (40%)"
                  },
                  {
                    "text": "Melan-A (+)"
                  }
                ],
                "Dysgerminoma": [
                  {
                    "text": "Diffuse growth with septa and lymphocytes"
                  },
                  {
                    "text": "Primitive nuclei with squared-off appearance"
                  },
                  {
                    "text": "OCT4, PLAP, and CD117 (+)"
                  }
                ],
                "Hilar Sertoli Cell Proliferation": [
                  {
                    "text": "Incidental and microscopic"
                  },
                  {
                    "text": "Centered in hilum"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Sertoli cell tumor may be part of PJS; thus, genetic counseling may be considered in appropriate clinical setting"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Although features predictive of malignant behavior in stage I tumors include > 5 cm, > 5 mitoses/10 HPF, nuclear atypia, &/or necrosis, isolated features can be seen in benign tumors"
                  },
                  {
                    "text": "Presence of more than rare Leydig cells should strongly raise possibility of Sertoli-Leydig cell tumor; thus, sampling may be helpful"
                  },
                  {
                    "text": "When considering differential diagnosis between Sertoli cell tumor and endometrioid carcinoma, important to use panel of antibodies, including EMA, PAX8, inhibin, &/or SF1, as Sertoli cell tumors can be (+) for keratins AE1/AE3 and CAM5.2"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Dysgerminoma": {
            "name": "Dysgerminoma",
            "url": "https://app.pathprimer.com/document/dda61647-67d5-4366-8fae-71f8ca03a142/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant primitive germ cell tumor with no pattern of differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common malignant germ cell tumor (~ 50%)"
                  },
                  {
                    "text": "Rare association with gonadal dysgenesis"
                  },
                  {
                    "text": "~ 70% stage I at diagnosis; low recurrence rate < 10%"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solid, white to tan, soft, lobulated cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Nests of cells intersected by fibrous septa (alveolar pattern) typically containing lymphocytes"
                  },
                  {
                    "text": "Other patterns: Diffuse > macronodular > insular, corded, trabecular > tubular > pseudoglandular > single cells"
                  },
                  {
                    "text": "Cells with abundant pale cytoplasm; large, rounded to squared-off nuclei; ≥ 1 prominent nucleoli"
                  },
                  {
                    "text": "Epithelioid histiocytes/granulomas (~ 20%)"
                  },
                  {
                    "text": "Syncytiotrophoblast cells (isolated or in groups) in 3-5%"
                  },
                  {
                    "text": "May be seen in association with gonadoblastoma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK20, EMA, high molecular weight keratin, SOX2, glypican-3, and CD30 (-)"
                  },
                  {
                    "text": "AE1/AE3 and NSE may be very focally (+)"
                  },
                  {
                    "text": "D2-40 (membranous and cytoplasmic) frequently (+)"
                  },
                  {
                    "text": "OCT4, SALL4 (nuclear), CD117 (membranous), PLAP (+)"
                  },
                  {
                    "text": "i12p or 12p amplifications;KITamplifications (~ 30%)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Clear cell carcinoma"
                  },
                  {
                    "text": "Yolk sac tumor, solid variant"
                  },
                  {
                    "text": "Embryonal carcinoma"
                  },
                  {
                    "text": "Undifferentiated carcinoma"
                  },
                  {
                    "text": "Large B-cell lymphoma"
                  },
                  {
                    "text": "Sertoli cell tumor"
                  },
                  {
                    "text": "Small cell carcinoma, hypercalcemic type"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant primitive germ cell tumor with no pattern of differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "Rare association with gonadal dysgenesis (Turner or Swyer syndrome, testicular feminization, and triple X syndrome)"
                  },
                  {
                    "text": "Extremely rare association with Cowden and Down syndromes"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1% of all ovarian malignancies"
                  },
                  {
                    "text": "Most common malignant germ cell tumor (~ 50%)"
                  }
                ],
                "Age": [
                  {
                    "text": "Most common in 2nd and 3rd decades (average: 19 years)"
                  }
                ],
                "Site": [
                  {
                    "text": "Typically unilateral (bilateral in < 10%)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal swelling or pain"
                  },
                  {
                    "text": "Hormonal manifestations, usually estrogenic"
                  },
                  {
                    "text": "Incidental (particularly when complicating gonadoblastoma in dysgenetic gonads)"
                  },
                  {
                    "text": "Hypercalcemia rarely (2nd most common tumor with this finding among young women)"
                  },
                  {
                    "text": "Serum CA125, hCG, LDH, and PLAP levels frequently elevated"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Unilateral salpingo-oophorectomy if stage I"
                  },
                  {
                    "text": "Adjuvant chemotherapy or radiation therapy if advanced"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Very good, as most tumors are stage I at diagnosis, and high-stage tumors are responsive to chemoradiation~ 70% are stage I at diagnosisLow recurrence rate (< 10%)Pelvic soft tissues, fallopian tube, peritoneum, and retroperitoneal lymph nodesRecurrences typically within first 2 years",
                    "sub_points": [
                      "~ 70% are stage I at diagnosis",
                      "Low recurrence rate (< 10%)Pelvic soft tissues, fallopian tube, peritoneum, and retroperitoneal lymph nodes",
                      "Pelvic soft tissues, fallopian tube, peritoneum, and retroperitoneal lymph nodes",
                      "Recurrences typically within first 2 years"
                    ]
                  },
                  {
                    "text": "KITmutations appear to be associated with advanced stage at presentation"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Solid adnexal mass that may show calcifications"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically intact bosselated external surface"
                  },
                  {
                    "text": "Solid, white to tan, soft, lobulated cut surface"
                  },
                  {
                    "text": "± cystic change, hemorrhage, &/or necrosis"
                  },
                  {
                    "text": "Streak gonad may be found at periphery ± calcifications (typically if associated with gonadoblastoma)"
                  }
                ],
                "Size": [
                  {
                    "text": "Typically large, mean: 13 cm (wide range)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Alveolar > diffuse > macronodular > insular, corded, trabecular > tubular > pseudoglandular > single cells"
                  },
                  {
                    "text": "Nests of cells intersected by fibrovascular septa (alveolar pattern)"
                  },
                  {
                    "text": "Tubules can be solid or hollow"
                  },
                  {
                    "text": "Septa typically with lymphocytes, sometimes forming follicles, and often extending beyond septa > > > > plasma cells"
                  },
                  {
                    "text": "Epithelioid histiocytes, sometimes forming small noncaseating granulomas in ~ 20%May be extensive effacing tumor architecture± Langhans cells within granulomas",
                    "sub_points": [
                      "May be extensive effacing tumor architecture",
                      "± Langhans cells within granulomas"
                    ]
                  },
                  {
                    "text": "Stroma typically delicate but may rarely be conspicuous, hyalinized, edematous, &/or myxoid"
                  },
                  {
                    "text": "Necrosis may be extensive, but ghost outlines of tumor cells and septa usually still appreciated"
                  },
                  {
                    "text": "Syncytiotrophoblast cells (isolated or in groups) in 3-5%, may be associated with hemorrhage"
                  },
                  {
                    "text": "± luteinized stromal cells, most conspicuous at periphery"
                  },
                  {
                    "text": "May be seen in association with gonadoblastoma"
                  },
                  {
                    "text": "May be component of mixed germ cell tumor (dysgerminoma and yolk sac tumor most common combination)"
                  },
                  {
                    "text": "Rarely association with ovarian sarcoma"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cells with abundant pale to clear cytoplasmMay be scant and eosinophilic often secondary to retraction due to poor fixationIf very vacuolated, may have signet-ring-like morphology",
                    "sub_points": [
                      "May be scant and eosinophilic often secondary to retraction due to poor fixation",
                      "If very vacuolated, may have signet-ring-like morphology"
                    ]
                  },
                  {
                    "text": "Large, rounded to squared-off nuclei with ≥ 1 prominent nucleoli"
                  },
                  {
                    "text": "Variable mitotic activity"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Dysgerminoma cellsOCT4 (nuclear), SALL4 (nuclear), CD117 (membranous), PLAP positiveD2-40 (membranous and cytoplasmic) frequently positiveNANOG, TSPY, NY-ESO-1, MAGE-A4, and LIN28 (stem cell markers) frequently positiveAE1/3 and NSE may be very focally positive (dot-like)CK20, EMA, high molecular weight keratin, SOX2, glypican-3, and CD30 negative",
                    "sub_points": [
                      "OCT4 (nuclear), SALL4 (nuclear), CD117 (membranous), PLAP positive",
                      "D2-40 (membranous and cytoplasmic) frequently positive",
                      "NANOG, TSPY, NY-ESO-1, MAGE-A4, and LIN28 (stem cell markers) frequently positive",
                      "AE1/3 and NSE may be very focally positive (dot-like)",
                      "CK20, EMA, high molecular weight keratin, SOX2, glypican-3, and CD30 negative"
                    ]
                  },
                  {
                    "text": "Syncytiotrophoblast cellsInhibin and hCG positive",
                    "sub_points": [
                      "Inhibin and hCG positive"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "KITmutations in ~ 1/3 (most common exon 17)"
                  },
                  {
                    "text": "Isochromosome 12p or 12p amplifications"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Clear Cell Carcinoma": [
                  {
                    "text": "Typically older patients"
                  },
                  {
                    "text": "Characteristic tubulocystic and papillary patterns"
                  },
                  {
                    "text": "Endometriosis or adenofibromatous background"
                  },
                  {
                    "text": "Prominent plasma cell component"
                  },
                  {
                    "text": "PAX8, EMA, napsin A, racemase, and HNF-1-β positive"
                  },
                  {
                    "text": "SALL4 negative"
                  }
                ],
                "Yolk Sac Tumor, Solid Variant": [
                  {
                    "text": "Typical yolk sac patterns present (reticular/microcystic)"
                  },
                  {
                    "text": "Typically lacks septa or lymphocytic infiltrate"
                  },
                  {
                    "text": "Nuclei with variable contours, shapes, and sizes"
                  },
                  {
                    "text": "No squared-off nuclei"
                  },
                  {
                    "text": "Glypican-3 and AFP positive; OCT3/4 negative"
                  }
                ],
                "Embryonal Carcinoma (Especially If Poor Fixation)": [
                  {
                    "text": "Typically glandular and papillary architecture"
                  },
                  {
                    "text": "No septa with sprinkling of lymphocytes"
                  },
                  {
                    "text": "Pleomorphic nuclei with dusky amphophilic cytoplasm"
                  },
                  {
                    "text": "Striking apoptotic cells imparting \"dirty\" background"
                  },
                  {
                    "text": "CD30, SOX2, and AE1/AE3 positive (latter not diffuse)"
                  },
                  {
                    "text": "Typically CD117 negative"
                  }
                ],
                "Undifferentiated Carcinoma": [
                  {
                    "text": "Older age"
                  },
                  {
                    "text": "Variegated cut surface with extensive hemorrhage and necrosis"
                  },
                  {
                    "text": "Minor differentiated epithelial component may be seen"
                  },
                  {
                    "text": "OCT3/4 and SALL4 negative; EMA positive"
                  }
                ],
                "Large B-Cell Lymphoma": [
                  {
                    "text": "Bilateral in up to 50%"
                  },
                  {
                    "text": "Lacks typical septa with rare exceptions"
                  },
                  {
                    "text": "Positive lymphoid markers"
                  }
                ],
                "Sertoli Cell Tumor": [
                  {
                    "text": "Diffuse tubular architecture common"
                  },
                  {
                    "text": "Cells with small nuclei and typically inconspicuous nucleoli"
                  },
                  {
                    "text": "Nuclei lack squared-off appearance"
                  },
                  {
                    "text": "Inhibin, calretinin, SF1 positive"
                  },
                  {
                    "text": "OCT3/4 and SALL4 negative"
                  }
                ],
                "Malignant Melanoma": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Cells may contain pigment"
                  },
                  {
                    "text": "S100, HMB-45, SOX10, and MART-1 positive"
                  }
                ],
                "Small Cell Carcinoma, Hypercalcemic Type": [
                  {
                    "text": "Cells typically small; if large ± rhabdoid inclusions"
                  },
                  {
                    "text": "EMA positive (especially large cells)"
                  },
                  {
                    "text": "SMARCA4 loss of expression"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Presence of syncytiotrophoblast cells in dysgerminoma should not lead to diagnosis of choriocarcinoma and does not impact prognosis"
                  },
                  {
                    "text": "Dysgerminoma can be diagnosed after secondary infarction, as ghost cells still show typical characteristics"
                  },
                  {
                    "text": "Following diagnosis of dysgerminoma, exclude possibility of gonadal dysgenesis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Yolk Sac Tumor": {
            "name": "Yolk Sac Tumor",
            "url": "https://app.pathprimer.com/document/7a75df0f-4627-4053-8828-1495eae5388f/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant primitive germ cell tumor showing variety of distinctive patterns, ranging from primitive gut and mesenchyme to derivatives of extraembryonal (secondary yolk sac and allantois) and embryonic somatic tissues (intestine, liver, and mesenchyme)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "~ 20% of malignant germ cell tumors"
                  },
                  {
                    "text": "< 30 (mean: 19) years except if associated with surface epithelial tumor (in latter poor prognosis)"
                  },
                  {
                    "text": "Most stage I and good response to chemotherapy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Honeycomb (multiple small cysts) if polyvesicular vitelline"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Meshwork of irregular channels (reticular), which expand to form cysts of different sizes (microcystic/macrocystic) > > papillae > > solid > > other"
                  },
                  {
                    "text": "Papillae with central blood vessel (Schiller-Duval body) in ~ 1/3 of cases (typically reticular)"
                  },
                  {
                    "text": "Glandular variant: Nonspecific, including goblet and Paneth cells (up to 50%), endometrioid-like (supra- and subnuclear vacuoles), and, rarely, intestinal (primitive cells with cribriform growth)"
                  },
                  {
                    "text": "Hepatoid variant: Typically minor component"
                  },
                  {
                    "text": "Polyvesicular vitelline variant: Conspicuous cysts, sometimes with eccentric constriction (simulating subdivision of primary yolk sac vesicle) often lined by flattened cells embedded in cellular or paucicellular stroma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "AFP, PLAP, glypican-3, LIN28, SALL4, ZBTB16, GATA3 (+)"
                  },
                  {
                    "text": "AE1/AE3, HNF-1β (common), PAX8 (up to 25%) (+)"
                  },
                  {
                    "text": "CK7 and EMA , if (+) only focal"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Clear cell or endometrioid carcinoma"
                  },
                  {
                    "text": "Dysgerminoma/immature teratoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Endodermal sinus tumor"
                  },
                  {
                    "text": "Primitive endodermal tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant primitive germ cell tumor showing variety of distinctive patterns, often with variable endodermal differentiation, ranging from primitive gut and mesenchyme to derivatives of extraembryonal (secondary yolk sac and allantois) and embryonic somatic tissues (intestine, liver, and mesenchyme)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "Rare association with gonadal dysgenesis/gonadoblastoma"
                  }
                ],
                "Dedifferentiation": [
                  {
                    "text": "May rarely arise from primary surface epithelial tumor (no 12p abnormalities but somatic abnormalities)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  },
                  {
                    "text": "~ 20% of malignant germ cell tumorsAs common as dysgerminoma in first 2 decades",
                    "sub_points": [
                      "As common as dysgerminoma in first 2 decades"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Usually < 30 (mean: 19) years"
                  },
                  {
                    "text": "Postmenopausal if associated with surface epithelial tumor (rare)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal swelling &/or pain"
                  },
                  {
                    "text": "Elevated serum AFP levels"
                  },
                  {
                    "text": "Hormonal manifestations rare"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Unilateral salpingo-oophorectomy"
                  },
                  {
                    "text": "Adjuvant chemotherapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Favorable due to response to chemotherapy even with extraovarian extension (> 30% of cases)> 90% survival, if stage I",
                    "sub_points": [
                      "> 90% survival, if stage I"
                    ]
                  },
                  {
                    "text": "Worse prognosis if arising from surface carcinoma"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Large, sometimes ruptured"
                  },
                  {
                    "text": "Fleshy, friable, gray to tan, solid and cystic cut surface > cystic > solid"
                  },
                  {
                    "text": "Honeycomb (multiple small cysts) appearance, if polyvesicular vitelline component"
                  },
                  {
                    "text": "Necrosis ± hemorrhage common"
                  },
                  {
                    "text": "May be associated with mature cystic teratoma or less often with surface epithelial tumors"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range, usually > 10 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Most commonly meshwork of irregular channels (reticular) that expand to form cysts of different sizes (microcystic/macrocystic)"
                  },
                  {
                    "text": "Papillae containing central blood vessel (Schiller-Duval body) present in ~ 1/3 of cases (typically in reticular areas)"
                  },
                  {
                    "text": "Cellular papillae with conspicuous budding may occur"
                  },
                  {
                    "text": "Long ribbons, sometimes in drape-like/festoon pattern"
                  },
                  {
                    "text": "Solid, labyrinthine, festoon patterns less common"
                  },
                  {
                    "text": "VariantsGlandular: Nonspecific, including goblet and Paneth cells (up to 50%), endometrioid-like (with supra- and subnuclear vacuoles), and, rarely, intestinal (primitive cells with cribriform growth)Hepatoid: Typically minor component (more often if gonadal dysgenesis)Polyvesicular vitelline: Conspicuous cysts, sometimes with eccentric constriction (simulating subdivision of primary yolk sac vesicle) often lined by flattened cells embedded in cellular or paucicellular stroma",
                    "sub_points": [
                      "Glandular: Nonspecific, including goblet and Paneth cells (up to 50%), endometrioid-like (with supra- and subnuclear vacuoles), and, rarely, intestinal (primitive cells with cribriform growth)",
                      "Hepatoid: Typically minor component (more often if gonadal dysgenesis)",
                      "Polyvesicular vitelline: Conspicuous cysts, sometimes with eccentric constriction (simulating subdivision of primary yolk sac vesicle) often lined by flattened cells embedded in cellular or paucicellular stroma"
                    ]
                  },
                  {
                    "text": "Deposition of delicate linear basement membrane-like material (parietal pattern) rare"
                  },
                  {
                    "text": "Sometimes conspicuously myxoid (magma reticulare)"
                  },
                  {
                    "text": "Stromal luteinization occasional (more common if pregnant)"
                  },
                  {
                    "text": "Admixed with other malignant germ cell tumor (most common dysgerminoma) or gonadoblastoma (if gonadal dysgenesis)"
                  },
                  {
                    "text": "± synchronous or metachronous ipsilateral or contralateral mature cystic teratoma"
                  },
                  {
                    "text": "Admixed with surface carcinoma (more common endometrioid and clear cell): Somatic yolk sac tumor with more common glandular pattern"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Pale cytoplasm, immature nuclei with small nucleoli"
                  },
                  {
                    "text": "Cells lining cysts may be deceptively innocuous"
                  },
                  {
                    "text": "Polygonal cells with abundant eosinophilic cytoplasm, round nuclei, and prominent nucleoli (if hepatoid)"
                  },
                  {
                    "text": "Intracellular hyaline bodies common"
                  },
                  {
                    "text": "Variable mitotic activity"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "AFP (may be patchy and weak), PLAP, glypican-3, LIN28, ZBTB16, SALL4 (+)"
                  },
                  {
                    "text": "GATA3 (not in glandular pattern) and villin (+)"
                  },
                  {
                    "text": "AE1/AE3, PAX8 (up to 25%), HNF-1-β (common) (+)"
                  },
                  {
                    "text": "CEA, HepPar1, and albumin (+) (hepatoid); TTF-1(+) foregut pattern"
                  },
                  {
                    "text": "CDX2 and TTF-1 (+) (intestinal)"
                  },
                  {
                    "text": "CK7 and EMA, if (+) only focal"
                  },
                  {
                    "text": "OCT3/4, D2-40, SOX2, and NANOG (-)"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Abnormalities in chromosome 12 common (iso12p most common) except if associated with carcinoma"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Clear Cell or Endometrioid Carcinoma": [
                  {
                    "text": "Typical architectural patterns (clear cell)"
                  },
                  {
                    "text": "Low nuclear features (endometrioid)"
                  },
                  {
                    "text": "Endometriosis or adenofibroma"
                  },
                  {
                    "text": "SALL4(-); napsin A (+) (clear cell), MMR/PTEN/ARID1 loss"
                  }
                ],
                "Dysgerminoma": [
                  {
                    "text": "Monotonous architecture"
                  },
                  {
                    "text": "No papillae; hyaline bodies rare; OCT3/4 and CD117 (+)"
                  }
                ],
                "Juvenile Granulosa Cell Tumor": [
                  {
                    "text": "Follicular architecture ± thecomatous component"
                  },
                  {
                    "text": "Inhibin (+); glypican-3 and SALL4 (-)"
                  }
                ],
                "Sertoli-Leydig Cell Tumor": [
                  {
                    "text": "Androgenic manifestations common"
                  },
                  {
                    "text": "Various typical patterns of Sertoli cell neoplasia"
                  },
                  {
                    "text": "Leydig cells conspicuous and next to Sertoli cells"
                  },
                  {
                    "text": "Inhibin, SF1, calretinin (+); SALL4(-)"
                  }
                ],
                "Immature Teratoma": [
                  {
                    "text": "Endodermal, mesodermal, and ectodermal elements"
                  }
                ],
                "Hepatoid Carcinoma": [
                  {
                    "text": "Postmenopausal women; common extraovarian spread"
                  },
                  {
                    "text": "Diffuse, corded, or trabecular patterns ± bile within canaliculi"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Yolk sac tumor may occur in postmenopausal women (associated with müllerian carcinoma and poor prognosis)"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Schiller-Duval bodies seen in only a minority of yolk sac tumors and typically not extensive"
                  },
                  {
                    "text": "Negative AFP does not exclude yolk sac tumor"
                  },
                  {
                    "text": "Glypican-3 is not very helpful in distinguishing yolk sac tumor from clear cell carcinoma or endometrioid carcinoma"
                  },
                  {
                    "text": "PAX8 may be (+) in yolk sac tumor, thus, not helpful in differential diagnosis with carcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Struma Ovarii": {
            "name": "Struma Ovarii",
            "url": "https://app.pathprimer.com/document/36243a4e-1870-4795-96a2-6a80ed614a14/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Monodermal teratoma forming mass composed of benign thyroid tissue identical to that of thyroid gland or being predominant component (> 50%) of ovarian teratoma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Often incidental finding"
                  },
                  {
                    "text": "Ascites (1/3) ± pleural effusion (Meigs syndrome)"
                  },
                  {
                    "text": "Hyperthyroidism (clinically detectable in 8%)"
                  },
                  {
                    "text": "Overall, excellent even when secondary malignancy (survival rates of 89% and 84% at 10 and 25 years, respectively)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solid, \"beefy,\" sometimes nodular (goiter-like) surface"
                  },
                  {
                    "text": "Predominantly cystic (uncommon)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Macrofollicular pattern (predominant)"
                  },
                  {
                    "text": "Diffuse (solid), microfollicular, trabecular, or pseudotubular patterns less common"
                  },
                  {
                    "text": "± peripheral stromal luteinization"
                  },
                  {
                    "text": "Secondary papillary, follicular, or anaplastic carcinoma rare"
                  },
                  {
                    "text": "± associated mature cystic teratoma > > carcinoid (typically trabecular), mucinous cystadenoma, Brenner tumor"
                  },
                  {
                    "text": "Flat, cuboidal, or columnar cells with pale or oxyphilic and, rarely, clear cytoplasm"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Thyroglobulin, TTF-1, PAX8 positive"
                  },
                  {
                    "text": "BRAF,RAS,RET::PTCmutations (papillary carcinoma)"
                  },
                  {
                    "text": "RAS,PAX8::PPARGrearrangement (follicular carcinoma)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary or metastatic clear cell carcinoma"
                  },
                  {
                    "text": "Sertoli and steroid cell tumors"
                  },
                  {
                    "text": "Serous cystadenoma"
                  },
                  {
                    "text": "Strumal carcinoid"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Monodermal teratoma forming mass composed of benign thyroid tissue identical to that of thyroid gland or being predominant component (> 50%) of ovarian teratoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Up to 1% of ovarian tumors and 3% of teratomas"
                  },
                  {
                    "text": "Most common monodermal teratoma"
                  },
                  {
                    "text": "Thyroid tissue grossly recognizable in < 5% of teratomas, but mass-forming thyroid tissue much less common"
                  },
                  {
                    "text": "0.3% malignant transformation"
                  }
                ],
                "Age": [
                  {
                    "text": "Wide range (mean: 48 years)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Incidental finding most common even when associated with malignant transformation"
                  },
                  {
                    "text": "Ascites (1/3) with abdominal fullness ± pleural effusion (Meigs syndrome) or pelvic pain"
                  },
                  {
                    "text": "Hyperthyroidism (clinically detectable in only 8%)Thyrotoxicosis, especially if malignant transformation (rare)",
                    "sub_points": [
                      "Thyrotoxicosis, especially if malignant transformation (rare)"
                    ]
                  },
                  {
                    "text": "Hormonal manifestations: Vaginal bleeding, infertility, menometrorrhagia (due to associated stromal luteinization)"
                  },
                  {
                    "text": "CA125 may be elevated"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Unilateral salpingo-oophorectomy"
                  },
                  {
                    "text": "Additional debulking or I-131 if malignant ± thyroidectomy (if ovarian lesion is metastasis)"
                  },
                  {
                    "text": "Tyrosine kinase inhibitors (if malignant)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall, excellent even when secondary malignancySurvival rates: 89% and 84% at 10 and 25 years, respectively",
                    "sub_points": [
                      "Survival rates: 89% and 84% at 10 and 25 years, respectively"
                    ]
                  },
                  {
                    "text": "Even when malignant, < 10% spread outside ovary"
                  },
                  {
                    "text": "Recurrences ± late"
                  },
                  {
                    "text": "Potential features associated with increased recurrence rateStruma component > 12 cm (80% rate of recurrence)Ascites (> 1 L)Adhesions or serosal defectsPapillary or differentiated/anaplastic carcinoma",
                    "sub_points": [
                      "Struma component > 12 cm (80% rate of recurrence)",
                      "Ascites (> 1 L)",
                      "Adhesions or serosal defects",
                      "Papillary or differentiated/anaplastic carcinoma"
                    ]
                  },
                  {
                    "text": "Metastases to peritoneum, including contralateral ovary, lymph nodes, bone, liver, brain, lungsMay be highly differentiated if follicular subtype (formerly referred to as strumosis if involving peritoneum)",
                    "sub_points": [
                      "May be highly differentiated if follicular subtype (formerly referred to as strumosis if involving peritoneum)"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Radioactive I-131: High uptake in pelvis with low uptake in thyroid (not very reliable)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unilateral"
                  },
                  {
                    "text": "Solid, \"beefy,\" sometimes nodular (goiter-like) cut surface"
                  },
                  {
                    "text": "Tan to orange or greenish brown"
                  },
                  {
                    "text": "± small cysts in mainly solid tumor"
                  },
                  {
                    "text": "Predominantly cystic (multilocular or unilocular) uncommon"
                  },
                  {
                    "text": "Cyst with hair, sebum, teeth, or other tissues can be juxtaposed (mature cystic teratoma component)"
                  }
                ],
                "Size": [
                  {
                    "text": "1-25 (mean: 12) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Follicles of different sizes but typically macrofollicles (predominant), either closely packed or variably separated"
                  },
                  {
                    "text": "Diffuse (solid), microfollicular, trabecular, or pseudopapillary, pseudotubular, cystic patterns less common, alone, or in combination"
                  },
                  {
                    "text": "Hyperplastic changes can be seen (\"proliferative struma\")"
                  },
                  {
                    "text": "Intraluminal dense eosinophilic material (colloid), but lumina may be empty"
                  },
                  {
                    "text": "Birefringent calcium oxalate crystals within colloid (uncommon)"
                  },
                  {
                    "text": "Scant stroma typical but can be prominent and edematous"
                  },
                  {
                    "text": "± focal chronic lymphocytic infiltrate"
                  },
                  {
                    "text": "± peripheral stromal luteinization"
                  },
                  {
                    "text": "± extraovarian metastases resembling nonneoplastic thyroid (\"highly differentiated follicular carcinoma\" = formerly \"strumosis\" )"
                  },
                  {
                    "text": "Malignant transformation as papillary, follicular, or anaplastic carcinoma rarePapillary carcinomaPapillae and (less commonly) follicles and psammoma bodiesFollicular carcinomaVascular invasion ± invasive growth (latter difficult to evaluate within ovary, as no capsule)AnaplasticSpindle and pleomorphic cells",
                    "sub_points": [
                      "Papillary carcinomaPapillae and (less commonly) follicles and psammoma bodies",
                      "Papillae and (less commonly) follicles and psammoma bodies",
                      "Follicular carcinomaVascular invasion ± invasive growth (latter difficult to evaluate within ovary, as no capsule)",
                      "Vascular invasion ± invasive growth (latter difficult to evaluate within ovary, as no capsule)",
                      "AnaplasticSpindle and pleomorphic cells",
                      "Spindle and pleomorphic cells"
                    ]
                  },
                  {
                    "text": "± associated mature cystic teratoma (most frequent), carcinoid (typically trabecular), mucinous cystadenoma, or Brenner tumor"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Flat, cuboidal, or columnar cells with pale or dense (oxyphilic) eosinophilic or, rarely, clear cytoplasm"
                  },
                  {
                    "text": "Small, round to oval nuclei with evenly distributed chromatin"
                  },
                  {
                    "text": "± enlarged nuclei (\"endocrine atypia\"), not indicative of malignancy"
                  },
                  {
                    "text": "Typically, rare mitoses (occasionally up to 5/10 HPF)"
                  },
                  {
                    "text": "Nuclear overlapping, grooves, optically clear nuclei, and nuclear pseudoinclusions, if papillary carcinoma"
                  },
                  {
                    "text": "Variable degree of cytologic atypia, often limited, if follicular carcinoma"
                  },
                  {
                    "text": "Marked cytologic atypia and mitoses, if anaplastic carcinoma"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Struma and carcinomaThyroglobulin, TTF-1, PAX8 positive",
                    "sub_points": [
                      "Thyroglobulin, TTF-1, PAX8 positive"
                    ]
                  },
                  {
                    "text": "Papillary carcinomaGalactin-3, HBME-1, BRAF positiveNapsin A rarely positive",
                    "sub_points": [
                      "Galactin-3, HBME-1, BRAF positive",
                      "Napsin A rarely positive"
                    ]
                  },
                  {
                    "text": "Follicular carcinomaHBME-1 positive",
                    "sub_points": [
                      "HBME-1 positive"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "BRAF,KRAS,RET::PTCmutations (papillary carcinoma, including follicular variant)"
                  },
                  {
                    "text": "RAS,PAX8::PPARGrearrangement (follicular carcinoma)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Clear Cell Carcinoma (If Clear Cells)": [
                  {
                    "text": "Admixture of tubulocystic, papillary, and solid patterns"
                  },
                  {
                    "text": "Hobnail and targetoid cells with hyaline globules"
                  },
                  {
                    "text": "Cytologic atypia and mitotic activity"
                  },
                  {
                    "text": "Associated endometriosis &/or adenofibroma"
                  },
                  {
                    "text": "HNF-1-α, napsin A, racemase positive, ± MMR &/or ARID1 loss"
                  },
                  {
                    "text": "Thyroglobulin and TTF-1 negative"
                  }
                ],
                "Metastatic Clear Cell Renal Carcinoma (If Clear Cells)": [
                  {
                    "text": "Clinical history"
                  },
                  {
                    "text": "Often hemorrhagic, sinusoidal vasculature, with cytologic atypia"
                  },
                  {
                    "text": "CD10, RCC, CAIX positive"
                  },
                  {
                    "text": "Thyroglobulin and TTF-1 negative"
                  }
                ],
                "Sertoli Cell Tumor": [
                  {
                    "text": "Lack of dense eosinophilic secretions"
                  },
                  {
                    "text": "Inhibin, calretinin, and SF1 positive; ±DICER1mutations; TTF-1 negative"
                  }
                ],
                "Steroid Cell Tumor (If Oxyphilic Cells)": [
                  {
                    "text": "May be associated with androgenic manifestations"
                  },
                  {
                    "text": "Diffuse growth; no follicles; cells with multiple small lipid droplets"
                  },
                  {
                    "text": "Inhibin, calretinin, and SF1 positive"
                  }
                ],
                "Serous Cystadenoma (If Cystic)": [
                  {
                    "text": "Presence of ciliated and peg cells"
                  },
                  {
                    "text": "WT1 positive; thyroglobulin and TTF-1 negative"
                  }
                ],
                "Strumal Carcinoid": [
                  {
                    "text": "Regular trabeculae and cords in addition to follicles"
                  },
                  {
                    "text": "Argentaffin granules and salt and pepper chromatin"
                  },
                  {
                    "text": "Chromogranin, CD56, NSE, and synaptophysin positive (carcinoid)"
                  }
                ],
                "Malignant Melanoma (If Oxyphilic Cells)": [
                  {
                    "text": "Melanin pigment and horseshoe- or popcorn-like cells"
                  },
                  {
                    "text": "Cytologic atypia and brisk mitotic activity"
                  },
                  {
                    "text": "S100, HMB-45, melan-A positive"
                  }
                ],
                "Pituitary Adenoma, Hepatoid Carcinoma, Others": [
                  {
                    "text": "Different morphology and immunohistochemical profile"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "In patient with hyperthyroidism and grossly normal thyroid, consider evaluation of ovaries"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Before making diagnosis of serous cystadenoma, evaluate cyst wall for presence of small thyroid follicles (cystic struma ovarii)"
                  },
                  {
                    "text": "In tumor with clear cells and banal cytology, consider diagnosis of clear cell struma before making diagnosis of clear cell carcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Immature Teratoma": {
            "name": "Immature Teratoma",
            "url": "https://app.pathprimer.com/document/9b2926df-19e0-4c8b-9b0b-fa855cb6d3dd/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant germ cell tumor composed of immature tissue derived from 3 germ layers with variable admixture of mature tissues"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "3rd most common malignant germ cell tumor"
                  },
                  {
                    "text": "Clinical history of mature cystic teratoma (multiple and ruptured) in same or contralateral ovary (rare)"
                  },
                  {
                    "text": "Growing teratoma syndrome: Persistence or enlargement of pelvic peritoneal mass after chemotherapy with low AFP levels and absence of immature tissues within mass"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Capsule rupture in ~ 50%"
                  },
                  {
                    "text": "Solid or solid and cystic; fleshy, gray to pink"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Variable admixture of mature and immature tissues derived from endoderm, mesoderm, and ectoderm"
                  },
                  {
                    "text": "Immature neuroepithelium most common element (neuroepithelial rosettes, pseudorosettes, primitive tubules, or mitotically active glia)Low grade (grade I): 1 low-power field (4x) in any slideHigh grade (grades II and III): > 1 low-power field in any slide",
                    "sub_points": [
                      "Low grade (grade I): 1 low-power field (4x) in any slide",
                      "High grade (grades II and III): > 1 low-power field in any slide"
                    ]
                  },
                  {
                    "text": "Gliomatosis peritonei: 2- to 3-mm, well-demarcated implants of mature (more commonly) or slightly immature glial tissue typically within peritoneum"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Mature cystic teratoma with microscopic foci of neuroepithelium"
                  },
                  {
                    "text": "Cerebellum in mature cystic teratoma"
                  },
                  {
                    "text": "Mature solid teratoma"
                  },
                  {
                    "text": "Malignant neuroectodermal tumor"
                  },
                  {
                    "text": "Malignant mixed mesodermal tumor"
                  },
                  {
                    "text": "Intermediate- to poorly differentiated Sertoli-Leydig cell tumor with heterologous elements"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Immature teratoma (IT)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant germ cell tumor composed of immature tissue derived from 3 germ layers with variable admixture of mature tissues"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neoplastic Transformation": [
                  {
                    "text": "From ovarian primordial germ cellsDisplay genetic homozygosity (as seen in mature teratomas)Typically lack 12p gain or isochromosome 12p (except if part of malignant mixed germ cell tumor)",
                    "sub_points": [
                      "Display genetic homozygosity (as seen in mature teratomas)",
                      "Typically lack 12p gain or isochromosome 12p (except if part of malignant mixed germ cell tumor)"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  },
                  {
                    "text": "< 1% of all ovarian cancer in USA"
                  },
                  {
                    "text": "20% of primitive germ cell tumors3rd most common malignant germ cell tumor",
                    "sub_points": [
                      "3rd most common malignant germ cell tumor"
                    ]
                  },
                  {
                    "text": "2% of all ovarian teratomas"
                  }
                ],
                "Age": [
                  {
                    "text": "Most in first 3 decades"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain/swelling"
                  },
                  {
                    "text": "Rapidly growing mass"
                  },
                  {
                    "text": "Elevated AFP serum levels (typically < 1,000 ng/mL)"
                  },
                  {
                    "text": "Elevated CA125 and CA19-9 serum levels common"
                  },
                  {
                    "text": "Elevated HCG serum levels rare"
                  },
                  {
                    "text": "Clinical history of mature cystic teratoma (multiple and ruptured) in same or contralateral ovary (rare)"
                  },
                  {
                    "text": "Rarely, anti-NMDAR encephalitis (psychiatric symptoms, amnesia, seizures, dyskinesias, autonomic dysfunction, and decreased level of consciousness)"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Growing teratoma syndromeUsually during first 2 years after initial diagnosis and characterized byPersistence or enlargement of pelvic peritoneal mass after chemotherapyLow AFP levelsAbsence of immature tissues within mass",
                    "sub_points": [
                      "Usually during first 2 years after initial diagnosis and characterized byPersistence or enlargement of pelvic peritoneal mass after chemotherapyLow AFP levelsAbsence of immature tissues within mass",
                      "Persistence or enlargement of pelvic peritoneal mass after chemotherapy",
                      "Low AFP levels",
                      "Absence of immature tissues within mass"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Unilateral salpingo-oophorectomy ± adjuvant chemotherapy (depending on grade and stage)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Related to grade and stage but greatly improved after introduction of adjuvant chemotherapy> 85% overall survival> 97% survival if confined to ovary (stage I) vs. 84% in stages III-IVExtraovarian spread in ~ 1/3 at presentationMature glial tissue (gliomatosis peritonei) > > > immature glial tissuePeritoneal involvementGliomatosis peritonei; if present, higher risk of recurrence but similar overall survival to that of IT without gliomatosisLymph node involvementRecurrences may occur (exceptional if confined to ovary and grade I)",
                    "sub_points": [
                      "> 85% overall survival",
                      "> 97% survival if confined to ovary (stage I) vs. 84% in stages III-IV",
                      "Extraovarian spread in ~ 1/3 at presentationMature glial tissue (gliomatosis peritonei) > > > immature glial tissuePeritoneal involvementGliomatosis peritonei; if present, higher risk of recurrence but similar overall survival to that of IT without gliomatosisLymph node involvement",
                      "Mature glial tissue (gliomatosis peritonei) > > > immature glial tissue",
                      "Peritoneal involvementGliomatosis peritonei; if present, higher risk of recurrence but similar overall survival to that of IT without gliomatosis",
                      "Gliomatosis peritonei; if present, higher risk of recurrence but similar overall survival to that of IT without gliomatosis",
                      "Lymph node involvement",
                      "Recurrences may occur (exceptional if confined to ovary and grade I)"
                    ]
                  },
                  {
                    "text": "Fertility-sparing surgery ~ 98% overall survival and low recurrence rate if tumor confined to ovary"
                  },
                  {
                    "text": "Neurologic deterioration may occur in patients with NMDAR encephalitis if symptoms persisted for long time before diagnosis of teratoma"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically unilateral"
                  },
                  {
                    "text": "Capsule rupture ~ 50% (especially if history of prior mature teratoma)"
                  },
                  {
                    "text": "Solid or solid and cystic (not purely cystic)"
                  },
                  {
                    "text": "Fleshy, gray to pink solid areas on cut surface"
                  },
                  {
                    "text": "Necrosis and hemorrhage common and may be extensive"
                  },
                  {
                    "text": "Hair and sebaceous material may be seen within cysts"
                  },
                  {
                    "text": "Other mature elements may be identified (~ 20%)"
                  },
                  {
                    "text": "Mature cystic teratoma in opposite ovary (~ 10%)"
                  }
                ],
                "Size": [
                  {
                    "text": "Large (range: 9-40 cm; mean: 17 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variable admixture of mature and immature tissues derived from endoderm, mesoderm, and ectodermImmature elements recapitulate embryonic tissuesImmature neuroepithelium most commonNeuroepithelial rosettes, pseudorosettes, primitive tubulesMitotically active gliaSmall areas resembling glioblastoma multiforme or neuroblastoma",
                    "sub_points": [
                      "Immature elements recapitulate embryonic tissues",
                      "Immature neuroepithelium most commonNeuroepithelial rosettes, pseudorosettes, primitive tubulesMitotically active gliaSmall areas resembling glioblastoma multiforme or neuroblastoma",
                      "Neuroepithelial rosettes, pseudorosettes, primitive tubules",
                      "Mitotically active glia",
                      "Small areas resembling glioblastoma multiforme or neuroblastoma"
                    ]
                  },
                  {
                    "text": "Original grading system of IT based on amount of neuroepitheliumGrade I: 1 low-power field (4x) in any slideGrade II: 2-3 low-power fields in any slideGrade III: ≥ 4 low-power fields in any slide",
                    "sub_points": [
                      "Grade I: 1 low-power field (4x) in any slide",
                      "Grade II: 2-3 low-power fields in any slide",
                      "Grade III: ≥ 4 low-power fields in any slide"
                    ]
                  },
                  {
                    "text": "Revised grading system of IT based on amount of neuroepitheliumLow grade (grade I): 1 low-power field (4x) in any slideHigh grade (grades II and III): > 1 low-power field in any slide",
                    "sub_points": [
                      "Low grade (grade I): 1 low-power field (4x) in any slide",
                      "High grade (grades II and III): > 1 low-power field in any slide"
                    ]
                  },
                  {
                    "text": "Infrequent findingsProminent vascular proliferation: Multiple tiny, thin, curvilinear to glomeruloid vessels admixed with immature neuroepithelium or gliaGliomatosis peritonei: 2- to 3-mm, well-demarcated implants of mature (more commonly) or slightly immature glial tissue typically within pelvis, omentum, or lymph nodes (graded using same system as primary tumor)Rarely, may be admixed with other teratoma elementsMay be associated with prominent vascular proliferationMay be juxtaposed to endometriosis or endosalpingiosisMalignant transformation to malignant neuroectodermal tumor may occurSmall foci of yolk sac tumor (< 2 mm)Scattered syncytiotrophoblastic cells",
                    "sub_points": [
                      "Prominent vascular proliferation: Multiple tiny, thin, curvilinear to glomeruloid vessels admixed with immature neuroepithelium or glia",
                      "Gliomatosis peritonei: 2- to 3-mm, well-demarcated implants of mature (more commonly) or slightly immature glial tissue typically within pelvis, omentum, or lymph nodes (graded using same system as primary tumor)Rarely, may be admixed with other teratoma elementsMay be associated with prominent vascular proliferationMay be juxtaposed to endometriosis or endosalpingiosisMalignant transformation to malignant neuroectodermal tumor may occur",
                      "Rarely, may be admixed with other teratoma elements",
                      "May be associated with prominent vascular proliferation",
                      "May be juxtaposed to endometriosis or endosalpingiosis",
                      "Malignant transformation to malignant neuroectodermal tumor may occur",
                      "Small foci of yolk sac tumor (< 2 mm)",
                      "Scattered syncytiotrophoblastic cells"
                    ]
                  },
                  {
                    "text": "Rarely, sarcomatous transformation/overgrowth (more often as rhabdomyosarcoma)"
                  },
                  {
                    "text": "Exceedingly rarely, IT does not have immature neuroectoderm but embryonic endodermal epithelia, ranging from early endoderm to tissues similar to esophagus, liver, and intestine"
                  },
                  {
                    "text": "May be part of malignant mixed germ cell tumor"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "NeuroepitheliumPrimitive, round to oval cells with scant cytoplasm, hyperchromatic nuclei with vesicular chromatinMitoses and apoptosis common",
                    "sub_points": [
                      "Primitive, round to oval cells with scant cytoplasm, hyperchromatic nuclei with vesicular chromatin",
                      "Mitoses and apoptosis common"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "GFAP, NSE, and S100 positive in neuroepithelium (mature and immature)"
                  },
                  {
                    "text": "SOX2 and glypican-3 may be focally positive in neuroectodermal tissue"
                  },
                  {
                    "text": "OCT4, PAX6 positive in immature neuroepithelium; CD56 and LIN28 often positive"
                  },
                  {
                    "text": "SALL4 may be positive in immature neuroepithelium and mesenchymal tissue; mostly negative in mature elements except enteric epithelium"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Diploid 92%"
                  },
                  {
                    "text": "i(12p) or other forms of 12p amplification only if part of malignant mixed germ cell tumor"
                  },
                  {
                    "text": "IDH1orIDH2mutation absent in associated secondary astrocytic overgrowth"
                  },
                  {
                    "text": "Extensive allelic imbalances shared between immature and extraovarian componentsClonal pattern of loss of heterozygosity vs. different patterns between teratoma and extraovarian disease (lack of consensus)",
                    "sub_points": [
                      "Clonal pattern of loss of heterozygosity vs. different patterns between teratoma and extraovarian disease (lack of consensus)"
                    ]
                  },
                  {
                    "text": "Methylation profile similar to that of mature cystic teratoma"
                  }
                ],
                "Array Comparative Genomic Hybridization": [
                  {
                    "text": "No specific alterations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Mature Cystic Teratoma With Microscopic Foci of Neuroepithelium": [
                  {
                    "text": "Size < 10 cm (mean: 9 cm)"
                  },
                  {
                    "text": "Typical \"dermoid cyst\" gross appearance (not solid and cystic)"
                  },
                  {
                    "text": "Only mature (fetal not embryonic) elements (besides microscopic foci of neuroepithelium)"
                  },
                  {
                    "text": "No necrosis or hemorrhage"
                  }
                ],
                "Cerebellum in Mature Cystic Teratoma": [
                  {
                    "text": "Organized arrangement of cell types by layers"
                  },
                  {
                    "text": "Purkinje and (internal) granular layers present"
                  },
                  {
                    "text": "Preserved zonal pattern of cellular proliferation by Ki-67"
                  }
                ],
                "Mature Solid Teratoma": [
                  {
                    "text": "Exceedingly rare: Requires extensive sampling to exclude IT"
                  },
                  {
                    "text": "All elements mature"
                  }
                ],
                "Malignant Neuroectodermal Tumor (as Monodermal Teratoma)": [
                  {
                    "text": "Confluent growth within IT"
                  },
                  {
                    "text": "No admixture of mesodermal or endodermal elements or skin and appendages"
                  }
                ],
                "Malignant Mixed Mesodermal Tumor": [
                  {
                    "text": "Older age"
                  },
                  {
                    "text": "High-grade epithelial and mesenchymal components"
                  },
                  {
                    "text": "Mesenchymal malignant component chondrosarcoma (no fetal cartilage) and others, including rhabdomyosarcoma"
                  },
                  {
                    "text": "Neuroectodermal differentiation rare"
                  }
                ],
                "Intermediate- to Poorly Differentiated Sertoli-Leydig Cell Tumor With Heterologous Elements": [
                  {
                    "text": "Typical areas of Sertoli-Leydig cell neoplasia with tubules and cords"
                  },
                  {
                    "text": "Lack of squamous epithelium and adnexa, respiratory epithelium, and others"
                  },
                  {
                    "text": "Inhibin, calretinin, and SF1 often at least focally positive"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Prognosis of IT is related to grade and stage but has greatly improved after chemotherapy era"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Gross assessment is crucial in distinction between immature from mature (cystic) teratoma, as former is typically larger (average: 16-17 cm), and it is solid or solid and cystic (but not purely cystic ± Rokitansky nodule) even though it may have hair and sebaceous material"
                  },
                  {
                    "text": "Very important to sample IT extensively; not only to assess amount of immature neuroepithelial tissue in order to grade appropriately but also to exclude other germ cell components"
                  },
                  {
                    "text": "In IT, neuroepithelium is only immature element assessed when gradingFetal cartilage can also be seen in mature cystic teratoma and should not be considered immature (embryonal) element",
                    "sub_points": [
                      "Fetal cartilage can also be seen in mature cystic teratoma and should not be considered immature (embryonal) element"
                    ]
                  },
                  {
                    "text": "Malignant transformation into CNS-type tumor can occur and should be excluded"
                  },
                  {
                    "text": "Immunohistochemical stains do not play role in diagnosis of IT"
                  },
                  {
                    "text": "Presence of microscopic foci of yolk sac neoplasia (< 2 mm) or syncytiotrophoblast cells does not affect prognosis of patients with ITPresence of syncytiotrophoblast cells is not evidence of choriocarcinoma, as it is lacking typical biphasic growth",
                    "sub_points": [
                      "Presence of syncytiotrophoblast cells is not evidence of choriocarcinoma, as it is lacking typical biphasic growth"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gonadoblastoma": {
            "name": "Gonadoblastoma",
            "url": "https://app.pathprimer.com/document/371fee23-043b-4ad4-854d-1e0178857598/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "In situ germ cell neoplasia with intimate admixture of germ cells and incompletely differentiated sex cord cells arranged in distinctive nested pattern"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Almost always associated with Y chromosome material"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Virilization of phenotypic female common (~ 50%)"
                  },
                  {
                    "text": "Males with hypospadias and cryptorchidism (~ 30%)"
                  },
                  {
                    "text": "Symptoms if overgrowth by malignant germ cell tumor"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically bilateral in background of dysgenetic gonad"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Variably separated discrete nests with germ and sex cord cells, latter at periphery and around basement-like material separated by fibromatous stroma"
                  },
                  {
                    "text": "Basement membrane-like material within nests"
                  },
                  {
                    "text": "Calcifications common, ranging from small flecks to large, mulberry-like aggregates"
                  },
                  {
                    "text": "Large coalescent nests of germ cells or small anastomosing nests or cord-like arrangements separated by scant stroma with minor number of sex cord cells (dissecting gonadoblastoma)"
                  },
                  {
                    "text": "If stromal invasion, most common as germinoma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Germ cells: POU5F1, SALL4, OCT3/4, c-kit, PLAP, and podoplanin (+)"
                  },
                  {
                    "text": "Sex cord and lutein/Leydig cells: Inhibin, FOXL2, calretinin, SF1, SOX9 (weak), CD56 (+); WT1 and AE1/3 may be (+)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Sex cord tumor with annular tubules"
                  },
                  {
                    "text": "Mixed germ cell/sex cord-stromal tumor, unclassified"
                  },
                  {
                    "text": "Gonadoblastoma-like foci in fetal/neonatal ovary"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Mixed germ cell-stromal tumor, usual type"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Distinctive form of in situ germ cell neoplasia with intimate admixture of germ cells (some similar to those seen in germ cell neoplasia in situ) and incompletely differentiated sex cord cells arranged in characteristic nested pattern"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "Almost always associated with Y chromosome material, including GBY locus that containsTSPY1geneMay be seen in Turner syndrome and androgen insensitivity syndrome",
                    "sub_points": [
                      "May be seen in Turner syndrome and androgen insensitivity syndrome"
                    ]
                  },
                  {
                    "text": "Mutations inWT1gene (Denys-Drash and Frasier syndrome) or SWR gene (Swyer syndrome)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  }
                ],
                "Age": [
                  {
                    "text": "Children and young adults"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Virilization of phenotypic female common (~ 50%) often with amenorrhea"
                  },
                  {
                    "text": "Males with hypospadias and cryptorchidism (~ 30%)"
                  },
                  {
                    "text": "Abdominal swelling or pain but usually only if overgrowth by malignant germ cell tumor"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Bilateral gonadectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent, if pure"
                  },
                  {
                    "text": "If overgrowth by malignancy, depends on type and extent"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Calcifications may be seen"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Almost always bilateral"
                  },
                  {
                    "text": "Solid, tan to yellow, and soft to firm, sometimes gritty"
                  },
                  {
                    "text": "Background gonad almost always dysgenetic (~ 20% as testis and 20% as streak)"
                  }
                ],
                "Size": [
                  {
                    "text": "Typically small (< 3 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Discrete nests ranging from closely packed to variably separated by stroma"
                  },
                  {
                    "text": "Nests contain germ and sex cord cells, latter typically located at periphery of nests and around basement-like material"
                  },
                  {
                    "text": "Variable basement membrane-like material within nests"
                  },
                  {
                    "text": "Fibromatous stroma with lutein/Leydig cells in 2/3"
                  },
                  {
                    "text": "Large coalescent nests of germ cells or small anastomosing nests or cord-like arrangements separated by scant stroma with minor number of sex cord cells (dissecting gonadoblastoma)"
                  },
                  {
                    "text": "Calcifications common in nests, ranging from small flecks to large, mulberry-like aggregatesMay efface nests and expand into stroma",
                    "sub_points": [
                      "May efface nests and expand into stroma"
                    ]
                  },
                  {
                    "text": "If stromal invasion, most common as germinoma (from microinvasive to grossly evident)"
                  },
                  {
                    "text": "Rarely, sex cord component undergoes malignant change"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Germ cells: Abundant pale cytoplasm; large, rounded nuclei; often prominent nucleoliVariable degree of maturation and common mitoses",
                    "sub_points": [
                      "Variable degree of maturation and common mitoses"
                    ]
                  },
                  {
                    "text": "Sex cord cells (not well developed) with scant cytoplasm and smaller nuclei with inconspicuous nucleoli"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Germ cells: POU5F1, SALL4, OCT3/4, c-kit, PLAP, and podoplanin (+)"
                  },
                  {
                    "text": "Sex cord and lutein/Leydig cells: Inhibin, FOXL2, calretinin, SF1, SOX9 (weak), CD56 (+); WT1 and AE1/3 may be (+)"
                  }
                ],
                "Molecular Findings": [
                  {
                    "text": "ActivatingKITmutations in only ~ 5% of dysgerminomas arising in gonadoblastomas, in contrast to > 50% in patients without disorders of sex development"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sex Cord Tumor With Annular Tubules": [
                  {
                    "text": "Normal karyotype and background gonad, no germ cells"
                  }
                ],
                "Mixed Germ Cell/Sex Cord-Stromal Tumor, Unclassified": [
                  {
                    "text": "Normal karyotype and background gonad"
                  },
                  {
                    "text": "Typically unilateral lacking distinctive nested architecture"
                  }
                ],
                "Gonadoblastoma-Like Foci in Fetal/Neonatal Ovary": [
                  {
                    "text": "Normal karyotype and background gonad and microscopic"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Important to exclude malignant germ cell tumor by rigorous sampling, particularly if large gonadoblastoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adult Granulosa Cell Tumor": {
            "name": "Adult Granulosa Cell Tumor",
            "url": "https://app.pathprimer.com/document/1819422d-90a9-4d70-a676-cb1f0f1417da/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Proliferation of granulosa cells with variety of patterns composing at least 10% of tumor, often in fibrothecomatous background"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Median: 50 years"
                  },
                  {
                    "text": "Estrogenic manifestations in up to 2/3"
                  },
                  {
                    "text": "Association with endometrial neoplasia"
                  },
                  {
                    "text": "Stage is most important prognostic factor; propensity for late recurrences"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Unilateral (> 95%); median size: 12 cm"
                  },
                  {
                    "text": "Yellow to white cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Varying architectural growth patterns"
                  },
                  {
                    "text": "Cells with scant cytoplasm and round to oval nuclei with longitudinal grooves"
                  },
                  {
                    "text": "If high-grade transformation, abrupt transition to cells with abundant eosinophilic cytoplasm, nuclear enlargement, mitoses"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Reticulin surrounds groups of cells"
                  },
                  {
                    "text": "Inhibin, calretinin, CD99, CD56, SF1, FOXL2 positive"
                  },
                  {
                    "text": "Keratin, CD10, WT1, SMA, desmin, ER, PR variably positive"
                  },
                  {
                    "text": "EMA, CK7 negative"
                  },
                  {
                    "text": "FOXL2c.402C>G somatic mutations in ~ 95%"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Sex cord-like endometrioid carcinoma"
                  },
                  {
                    "text": "Transitional cell carcinoma"
                  },
                  {
                    "text": "Carcinoid tumor"
                  },
                  {
                    "text": "Cellular fibroma ± sex cord elements"
                  },
                  {
                    "text": "Thecoma"
                  },
                  {
                    "text": "Follicle cyst"
                  },
                  {
                    "text": "Sex cord tumor with annular tubules"
                  },
                  {
                    "text": "Endometrioid stromal sarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Proliferation of granulosa cells with variety of patterns composing at least 10% of tumor, often in fibrothecomatous background"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2-3% of primary ovarian malignancies"
                  }
                ],
                "Age": [
                  {
                    "text": "Median: 50 years; wide range: 1st-10th decades"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Estrogenic manifestations (up to 2/3)Menometrorrhagia or postmenopausal bleedingAssociation with endometrial neoplasiaIsosexual pseudoprecocity in prepubertal girls",
                    "sub_points": [
                      "Menometrorrhagia or postmenopausal bleedingAssociation with endometrial neoplasia",
                      "Association with endometrial neoplasia",
                      "Isosexual pseudoprecocity in prepubertal girls"
                    ]
                  },
                  {
                    "text": "Abdominal mass or pain"
                  },
                  {
                    "text": "Androgenic manifestations (10%)Secondary amenorrhea",
                    "sub_points": [
                      "Secondary amenorrhea"
                    ]
                  },
                  {
                    "text": "Hemoperitoneum secondary to rupture (10%)"
                  },
                  {
                    "text": "Extraovarian disease more common in high-grade transformation"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Inhibin B serum levels &/or circulating tumor DNA showingFOXL2402C>G (C134W) mutation may be used as biomarkers for recurrence"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Salpingo-oophorectomy"
                  },
                  {
                    "text": "Chemotherapy, if advanced stage, recurrent tumor or high-grade transformation"
                  },
                  {
                    "text": "Some patients may benefit from pembrolizumab"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Stage is most important prognostic factorStage I: 5-year survival rate of 84-87%Stages II-IV: 5-year survival rate of 38-60%",
                    "sub_points": [
                      "Stage I: 5-year survival rate of 84-87%",
                      "Stages II-IV: 5-year survival rate of 38-60%"
                    ]
                  },
                  {
                    "text": "High-grade transformation likely associated with poor outcome"
                  },
                  {
                    "text": "Propensity for late recurrencesAverage 5 years but may be decades laterLifelong follow-up required",
                    "sub_points": [
                      "Average 5 years but may be decades later",
                      "Lifelong follow-up required"
                    ]
                  },
                  {
                    "text": "Other potentially unfavorable factorsPostmenopausal status and older ageTumor ruptureSize > 5 cmMitoses > 5/10 HPFExtent and intensity of PR stainingTERTpromoter mutationTP53mutation",
                    "sub_points": [
                      "Postmenopausal status and older age",
                      "Tumor rupture",
                      "Size > 5 cm",
                      "Mitoses > 5/10 HPF",
                      "Extent and intensity of PR staining",
                      "TERTpromoter mutation",
                      "TP53mutation"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unilateral (> 95%)"
                  },
                  {
                    "text": "Usually solid or solid and cystic"
                  },
                  {
                    "text": "Rarely, unilocular or multilocular cyst"
                  },
                  {
                    "text": "Yellow to white cut surface"
                  },
                  {
                    "text": "Frequent areas of hemorrhage/necrosis (torsion)"
                  }
                ],
                "Size": [
                  {
                    "text": "Up to 20 (median: 12) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Admixture of patterns commonDiffuse, fibromatous, insular, trabecular, corded, microfollicular (Call-Exner), and, less commonly, macrofollicular, gyriform, watered silk, pseudopapillary, gland-like",
                    "sub_points": [
                      "Diffuse, fibromatous, insular, trabecular, corded, microfollicular (Call-Exner), and, less commonly, macrofollicular, gyriform, watered silk, pseudopapillary, gland-like"
                    ]
                  },
                  {
                    "text": "If cystic, multiple layers of granulosa cells sometimes forming Call-Exner bodies and associated with nests of tumor cells in cyst wall"
                  },
                  {
                    "text": "If high-grade transformation, abrupt transition from typical adult granulosa cell tumor morphology"
                  },
                  {
                    "text": "Background ovarian stromal hyperthecosis may be seen"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Granulosa cell componentCells with scant eosinophilic cytoplasmRound to oval nuclei with longitudinal grooveFine chromatin ± conspicuous nucleoliMinimal cytologic atypia and mitoses usually < 5/10 HPFMore abundant eosinophilic cytoplasm, nuclear enlargement, and mitoses, if high-grade transformationRarely enlarged, hyperchromatic, irregular (bizarre) nuclei (usually focal); extensive luteinization (abundant eosinophilic cytoplasm and round nuclei with absence of grooves); signet ring cells; hepatic differentiation (nests, acini, or trabeculae)",
                    "sub_points": [
                      "Cells with scant eosinophilic cytoplasm",
                      "Round to oval nuclei with longitudinal groove",
                      "Fine chromatin ± conspicuous nucleoli",
                      "Minimal cytologic atypia and mitoses usually < 5/10 HPF",
                      "More abundant eosinophilic cytoplasm, nuclear enlargement, and mitoses, if high-grade transformation",
                      "Rarely enlarged, hyperchromatic, irregular (bizarre) nuclei (usually focal); extensive luteinization (abundant eosinophilic cytoplasm and round nuclei with absence of grooves); signet ring cells; hepatic differentiation (nests, acini, or trabeculae)"
                    ]
                  },
                  {
                    "text": "Stromal cell componentSpindled or polygonal cells with eosinophilic to vacuolated cytoplasm and round nuclei",
                    "sub_points": [
                      "Spindled or polygonal cells with eosinophilic to vacuolated cytoplasm and round nuclei"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Reticulin surrounds groups or nests of cells"
                  },
                  {
                    "text": "Inhibin, calretinin, CD99, CD56, SF1, FOXL2 positive"
                  },
                  {
                    "text": "Keratin, CD10, WT1, SMA, desmin, ER, PR variably positive"
                  },
                  {
                    "text": "Androgen receptor often positive (~ 50%)"
                  },
                  {
                    "text": "EMA, CK7 negative"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "FOXL2c.402C>G somatic mutations in 95%"
                  },
                  {
                    "text": "TERTpromoter mutation ~ 40%"
                  },
                  {
                    "text": "TP53mutations may be seen with high-grade transformation"
                  }
                ],
                "Serologic Testing": [
                  {
                    "text": "Inhibin B"
                  },
                  {
                    "text": "Antimüllerian hormone"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sex Cord-Like Endometrioid Adenocarcinoma": [
                  {
                    "text": "Presence of squamous or mucinous differentiation"
                  },
                  {
                    "text": "Association with endometriosis"
                  },
                  {
                    "text": "EMA and PAX8 positive; inhibin, SF1, and FOXL2 negative"
                  }
                ],
                "Transitional Cell Carcinoma": [
                  {
                    "text": "Often spreads beyond ovary"
                  },
                  {
                    "text": "High-grade cytologic atypia and necrosis"
                  },
                  {
                    "text": "May be associated with serous carcinoma component"
                  },
                  {
                    "text": "PAX8, p16, EMA positive; often p53 mutant pattern"
                  }
                ],
                "Carcinoid Tumor": [
                  {
                    "text": "Chromatin with salt and pepper appearance; ± Paneth cells"
                  },
                  {
                    "text": "Chromogranin, synaptophysin positive; SF1, inhibin negative"
                  }
                ],
                "Cellular Fibroma": [
                  {
                    "text": "Lack of nested pattern by reticulin stain"
                  },
                  {
                    "text": "Sex cord elements < 10%"
                  }
                ],
                "Thecoma": [
                  {
                    "text": "Abundant pale gray cytoplasm with syncytial appearance"
                  },
                  {
                    "text": "Reticulin surrounds individual cells"
                  }
                ],
                "Follicle Cyst": [
                  {
                    "text": "Typically < 8 cm"
                  },
                  {
                    "text": "Thin wall with delicate appearance"
                  },
                  {
                    "text": "Lack of granulosa cell proliferation in wall"
                  },
                  {
                    "text": "Round, uniform nuclei without nuclear grooves"
                  }
                ],
                "Sex Cord Tumor With Annular Tubules": [
                  {
                    "text": "Associated with Peutz-Jeghers syndrome (subset)"
                  },
                  {
                    "text": "Complex annular tubules with peripheral nuclei"
                  },
                  {
                    "text": "Dense deposits of basement membrane-like material"
                  }
                ],
                "Endometrioid Stromal Sarcoma": [
                  {
                    "text": "Characteristic arteriolar vascular pattern"
                  },
                  {
                    "text": "Lack of nuclear grooves"
                  },
                  {
                    "text": "CD10 positive; inhibin negative (if no sex cord-like differentiation)"
                  }
                ],
                "Granulosa Cell Proliferations of Pregnancy": [
                  {
                    "text": "Microscopic, incidental finding"
                  },
                  {
                    "text": "Typically multiple and associated with atretic follicles"
                  }
                ],
                "Female Adnexal Tumor of Probable Wolffian Origin": [
                  {
                    "text": "Typically paraovarian soft tissue; rarely ovary"
                  },
                  {
                    "text": "SF1, ER/PR negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Cystic granulosa cell tumor most commonly associated with androgenic manifestations"
                  },
                  {
                    "text": "Distinction of fibromatous granulosa cell tumor from cellular fibroma can be difficult on morphologic grounds alone; reticulin can help resolve this differential"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Secondary Tumors in Teratomas": {
            "name": "Secondary Tumors in Teratomas",
            "url": "https://app.pathprimer.com/document/8a5e0b76-c88e-4bfc-8887-4bc6f6875b79/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign or malignant neoplasm arising from tissues normally present within teratoma (mature or immature)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Up to 2% of mature cystic teratomas~ 80% of malignant tumors are squamous cell carcinomaSquamous cell carcinoma > > > adenocarcinoma and sarcoma",
                    "sub_points": [
                      "~ 80% of malignant tumors are squamous cell carcinoma",
                      "Squamous cell carcinoma > > > adenocarcinoma and sarcoma"
                    ]
                  },
                  {
                    "text": "Exceedingly rare in immature teratomas"
                  },
                  {
                    "text": "Range: 21-75 (mean: 53) years"
                  },
                  {
                    "text": "Prognosis dependent on tumor type and stage"
                  },
                  {
                    "text": "If malignant, good outcome if stage I (~ 75% survival at 5 years)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Thickening or nodule protruding from wall"
                  },
                  {
                    "text": "Solid and cystic, multicystic, papillary"
                  },
                  {
                    "text": "May overgrow most of underlying teratoma"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Squamous cell carcinomaWide spectrum: Well to poorly differentiated ± keratinizing, papillary, acantholytic, sarcomatoid, other± squamous cell carcinoma in situ or squamous dysplasia",
                    "sub_points": [
                      "Wide spectrum: Well to poorly differentiated ± keratinizing, papillary, acantholytic, sarcomatoid, other",
                      "± squamous cell carcinoma in situ or squamous dysplasia"
                    ]
                  },
                  {
                    "text": "Benign to low-grade mucinous neoplasmsTypically originating from intestinal-type epitheliumMay be associated with mucin extravasation in ovarian stroma (\"pseudomyxoma ovarii\")",
                    "sub_points": [
                      "Typically originating from intestinal-type epithelium",
                      "May be associated with mucin extravasation in ovarian stroma (\"pseudomyxoma ovarii\")"
                    ]
                  },
                  {
                    "text": "Other carcinomas (adenocarcinoma, adenosquamous carcinoma, small cell carcinoma, other), sarcomas (leiomyosarcoma, rhabdomyosarcoma, other), melanocytic proliferations, lymphoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Metastatic squamous cell carcinoma from other sites"
                  },
                  {
                    "text": "Metastatic appendiceal mucinous tumor"
                  },
                  {
                    "text": "Other metastatic malignant tumors (carcinoma > lymphoma > sarcoma)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign or malignant neoplasm arising from tissues normally present within teratoma (mature or immature)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Up to 2% of mature cystic teratomas~ 80% of malignant tumors are squamous cell carcinomasSquamous cell carcinoma > > > adenocarcinoma and sarcoma",
                    "sub_points": [
                      "~ 80% of malignant tumors are squamous cell carcinomasSquamous cell carcinoma > > > adenocarcinoma and sarcoma",
                      "Squamous cell carcinoma > > > adenocarcinoma and sarcoma"
                    ]
                  },
                  {
                    "text": "Exceedingly rare in immature teratomas"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 21-75 (mean: 53) yearsSarcomas in younger patients than carcinomas",
                    "sub_points": [
                      "Sarcomas in younger patients than carcinomas"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Rapid abdominal swelling/acute pain"
                  },
                  {
                    "text": "Incidental finding"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Oophorectomy, if benign"
                  },
                  {
                    "text": "Bilateral salpingo-oophorectomy + hysterectomy ± debulking if malignant"
                  },
                  {
                    "text": "Chemotherapy &/or radiation, if advanced stage"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tumor type and stage dependentIf benign, good outcomeIf malignant, good outcome if stage I (~ 75% survival at 5 years)Extraovarian spread at diagnosis (occurs in ~ 50%) associated with poor prognosis",
                    "sub_points": [
                      "If benign, good outcome",
                      "If malignant, good outcome if stage I (~ 75% survival at 5 years)",
                      "Extraovarian spread at diagnosis (occurs in ~ 50%) associated with poor prognosis"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Thickening or nodule protruding from wall of dermoid cyst"
                  },
                  {
                    "text": "Solid and cystic, multicystic, papillary"
                  },
                  {
                    "text": "May overgrow most of underlying teratoma"
                  },
                  {
                    "text": "Necrosis &/or hemorrhage common"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range if squamous cell carcinomaMean: 13 cm",
                    "sub_points": [
                      "Mean: 13 cm"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Squamous cell carcinomaWide spectrum: Well to poorly differentiated ± keratinizing, papillary, acantholytic, sarcomatoid, other± cystic degeneration with keratin debris± squamous cell carcinoma in situ or squamous dysplasia",
                    "sub_points": [
                      "Wide spectrum: Well to poorly differentiated ± keratinizing, papillary, acantholytic, sarcomatoid, other",
                      "± cystic degeneration with keratin debris",
                      "± squamous cell carcinoma in situ or squamous dysplasia"
                    ]
                  },
                  {
                    "text": "Benign to low-grade mucinous neoplasmsTypically originating from intestinal-type epitheliumMay be associated with mucin extravasation in ovarian stroma (\"pseudomyxoma ovarii\")Transition to mucinous glands of mature cystic teratoma",
                    "sub_points": [
                      "Typically originating from intestinal-type epithelium",
                      "May be associated with mucin extravasation in ovarian stroma (\"pseudomyxoma ovarii\")",
                      "Transition to mucinous glands of mature cystic teratoma"
                    ]
                  },
                  {
                    "text": "OthersAdenocarcinoma (gastric, bronchial, others), adenosquamous carcinoma, small cell carcinoma, adnexal tumors, pituitary adenoma, othersMalignant melanoma (pseudopapillary ± pseudofollicular spaces); other melanocytic proliferationsSarcoma: Leiomyosarcoma, rhabdomyosarcoma (in mature and immature teratoma), osteosarcoma, chondrosarcoma, liposarcoma, angiosarcoma, othersParaganglioma, rhabdomyoma, glomus tumor, choroid plexus papilloma, lymphoma, others",
                    "sub_points": [
                      "Adenocarcinoma (gastric, bronchial, others), adenosquamous carcinoma, small cell carcinoma, adnexal tumors, pituitary adenoma, others",
                      "Malignant melanoma (pseudopapillary ± pseudofollicular spaces); other melanocytic proliferations",
                      "Sarcoma: Leiomyosarcoma, rhabdomyosarcoma (in mature and immature teratoma), osteosarcoma, chondrosarcoma, liposarcoma, angiosarcoma, others",
                      "Paraganglioma, rhabdomyoma, glomus tumor, choroid plexus papilloma, lymphoma, others"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Metastatic Squamous Cell Carcinoma From Other Sites": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Bilateral ovarian involvement more frequent"
                  },
                  {
                    "text": "No association with dermoid cyst"
                  },
                  {
                    "text": "p16 diffusely positive if cervical origin"
                  }
                ],
                "Metastatic Appendiceal Mucinous Tumor": [
                  {
                    "text": "Abnormal appendix"
                  },
                  {
                    "text": "More often \"pseudomyxoma peritonei\""
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In absence of definitive dermoid associated with squamous cell carcinoma in ovary, exclude possibility of metastasis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Benign Mucinous Tumors": {
            "name": "Benign Mucinous Tumors",
            "url": "https://app.pathprimer.com/document/3aff3257-2b4d-489f-b3d4-d16b753ce648/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Cystadenoma: Benign cystic neoplasm lined by single layer of gastrointestinal or endocervical (müllerian)-type mucinous epithelium"
                  },
                  {
                    "text": "Adenofibroma/cystadenofibroma: Benign, variably solid and cystic neoplasm composed of small glands &/or cysts lined by single layer of gastrointestinal or endocervical (müllerian)-type mucinous epithelium embedded in fibromatous stroma"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "May originate from mature cystic teratoma, Brenner tumor, endometriosis, epithelial inclusions, sex cord tumors"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "80% of primary ovarian mucinous tumors"
                  },
                  {
                    "text": "Cystadenoma > > > > > > > adenofibroma"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically unilateral with smooth or bosselated surface"
                  },
                  {
                    "text": "Variably sized smooth-walled cyst(s) with dense, viscous, sticky contents"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Single layer of columnar, cuboidal to flat cells"
                  },
                  {
                    "text": "Variable amounts of apical mucinous cytoplasm"
                  },
                  {
                    "text": "Variably cellular fibromatous stroma"
                  },
                  {
                    "text": "Basally located nuclei with minimal to no atypia"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7 positive, except if arising in teratoma"
                  },
                  {
                    "text": "CK20, CDX2 variably positive if intestinal"
                  },
                  {
                    "text": "ER, PR, SATB2 negative; SATB2 positive if association with teratoma"
                  },
                  {
                    "text": "KRASmutations (~ 60%)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Mucinous tumor with focal atypia/epithelial proliferation"
                  },
                  {
                    "text": "Involvement by low-grade appendiceal mucinous neoplasm"
                  },
                  {
                    "text": "Metastatic adenocarcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Cystadenoma: Benign cystic neoplasm lined by single layer of gastrointestinal or endocervical (müllerian)-type mucinous epithelium"
                  },
                  {
                    "text": "Adenofibroma/cystadenofibroma: Benign, variably solid and cystic neoplasm composed of small glands &/or cysts lined by single layer of gastrointestinal or endocervical (müllerian)-type mucinous epithelium embedded in fibromatous stroma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Uncertain": [
                  {
                    "text": "May originate from mature cystic teratomaGerm cell origin as highest association among epithelial tumors, if intestinal type, with mature cystic teratoma",
                    "sub_points": [
                      "Germ cell origin as highest association among epithelial tumors, if intestinal type, with mature cystic teratoma"
                    ]
                  },
                  {
                    "text": "May originate from endometriosis or surface epithelial inclusionsSurface epithelial origin if endocervical type",
                    "sub_points": [
                      "Surface epithelial origin if endocervical type"
                    ]
                  },
                  {
                    "text": "May originate from Brenner tumorInnermost layer of transitional nests may be lined by mucinous epithelium",
                    "sub_points": [
                      "Innermost layer of transitional nests may be lined by mucinous epithelium"
                    ]
                  },
                  {
                    "text": "May originate from Sertoli-Leydig cell tumor or, rarely, adult granulosa cell tumor and be predominant component forming mass"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "80% of primary ovarian mucinous tumorsBenign mucinous tumors > > > borderline > > > > malignant",
                    "sub_points": [
                      "Benign mucinous tumors > > > borderline > > > > malignant"
                    ]
                  },
                  {
                    "text": "Cystadenoma > > > > > > > adenofibroma"
                  }
                ],
                "Age": [
                  {
                    "text": "Reproductive years most commonCan occur in pediatric population (< 18 years) but less common than serous counterpart",
                    "sub_points": [
                      "Can occur in pediatric population (< 18 years) but less common than serous counterpart"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Ovary > > > > retroperitoneum"
                  },
                  {
                    "text": "Rarely bilateral"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Gradual abdominal distention ± palpable mass"
                  },
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Rarely estrogenic or androgenic manifestations (if stromal luteinization)"
                  },
                  {
                    "text": "Zollinger-Ellison syndrome exceedingly rare (elevated gastrin levels in plasma)"
                  },
                  {
                    "text": "Occasional association with Peutz-Jeghers syndrome"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cystectomy or unilateral salpingo-oophorectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "ExcellentRecurrences may occur if adhesions or rupture",
                    "sub_points": [
                      "Recurrences may occur if adhesions or rupture"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "US/MR findings": [
                  {
                    "text": "Typically large, uni- or multiloculated cystic mass with locules varying in echogenicity, attenuation, and signal intensity"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically, unilateral with smooth or bosselated surface"
                  },
                  {
                    "text": "Variably sized smooth-walled cyst(s) with dense, viscous, sticky contents; papillary excrescences or friable solid areas absentUnilocular or multilocular cyst with thin walls (cystadenoma)Multilocular cyst with variable amount of white solid areas (adenofibroma/cystadenofibroma)",
                    "sub_points": [
                      "Unilocular or multilocular cyst with thin walls (cystadenoma)",
                      "Multilocular cyst with variable amount of white solid areas (adenofibroma/cystadenofibroma)"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Mean: 10 cm, but they can be very large (> 30 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variably sized cyst(s) lined by single layer of cells"
                  },
                  {
                    "text": "Cysts may contain tubular crypt-like outpouchings or papillary infoldingsRarely papillae may be prominent if endocervical type",
                    "sub_points": [
                      "Rarely papillae may be prominent if endocervical type"
                    ]
                  },
                  {
                    "text": "± mucin granulomas with numerous macrophages ± multinucleated giant cells (secondary to gland rupture)"
                  },
                  {
                    "text": "Variably collagenous to cellular fibromatous stroma"
                  },
                  {
                    "text": "Periglandular stromal condensation and luteinization (especially in pregnancy), rarely sex cord-like differentiation"
                  },
                  {
                    "text": "Spiculated calcifications within cyst walls"
                  },
                  {
                    "text": "Brenner or teratomatous component (5-10%)"
                  },
                  {
                    "text": "Secondary neuroendocrine hyperplasia and carcinoid tumor rare"
                  },
                  {
                    "text": "Rare mural nodules in cyst wall (more often leiomyoma)"
                  },
                  {
                    "text": "Rare association with Sertoli-Leydig cell tumor or adult granulosa cell tumor"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Columnar, cuboidal to flat cells with variable amounts of apical mucinous cytoplasm and basally located nuclei (endocervical, gastric foveolar, intestinal, or pancreatic morphology)"
                  },
                  {
                    "text": "Goblet, neuroendocrine, Paneth cells rareGastrointestinal differentiation less common than in borderline tumors and carcinoma",
                    "sub_points": [
                      "Gastrointestinal differentiation less common than in borderline tumors and carcinoma"
                    ]
                  },
                  {
                    "text": "Minimal to absent cytologic atypia and rare mitoses"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7 positive, except if associated with teratoma"
                  },
                  {
                    "text": "CK20, CDX2 variably positive if intestinal/gastric/pancreatic differentiation/associated with teratoma"
                  },
                  {
                    "text": "PAX8 may be positive (negative if associated with teratoma)"
                  },
                  {
                    "text": "ER, PR, SATB2 negative; SATB2 positive if association with teratoma"
                  }
                ],
                "Molecular Studies": [
                  {
                    "text": "KRASmutations (~ 60%)"
                  },
                  {
                    "text": "Frequent loss of heterozygosity (LOH) targeting chromosome 9 and 9p9p LOH commonly associated withKRASmutations",
                    "sub_points": [
                      "9p LOH commonly associated withKRASmutations"
                    ]
                  },
                  {
                    "text": "NoTP53mutations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Mucinous Tumor With Focal Atypia/Epithelial Proliferation (vs. Mucinous Cystadenoma)": [
                  {
                    "text": "Focal (< 10%) architectural complexity (including papillae and tufting) &/or nuclear pseudostratification and crowding"
                  }
                ],
                "Ovarian Involvement by Low-Grade Appendiceal Mucinous Neoplasm": [
                  {
                    "text": "Often mucin on ovarian and extraovarian surfaces (pseudomyxoma peritonei)"
                  },
                  {
                    "text": "Bilateral ovarian involvement frequent"
                  },
                  {
                    "text": "Detachment of mucinous epithelium from stroma"
                  },
                  {
                    "text": "Very tall mucinous cytoplasm"
                  },
                  {
                    "text": "CDX2, SATB2, and CK20 positive; CK7 negative"
                  }
                ],
                "Metastatic Adenocarcinoma": [
                  {
                    "text": "Spectrum of differentiation and areas with high-grade nuclear atypia and mitotic rate (gastrointestinal and hepatobiliary tract)"
                  },
                  {
                    "text": "Nuclear pseudostratification, apical mitoses, and apoptosis (endocervical)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Open all locules to ensure smooth lining and to exclude solid/fleshy component that may represent mucinous borderline tumor or carcinoma"
                  },
                  {
                    "text": "Granular or thickened areas within cyst wall should be sampled to exclude more significant lesion"
                  },
                  {
                    "text": "Possibility of metastasis should be strongly considered if bilateral involvement, surface mucin, or lack of correlation between architecture and cytology, even if tumors are predominantly cystic"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Small Cell Carcinoma, Pulmonary Type": {
            "name": "Small Cell Carcinoma, Pulmonary Type",
            "url": "https://app.pathprimer.com/document/0545879a-da21-4abf-8a8d-ccbaf2a9a06a/lesson/58472452-9e32-47ac-9b1b-e9b8e409a59c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial tumor with neuroendocrine features resembling its pulmonary counterpart"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "28-85 (mean: 59) years"
                  },
                  {
                    "text": "Abdominal or pelvic mass or swelling"
                  },
                  {
                    "text": "Neuroendocrine manifestations (Cushing syndrome; inappropriate antidiuretic hormone secretion)"
                  },
                  {
                    "text": "Poor outcome for all stages"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically solid with minor cystic component"
                  },
                  {
                    "text": "Yellow to tan, gray to white, red to brown cut surface"
                  },
                  {
                    "text": "Necrosis and hemorrhage common"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Typically sheets and nested growth"
                  },
                  {
                    "text": "Small cells: Scant cytoplasm, small, oval to elongated nuclei, evenly distributed chromatin, inconspicuous nucleoli, nuclear molding"
                  },
                  {
                    "text": "Associated surface epithelial tumor or teratoma"
                  },
                  {
                    "text": "Brisk mitotic activity, including atypical forms"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Keratins, CK20 (paranuclear dot-like), EMA positive"
                  },
                  {
                    "text": "Chromogranin, NSE, CD56, INSM1, and synaptophysin (+/-)"
                  },
                  {
                    "text": "TTF-1 may be positive"
                  },
                  {
                    "text": "ER, PR, WT1, and vimentin typically negative"
                  },
                  {
                    "text": "SMARCA2(BRM) andSMARCA4(BRG1) expression intact"
                  },
                  {
                    "text": "Aneuploid (65%)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Small cell carcinoma, hypercalcemic type"
                  },
                  {
                    "text": "Small cell carcinoma, pulmonary type, metastatic"
                  },
                  {
                    "text": "Desmoplastic small round cell tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Small cell neuroendocrine carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial tumor with neuroendocrine features resembling its pulmonary counterpart"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  }
                ],
                "Age": [
                  {
                    "text": "28-85 (mean: 59) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal or pelvic mass; abdominal swelling"
                  },
                  {
                    "text": "Asymptomatic"
                  },
                  {
                    "text": "Neuroendocrine manifestations (Cushing syndrome; inappropriate antidiuretic hormone secretion)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Radical hysterectomy and bilateral salpingo-oophorectomy with debulking if extraovarian extension"
                  },
                  {
                    "text": "Adjuvant chemotherapy &/or radiation therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor outcome for all stages"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically solid with minor cystic component"
                  },
                  {
                    "text": "Yellow to tan, gray to white, red to brown cut surface"
                  },
                  {
                    "text": "Necrosis and hemorrhage common"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range (mean: 13 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Typically sheets and nested growth"
                  },
                  {
                    "text": "Trabeculae and rosette-like formation may be seen"
                  },
                  {
                    "text": "Extensive single-cell apoptosis and necrosis"
                  },
                  {
                    "text": "Often associated with surface epithelial tumorEndometrioid carcinoma, mucinous or Brenner tumor",
                    "sub_points": [
                      "Endometrioid carcinoma, mucinous or Brenner tumor"
                    ]
                  },
                  {
                    "text": "Mature cystic teratoma may coexist"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cells with scant cytoplasm, small to medium-sized, oval to elongated nuclei with evenly distributed chromatin, inconspicuous nucleoli, and nuclear molding"
                  },
                  {
                    "text": "Brisk mitoses, including atypical forms, and apoptosis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Keratins, CK20 (paranuclear dot-like), EMA positive"
                  },
                  {
                    "text": "Chromogranin, NSE, CD56, ISNM1 and synaptophysin (+/-)"
                  },
                  {
                    "text": "TTF1 may be positive"
                  },
                  {
                    "text": "ER, PR, WT1, and vimentin typically negative"
                  },
                  {
                    "text": "SMARCA2(BRM) andSMARCA4(BRG1) expression intact"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Aneuploid (65%)"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Neurosecretory granules"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Small Cell Carcinoma, Hypercalcemic Type": [
                  {
                    "text": "Mean age: 24 years ± paraneoplastic hypercalcemia"
                  },
                  {
                    "text": "Follicle-like spaces"
                  },
                  {
                    "text": "± large cells with abundant cytoplasm and prominent nucleoli"
                  },
                  {
                    "text": "Vimentin and WT1 positive;SMARCA4/SMARCA2loss"
                  },
                  {
                    "text": "Diploid"
                  }
                ],
                "Small Cell Carcinoma, Pulmonary Type, Metastatic": [
                  {
                    "text": "Clinical history"
                  },
                  {
                    "text": "No associated teratoma or other epithelial ovarian tumor"
                  }
                ],
                "Desmoplastic Small Round Cell Tumor": [
                  {
                    "text": "Young patients"
                  },
                  {
                    "text": "Prominent desmoplastic stroma"
                  },
                  {
                    "text": "Dual expression of epithelial markers and desmin (paranuclear dot-like); t(11;22)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Metastatic small cell carcinoma may present as ovarian mass without prior known history, and both tumors may be bilateral"
                  },
                  {
                    "text": "Diagnosis of small cell carcinoma, pulmonary type, does not require neuroendocrine marker positivity"
                  },
                  {
                    "text": "TTF-1 is not helpful in separating primary from metastatic small cell carcinoma of pulmonary type"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Uterine Corpus: Nonneoplastic Lesions": {
        "name": "Uterine Corpus: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/40266b68-18a9-4b52-b806-ee81102eefcb",
        "topics": {
          "Endometriosis": {
            "name": "Endometriosis",
            "url": "https://app.pathprimer.com/document/3a002ed2-a50f-471a-9d85-56897b81486f/lesson/40266b68-18a9-4b52-b806-ee81102eefcb",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Presence of ectopic endometrial-type epithelium, stroma, &/or evidence of old or recent blood"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Genetic and hormonal factors"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "< 2% of reproductive-aged females (vulva/vagina)"
                  },
                  {
                    "text": "5-15% of reproductive-aged females (female genital tract)"
                  },
                  {
                    "text": "Most commonly 3rd and 4th decades"
                  },
                  {
                    "text": "Often located in prior obstetric or surgical sites; most commonly episiotomy scar"
                  },
                  {
                    "text": "Pain or bleeding or cyst that may fluctuate in size with menstrual cycle"
                  },
                  {
                    "text": "Rarely, malignant transformation (most commonly clear cell carcinoma)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Cyst or submucosal mass"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Glands ± cysts lined by müllerian-type epithelium ± reactive, hyperplastic or neoplastic changes"
                  },
                  {
                    "text": "Endometrial-type stroma, similar to eutopic endometrium (proliferative phase most common)"
                  },
                  {
                    "text": "Stroma may be inconspicuous > > > unassociated with endometrial-type glands"
                  },
                  {
                    "text": "Recent or old hemorrhage"
                  },
                  {
                    "text": "Metaplastic changes: Mucinous, ciliated, hobnail, secretory"
                  },
                  {
                    "text": "Variable mitotic activity in both compartments (more prominent in proliferative phase)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Bartholin cyst"
                  },
                  {
                    "text": "Ciliated cyst"
                  },
                  {
                    "text": "Ectopic breast tissue"
                  },
                  {
                    "text": "Metastatic endometrioid adenocarcinoma"
                  },
                  {
                    "text": "Müllerian adenosarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Endometriosis externa"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Presence of ectopic endometrial-type epithelium, stroma, &/or evidence of recent or old hemorrhage"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Factors": [
                  {
                    "text": "More common in female relatives of affected individuals"
                  },
                  {
                    "text": "More common in monozygotic, but not dizygotic, twins"
                  }
                ],
                "Hormonal Aspects": [
                  {
                    "text": "Rare before puberty"
                  },
                  {
                    "text": "Cyclic growth and regression with menstrual cycle"
                  },
                  {
                    "text": "More common with prolonged estrogen exposure"
                  },
                  {
                    "text": "Typical regression after menopause"
                  }
                ],
                "Other Factors": [
                  {
                    "text": "Often located in prior obstetric or surgical sites; most commonly episiotomy scar"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "< 2% of reproductive-aged females (vulva/vagina)"
                  },
                  {
                    "text": "5-15% of reproductive-aged females (female genital tract)"
                  }
                ],
                "Age": [
                  {
                    "text": "Reproductive, most commonly 3rd and 4th decades"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Pain or bleeding"
                  },
                  {
                    "text": "Cyst ± size fluctuation during menstrual cycle"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Local excision, if possible"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  },
                  {
                    "text": "Rarely, malignant transformation (most common clear cell carcinoma)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Cyst or submucosal mass"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Glands ± cysts lined by müllerian-type epithelium± hyperplastic or neoplastic changes",
                    "sub_points": [
                      "± hyperplastic or neoplastic changes"
                    ]
                  },
                  {
                    "text": "Endometrial-type stromaSimilar to eutopic endometrium (proliferative phase most common)Stroma may be inconspicuous > > > > unassociated with endometrial-type glandsFibrosis, smooth muscle metaplasia, elastosis",
                    "sub_points": [
                      "Similar to eutopic endometrium (proliferative phase most common)",
                      "Stroma may be inconspicuous > > > > unassociated with endometrial-type glands",
                      "Fibrosis, smooth muscle metaplasia, elastosis"
                    ]
                  },
                  {
                    "text": "Recent or old hemorrhageVariable amounts of hemosiderin-laden macrophages or extracellular hemosiderin deposition",
                    "sub_points": [
                      "Variable amounts of hemosiderin-laden macrophages or extracellular hemosiderin deposition"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Epithelial cellsCuboidal to columnar with eosinophilic to pale cytoplasm, oval nuclei with tiny nucleoliMetaplastic changes (mucinous, ciliated, hobnail, or secretory)± degenerative or reactive nuclear changes (rare)",
                    "sub_points": [
                      "Cuboidal to columnar with eosinophilic to pale cytoplasm, oval nuclei with tiny nucleoliMetaplastic changes (mucinous, ciliated, hobnail, or secretory)± degenerative or reactive nuclear changes (rare)",
                      "Metaplastic changes (mucinous, ciliated, hobnail, or secretory)",
                      "± degenerative or reactive nuclear changes (rare)"
                    ]
                  },
                  {
                    "text": "Stromal cellsSmall, spindle-shaped with inconspicuous cytoplasm and oval, darkly staining nuclei",
                    "sub_points": [
                      "Small, spindle-shaped with inconspicuous cytoplasm and oval, darkly staining nuclei"
                    ]
                  },
                  {
                    "text": "Variable mitotic activity in both components (more prominent in proliferative phase)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Epithelium: PAX2, PAX8 positive"
                  },
                  {
                    "text": "Stroma: CD10 positive"
                  },
                  {
                    "text": "Both: PR and ER variably positive"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Bartholin Cyst": [
                  {
                    "text": "Transitional, low cuboidal, or mucinous lining epithelium"
                  },
                  {
                    "text": "Normal (residual) mucinous glands often adjacent to cyst"
                  },
                  {
                    "text": "No endometrial-type stroma"
                  }
                ],
                "Ciliated Cyst": [
                  {
                    "text": "No endometrial-type stroma or hemorrhage"
                  }
                ],
                "Ectopic Breast Tissue": [
                  {
                    "text": "Glands or cysts lined by double cell layer (epithelial and myoepithelial)"
                  },
                  {
                    "text": "Usually \"specialized\" stroma"
                  },
                  {
                    "text": "GCDFP-15 and GATA3 positive"
                  }
                ],
                "Metastatic Endometrioid Adenocarcinoma": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Cribriform growth and squamous differentiation"
                  },
                  {
                    "text": "Glands lined by cells with malignant cytologic features"
                  },
                  {
                    "text": "Often desmoplastic, but not endometrial-type, stroma"
                  }
                ],
                "Müllerian Adenosarcoma": [
                  {
                    "text": "Phyllodes or leaf-like glandular architecture"
                  },
                  {
                    "text": "Periglandular stromal hypercellularity"
                  },
                  {
                    "text": "Stromal component may have cytologic atypia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Uterus": {
            "name": "Uterus",
            "url": "https://app.pathprimer.com/document/faa42893-b752-4a8a-9b2e-f1fcd89ed886/lesson/40266b68-18a9-4b52-b806-ee81102eefcb",
            "content": {
              "UTERUS": {
                "Macroscopic Anatomy": [
                  {
                    "text": "Complex organ with multiple regions: Ectocervix, endocervix, lower uterine segment, endometrium, myometrium, and serosa"
                  },
                  {
                    "text": "Ectocervix: Distal end of uterus, typically covered by stratified squamous epithelium"
                  },
                  {
                    "text": "Endocervix: Tunnel-like lumen of uterine cervix, lined by mucin-secreting pits"
                  },
                  {
                    "text": "Lower uterine segment: Triangle-shaped transition from endocervix to uterine corpus"
                  },
                  {
                    "text": "Endometrium: Uterine mucosa composed of glands and stroma"
                  },
                  {
                    "text": "Myometrium: Muscular wall of uterus composed of layers of smooth muscle"
                  },
                  {
                    "text": "Serosa: Thin lining of body and fundus of uterus; covers portions of uterus that are not retroperitoneal"
                  }
                ],
                "Microscopic Anatomy": [
                  {
                    "text": "Ectocervix: Stratified squamous epithelium overlying fibrous stroma"
                  },
                  {
                    "text": "Transformation zoneSquamocolumnar junction that lies between ectocervix and endocervixZone identified by squamous metaplasia of endocervix; migrates during reproductive years",
                    "sub_points": [
                      "Squamocolumnar junction that lies between ectocervix and endocervix",
                      "Zone identified by squamous metaplasia of endocervix; migrates during reproductive years"
                    ]
                  },
                  {
                    "text": "Endocervix: Simple, columnar mucinous epithelial cells line endocervical pits that extend into fibrous stroma"
                  },
                  {
                    "text": "Lower uterine segment: Transition between endocervix and endometrium; admixtures of endometrial and endocervical glands and stroma may be seen in this region"
                  },
                  {
                    "text": "Endometrial glandsColumnar epithelial cells that vary from simple to pseudostratifiedEpithelium may contain vacuoles (secretory) or be ciliatedFunctionalis: Superficial endometrial layer, lost during menstruationBasalis: Deep layer of more monomorphic glands that regenerates functionalis after shedding",
                    "sub_points": [
                      "Columnar epithelial cells that vary from simple to pseudostratified",
                      "Epithelium may contain vacuoles (secretory) or be ciliated",
                      "Functionalis: Superficial endometrial layer, lost during menstruation",
                      "Basalis: Deep layer of more monomorphic glands that regenerates functionalis after shedding"
                    ]
                  },
                  {
                    "text": "Endometrial stromaDensely cellular supporting stroma composed of spindle cells with elongated nuclei admixed with blood vessels (spiral arterioles)Stromal cells range from small and spindled (proliferative phase) to large, eosinophilic, and polygonal (secretory phase, pregnancy, hormone effect)",
                    "sub_points": [
                      "Densely cellular supporting stroma composed of spindle cells with elongated nuclei admixed with blood vessels (spiral arterioles)",
                      "Stromal cells range from small and spindled (proliferative phase) to large, eosinophilic, and polygonal (secretory phase, pregnancy, hormone effect)"
                    ]
                  },
                  {
                    "text": "Myometrium: Smooth muscle wall of uterus, composed of 3 layers (inner longitudinal, middle circular, and outer longitudinal)Middle circular layer heavily vascularized and contains arcuate arteries",
                    "sub_points": [
                      "Middle circular layer heavily vascularized and contains arcuate arteries"
                    ]
                  },
                  {
                    "text": "Serosa: Thin mesothelial lining of uterine corpus and fundus"
                  }
                ]
              },
              "CONSIDERATIONS AND VARIATIONS": {
                "Age-Relation Variations": [
                  {
                    "text": "During puberty, endocervical epithelium migrates toward ectocervix (ectropion) and then is slowly replaced by squamous epithelium during reproductive years"
                  },
                  {
                    "text": "Endometrial atrophy: Inactive, cystically dilated glands may be present after menopause"
                  }
                ],
                "Metaplasia": [
                  {
                    "text": "Squamous metaplasia: Occurs along transformation zone"
                  },
                  {
                    "text": "Ciliated (tubal) metaplasia: Common; occurs in endocervix and endometrial glands"
                  },
                  {
                    "text": "Mucinous metaplasia: Uncommon metaplasia of endometrium; typically consists of simple to stratified, columnar mucinous epithelial cells"
                  }
                ],
                "Pitfalls and Artifacts": [
                  {
                    "text": "Glandular compression, simulating hyperplasia, may be seen following biopsy"
                  },
                  {
                    "text": "Suction created by biopsy instruments may lead to \"gland-in-gland\" artifact"
                  },
                  {
                    "text": "Exfoliation artifact leads to epithelial shedding, which can mimic serous carcinoma"
                  },
                  {
                    "text": "Arias-Stella effect may closely resemble carcinoma due to marked atypia and glandular crowding"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Uterine Corpus: Neoplasms": {
        "name": "Uterine Corpus: Neoplasms",
        "url": "https://app.pathprimer.com/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
        "topics": {
          "Müllerian Adenosarcoma": {
            "name": "Müllerian Adenosarcoma",
            "url": "https://app.pathprimer.com/document/4b81a8a5-835d-47ab-b947-9c32a7704b4f/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Biphasic low-grade tumor composed of benign müllerian (rarely up to carcinoma in situ) glands and low-grade malignant stroma (often homologous)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Peri- or postmenopausal"
                  },
                  {
                    "text": "Recurrence rate of 30-50% mostly related to sarcomatous overgrowth, high-grade stroma, myometrial invasion, or underdiagnosis"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Polypoid mass filling endometrial cavity"
                  },
                  {
                    "text": "Solid and cystic, white to gray to tan cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Periglandular \"cuffing\" of low-grade malignant stroma resembling endometrial or fibroblastic stroma often forming intraluminal polypoid projections"
                  },
                  {
                    "text": "Glands with phyllodes architecture, cystically dilated or, less commonly, small"
                  },
                  {
                    "text": "Proliferative-type endometrial epithelium (most common) with variable cytologic atypia"
                  },
                  {
                    "text": "High-grade stromal cytologic atypia uncommon"
                  },
                  {
                    "text": "Diagnostic criteria: Marked \"cuffing\" &/or cytologic atypia of stroma typically with > 2 mitoses/10HPF"
                  },
                  {
                    "text": "Sarcomatous overgrowth: > 25% of tumor composed of only neoplastic stroma, typically high grade"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Stromal component ER, PR, CD10, WT1 positive"
                  },
                  {
                    "text": "ER, PR, and CD10 minimal if sarcomatous overgrowth"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cellular endometrial polyp or polyp with features overlapping with müllerian adenosarcoma"
                  },
                  {
                    "text": "Endometrial stromal sarcoma with glands"
                  },
                  {
                    "text": "Embryonal rhabdomyosarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Low-grade müllerian adenosarcoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Biphasic low-grade tumor composed of benign müllerian (rarely up to carcinoma in situ) glands and low-grade malignant stroma (often homologous)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "History of estrogen use or prior radiation therapy"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually peri- or postmenopausal"
                  },
                  {
                    "text": "Range: 10-90 (mean: 58) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abnormal vaginal bleeding (most common)"
                  },
                  {
                    "text": "Pelvic pain"
                  },
                  {
                    "text": "\"Recurrent\" endometrial polyps"
                  },
                  {
                    "text": "Uterine enlargement"
                  },
                  {
                    "text": "Symptoms related to prolapse"
                  },
                  {
                    "text": "Abnormal Papanicolaou smear"
                  },
                  {
                    "text": "Asymptomatic"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Total abdominal hysterectomy and bilateral adnexectomy"
                  },
                  {
                    "text": "Adjuvant radiation or chemotherapy if deep myometrial invasion, high-grade stroma, or sarcomatous overgrowth"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent prognosis if no myometrial invasion (early stage) or sarcomatous overgrowth"
                  },
                  {
                    "text": "Worse prognosis in older women"
                  },
                  {
                    "text": "Recurrence rate of 30-50% mostly related to sarcomatous overgrowth (> 40% recurrence rate), high-grade stroma, myometrial invasion (< 15% recurrence rate), or underdiagnosisVagina and pelvis common sites",
                    "sub_points": [
                      "Vagina and pelvis common sites"
                    ]
                  },
                  {
                    "text": "20-30% death rate related to sarcomatous overgrowth, high-grade stroma, or deep myometrial invasion"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Tissue protruding from cervical os"
                  },
                  {
                    "text": "Centered in endometrium; rarely lower uterine segment or myometrium"
                  },
                  {
                    "text": "Polypoid mass(es) filling endometrial cavity"
                  },
                  {
                    "text": "Multiple small polyps (botryoid appearance) much less common"
                  },
                  {
                    "text": "Up to 20 (mean: 5) cm"
                  },
                  {
                    "text": "Solid and cystic, white-gray-tan cut surface"
                  },
                  {
                    "text": "Firm to rubbery consistency of solid areas"
                  },
                  {
                    "text": "Variably sized cysts (spongy)"
                  },
                  {
                    "text": "± areas of hemorrhage and necrosis"
                  },
                  {
                    "text": "If sarcomatous overgrowth, fleshy cut surface and frequent necrosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Condensation of malignant stroma (\"periglandular cuffing\") around epithelium frequently forming intraluminal polypoid projectionsLow-grade malignant stroma often resembling endometrial or fibroblastic stromaHigh-grade malignant stroma uncommon but may be extensive (often associated with stromal overgrowth)± stromal fibrosis, hyalinization, elastosis, edema, myxoid change, cells with bizarre nuclei and foamy histiocytes± sex cord-like, smooth muscle, osseous, rhabdomyoblastic, cartilaginous, adipocytic differentiationSex-cord component may show overgrowth (mass forming) (no prognostic significance)",
                    "sub_points": [
                      "Low-grade malignant stroma often resembling endometrial or fibroblastic stroma",
                      "High-grade malignant stroma uncommon but may be extensive (often associated with stromal overgrowth)",
                      "± stromal fibrosis, hyalinization, elastosis, edema, myxoid change, cells with bizarre nuclei and foamy histiocytes",
                      "± sex cord-like, smooth muscle, osseous, rhabdomyoblastic, cartilaginous, adipocytic differentiationSex-cord component may show overgrowth (mass forming) (no prognostic significance)",
                      "Sex-cord component may show overgrowth (mass forming) (no prognostic significance)"
                    ]
                  },
                  {
                    "text": "Glands with phyllodes-type architecture, cystically dilated, or, less commonly, smallComplex architecture of glandular component (~ 10%)",
                    "sub_points": [
                      "Complex architecture of glandular component (~ 10%)"
                    ]
                  },
                  {
                    "text": "Myometrial invasion typically with infiltrative border containing glands and stroma (latter typically higher grade)Deep myometrial invasion (outer 1/2) (< 10%)",
                    "sub_points": [
                      "Deep myometrial invasion (outer 1/2) (< 10%)"
                    ]
                  },
                  {
                    "text": "Sarcomatous overgrowth: > 25% of tumor composed of only neoplastic stroma, typically high grade (often with rhabdomyoblastic differentiation-embryonal rhabdomyosarcoma) but can be low grade (infrequently)"
                  },
                  {
                    "text": "May arise from adenomyosis or in an adenomyoma"
                  },
                  {
                    "text": "Recurrences consist of pure high-grade sarcoma or sarcoma admixed with glands"
                  },
                  {
                    "text": "Hyperplasia and carcinoma (commonly endometrioid) may be seen in close association"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Stromal component with low-grade cytologic atypia but variable mitotic activityHigh-grade cytologic atypia (high-grade sarcoma) with brisk mitotic activity uncommonSarcomatous overgrowth more frequent if stroma shows high-grade cytologic atypia",
                    "sub_points": [
                      "High-grade cytologic atypia (high-grade sarcoma) with brisk mitotic activity uncommon",
                      "Sarcomatous overgrowth more frequent if stroma shows high-grade cytologic atypia"
                    ]
                  },
                  {
                    "text": "Glands lined by endometrioid (proliferative-like most common), tubal, hobnail, mucinous, or squamous epitheliumVariable cytologic atypia (up to carcinoma in situ) and mitoses (30%)",
                    "sub_points": [
                      "Variable cytologic atypia (up to carcinoma in situ) and mitoses (30%)"
                    ]
                  },
                  {
                    "text": "Sarcomatous overgrowth: High-grade cytologic atypia (pleomorphism, hyperchromasia, nuclear enlargement) and brisk mitoses"
                  }
                ],
                "Diagnostic Criteria": [
                  {
                    "text": "Marked cellularity with periglandular \"cuffing\" &/or significant cytologic atypia of stromal component"
                  },
                  {
                    "text": "Typically ≥ 2 mitoses/10 HPF in stromal component"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Stromal componentER, PR, and, frequently, AR positiveCD10 and WT1 positiveSmooth muscle actin (60%), desmin (stroma NOS, smooth muscle, and rhabdomyoblastic differentiation), and CD34 (25%) positiveAE1/3 and calretinin positivity uncommon (10%)± inhibin, calretinin, melan-A, desmin, and WT1, if sex cord-like differentiationER, PR, and CD10 expression very low if sarcomatous overgrowthc-kit negativep53 abnormalities (overexpression or no expression) in high-grade sarcoma or sarcomatous overgrowthBCOR positivity more often and stronger in high-grade sarcomatous component",
                    "sub_points": [
                      "ER, PR, and, frequently, AR positive",
                      "CD10 and WT1 positive",
                      "Smooth muscle actin (60%), desmin (stroma NOS, smooth muscle, and rhabdomyoblastic differentiation), and CD34 (25%) positive",
                      "AE1/3 and calretinin positivity uncommon (10%)",
                      "± inhibin, calretinin, melan-A, desmin, and WT1, if sex cord-like differentiation",
                      "ER, PR, and CD10 expression very low if sarcomatous overgrowth",
                      "c-kit negative",
                      "p53 abnormalities (overexpression or no expression) in high-grade sarcoma or sarcomatous overgrowth",
                      "BCOR positivity more often and stronger in high-grade sarcomatous component"
                    ]
                  },
                  {
                    "text": "Epithelial componentAE1/3, ER, and PR typically positiveCD10 and AR uncommonly positive",
                    "sub_points": [
                      "AE1/3, ER, and PR typically positive",
                      "CD10 and AR uncommonly positive"
                    ]
                  }
                ],
                "Molecular and Cytogenetic Findings": [
                  {
                    "text": "Mesenchymal and epithelial components clonally unrelated except when carcinoma arising from adenosarcoma"
                  },
                  {
                    "text": "MDM2/CDK4/HMGA2(most common) andTERTgene amplification"
                  },
                  {
                    "text": "PIK3CA/AKT1/PTENpathway alterations common"
                  },
                  {
                    "text": "FGFR2,KMT2C, andDICER1recurrent mutations"
                  },
                  {
                    "text": "BAP1homozygous deletions"
                  },
                  {
                    "text": "TP53,ATRX,MDM2, andCCNE1alterations more common in high-grade adenosarcomas"
                  },
                  {
                    "text": "RarelyNCOA2/NCOA3fusions"
                  },
                  {
                    "text": "RarelyJAZF1andBCORL1rearrangements"
                  },
                  {
                    "text": "Often noncomplex clonal aberrations, more commonly involving chromosome 8"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endometrial Polyp With Features Overlapping With Müllerian Adenosarcoma (Atypical Uterine Polyp)": [
                  {
                    "text": "Incidental focal microscopic finding"
                  },
                  {
                    "text": "Phyllodes architecture not well developed"
                  },
                  {
                    "text": "Focal and ill-defined \"cuffing\""
                  },
                  {
                    "text": "No stromal cytologic atypia"
                  }
                ],
                "Cellular Endometrial Polyp": [
                  {
                    "text": "Uniform increase in cellularity throughout"
                  },
                  {
                    "text": "No periglandular \"cuffing\""
                  },
                  {
                    "text": "No cytologic atypia and rare mitotic activity"
                  }
                ],
                "Endometrial Polyp With Atypical Bizarre Stromal Cells": [
                  {
                    "text": "No stromal hypercellularity, periglandular \"cuffing,\" or phyllodes-like architecture"
                  },
                  {
                    "text": "Atypical cells often within loose collagenous background"
                  }
                ],
                "Müllerian Adenofibroma (Entity Abandoned in 2020 WHO)": [
                  {
                    "text": "No periglandular \"cuffing\""
                  },
                  {
                    "text": "Diffusely hypocellular stroma"
                  },
                  {
                    "text": "No cytologic atypia or mitotic activity"
                  }
                ],
                "Müllerian Adenomyoma": [
                  {
                    "text": "Very rarely polypoid and intraluminal"
                  },
                  {
                    "text": "Most commonly centered in myometrium"
                  },
                  {
                    "text": "Benign endometrioid-type glands and smooth muscle"
                  },
                  {
                    "text": "Variable amount of endometrial stroma around glands without \"cuffing\" or cytologic atypia"
                  }
                ],
                "Atypical Polypoid Adenomyoma": [
                  {
                    "text": "Often lobular architecture"
                  },
                  {
                    "text": "No phyllodes-type glands"
                  },
                  {
                    "text": "Endometrioid-type glands often small or confluent with squamous morular metaplasia that may show central necrosis"
                  },
                  {
                    "text": "Stroma predominantly composed of tightly arranged smooth muscle fascicles"
                  }
                ],
                "Endometrial Stromal Sarcoma With Gland Differentiation": [
                  {
                    "text": "Typically tan to yellow cut surface"
                  },
                  {
                    "text": "No phyllodes-like architecture"
                  },
                  {
                    "text": "Permeative growth"
                  },
                  {
                    "text": "Low-grade stroma within infiltrative component"
                  },
                  {
                    "text": "Typically only endometrioid-type glands but not tubal, mucinous, or squamous epithelium"
                  }
                ],
                "Embryonal Rhabdomyosarcoma": [
                  {
                    "text": "Rare in uterine corpus"
                  },
                  {
                    "text": "Prominent cambium layer"
                  },
                  {
                    "text": "Minimal glandular component (not integral part of tumor)"
                  },
                  {
                    "text": "Primitive-appearing neoplastic mesenchymal cells with brisk mitoses and apoptotic rate"
                  }
                ],
                "Malignant Mixed Müllerian Tumor": [
                  {
                    "text": "Typically postmenopausal women"
                  },
                  {
                    "text": "Extensive areas of necrosis and hemorrhage"
                  },
                  {
                    "text": "Epithelial and stromal components typically cytologically high gradeEven though some areas architecturally may resemble adenosarcoma, cytology always high grade",
                    "sub_points": [
                      "Even though some areas architecturally may resemble adenosarcoma, cytology always high grade"
                    ]
                  }
                ],
                "Intravascular Adenomyomatosis": [
                  {
                    "text": "Only intravascular growth"
                  },
                  {
                    "text": "Only leiomyoma(s) or adenomyosis within uterus"
                  },
                  {
                    "text": "Bland cytologic appearance of smooth muscle component"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Most müllerian adenosarcomas (except if high grade or stromal overgrowth) are associated with good prognosis, as typically polypoid with minimal infiltration"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diagnosis of low-grade adenosarcoma should be suspected if \"recurrent\" endometrial polyps"
                  },
                  {
                    "text": "Müllerian adenofibroma diagnosis should be avoided; no longer included in WHO 2020, as these tumors likely represent underdiagnosed low-grade müllerian adenosarcomas or polyps with unusual morphology"
                  },
                  {
                    "text": "Finding focal increased cellularity around endometrial glands is not sufficient to establish diagnosis of low-grade müllerian adenosarcoma"
                  },
                  {
                    "text": "Extensive sampling of \"fleshy\" areas should be performed to exclude sarcomatous overgrowth (associated with dismal prognosis)"
                  },
                  {
                    "text": "Even though sarcomatous overgrowth is typically high grade, it can rarely be low grade"
                  },
                  {
                    "text": "Finding of high-grade stroma does not qualify for sarcomatous overgrowth if it does not occupy > 25% of tumorHowever, its presence should prompt additional sampling (as it is often associated with sarcomatous overgrowth) as well as documentation in report (as it is associated with poor outcome)",
                    "sub_points": [
                      "However, its presence should prompt additional sampling (as it is often associated with sarcomatous overgrowth) as well as documentation in report (as it is associated with poor outcome)"
                    ]
                  },
                  {
                    "text": "Some molecular alterations reported in müllerian adenosarcomas overlap with those of completely unrelated tumors; thus, morphologic correlation is key in establishing correct diagnosis, especially at metastatic sites"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Endometrioid Adenocarcinoma": {
            "name": "Endometrioid Adenocarcinoma",
            "url": "https://app.pathprimer.com/document/469c2df3-6b04-4eab-8287-8a4dacb7031e/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Primary epithelial malignancy exhibiting endometrioid morphology"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "< 25% of all primary fallopian tube carcinomas"
                  },
                  {
                    "text": "6th-7th decades most common"
                  },
                  {
                    "text": "Asymptomatic (up to 40%)"
                  },
                  {
                    "text": "Worse prognosis in fimbrial tumors, even if noninvasive"
                  },
                  {
                    "text": "Tumor grade and depth of invasion variably associated with prognosis"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Gray-white to tan-yellow cut surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Predominately intraluminal polypoid growth"
                  },
                  {
                    "text": "Pushing or infiltrative border"
                  },
                  {
                    "text": "Glandular (back-to-back, small to large, tubular to convoluted), cribriform, trabecular, solid growth(s)"
                  },
                  {
                    "text": "Female adnexal tumor of probable wolffian origin (FATPWO)-like areas with irregular, sieve-like spaces &/or whorls or sheets of spindle cells, often transitioning to small tubular endometrioid glands"
                  },
                  {
                    "text": "± squamous or mucinous differentiation"
                  },
                  {
                    "text": "Grading similar to its endometrial counterpart"
                  },
                  {
                    "text": "± concurrent endometrioid adenocarcinoma of endometrium"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, ER, PR, and PAX8 positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Metastatic endometrioid adenocarcinoma"
                  },
                  {
                    "text": "FATPWO"
                  },
                  {
                    "text": "Carcinosarcoma"
                  },
                  {
                    "text": "Pseudocarcinomatous hyperplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Primary epithelial malignancy exhibiting endometrioid morphology"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Acquired Genetic Defect": [
                  {
                    "text": "Aberrant β-catenin expression similar to endometrioid neoplasia in other sites"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon< 25% of all primary fallopian tube carcinomas",
                    "sub_points": [
                      "< 25% of all primary fallopian tube carcinomas"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "6th-7th decades most common"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic (up to 40%)"
                  },
                  {
                    "text": "Pelvic pain"
                  },
                  {
                    "text": "Vaginal bleeding"
                  },
                  {
                    "text": "Signs and symptoms related to endometriosis (precursor)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Bilateral salpingo-oophorectomy + hysterectomy ± staging biopsies"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good outcome if low stage at presentation"
                  },
                  {
                    "text": "Worse outcome if fimbrial location, even if noninvasive"
                  },
                  {
                    "text": "Tumor grade and depth of invasion variably associated with prognosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "If in fimbriated endVariably sized nodule(s) (< 1 cm to 6 cm)Obliteration or fusion of fimbriaeSecondary proximal dilation of fallopian tube",
                    "sub_points": [
                      "Variably sized nodule(s) (< 1 cm to 6 cm)",
                      "Obliteration or fusion of fimbriae",
                      "Secondary proximal dilation of fallopian tube"
                    ]
                  },
                  {
                    "text": "If in distal 2/3 of fallopian tubePredominately intraluminal massObstruction and dilation of proximal fallopian tube",
                    "sub_points": [
                      "Predominately intraluminal mass",
                      "Obstruction and dilation of proximal fallopian tube"
                    ]
                  },
                  {
                    "text": "Gray-white to tan-yellow cut surface"
                  },
                  {
                    "text": "± necrosis and hemorrhage"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Predominately intraluminal polypoid growth"
                  },
                  {
                    "text": "Pushing or infiltrative border"
                  },
                  {
                    "text": "Glandular (back-to-back, small to large, tubular to convoluted), cribriform, trabecular, &/or solid growth(s)"
                  },
                  {
                    "text": "Female adnexal tumor of probable wolffian origin (FATPWO)-like areasIrregular, sieve-like spacesWhorls or sheets of spindle cellsOften transition to small tubular endometrioid glands",
                    "sub_points": [
                      "Irregular, sieve-like spaces",
                      "Whorls or sheets of spindle cells",
                      "Often transition to small tubular endometrioid glands"
                    ]
                  },
                  {
                    "text": "Intraluminal mucin or eosinophilic secretion"
                  },
                  {
                    "text": "± squamous or mucinous differentiation"
                  },
                  {
                    "text": "± stromal osseous metaplasia"
                  },
                  {
                    "text": "Grading similar to that of endometrial endometrioid carcinoma"
                  },
                  {
                    "text": "± concurrent endometrioid adenocarcinoma of endometrium or endometriosis"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cells with variable amounts of cytoplasm, pseudostratified nuclei, and variable degrees of cytologic atypia and mitotic activity± abundant eosinophilic cytoplasm (oxyphilic)",
                    "sub_points": [
                      "± abundant eosinophilic cytoplasm (oxyphilic)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7, ER, PR, and PAX8 positive"
                  },
                  {
                    "text": "Calretinin may be positive"
                  },
                  {
                    "text": "Inhibin negative"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Metastatic Endometrioid Adenocarcinoma": [
                  {
                    "text": "Bulk of tumor in uterus or ovary"
                  },
                  {
                    "text": "Typically centered in paratubal tissues"
                  }
                ],
                "Female Adnexal Tumor of Probable Wolffian Origin": [
                  {
                    "text": "Located in broad ligament or fallopian tube serosa with no intraluminal growth"
                  },
                  {
                    "text": "No intracellular mucin or squamous differentiation"
                  },
                  {
                    "text": "Inhibin focal to patchy positive"
                  }
                ],
                "Carcinosarcoma": [
                  {
                    "text": "High-grade epithelial (most commonly serous) and mesenchymal components"
                  },
                  {
                    "text": "Malignant heterologous components may be seen"
                  }
                ],
                "Pseudocarcinomatous Hyperplasia": [
                  {
                    "text": "Not mass forming"
                  },
                  {
                    "text": "Marked inflammatory infiltrate"
                  },
                  {
                    "text": "Lacks desmoplasia"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Prior to making diagnosis of primary endometrioid carcinoma of fallopian tube, secondary involvement of tube must be excluded"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Benign and Low-Grade Endometrial Stromal Tumors": {
            "name": "Benign and Low-Grade Endometrial Stromal Tumors",
            "url": "https://app.pathprimer.com/document/726f18ec-af84-42e6-bc44-c9f33c0b7865/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Endometrial stromal nodule (ESN): Absent, to at most minimal, myometrial invasion (< 3 mm and < 3 protrusions) lacking vascular invasion"
                  },
                  {
                    "text": "Endometrial stromal sarcoma (ESS): Endometrial stromal tumor (EST) with myometrial &/or vascular invasion"
                  },
                  {
                    "text": "EST with limited infiltration: More infiltration of adjacent myometrium than allowed for ESN but no overt permeation, as seen in ESS and absent lymphovascular invasion"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "90% 5-year disease-free survival if stage I or II ESS; 70% at 10 years"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "ESN: Well-circumscribed, pushing margins ± small irregularities, as lobulated or finger-like projections (< 3 in number and < 3 mm in size) into myometrium; no lymphovascular invasion"
                  },
                  {
                    "text": "ESS: \"Blue\" islands with irregular contours permeating myometrium (tongue-like) ± vessel invasion"
                  },
                  {
                    "text": "ESN and ESS: Diffuse monotonous growth of small \"blue\" cells with arterioles ± collagen plaques"
                  },
                  {
                    "text": "Variants: Smooth muscle and rhabdomyoblastic differentiation; myxoid and fibroblastic; epithelioid with sex cord-like, glandular elements; with clear, granular, rhabdoid cells, pseudopapillary with adipose tissue or bizarre or multinucleated cells"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Vimentin, CD10, WT1, ER, PR, and actins typically positiveCD10 may be negative",
                    "sub_points": [
                      "CD10 may be negative"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Highly cellular leiomyoma"
                  },
                  {
                    "text": "Endometrial polyp (in curettage)"
                  },
                  {
                    "text": "Gland poor and intravascular adenomyosis"
                  },
                  {
                    "text": "Cellular intravenous leiomyomatosis"
                  },
                  {
                    "text": "Uterine tumor resembling ovarian sex cord-stromal tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Endometrial stromal tumor (EST)"
                  },
                  {
                    "text": "Endometrial stromal nodule (ESN)"
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcoma (LG-ESS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "ESN: EST with absent, to at most minimal, myometrial invasion (< 3 mm and < 3 protrusions) lacking vascular invasion"
                  },
                  {
                    "text": "LG-ESS: EST with myometrial &/or vascular invasion"
                  },
                  {
                    "text": "EST with limited infiltration: More myometrial infiltration than allowed in ESN but no overt permeation, as seen in ESS; absent lymphovascular invasion"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Hyperestrogenism, tamoxifen therapy, radiation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Endometrial stromal noduleRare",
                    "sub_points": [
                      "Rare"
                    ]
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcoma6-20% of all uterine sarcomas0.1-1.0% of all uterine malignancies",
                    "sub_points": [
                      "6-20% of all uterine sarcomas",
                      "0.1-1.0% of all uterine malignancies"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "17-96 (mean: 55) years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abnormal vaginal bleeding or asymptomatic"
                  },
                  {
                    "text": "Pelvic mass"
                  },
                  {
                    "text": "Symptoms and signs related to extrauterine spread (latter seen in 1/3 of ESS; most commonly ovary)In lungs, lesions may be cystic",
                    "sub_points": [
                      "In lungs, lesions may be cystic"
                    ]
                  },
                  {
                    "text": "Rarely, paraneoplastic syndrome"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Endometrial stromal noduleHysterectomyIf fertility preservation desired, consideration of excision followed by hysteroscopy &/or radiologic imaging (e.g., ultrasound) to monitor for regrowth",
                    "sub_points": [
                      "Hysterectomy",
                      "If fertility preservation desired, consideration of excision followed by hysteroscopy &/or radiologic imaging (e.g., ultrasound) to monitor for regrowth"
                    ]
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcomaHysterectomy ± adnexectomy and lymph node dissectionRadiation, hormone therapy, or aromatase inhibitors",
                    "sub_points": [
                      "Hysterectomy ± adnexectomy and lymph node dissection",
                      "Radiation, hormone therapy, or aromatase inhibitors"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Endometrial stromal noduleExcellent",
                    "sub_points": [
                      "Excellent"
                    ]
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcoma90% and 70% 5- and 10-year disease-free survival if stage I or II, respectively50% 5-year survival if stage III or IVOlder age (> 50 years), Blacks, advanced stage, no surgery, and lymph node metastases associated with worse outcomeMitoses not predictive of recurrence if stage I tumorsNecrosis ± prognostic factor",
                    "sub_points": [
                      "90% and 70% 5- and 10-year disease-free survival if stage I or II, respectively",
                      "50% 5-year survival if stage III or IV",
                      "Older age (> 50 years), Blacks, advanced stage, no surgery, and lymph node metastases associated with worse outcome",
                      "Mitoses not predictive of recurrence if stage I tumors",
                      "Necrosis ± prognostic factor"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Corpus > > > cervix"
                  },
                  {
                    "text": "Endometrial stromal noduleFrequently polypoid mass protruding into uterine cavityMay be intramyometrialUniform, tan to yellow, soft cut surface± cyst formationNecrosis and hemorrhage may be seen",
                    "sub_points": [
                      "Frequently polypoid mass protruding into uterine cavity",
                      "May be intramyometrial",
                      "Uniform, tan to yellow, soft cut surface",
                      "± cyst formation",
                      "Necrosis and hemorrhage may be seen"
                    ]
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcomaSeveral to multiple coalescent, poorly defined nodules within endometrium and myometriumWorm-like plugs of tumor within vascular spaces (may be more obvious in parauterine soft tissues)Rarely, well circumscribedTan to yellow, soft cut surface",
                    "sub_points": [
                      "Several to multiple coalescent, poorly defined nodules within endometrium and myometrium",
                      "Worm-like plugs of tumor within vascular spaces (may be more obvious in parauterine soft tissues)",
                      "Rarely, well circumscribed",
                      "Tan to yellow, soft cut surface"
                    ]
                  },
                  {
                    "text": "Slightly firm, pale-gray to white areas alternating with tan areas if smooth muscle differentiation"
                  },
                  {
                    "text": "Gelatinous (\"sticky\") if myxoid"
                  },
                  {
                    "text": "White and firm (leiomyoma-like) cut surface if fibroblastic"
                  },
                  {
                    "text": "± necrosis &/or hemorrhage"
                  }
                ],
                "Size": [
                  {
                    "text": "ESN: Up to 12 cm"
                  },
                  {
                    "text": "ESS: Variable"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Endometrial stromal noduleWell-circumscribed, pushing marginsSmall irregularities, seen as lobulated or finger-like projections (< 3 in number and < 3 mm) into underlying myometrium may occurNo lymphovascular invasion",
                    "sub_points": [
                      "Well-circumscribed, pushing margins",
                      "Small irregularities, seen as lobulated or finger-like projections (< 3 in number and < 3 mm) into underlying myometrium may occur",
                      "No lymphovascular invasion"
                    ]
                  },
                  {
                    "text": "Low-grade endometrial stromal sarcoma\"Blue\" islands with irregular contours permeating myometrium (tongue-like) without stromal response",
                    "sub_points": [
                      "\"Blue\" islands with irregular contours permeating myometrium (tongue-like) without stromal response"
                    ]
                  },
                  {
                    "text": "ESN and LG-ESSDiffuse monotonous growth of small \"blue\" cellsSmall vessels reminiscent of proliferative-type arterioles in 1/3 of tumors ± curvilinear or with hyalinized wallsCollagen bands and plaquesHistiocytes (isolated or in groups) admixed with tumor cells or near areas of necrosis ± cholesterol cleftsLarge, thick blood vessels uncommon; if present, usually close to tumor-myometrium interface",
                    "sub_points": [
                      "Diffuse monotonous growth of small \"blue\" cells",
                      "Small vessels reminiscent of proliferative-type arterioles in 1/3 of tumors ± curvilinear or with hyalinized walls",
                      "Collagen bands and plaques",
                      "Histiocytes (isolated or in groups) admixed with tumor cells or near areas of necrosis ± cholesterol clefts",
                      "Large, thick blood vessels uncommon; if present, usually close to tumor-myometrium interface"
                    ]
                  },
                  {
                    "text": "Variant featuresSmooth muscle differentiationPale \"pink\" islands in background of endometrial stromal cellsStarburst pattern: Central area of hyalinization with collagen bands radiating toward periphery embedding plumper cells, which transition to small and disorganized fascicles of smooth muscle, and in turn well-formed, long fasciclesMay be seen as \"band\" between areas of endometrial stromal neoplasia and myometrium (in nodules)May merge with areas of sex cord-like differentiationRhabdomyoblastic differentiationIsolated cells with abundant eosinophilic cytoplasm and, rarely, cross striationsMyxoid backgroundHypocellular with abundant, pale myxoid matrixFibroblasticHypocellular due to abundant and thin collagen fibersWith sex cord-like differentiationCords, trabeculae, insulae, less frequently tubules, retiform, or diffuse growthCells ± abundant eosinophilic or vacuolated cytoplasmWith endometrioid glandsWell-formed glands lined by cuboidal to columnar cells with pseudostratified nuclei (benign > > > malignant)EpithelioidCells with abundant eosinophilic cytoplasmWith clear cells or granular cytoplasmWith rhabdoid featuresIntracytoplasmic eosinophilic hyaline inclusions pushing aside nucleusWith bizarre cellsScattered cells with large nuclei, sometimes bi- or multinucleated with smudgy chromatinWith adipose tissueTypically mature adipocytes (focal)Papillary or pseudopapillary architectureProbably related to artifactTypically focal; may be admixed with sex cord-like differentiationWith multinucleated giant cells",
                    "sub_points": [
                      "Smooth muscle differentiationPale \"pink\" islands in background of endometrial stromal cellsStarburst pattern: Central area of hyalinization with collagen bands radiating toward periphery embedding plumper cells, which transition to small and disorganized fascicles of smooth muscle, and in turn well-formed, long fasciclesMay be seen as \"band\" between areas of endometrial stromal neoplasia and myometrium (in nodules)May merge with areas of sex cord-like differentiation",
                      "Pale \"pink\" islands in background of endometrial stromal cells",
                      "Starburst pattern: Central area of hyalinization with collagen bands radiating toward periphery embedding plumper cells, which transition to small and disorganized fascicles of smooth muscle, and in turn well-formed, long fascicles",
                      "May be seen as \"band\" between areas of endometrial stromal neoplasia and myometrium (in nodules)",
                      "May merge with areas of sex cord-like differentiation",
                      "Rhabdomyoblastic differentiationIsolated cells with abundant eosinophilic cytoplasm and, rarely, cross striations",
                      "Isolated cells with abundant eosinophilic cytoplasm and, rarely, cross striations",
                      "Myxoid backgroundHypocellular with abundant, pale myxoid matrix",
                      "Hypocellular with abundant, pale myxoid matrix",
                      "FibroblasticHypocellular due to abundant and thin collagen fibers",
                      "Hypocellular due to abundant and thin collagen fibers",
                      "With sex cord-like differentiationCords, trabeculae, insulae, less frequently tubules, retiform, or diffuse growthCells ± abundant eosinophilic or vacuolated cytoplasm",
                      "Cords, trabeculae, insulae, less frequently tubules, retiform, or diffuse growth",
                      "Cells ± abundant eosinophilic or vacuolated cytoplasm",
                      "With endometrioid glandsWell-formed glands lined by cuboidal to columnar cells with pseudostratified nuclei (benign > > > malignant)",
                      "Well-formed glands lined by cuboidal to columnar cells with pseudostratified nuclei (benign > > > malignant)",
                      "EpithelioidCells with abundant eosinophilic cytoplasm",
                      "Cells with abundant eosinophilic cytoplasm",
                      "With clear cells or granular cytoplasm",
                      "With rhabdoid featuresIntracytoplasmic eosinophilic hyaline inclusions pushing aside nucleus",
                      "Intracytoplasmic eosinophilic hyaline inclusions pushing aside nucleus",
                      "With bizarre cellsScattered cells with large nuclei, sometimes bi- or multinucleated with smudgy chromatin",
                      "Scattered cells with large nuclei, sometimes bi- or multinucleated with smudgy chromatin",
                      "With adipose tissueTypically mature adipocytes (focal)",
                      "Typically mature adipocytes (focal)",
                      "Papillary or pseudopapillary architectureProbably related to artifactTypically focal; may be admixed with sex cord-like differentiation",
                      "Probably related to artifact",
                      "Typically focal; may be admixed with sex cord-like differentiation",
                      "With multinucleated giant cells"
                    ]
                  },
                  {
                    "text": "± high-gradeYWHAE::NUTM2A/NUTM2Bfusion or high-grade NOS, ESS"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "ESN and LG-ESSHigh nuclear:cytoplasmic ratio with small, oval nuclei, evenly distributed chromatin and small nucleoliMitotic activity typically low (< 5/10 HPF) but may be high (up to 15-20/10 HPF)",
                    "sub_points": [
                      "High nuclear:cytoplasmic ratio with small, oval nuclei, evenly distributed chromatin and small nucleoli",
                      "Mitotic activity typically low (< 5/10 HPF) but may be high (up to 15-20/10 HPF)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Vimentin, CD10, IFITM1, and actins typically positiveCD10 may be only focally positive or negative",
                    "sub_points": [
                      "CD10 may be only focally positive or negative"
                    ]
                  },
                  {
                    "text": "WT1, ER, and PR typically positive (ER and PR with heterogenous expression); ± AR positive"
                  },
                  {
                    "text": "AE1.3/Cam5.2, MNF116, CK8/18 may be positive in typical ESTs, glandular and sex cord-like areas"
                  },
                  {
                    "text": "Desmin/caldesmon rarely positive in typical EST but commonly positive if smooth muscle > > sex cord-like differentiation"
                  },
                  {
                    "text": "Cyclin-D1, BCOR, DOG1 typically negative (exceptions)"
                  },
                  {
                    "text": "Inhibin, calretinin, CD99, and melan-A (rarely HMB-45), CD56 ± in sex cord-like elements"
                  },
                  {
                    "text": "FOXL2 negative"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "t(7;17) most common (JAZF1::SUZ12)"
                  },
                  {
                    "text": "PHF1gene rearrangements (if sex cord areas)"
                  },
                  {
                    "text": "Other less common translocations"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Highly Cellular Leiomyoma (vs. ESTs)": [
                  {
                    "text": "Large, thick blood vessels and cleft-like spaces"
                  },
                  {
                    "text": "Spindle cells merge with myometrium at periphery"
                  },
                  {
                    "text": "Desmin and caldesmon diffusely positive"
                  }
                ],
                "Cellular Endometrial Polyp (in Curettage vs. ESTs)": [
                  {
                    "text": "Atrophic appearance of stromal cells with no mitoses"
                  },
                  {
                    "text": "Large, thick-walled blood vessels in some fragments"
                  }
                ],
                "Gland Poor and Intravascular Adenomyosis (vs. LG-ESS)": [
                  {
                    "text": "Not mass forming; at most, irregular myometrial thickening"
                  },
                  {
                    "text": "No expansile stromal islands and conventional adenomyosis"
                  }
                ],
                "Cellular Intravenous Leiomyomatosis/Adenomyomatosis": [
                  {
                    "text": "Thick-walled blood vessels and clefted contours"
                  },
                  {
                    "text": "Fascicular architecture and spindle cells"
                  },
                  {
                    "text": "Desmin and caldesmon diffusely positive"
                  }
                ],
                "Primitive Neuroectodermal Tumor/Ewing Sarcoma": [
                  {
                    "text": "Small \"blue\" cells without delicate vasculature"
                  },
                  {
                    "text": "Neuroectodermal differentiation may be seen if cNET"
                  },
                  {
                    "text": "GFAP positive in ~ 50% cNET"
                  },
                  {
                    "text": "NKX2.2 positive and t(11;22) if Ewing sarcoma"
                  }
                ],
                "Embryonal Rhabdomyosarcoma": [
                  {
                    "text": "Alternating hypo- and hypercellular areas"
                  },
                  {
                    "text": "Rhabdomyoblastic differentiation common"
                  },
                  {
                    "text": "Primitive-appearing cells with brisk mitotic activity"
                  },
                  {
                    "text": "Myogenin, PAX7, myoD1 positive"
                  }
                ],
                "Myxoid and Epithelioid Smooth Muscle Tumors (vs. ESTs)": [
                  {
                    "text": "No tongue-like pattern of infiltration and vasculature"
                  },
                  {
                    "text": "Desmin and caldesmon positive"
                  }
                ],
                "Uterine Tumor Resembling Ovarian Sex Cord-Stromal Tumor (vs. EST With Sex Cord-Like Differentiation)": [
                  {
                    "text": "No typical EST areas; NCOA1/2 fusions"
                  }
                ],
                "Müllerian Adenosarcoma (vs. EST With Glands)": [
                  {
                    "text": "Often centered in endometrium without myometrial invasion (< 20% of cases)"
                  },
                  {
                    "text": "Characteristic phyllodes-type glands"
                  },
                  {
                    "text": "Collaring of low-grade malignant stroma around glands"
                  },
                  {
                    "text": "Different types of müllerian epithelium"
                  }
                ],
                "Müllerian Adenomyoma (vs. EST With Glands)": [
                  {
                    "text": "Gross appearance of solid areas similar to leiomyoma"
                  },
                  {
                    "text": "Typically small component of endometrial stroma"
                  },
                  {
                    "text": "Predominance of benign smooth muscle (leiomyoma-like)"
                  }
                ],
                "GREB1-Rearranged Sarcoma (vs. LG-ESS)": [
                  {
                    "text": "Lacks typical EST areas;GREB1fusion"
                  }
                ],
                "Sarcomas WithGLI1Alterations (vs. Myxoid LG-ESS)": [
                  {
                    "text": "Variable degree of pleomorphism, no typical EST areas"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In curettage, endometrial stromal proliferation can only be diagnosed as EST, as evaluation of margins not possible"
                  },
                  {
                    "text": "If ESS involves ovary, inquiry about prior hysterectomy mandatory; EST is by far more common in uterus"
                  },
                  {
                    "text": "Extensive sampling of tumor-myometrial interface required to disclose enough myometrial invasion for ESS diagnosis"
                  },
                  {
                    "text": "As ESTs with limited infiltration occasionally may metastasize, they should be diagnosed as LG-ESSNote may be added emphasizing limited infiltration",
                    "sub_points": [
                      "Note may be added emphasizing limited infiltration"
                    ]
                  },
                  {
                    "text": "Tumor with typical morphology resembling proliferative-phase endometrial stroma and typical pattern of infiltration should be classified as ESS independent of mitoses"
                  },
                  {
                    "text": "If assessing tumor with only sex cord-like differentiation in curettage, diagnosis of uterine tumor resembling ovarian sex cord-stromal tumor cannot be established, as may represent EST with extensive sex cord-like differentiation; thus, hysterectomy is required"
                  },
                  {
                    "text": "In differential diagnosis of EST vs. highly cellular leiomyoma, panel of antibodies, including CD10, desmin, and caldesmon, is useful, as latter often CD10 positiveActin not helpful, as both positive",
                    "sub_points": [
                      "Actin not helpful, as both positive"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia": {
            "name": "Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia",
            "url": "https://app.pathprimer.com/document/5d1eadd6-ae05-45eb-950f-af11b21401e1/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Precancerous glandular lesion of endometrium characterized by abnormal architecture and cytology distinct from surrounding endometrium and prone to malignant transformation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Wide range (mean: 6th decade)"
                  },
                  {
                    "text": "Abnormal vaginal bleeding"
                  },
                  {
                    "text": "Excellent prognosis (if no coexistent adenocarcinoma)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Endometrial intraepithelial neoplasia diagnostic criteriaAt least 1 mm in sizeGlands:stroma ratio exceeds 1:1 (glands compose > 50% of lesional area)Glandular epithelium cytologically distinct from background endometrium",
                    "sub_points": [
                      "At least 1 mm in size",
                      "Glands:stroma ratio exceeds 1:1 (glands compose > 50% of lesional area)",
                      "Glandular epithelium cytologically distinct from background endometrium"
                    ]
                  },
                  {
                    "text": "May involve endometrial polyp(s) (1/3)"
                  },
                  {
                    "text": "Nonendometrioid differentiation (metaplasia) common: Squamous (typically morules), mucinous, tubal, secretory"
                  },
                  {
                    "text": "~ 20% involve entire endometrium (nonlocalized)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "ER, PR positive; p16 negative"
                  },
                  {
                    "text": "p53 wild-type pattern"
                  },
                  {
                    "text": "PTEN44% inactivated;PAX271% inactivated"
                  },
                  {
                    "text": "CombinedPTENandPAX2mutations (30%)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Technical artifacts"
                  },
                  {
                    "text": "Endometrial polyp"
                  },
                  {
                    "text": "Atypical polypoid adenomyoma"
                  },
                  {
                    "text": "Endometrial hyperplasia without atypia"
                  },
                  {
                    "text": "Endometrioid adenocarcinoma"
                  },
                  {
                    "text": "HPV-associated endocervical adenocarcinoma in situ (\"colonization of endometrial glands\")"
                  },
                  {
                    "text": "Uterine serous carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Endometrial/endometrioid intraepithelial neoplasia (EIN)"
                  },
                  {
                    "text": "Atypical endometrial hyperplasia (AEH)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Precancerous glandular lesion of endometrium characterized by abnormal architecture and cytology distinct from surrounding endometrium and prone to malignant transformation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hormonal (Estrogenic) Effects": [
                  {
                    "text": "Obesity (secondary to peripheral aromatase activity in adipose tissue)"
                  },
                  {
                    "text": "Prolonged anovulatory cycles"
                  },
                  {
                    "text": "Hormonal therapy (estrogen without progestin)"
                  },
                  {
                    "text": "Polycystic ovarian syndrome"
                  },
                  {
                    "text": "Estrogen-producing tumors"
                  }
                ],
                "Molecular Abnormalities (Somatic)": [
                  {
                    "text": "Clonal expansion"
                  },
                  {
                    "text": "Inactivation ofPTEN(tumor suppressor), most frequent"
                  },
                  {
                    "text": "Microsatellite instability (20-25%) (Lynch and Cowden syndromes)"
                  },
                  {
                    "text": "KRASactivating mutations (~ 15%)"
                  },
                  {
                    "text": "CTNNB1mutations (25-30%)"
                  },
                  {
                    "text": "MLH1epigenetic inactivation (15-20%)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "In ~ 1.5% of all endometrial samples (any indication)"
                  }
                ],
                "Age": [
                  {
                    "text": "Wide range (mean: 6th decade)Average: 7-8 years younger than endometrioid adenocarcinoma",
                    "sub_points": [
                      "Average: 7-8 years younger than endometrioid adenocarcinoma"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abnormal vaginal bleeding"
                  }
                ],
                "Natural History": [
                  {
                    "text": "~ 45x increased risk of developing adenocarcinoma if EIN"
                  },
                  {
                    "text": "25-35% rate of coexistent adenocarcinoma if EIN"
                  },
                  {
                    "text": "Absence of EIN in endometrial biopsy has 99% negative predictive value for cancer outcome"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Progestin therapy (if poor surgical candidate or fertility desired)~ 1/3 regress with progestin therapyNo guidelines for type (oral vs. progestin-releasing IUD), course (interrupted or continuous), or durationFrequent rebiopsy indicated to exclude adenocarcinoma (based on clinical indications)Progestin therapy should be discontinued prior to rebiopsy to augment optimal interpretation",
                    "sub_points": [
                      "~ 1/3 regress with progestin therapy",
                      "No guidelines for type (oral vs. progestin-releasing IUD), course (interrupted or continuous), or duration",
                      "Frequent rebiopsy indicated to exclude adenocarcinoma (based on clinical indications)",
                      "Progestin therapy should be discontinued prior to rebiopsy to augment optimal interpretation"
                    ]
                  },
                  {
                    "text": "Hysterectomy and bilateral salpingo-oophorectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent (if no coexistent adenocarcinoma)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically no grossly identifiable mass when not associated with carcinoma"
                  },
                  {
                    "text": "Thickened endometrium or polyp may be seen"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "EIN diagnostic criteriaAt least 1 mm in sizeGlands:stroma ratio exceeds 1:1 (glands compose > 50% of lesional area)Glandular epithelium cytologically distinct from background endometrium",
                    "sub_points": [
                      "At least 1 mm in size",
                      "Glands:stroma ratio exceeds 1:1 (glands compose > 50% of lesional area)",
                      "Glandular epithelium cytologically distinct from background endometrium"
                    ]
                  },
                  {
                    "text": "Intraglandular, small nonvillous papillae may be seen"
                  },
                  {
                    "text": "No confluent back-to-back glandular growth or invasion of myometrium"
                  },
                  {
                    "text": "May involve endometrial polyp(s) (1/3)"
                  },
                  {
                    "text": "~ 20% involve entire endometrium (nonlocalized)"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Cytology different from background endometrium and may have variable appearanceEndometrioid with elongated pseudostratified nucleiRound, nonstratified ± prominent nucleoliNonendometrioid differentiation (metaplasia) frequent; may be admixedSquamous (typically morules) most commonMucinous (endocervical type) with bland, basally located nuclei (most common)Tubal (eosinophilic cytoplasm, rounded nuclei ± cilia)Secretory (sub- &/or supranuclear vacuoles ± luminal secretions)",
                    "sub_points": [
                      "Endometrioid with elongated pseudostratified nuclei",
                      "Round, nonstratified ± prominent nucleoli",
                      "Nonendometrioid differentiation (metaplasia) frequent; may be admixedSquamous (typically morules) most commonMucinous (endocervical type) with bland, basally located nuclei (most common)Tubal (eosinophilic cytoplasm, rounded nuclei ± cilia)Secretory (sub- &/or supranuclear vacuoles ± luminal secretions)",
                      "Squamous (typically morules) most common",
                      "Mucinous (endocervical type) with bland, basally located nuclei (most common)",
                      "Tubal (eosinophilic cytoplasm, rounded nuclei ± cilia)",
                      "Secretory (sub- &/or supranuclear vacuoles ± luminal secretions)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "ER, PR positive"
                  },
                  {
                    "text": "p16 negative; ± PAX2 and PTEN loss"
                  },
                  {
                    "text": "p53 wild-type pattern"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "PTEN44% inactivated"
                  },
                  {
                    "text": "PAX271% inactivated"
                  },
                  {
                    "text": "CombinedPTENandPAX2mutations (30%)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Technical Artifacts": [
                  {
                    "text": "\"Telescoping\" of normal benign endometrial glandsGlandular epithelium \"piles up,\" creating artifactual gland crowdingCytologic features similar between crowded and noncrowded glands",
                    "sub_points": [
                      "Glandular epithelium \"piles up,\" creating artifactual gland crowding",
                      "Cytologic features similar between crowded and noncrowded glands"
                    ]
                  },
                  {
                    "text": "Fragmentation and \"push\" artifactSeparation of glands from stromaFragmented glands",
                    "sub_points": [
                      "Separation of glands from stroma",
                      "Fragmented glands"
                    ]
                  }
                ],
                "Endometrial Polyp": [
                  {
                    "text": "Gland crowding and irregularity but no cytologic demarcation"
                  }
                ],
                "Atypical Polypoid Adenomyoma": [
                  {
                    "text": "Lobulated architecture"
                  },
                  {
                    "text": "Fibromyomatous stroma"
                  }
                ],
                "Endometrial Hyperplasia Without Atypia (Diffuse Hormonal Change)": [
                  {
                    "text": "Diffuse and random gland crowding"
                  },
                  {
                    "text": "Uniform or randomly irregular cytologic appearance throughout endometrium (no cytologic demarcation)"
                  },
                  {
                    "text": "Fibrin thrombi, stromal breakdown, and reparative endometrial epithelium common"
                  }
                ],
                "Endometrial Adenocarcinoma (If Biopsy)": [
                  {
                    "text": "Typically mass forming"
                  },
                  {
                    "text": "Complex architecture with 1 or more of followingExtensive cribriformingVilloglandular patternSolid growth of nonmetaplastic epithelium",
                    "sub_points": [
                      "Extensive cribriforming",
                      "Villoglandular pattern",
                      "Solid growth of nonmetaplastic epithelium"
                    ]
                  }
                ],
                "HPV-Associated Endocervical Adenocarcinoma In Situ (Colonization of Endometrial Glands)": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Crowded, elongated, hyperchromatic nuclei with apical mitoses and apoptotic bodies"
                  },
                  {
                    "text": "p16 diffusely positive; ER, PR typically negative"
                  },
                  {
                    "text": "HPV positive by in situ hybridization or PCR"
                  }
                ],
                "Uterine Serous Carcinoma": [
                  {
                    "text": "Marked cytologic atypia"
                  },
                  {
                    "text": "Brisk mitoses, including atypical forms"
                  },
                  {
                    "text": "p53 diffusely positive or completely negative (null)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In hysterectomy specimens, endometrium should be entirely submitted for histologic examination to exclude adenocarcinoma"
                  },
                  {
                    "text": "If precancerous lesion involves endometrial polyp, nonneoplastic glands within polyp should be used as reference for cytologic comparison and not background endometrium"
                  },
                  {
                    "text": "Cytologic appearance of endometrial glandular epithelium is not static and fluctuates based on hormonal environment (normal and hyperplastic)Difference in cytologic appearance of focus in question critical in evaluating presence of precancerous lesion",
                    "sub_points": [
                      "Difference in cytologic appearance of focus in question critical in evaluating presence of precancerous lesion"
                    ]
                  },
                  {
                    "text": "PTEN and PAX2 immunohistochemical stains, while helpful in understanding pathogenesis of endometrial neoplasia, should not be used as routine diagnostic markers, as 1/2 of EINs retain PTEN and 1/3 retain PAX2 expression"
                  },
                  {
                    "text": "Finding intraglandular nonvillous papillae should not be misinterpreted as well-differentiated adenocarcinoma in absence of confluent glandular growth"
                  },
                  {
                    "text": "Presence of crowded but individually defined glands helps distinguish EIN from well-differentiated adenocarcinoma, which characteristically has complex architecture"
                  },
                  {
                    "text": "If focus is not diagnostic for EIN (< 1 mm or close to but does not meet 50% threshold for gland crowding), follow-up sampling indicated as \"gland crowding\" associated with subsequent EIN (20%)"
                  },
                  {
                    "text": "EIN/AEH can involve adenomyosis and should not be mistaken for invasive carcinoma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Leiomyosarcoma": {
            "name": "Leiomyosarcoma",
            "url": "https://app.pathprimer.com/document/7ea2a8d0-b06e-474e-a876-b2bbd59b1f31/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant mesenchymal tumor of smooth muscle lineage with variable morphology and degrees of differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "~ 45% of uterine sarcomas"
                  },
                  {
                    "text": "Typically > 40 years of age with peak at 50 years"
                  },
                  {
                    "text": "Increased incidence in Blacks"
                  },
                  {
                    "text": "Overall, 25-75% 5-year survival rate"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary large mass; variably circumscribed margins"
                  },
                  {
                    "text": "Gelatinous appearance if myxoid"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Spindle: Usually long intersecting fascicles (often cellular)"
                  },
                  {
                    "text": "Epithelioid: Diffuse, nested, corded, plexiform growths (> 50% of cells)"
                  },
                  {
                    "text": "Myxoid: Abundant intercellular myxoid background"
                  },
                  {
                    "text": "Cytologic atypia and mitotic activity"
                  },
                  {
                    "text": "Tumor cell necrosis (abrupt transition from viable to necrotic tumor with no intervening area of granulation tissue; atypical cells within areas of necrosis are atypical)"
                  },
                  {
                    "text": "Infarct-type necrosis (characterized by interface between necrotic and viable tumor being composed of granulation tissue often with associated hemorrhage; necrotic areas have mummified appearance with no viable perivascular tumor)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Smooth muscle actin, desmin, caldesmon, transgelin (+)"
                  },
                  {
                    "text": "ER, PR, and AR (less frequently) positive"
                  },
                  {
                    "text": "p16, p53, CD10, BCL2, WT1, c-kit often positive"
                  },
                  {
                    "text": "Keratin and EMA (+), especially if epithelioid"
                  },
                  {
                    "text": "IMP3 and HMGA2 frequently (+); PLAG1(+) if myxoid"
                  },
                  {
                    "text": "HMB-45 and cathepsin-K can be (+); melan-A (-)"
                  },
                  {
                    "text": "BCOR and Pan-Trk may be (+); cyclin-D1 (-) (rare exceptions)"
                  },
                  {
                    "text": "FrequentTP53,RB1, HMGA2, andATRXmutations"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Leiomyosarcoma (LMS)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Malignant smooth muscle tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant mesenchymal tumor of smooth muscle lineage with variable morphology and degrees of differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "May be related to prior radiation therapy"
                  },
                  {
                    "text": "History of oral contraceptives, tamoxifen"
                  },
                  {
                    "text": "Body mass index > 27"
                  }
                ],
                "Genetic Susceptibility": [
                  {
                    "text": "Increased incidence in patients with retinoblastoma, Li-Fraumeni, or hereditary leiomyomatosis/renal cell carcinoma syndrome"
                  }
                ],
                "Precursor Lesion": [
                  {
                    "text": "Rarely, malignant transformation of leiomyoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "~ 7% of soft tissue sarcomas"
                  },
                  {
                    "text": "~ 40% of LMS in female patients originate in uterus"
                  },
                  {
                    "text": "< 1% of all uterine malignancies"
                  },
                  {
                    "text": "~ 45% of uterine sarcomas"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically reproductive and postmenopausal (> 40 with peak at 50 years)"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Increased incidence in Blacks (< < < leiomyoma)"
                  }
                ],
                "Site": [
                  {
                    "text": "Corpus > > > > > > cervix"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abnormal vaginal bleeding &/or pelvic pain"
                  },
                  {
                    "text": "Rapidly growing \"leiomyoma\""
                  },
                  {
                    "text": "Hemoperitoneum due to tumor rupture"
                  },
                  {
                    "text": "Symptoms and signs related to extrauterine extension or metastases"
                  },
                  {
                    "text": "Nonspecific symptoms, including weight loss, weakness, ± fever"
                  },
                  {
                    "text": "Rarely, hyperphosphatemia or hematologic manifestations"
                  },
                  {
                    "text": "Paraneoplastic syndromes (myasthenia gravis, Lambert-Eaton myasthenic syndrome, multiple seborrheic keratosis, Guillain-Barre syndrome) may occur"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Extrauterine disease at time of diagnosis in ~ 35%"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Radical hysterectomy (± adnexectomy &/or lymph nodes)"
                  },
                  {
                    "text": "No obvious benefit from radiation or chemotherapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall 25-75% 5-year survival rate; 50-70% if stage IWorse prognosis if dedifferentiated",
                    "sub_points": [
                      "Worse prognosis if dedifferentiated"
                    ]
                  },
                  {
                    "text": "Pathologic stage strongest predictor of outcome, but, in general, histologic or molecular parameters not good predictors"
                  },
                  {
                    "text": "Common recurrences (45-73%) even in stage I tumors"
                  },
                  {
                    "text": "Recurrences within 2 years in spindle LMS and even up to 10 years in myxoid and epithelioid LMS"
                  },
                  {
                    "text": "Tumor fragmentation (morcellation) associated with increased risk of recurrences, especially peritoneal"
                  },
                  {
                    "text": "Alterations in DNA damage repair genes associated with poor outcomes"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary, large mass with variably circumscribed margins"
                  },
                  {
                    "text": "If associated with other uterine smooth muscle tumors, typically largest mass"
                  },
                  {
                    "text": "2/3 intramural in corpus, rarely in cervix"
                  },
                  {
                    "text": "Soft, fleshy, bulging, and white-gray to pink cut surface"
                  },
                  {
                    "text": "Softer consistency and yellow to tan if epithelioid"
                  },
                  {
                    "text": "Gelatinous appearance if myxoid"
                  },
                  {
                    "text": "± necrosis, hemorrhage, or cyst formation"
                  },
                  {
                    "text": "Prominent intravascular invasion may occur (intravenous leiomyosarcomatosis)"
                  }
                ],
                "Size": [
                  {
                    "text": "Range: 1-30 (mean: 9) cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Destructive infiltrative margin common"
                  },
                  {
                    "text": "SpindleLong intersecting fascicles (often cellular)± bizarre cells",
                    "sub_points": [
                      "Long intersecting fascicles (often cellular)",
                      "± bizarre cells"
                    ]
                  },
                  {
                    "text": "EpithelioidEpithelioid (polygonal) morphology in > 50% of cellsDiffuse, nested, corded, plexiform growths± cyst formation or gland-like spaces",
                    "sub_points": [
                      "Epithelioid (polygonal) morphology in > 50% of cells",
                      "Diffuse, nested, corded, plexiform growths",
                      "± cyst formation or gland-like spaces"
                    ]
                  },
                  {
                    "text": "MyxoidDiffuse or fascicular growthOften hypocellular due to myxoid background± cyst formation",
                    "sub_points": [
                      "Diffuse or fascicular growth",
                      "Often hypocellular due to myxoid background",
                      "± cyst formation"
                    ]
                  },
                  {
                    "text": "Admixture of histologic subtypes not infrequent"
                  },
                  {
                    "text": "Tumor cell necrosis (abrupt transition from viable to necrotic tumor with no intervening area of granulation tissue; atypical cells within areas of necrosis)"
                  },
                  {
                    "text": "± infarct-type necrosis (interface between necrotic and viable tumor composed of granulation tissue often with associated hemorrhage; mummified appearance in necrotic areas with no viable perivascular tumor)"
                  },
                  {
                    "text": "Dedifferentiation may occur: Discrete transition from differentiated to high-grade pleomorphic areas± heterologous elements: Osteosarcoma, chondrosarcoma, liposarcoma, or other",
                    "sub_points": [
                      "± heterologous elements: Osteosarcoma, chondrosarcoma, liposarcoma, or other"
                    ]
                  },
                  {
                    "text": "± lymphovascular invasion (may be extensive)"
                  },
                  {
                    "text": "May coexist with leiomyomas"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "SpindleSpindle cells ± paranuclear vacuolesVariable nuclear:cytoplasmic ratio, cigar-shaped nuclei with variable degrees of cytologic atypia; often prominent nucleoliBrisk mitotic activity",
                    "sub_points": [
                      "Spindle cells ± paranuclear vacuolesVariable nuclear:cytoplasmic ratio, cigar-shaped nuclei with variable degrees of cytologic atypia; often prominent nucleoli",
                      "Variable nuclear:cytoplasmic ratio, cigar-shaped nuclei with variable degrees of cytologic atypia; often prominent nucleoli",
                      "Brisk mitotic activity"
                    ]
                  },
                  {
                    "text": "EpithelioidPolygonal cells with variable amounts of eosinophilic (more often) or clear cytoplasmCells with variable nuclear:cytoplasmic ratio, round nuclei with varying degrees of cytologic atypia; often visible nucleoli",
                    "sub_points": [
                      "Polygonal cells with variable amounts of eosinophilic (more often) or clear cytoplasm",
                      "Cells with variable nuclear:cytoplasmic ratio, round nuclei with varying degrees of cytologic atypia; often visible nucleoli"
                    ]
                  },
                  {
                    "text": "MyxoidSpindle to stellate cells with scant eosinophilic cytoplasm, elongated but not cigar-shaped nucleiMinimal to marked cytologic atypiaVariable mitotic activity; may be low if no overt malignant cytologic featuresAbundant myxoid matrix (hyaluronic acid)Threshold of myxoid background to establish diagnosis of myxoid background ranges from > 30% to > 50%",
                    "sub_points": [
                      "Spindle to stellate cells with scant eosinophilic cytoplasm, elongated but not cigar-shaped nuclei",
                      "Minimal to marked cytologic atypia",
                      "Variable mitotic activity; may be low if no overt malignant cytologic features",
                      "Abundant myxoid matrix (hyaluronic acid)Threshold of myxoid background to establish diagnosis of myxoid background ranges from > 30% to > 50%",
                      "Threshold of myxoid background to establish diagnosis of myxoid background ranges from > 30% to > 50%"
                    ]
                  },
                  {
                    "text": "Osteoclastic-type giant cells, xanthomatous, or rhabdoid cells may be seen"
                  },
                  {
                    "text": "DedifferentiatedNoncohesive polygonal cellsModerate to abundant cytoplasm and pleomorphic nuclei with 1 or more macronucleoliFrequent multinucleation",
                    "sub_points": [
                      "Noncohesive polygonal cells",
                      "Moderate to abundant cytoplasm and pleomorphic nuclei with 1 or more macronucleoli",
                      "Frequent multinucleation"
                    ]
                  }
                ],
                "Diagnostic Criteria for LMS (Dependent on Histologic Subtype)": [
                  {
                    "text": "Spindle (2 of 3 should be present)Moderate to severe cytologic atypiaTumor cell necrosis≥ 10 mitoses/10 HPF",
                    "sub_points": [
                      "Moderate to severe cytologic atypia",
                      "Tumor cell necrosis",
                      "≥ 10 mitoses/10 HPF"
                    ]
                  },
                  {
                    "text": "Epithelioid≥ 4 mitoses/10 HPF and moderate to severe cytologic atypia or tumor cell necrosisOnly tumors with < 2 mitoses/10 HPF, no cytologic atypia, and well-circumscribed margins should be regarded as leiomyoma",
                    "sub_points": [
                      "≥ 4 mitoses/10 HPF and moderate to severe cytologic atypia or tumor cell necrosis",
                      "Only tumors with < 2 mitoses/10 HPF, no cytologic atypia, and well-circumscribed margins should be regarded as leiomyoma"
                    ]
                  },
                  {
                    "text": "MyxoidMarked cytologic atypia or tumor cell necrosis> 1-2 mitoses/10 HPF in absence of cytologic atypia or tumor cell necrosis, especially if infiltrative margins",
                    "sub_points": [
                      "Marked cytologic atypia or tumor cell necrosis",
                      "> 1-2 mitoses/10 HPF in absence of cytologic atypia or tumor cell necrosis, especially if infiltrative margins"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Smooth muscle actin, desmin, caldesmon, HDCA8, transgelin, and calponin (+)"
                  },
                  {
                    "text": "ER, PR, and AR (less frequently) (+)"
                  },
                  {
                    "text": "p16, p53, CD10, BCL2, WT1 often (+)"
                  },
                  {
                    "text": "Cytokeratin and EMA ± (more extensively if epithelioid)"
                  },
                  {
                    "text": "IMP3 and HMGA2 frequently (+)"
                  },
                  {
                    "text": "HMB-45 and cathepsin-K can be (+); melan-A and TFE3 (-)"
                  },
                  {
                    "text": "CD117 (c-kit) often (+) but no associated mutations"
                  },
                  {
                    "text": "PLAG1 positivity if myxoid (~ 50%)"
                  },
                  {
                    "text": "BCOR and Pan-Trk may be (+); cyclin-D1 (-) (rare exceptions)"
                  },
                  {
                    "text": "Alcian blue (pH 2.5) and colloidal iron (+) if myxoid"
                  },
                  {
                    "text": "ALK-1 and S100 (-)"
                  },
                  {
                    "text": "Loss of FH may be seen (~ 2%)"
                  }
                ],
                "Molecular Abnormalities": [
                  {
                    "text": "FrequentTP53(~ 40%),ATRX(25%),RB1, andHMGA2mutations"
                  },
                  {
                    "text": "MED12mutations much less common than leiomyomas (~ 20%)MED12andHMGA2mutations mutually exclusive",
                    "sub_points": [
                      "MED12andHMGA2mutations mutually exclusive"
                    ]
                  },
                  {
                    "text": "PLAG1mutations in ~ 25% of myxoid LMSs (no morphologic differences between LMS ± mutations)"
                  },
                  {
                    "text": "PGRmutations in subset of epithelioid LMS (with focal rhabdoid features)"
                  },
                  {
                    "text": "BRCAmutations rare"
                  },
                  {
                    "text": "Complex numerical and structural chromosomal abnormalitiesLosses on 10q, 11q, 13q, 22q, and gains on Xp, 1q, 5p, 8q, and 17pHigh genomic indexes",
                    "sub_points": [
                      "Losses on 10q, 11q, 13q, 22q, and gains on Xp, 1q, 5p, 8q, and 17p",
                      "High genomic indexes"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Leiomyoma Variants (vs. Spindle LMS)": [
                  {
                    "text": "Mitotically activeNo cytologic atypia",
                    "sub_points": [
                      "No cytologic atypia"
                    ]
                  },
                  {
                    "text": "With bizarre nucleiUp to 2 mitoses/10 HPF by mean mitotic count",
                    "sub_points": [
                      "Up to 2 mitoses/10 HPF by mean mitotic count"
                    ]
                  },
                  {
                    "text": "ApoplecticBland cytologic features and minimal mitotic activity in areas away from necrosis",
                    "sub_points": [
                      "Bland cytologic features and minimal mitotic activity in areas away from necrosis"
                    ]
                  }
                ],
                "Rhabdomyosarcoma (vs. Spindle LMS)": [
                  {
                    "text": "Cross striations may be present"
                  },
                  {
                    "text": "Bright eosinophilic cytoplasm"
                  },
                  {
                    "text": "myoD1, myogenin, and myoglobin (+)"
                  }
                ],
                "NTRK Sarcoma (vs. Spindle LMS)": [
                  {
                    "text": "More commonly centered in cervix"
                  },
                  {
                    "text": "Patternless or herringbone growth"
                  },
                  {
                    "text": "Typically mild to moderate cytologic atypia"
                  },
                  {
                    "text": "Perivascular hyalinization and lymphoid infiltrate common"
                  },
                  {
                    "text": "Desmin and h-caldesmon (-); ER and PR typically (-)"
                  },
                  {
                    "text": "Pan-Trk(+) with NTRK fusion"
                  },
                  {
                    "text": "S100 > CD34 (+)"
                  }
                ],
                "PEComa (vs. Spindle or Epithelioid LMS)": [
                  {
                    "text": "May be associated with tuberous sclerosis complex"
                  },
                  {
                    "text": "Perivascular arrangement of tumor cells"
                  },
                  {
                    "text": "Prominent delicate vasculature"
                  },
                  {
                    "text": "Spider and floret-type cells"
                  },
                  {
                    "text": "± intracytoplasmic melanin pigment"
                  },
                  {
                    "text": "Melan-A, PNL2, and TFE3 may be (+)"
                  },
                  {
                    "text": "TSC1/TSC2ofTFE3alterations"
                  }
                ],
                "Gastrointestinal Stromal Tumor (vs. Spindle and Epithelioid LMS)": [
                  {
                    "text": "Typically centered in outer aspect of uterine wall"
                  },
                  {
                    "text": "CD34 and DOG1 (+)"
                  }
                ],
                "Intermediate Trophoblast-Derived Tumors (vs. Epithelioid LMS)": [
                  {
                    "text": "Tumor cells infiltrate vascular wall replacing endothelial cells with associated fibrin deposition (placental site trophoblastic tumor)"
                  },
                  {
                    "text": "Tumor cells with perivascular arrangement and intervening areas with abundant eosinophilic material (epithelioid trophoblastic tumor)"
                  },
                  {
                    "text": "Inhibin, HPL, MEL-CAM (+)"
                  },
                  {
                    "text": "p63(+) (epithelioid trophoblastic tumor)"
                  },
                  {
                    "text": "HCG may be focally (+)"
                  },
                  {
                    "text": "Smooth muscle markers (-)"
                  }
                ],
                "Melanoma (vs. Epithelioid LMS)": [
                  {
                    "text": "If metastatic: Prior history"
                  },
                  {
                    "text": "Frequent lymphovascular involvement"
                  },
                  {
                    "text": "Melan-A, S100, SOX10 (+)"
                  },
                  {
                    "text": "Smooth muscle markers and keratins (-)"
                  }
                ],
                "Undifferentiated Carcinoma (vs. Epithelioid LMS)": [
                  {
                    "text": "Focal glandular differentiation"
                  },
                  {
                    "text": "Desmin and caldesmon (-); CK18(+)"
                  }
                ],
                "Uterine Tumor Resembling Ovarian Sex Cord Tumor (vs. Epithelioid LMS)": [
                  {
                    "text": "Retiform, sertoliform, or insular patterns"
                  },
                  {
                    "text": "Cells with abundant vacuolated cytoplasm"
                  },
                  {
                    "text": "Inhibin and melan-A (+)"
                  },
                  {
                    "text": "NCOA2/NCOA3fusions"
                  }
                ],
                "Metastatic Lobular Carcinoma (vs. Epithelioid LMS)": [
                  {
                    "text": "Prior history"
                  },
                  {
                    "text": "Presence of intracytoplasmic lumina"
                  },
                  {
                    "text": "Mammaglobin, GATA3, TRPS-1, GCDFP-15 (~ 50%)"
                  },
                  {
                    "text": "Desmin and caldesmon (-)"
                  }
                ],
                "Epithelioid Angiosarcoma (vs. Epithelioid LMS)": [
                  {
                    "text": "Hemorrhagic gross cut surface"
                  },
                  {
                    "text": "Well- to poorly formed vascular spaces with red blood cells"
                  },
                  {
                    "text": "CD31 and other vascular markers (+)"
                  }
                ],
                "GREB1-Rearranged Uterine Sarcoma (vs. Epithelioid LMS)": [
                  {
                    "text": "± sex cord-like patterns"
                  },
                  {
                    "text": "GREB1rearrangements"
                  }
                ],
                "Myxoid or Epithelioid Endometrial Stromal Sarcoma": [
                  {
                    "text": "Characteristic tongue-like infiltrative growth"
                  },
                  {
                    "text": "Arterioles and bland cytologic features"
                  },
                  {
                    "text": "Desmin and caldesmon (-)"
                  }
                ],
                "Myxoid Leiomyoma (vs. Myxoid LMS)": [
                  {
                    "text": "Typically well demarcated and < 5 cm"
                  },
                  {
                    "text": "No cytologic atypia and rare to absent mitoses"
                  }
                ],
                "Leiomyoma With Myxoid and Conventional Areas (vs. Myxoid LMS)": [
                  {
                    "text": "Demarcated from surrounding myometrium"
                  },
                  {
                    "text": "Alternating myxoid (focal) and nonmyxoid areas"
                  },
                  {
                    "text": "No cytologic atypia or mitoses"
                  }
                ],
                "Leiomyoma With Hydropic Change (vs. Myxoid LMS)": [
                  {
                    "text": "Watery (not sticky) and multinodular [Alcian blue (-)]"
                  },
                  {
                    "text": "No cytologic atypia and rare to absent mitoses"
                  }
                ],
                "Inflammatory Myofibroblastic Tumor (vs. Spindle or Myxoid LMS)": [
                  {
                    "text": "Disorganized fascicular growth"
                  },
                  {
                    "text": "Often prominent plasma cells and lymphocytes"
                  },
                  {
                    "text": "ALK1 or ROS1 (+) and caldesmon (-)"
                  },
                  {
                    "text": "p53 wild type;ALK1,ROS1rearrangements"
                  }
                ],
                "High-Grade Endometrial Stromal Sarcoma WithBCORAbnormalities (vs. Myxoid LMS)": [
                  {
                    "text": "ZC3H7B::BCORfusion orBCORinternal tandem duplication"
                  },
                  {
                    "text": "Cyclin-D1 and BCOR (~ 50%) (+)"
                  },
                  {
                    "text": "Minimal to absent positivity for muscle markers"
                  }
                ],
                "GLI1-Altered Sarcomas (vs. Myxoid ± Epithelioid LMS)": [
                  {
                    "text": "Fusion, amplification, or gene rearrangement"
                  }
                ],
                "Undifferentiated Uterine Sarcoma": [
                  {
                    "text": "No distinct patterns"
                  },
                  {
                    "text": "Lack of staining for smooth muscle markers"
                  },
                  {
                    "text": "No known molecular abnormalities for LMS"
                  }
                ],
                "Carcinosarcoma (vs. Dedifferentiated LMS With Heterologous Elements)": [
                  {
                    "text": "Epithelial elements"
                  },
                  {
                    "text": "±MMRorPOLEalterations"
                  },
                  {
                    "text": "Lack ofRB1,HMGA2, andATRXmutations"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "When evaluating cytologic atypia in smooth muscle tumors, use 10x objective, and, if possible, compare cytologic features of tumor with surrounding myometrium"
                  },
                  {
                    "text": "Distinction between tumor cell and infarct-type necrosis may be difficult and interpretation not reproducible; thus, important to evaluate cytologic atypia and mitoses"
                  },
                  {
                    "text": "Extensive sampling always useful, especially in epithelioid and myxoid LMS to uncover areas with increased mitoses, which can be key to establishing correct diagnosis"
                  },
                  {
                    "text": "Threshold of myxoid background to diagnose LMS, as myxoid ranges between 30-60% but recommended to use lower threshold, as tumors are aggressive"
                  },
                  {
                    "text": "When using immunohistochemistry in differentiating smooth muscle tumors from their mimics, panel of antibodies should be used, as overlapping results with single antibodies are not infrequent (e.g., PEComa may express desmin, and LMS may express HMB-45)"
                  },
                  {
                    "text": "Molecular studies may be helpful when immunostains are not definitive in distinguishing among tumors"
                  },
                  {
                    "text": "Loss of FH staining in smooth muscle tumor does not preclude malignancy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Leiomyoma and Variants": {
            "name": "Leiomyoma and Variants",
            "url": "https://app.pathprimer.com/document/2d99bb8b-3647-4017-bdb4-a5bc07561350/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign smooth muscle tumor with wide gross and morphologic spectrum"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typical: Bulging white to minimally pink, firm, whorled cut surface"
                  },
                  {
                    "text": "Red degeneration: Beefy appearance (infarction and secondary hemorrhage, if pregnant or on oral contraceptives)"
                  },
                  {
                    "text": "Highly cellular leiomyoma: Often tan to yellow and soft cut surface"
                  },
                  {
                    "text": "Apoplectic/hemorrhagic leiomyoma: Stellate hemorrhage ± cystic change"
                  },
                  {
                    "text": "Leiomyoma with diffuse perinodular hydropic change: Multiple nodules separated by edema"
                  },
                  {
                    "text": "Myxoid leiomyoma: Gelatinous, soft, and gray"
                  },
                  {
                    "text": "Lipoleiomyoma: Yellow and white areas"
                  },
                  {
                    "text": "Dissecting leiomyoma (including cotyledonoid leiomyoma or \"Sternberg tumor\"): Placenta-like appearance with multiple bulbous red nodules, typically attached to each other by thin membranes, dissecting through myometrium"
                  },
                  {
                    "text": "Diffuse leiomyomatosis: Diffuse, regular thickening of myometrial wall due to multiple and confluent leiomyomas < 1 cm"
                  },
                  {
                    "text": "Diffuse peritoneal leiomyomatosis: Variable number of nodules with firm, white, whorled cut surface scattered in pelvis/peritoneum, typically < 2 cm, although rarely some may be large"
                  },
                  {
                    "text": "Intravenous leiomyomatosis: Multiple worm-like plugs of white to slightly pink or tan tissue filling and distending myometrial &/or parametrial soft tissues outside of leiomyoma (if present)"
                  },
                  {
                    "text": "Benign metastasizing leiomyoma: Well-circumscribed, firm, white, and whorled nodules typically in lungs"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign smooth muscle tumor with wide gross and morphologic spectrum"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic": [
                  {
                    "text": "~ 40% clonal cytogenetic aberrationst(12;14) best studied in intravenous leiomyomatosisBalanced translocation betweenHMGA2andRAD51B",
                    "sub_points": [
                      "t(12;14) best studied in intravenous leiomyomatosisBalanced translocation betweenHMGA2andRAD51B",
                      "Balanced translocation betweenHMGA2andRAD51B"
                    ]
                  },
                  {
                    "text": "Renal carcinoma-leiomyomatosis syndromeMultiple skin and uterine leiomyomas and renal cell carcinomaYounger age and multiple leiomyomasGermline heterozygous loss-of-function mutation of fumarate hydratase gene,FH(1q43)Not seen in sporadic leiomyoma",
                    "sub_points": [
                      "Multiple skin and uterine leiomyomas and renal cell carcinoma",
                      "Younger age and multiple leiomyomas",
                      "Germline heterozygous loss-of-function mutation of fumarate hydratase gene,FH(1q43)Not seen in sporadic leiomyoma",
                      "Not seen in sporadic leiomyoma"
                    ]
                  },
                  {
                    "text": "Alport syndromeDiffuse leiomyomatosis",
                    "sub_points": [
                      "Diffuse leiomyomatosis"
                    ]
                  },
                  {
                    "text": "Cowden syndromeUterine leiomyomas minor diagnostic criterion",
                    "sub_points": [
                      "Uterine leiomyomas minor diagnostic criterion"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common tumor of female genital tract"
                  },
                  {
                    "text": "Found in ~ 70% of hysterectomy specimens"
                  }
                ],
                "Age": [
                  {
                    "text": "> 30 years: 20-30%"
                  },
                  {
                    "text": "> 40 years: > 40%"
                  },
                  {
                    "text": "Early age (mean: 28 years) in patients withFHgermline mutations"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Higher incidence in African Americans at younger age"
                  }
                ],
                "Site": [
                  {
                    "text": "Fundus most common > > cervix (2%)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic most common"
                  },
                  {
                    "text": "Vaginal bleeding, most commonly if submucosal (± anemia if severe)Menorrhagia or hypermenorrhea",
                    "sub_points": [
                      "Menorrhagia or hypermenorrhea"
                    ]
                  },
                  {
                    "text": "Abdominal pain/swellingOften secondary to acute hemorrhage within leiomyomaEspecially apoplectic leiomyoma or torsionMay be secondary to obstruction of other organs if large",
                    "sub_points": [
                      "Often secondary to acute hemorrhage within leiomyomaEspecially apoplectic leiomyoma or torsion",
                      "Especially apoplectic leiomyoma or torsion",
                      "May be secondary to obstruction of other organs if large"
                    ]
                  },
                  {
                    "text": "Infertility or history of repeated abortionsEspecially if distorted uterus by multiple leiomyomas or if submucosal",
                    "sub_points": [
                      "Especially if distorted uterus by multiple leiomyomas or if submucosal"
                    ]
                  },
                  {
                    "text": "Rapid growth especially in leiomyoma with hydropic change"
                  },
                  {
                    "text": "Acute abdominal symptoms if ruptureMost common in pregnancy or postpartum",
                    "sub_points": [
                      "Most common in pregnancy or postpartum"
                    ]
                  },
                  {
                    "text": "Cardiac manifestations if intravenous leiomyomatosis (e.g., insufficiency, thromboembolism)"
                  },
                  {
                    "text": "Rarely, erythrocytosis, infection, ascites (pseudo-Meigs syndrome)"
                  },
                  {
                    "text": "Diffuse peritoneal leiomyomatosisTypically if pregnant or postpartum",
                    "sub_points": [
                      "Typically if pregnant or postpartum"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Myomectomy or simple hysterectomy"
                  },
                  {
                    "text": "Hysterectomy, bilateral adnexectomy, and resection of tumor at other locations (if intravenous leiomyomatosis, peritoneal leiomyomatosis)"
                  },
                  {
                    "text": "Gonadotropin-releasing hormone agonists (GnRHa), selective progesterone receptor modulators, progestins, or antifibrinolytic agentsOften no complete responseMay only treat symptomsMay cause morphologic changes that raise concern for leiomyosarcoma",
                    "sub_points": [
                      "Often no complete response",
                      "May only treat symptoms",
                      "May cause morphologic changes that raise concern for leiomyosarcoma"
                    ]
                  },
                  {
                    "text": "Uterine artery embolization"
                  },
                  {
                    "text": "Morcellation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "ExcellentRecurrence if incompletely excised (in up to 60%)Distant recurrences up to 20 years (leiomyoma with vascular invasion, intravenous leiomyomatosis, or benign metastasizing leiomyoma)Lungs > > > pelvis, bone, lymph nodesThromboembolism or cardiac insufficiency (intravenous leiomyomatosis)Tumor spillage and peritoneal regrowth (morcellation)",
                    "sub_points": [
                      "Recurrence if incompletely excised (in up to 60%)",
                      "Distant recurrences up to 20 years (leiomyoma with vascular invasion, intravenous leiomyomatosis, or benign metastasizing leiomyoma)Lungs > > > pelvis, bone, lymph nodes",
                      "Lungs > > > pelvis, bone, lymph nodes",
                      "Thromboembolism or cardiac insufficiency (intravenous leiomyomatosis)",
                      "Tumor spillage and peritoneal regrowth (morcellation)"
                    ]
                  },
                  {
                    "text": "Progression to leiomyosarcoma (< 3%)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Multiple (more frequently in African Americans) > solitary"
                  },
                  {
                    "text": "If pedunculated (subserosal), may torse and detach (parasitic leiomyoma)"
                  },
                  {
                    "text": "Well circumscribed, unencapsulated (\"shells out\")"
                  },
                  {
                    "text": "Bulging white to minimally pink, firm, whorled cut surface"
                  },
                  {
                    "text": "Red degeneration beefy appearanceDue to infarction and secondary hemorrhage if pregnant or on oral contraceptives",
                    "sub_points": [
                      "Due to infarction and secondary hemorrhage if pregnant or on oral contraceptives"
                    ]
                  },
                  {
                    "text": "± necrosis &/or discrete foci of hemorrhage"
                  },
                  {
                    "text": "Ulceration, if submucosal"
                  },
                  {
                    "text": "Edema, cyst formation, calcification"
                  },
                  {
                    "text": "Differences can occur in some leiomyoma variants or unusual growthsHighly cellular leiomyoma: Often tan to yellow and soft cut surfaceApoplectic/hemorrhagic leiomyoma: Stellate hemorrhage ± cystic changeLeiomyoma with diffuse perinodular hydropic change: Multiple nodules within mass separated by edemaEpithelioid leiomyoma: Often soft, tan cut surfaceMyxoid leiomyoma: Gelatinous, soft and gray cut surfaceLipoleiomyoma: Alternating yellow and white areasDissecting leiomyoma (including cotyledonoid leiomyoma or Sternberg tumor)Placenta-like appearance with multiple bulbous red nodules, typically attached to each other by thin membranes, dissecting through myometriumDiffuse leiomyomatosisDiffuse, regular thickening of uterine wall due to multiple and confluent leiomyomas < 1 cmDiffuse peritoneal leiomyomatosisVariable number of nodules with firm, white, whorled cut surface scattered in pelvis/peritoneum, including omentumTypically < 2 cm, although rarely up to 10 cmIntravenous leiomyomatosisMultiple worm-like plugs of white to slightly pink or tan tissue filling and distending myometrial &/or parametrial vascular spaces present outside confines of leiomyoma (if present)Benign metastasizing leiomyoma≥ 1 extrauterine, well-circumscribed, firm, white, and whorled nodules in lung (most common), retroperitoneal and mediastinal lymph nodes, soft tissues, &/or bone",
                    "sub_points": [
                      "Highly cellular leiomyoma: Often tan to yellow and soft cut surface",
                      "Apoplectic/hemorrhagic leiomyoma: Stellate hemorrhage ± cystic change",
                      "Leiomyoma with diffuse perinodular hydropic change: Multiple nodules within mass separated by edema",
                      "Epithelioid leiomyoma: Often soft, tan cut surface",
                      "Myxoid leiomyoma: Gelatinous, soft and gray cut surface",
                      "Lipoleiomyoma: Alternating yellow and white areas",
                      "Dissecting leiomyoma (including cotyledonoid leiomyoma or Sternberg tumor)Placenta-like appearance with multiple bulbous red nodules, typically attached to each other by thin membranes, dissecting through myometrium",
                      "Placenta-like appearance with multiple bulbous red nodules, typically attached to each other by thin membranes, dissecting through myometrium",
                      "Diffuse leiomyomatosisDiffuse, regular thickening of uterine wall due to multiple and confluent leiomyomas < 1 cm",
                      "Diffuse, regular thickening of uterine wall due to multiple and confluent leiomyomas < 1 cm",
                      "Diffuse peritoneal leiomyomatosisVariable number of nodules with firm, white, whorled cut surface scattered in pelvis/peritoneum, including omentumTypically < 2 cm, although rarely up to 10 cm",
                      "Variable number of nodules with firm, white, whorled cut surface scattered in pelvis/peritoneum, including omentum",
                      "Typically < 2 cm, although rarely up to 10 cm",
                      "Intravenous leiomyomatosisMultiple worm-like plugs of white to slightly pink or tan tissue filling and distending myometrial &/or parametrial vascular spaces present outside confines of leiomyoma (if present)",
                      "Multiple worm-like plugs of white to slightly pink or tan tissue filling and distending myometrial &/or parametrial vascular spaces present outside confines of leiomyoma (if present)",
                      "Benign metastasizing leiomyoma≥ 1 extrauterine, well-circumscribed, firm, white, and whorled nodules in lung (most common), retroperitoneal and mediastinal lymph nodes, soft tissues, &/or bone",
                      "≥ 1 extrauterine, well-circumscribed, firm, white, and whorled nodules in lung (most common), retroperitoneal and mediastinal lymph nodes, soft tissues, &/or bone"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Intersecting fascicles of spindle cells"
                  },
                  {
                    "text": "Variable collagen deposition, including collagen bands"
                  },
                  {
                    "text": "± nuclear palisading (neurilemoma-like)"
                  },
                  {
                    "text": "Variable numbers of mast cells common"
                  },
                  {
                    "text": "Prominent, large, thick blood vesselsIf many thick blood vessels, term angioleiomyoma applied by someSometimes smaller and abundant vessels with dropout of smooth muscle cells (vascular leiomyoma)",
                    "sub_points": [
                      "If many thick blood vessels, term angioleiomyoma applied by some",
                      "Sometimes smaller and abundant vessels with dropout of smooth muscle cells (vascular leiomyoma)"
                    ]
                  },
                  {
                    "text": "± ulceration with associated acute and chronic inflammation (if submucosal)"
                  },
                  {
                    "text": "Infarct-type necrosisGranulation tissue with recent or old hemorrhage &/or fibrosis between nonviable and viable areasNonviable areas \"mummified\" with ghost cell outlines still visible and associated with dead vessels; typically no perivascular sparingViable areas without cytologic atypia",
                    "sub_points": [
                      "Granulation tissue with recent or old hemorrhage &/or fibrosis between nonviable and viable areas",
                      "Nonviable areas \"mummified\" with ghost cell outlines still visible and associated with dead vessels; typically no perivascular sparing",
                      "Viable areas without cytologic atypia"
                    ]
                  },
                  {
                    "text": "Rhabdoid cells, massive neutrophilic, eosinophilic, lymphocytic infiltrate, extramedullary hematopoiesis, prominent histiocytes rare (more common if treated with GnRHa)"
                  },
                  {
                    "text": "Amianthoid-like fibers rare"
                  },
                  {
                    "text": "Leiomyoma variantsMitotically active: Increased mitotic activity (6-14/10 HPF), no cytologic atypia or tumor cell necrosisMay be progesterone relatedIf > 15 mitoses/10 HPF best classified as low/uncertain malignant potential as very limited experienceWith bizarre nuclei (without fumarate hydratase abnormalities)Patchy distribution (may be diffuse) of atypical binucleated or multinucleated atypical cells interspersed with banal smooth muscle cells (striking atypia due most likely to abundant heterochromatin, known to be associated with inactivated DNA)Abundant eosinophilic cytoplasm, may have \"rhabdoid\" inclusions; ± prominent nucleoli or smudgy chromatinKaryorrhectic nuclei (densely eosinophilic cytoplasm with coarse fragmented chromatin) not to be confused with mitosesOften vascular changes (fibrinoid necrosis, vascular occlusion, perivascular infiltrate)Leiomyoma with fumarate hydratase abnormalityStaghorn vesselsIncreased cellularity and alveolar-type edemaFibrillary background and rhabdoid cellsMultinucleated cells with degenerative atypiaNuclei with large orangeophilic nucleoli surrounded by perinucleolar haloCellular leiomyomaTypical leiomyoma \"significantly\" more cellular than adjacent myometrium (removed from latest WHO)Highly cellular leiomyomaLeiomyoma with cellular density similar to that seen in endometrial stromal tumors, no cytologic atypia and typically < 4 mitoses/10 HPF± irregular \"pseudoinfiltrative borders\"; merging at periphery with myometriumOften large, thick-walled blood vessels throughout and cleft-like spaces (compressed vessels or retraction artifact)Small cells with scant cytoplasm; therefore, fascicular growth may not be as evidentLeiomyoma with hormone-related changes (pregnancy or progestin)Hemorrhage, edema, myxoid change in various proportionsAbnormal vessels with thickening and fibrosis of intimal layerFocal hypercellularity, some nuclear pleomorphism, and increased mitotic activityApoplectic leiomyoma: Well-defined areas of hemorrhage surrounded by cellular rim of smooth muscle cells with plump nuclei, relatively prominent nucleoli, and increased mitotic activity (up to 9/10 HPF) in background that may be myxomatousAway from those areas, appearance is that of benign smooth muscle tumor (\"zonation\" phenomenon)Often vascular alterationsWith hydropic changeTypically well-defined areas of edema within connective tissue-containing vessels and scattered fibroblasts separating well-defined areas of benign-appearing smooth muscle that may appear as islands, cords, or trabeculaeIf prominent, ± perinodular architecture of smooth muscle cells with effacement of compact fascicular appearance± marked hyalinizationEpithelioid: Cells that resemble epithelial cells constituting > 50% of tumor, no cytologic atypia, ≤ 2 mitoses/10 HPF, and no tumor cell necrosisDiffuse, nested, cord-like, or trabecular architectureIf corded and ≤ 1 cm: Plexiform tumorlet (endometrium, myometrium, or both) (1 or multiple)± pseudoglandular spacesMyxoid: Abundant extracellular myxoid matrix (rich in acid mucins), bland cytologic features, < 2 mitoses/10 HPF, and no tumor cell necrosisOften admixed with conventional areasMay occur during pregnancy",
                    "sub_points": [
                      "Mitotically active: Increased mitotic activity (6-14/10 HPF), no cytologic atypia or tumor cell necrosisMay be progesterone relatedIf > 15 mitoses/10 HPF best classified as low/uncertain malignant potential as very limited experience",
                      "May be progesterone related",
                      "If > 15 mitoses/10 HPF best classified as low/uncertain malignant potential as very limited experience",
                      "With bizarre nuclei (without fumarate hydratase abnormalities)Patchy distribution (may be diffuse) of atypical binucleated or multinucleated atypical cells interspersed with banal smooth muscle cells (striking atypia due most likely to abundant heterochromatin, known to be associated with inactivated DNA)Abundant eosinophilic cytoplasm, may have \"rhabdoid\" inclusions; ± prominent nucleoli or smudgy chromatinKaryorrhectic nuclei (densely eosinophilic cytoplasm with coarse fragmented chromatin) not to be confused with mitosesOften vascular changes (fibrinoid necrosis, vascular occlusion, perivascular infiltrate)",
                      "Patchy distribution (may be diffuse) of atypical binucleated or multinucleated atypical cells interspersed with banal smooth muscle cells (striking atypia due most likely to abundant heterochromatin, known to be associated with inactivated DNA)",
                      "Abundant eosinophilic cytoplasm, may have \"rhabdoid\" inclusions; ± prominent nucleoli or smudgy chromatin",
                      "Karyorrhectic nuclei (densely eosinophilic cytoplasm with coarse fragmented chromatin) not to be confused with mitoses",
                      "Often vascular changes (fibrinoid necrosis, vascular occlusion, perivascular infiltrate)",
                      "Leiomyoma with fumarate hydratase abnormalityStaghorn vesselsIncreased cellularity and alveolar-type edemaFibrillary background and rhabdoid cellsMultinucleated cells with degenerative atypiaNuclei with large orangeophilic nucleoli surrounded by perinucleolar halo",
                      "Staghorn vessels",
                      "Increased cellularity and alveolar-type edema",
                      "Fibrillary background and rhabdoid cells",
                      "Multinucleated cells with degenerative atypia",
                      "Nuclei with large orangeophilic nucleoli surrounded by perinucleolar halo",
                      "Cellular leiomyomaTypical leiomyoma \"significantly\" more cellular than adjacent myometrium (removed from latest WHO)",
                      "Typical leiomyoma \"significantly\" more cellular than adjacent myometrium (removed from latest WHO)",
                      "Highly cellular leiomyomaLeiomyoma with cellular density similar to that seen in endometrial stromal tumors, no cytologic atypia and typically < 4 mitoses/10 HPF± irregular \"pseudoinfiltrative borders\"; merging at periphery with myometriumOften large, thick-walled blood vessels throughout and cleft-like spaces (compressed vessels or retraction artifact)Small cells with scant cytoplasm; therefore, fascicular growth may not be as evident",
                      "Leiomyoma with cellular density similar to that seen in endometrial stromal tumors, no cytologic atypia and typically < 4 mitoses/10 HPF",
                      "± irregular \"pseudoinfiltrative borders\"; merging at periphery with myometrium",
                      "Often large, thick-walled blood vessels throughout and cleft-like spaces (compressed vessels or retraction artifact)",
                      "Small cells with scant cytoplasm; therefore, fascicular growth may not be as evident",
                      "Leiomyoma with hormone-related changes (pregnancy or progestin)Hemorrhage, edema, myxoid change in various proportionsAbnormal vessels with thickening and fibrosis of intimal layerFocal hypercellularity, some nuclear pleomorphism, and increased mitotic activityApoplectic leiomyoma: Well-defined areas of hemorrhage surrounded by cellular rim of smooth muscle cells with plump nuclei, relatively prominent nucleoli, and increased mitotic activity (up to 9/10 HPF) in background that may be myxomatousAway from those areas, appearance is that of benign smooth muscle tumor (\"zonation\" phenomenon)Often vascular alterations",
                      "Hemorrhage, edema, myxoid change in various proportions",
                      "Abnormal vessels with thickening and fibrosis of intimal layer",
                      "Focal hypercellularity, some nuclear pleomorphism, and increased mitotic activity",
                      "Apoplectic leiomyoma: Well-defined areas of hemorrhage surrounded by cellular rim of smooth muscle cells with plump nuclei, relatively prominent nucleoli, and increased mitotic activity (up to 9/10 HPF) in background that may be myxomatousAway from those areas, appearance is that of benign smooth muscle tumor (\"zonation\" phenomenon)",
                      "Away from those areas, appearance is that of benign smooth muscle tumor (\"zonation\" phenomenon)",
                      "Often vascular alterations",
                      "With hydropic changeTypically well-defined areas of edema within connective tissue-containing vessels and scattered fibroblasts separating well-defined areas of benign-appearing smooth muscle that may appear as islands, cords, or trabeculaeIf prominent, ± perinodular architecture of smooth muscle cells with effacement of compact fascicular appearance± marked hyalinization",
                      "Typically well-defined areas of edema within connective tissue-containing vessels and scattered fibroblasts separating well-defined areas of benign-appearing smooth muscle that may appear as islands, cords, or trabeculae",
                      "If prominent, ± perinodular architecture of smooth muscle cells with effacement of compact fascicular appearance",
                      "± marked hyalinization",
                      "Epithelioid: Cells that resemble epithelial cells constituting > 50% of tumor, no cytologic atypia, ≤ 2 mitoses/10 HPF, and no tumor cell necrosisDiffuse, nested, cord-like, or trabecular architectureIf corded and ≤ 1 cm: Plexiform tumorlet (endometrium, myometrium, or both) (1 or multiple)± pseudoglandular spaces",
                      "Diffuse, nested, cord-like, or trabecular architecture",
                      "If corded and ≤ 1 cm: Plexiform tumorlet (endometrium, myometrium, or both) (1 or multiple)",
                      "± pseudoglandular spaces",
                      "Myxoid: Abundant extracellular myxoid matrix (rich in acid mucins), bland cytologic features, < 2 mitoses/10 HPF, and no tumor cell necrosisOften admixed with conventional areasMay occur during pregnancy",
                      "Often admixed with conventional areas",
                      "May occur during pregnancy"
                    ]
                  },
                  {
                    "text": "OthersTreated leiomyoma (GnRHa; uterine artery embolization with polyvinyl alcohol or with trisacryl gelatin microspheres; antifibrinolytics)Smaller tumor size (\"shrinking\")Vascular changes (fewer vessels, decreased vessel diameter, intimal fibrosis, myxoid and fibrinoid change, thrombosis)Infarct-type necrosis, hyalinization, lymphocytic infiltrateNuclear crowding, increased mitotic activity (if tumor removed several weeks after hormonal treatment)Aggregates of embolized particles, infarct-type necrosis, and foreign body giant cell reaction (secondarily may induce necrosis of part of myometrium)With heterologous elementsLipoleiomyoma: Typical leiomyoma with variable amounts of mature adipocytes; rarely brown fat \"lipohibernoma\"; chondroid-like areas or malignant transformation to liposarcomaOthers: Skeletal muscle, bony or cartilaginous differentiationSeedling leiomyoma(s)Tiny leiomyomas at periphery of large oneUnusual growth patternsDissecting leiomyoma (including cotyledonoid leiomyoma or Sternberg tumor): Swirled growth of spindle cells with prominent vessels and hydropic change separated by delicate fibroblastic matrix with large muscular vessels, often dissecting myometrium and extending into serosaDiffuse leiomyomatosis: Poorly defined, closely packed small nodules composed of fascicles of spindled cells with tendency to merge with each otherLeiomyoma with vascular invasion: Typical leiomyoma or leiomyoma variant with microscopic intravascular growth within tumorIntravenous leiomyomatosis: Endothelial covered protrusions of smooth muscle resembling either typical leiomyoma or variants outside confines of leiomyoma, if present; subendothelial proliferation of benign smooth muscle may merge with intravascular tumorDiffuse leiomyomatosis peritonealis: Well-defined nodules composed of fascicles of spindled cells with no cytologic atypia or brisk mitotic activity; decidual cells may be admixedBenign metastasizing leiomyoma: Relatively well-defined nodule of spindle cells with fascicular growth and benign cytologic features, most commonly in lung where alveolar spaces may be entrapped",
                    "sub_points": [
                      "Treated leiomyoma (GnRHa; uterine artery embolization with polyvinyl alcohol or with trisacryl gelatin microspheres; antifibrinolytics)Smaller tumor size (\"shrinking\")Vascular changes (fewer vessels, decreased vessel diameter, intimal fibrosis, myxoid and fibrinoid change, thrombosis)Infarct-type necrosis, hyalinization, lymphocytic infiltrateNuclear crowding, increased mitotic activity (if tumor removed several weeks after hormonal treatment)Aggregates of embolized particles, infarct-type necrosis, and foreign body giant cell reaction (secondarily may induce necrosis of part of myometrium)",
                      "Smaller tumor size (\"shrinking\")",
                      "Vascular changes (fewer vessels, decreased vessel diameter, intimal fibrosis, myxoid and fibrinoid change, thrombosis)",
                      "Infarct-type necrosis, hyalinization, lymphocytic infiltrate",
                      "Nuclear crowding, increased mitotic activity (if tumor removed several weeks after hormonal treatment)",
                      "Aggregates of embolized particles, infarct-type necrosis, and foreign body giant cell reaction (secondarily may induce necrosis of part of myometrium)",
                      "With heterologous elementsLipoleiomyoma: Typical leiomyoma with variable amounts of mature adipocytes; rarely brown fat \"lipohibernoma\"; chondroid-like areas or malignant transformation to liposarcomaOthers: Skeletal muscle, bony or cartilaginous differentiation",
                      "Lipoleiomyoma: Typical leiomyoma with variable amounts of mature adipocytes; rarely brown fat \"lipohibernoma\"; chondroid-like areas or malignant transformation to liposarcoma",
                      "Others: Skeletal muscle, bony or cartilaginous differentiation",
                      "Seedling leiomyoma(s)Tiny leiomyomas at periphery of large one",
                      "Tiny leiomyomas at periphery of large one",
                      "Unusual growth patternsDissecting leiomyoma (including cotyledonoid leiomyoma or Sternberg tumor): Swirled growth of spindle cells with prominent vessels and hydropic change separated by delicate fibroblastic matrix with large muscular vessels, often dissecting myometrium and extending into serosaDiffuse leiomyomatosis: Poorly defined, closely packed small nodules composed of fascicles of spindled cells with tendency to merge with each otherLeiomyoma with vascular invasion: Typical leiomyoma or leiomyoma variant with microscopic intravascular growth within tumorIntravenous leiomyomatosis: Endothelial covered protrusions of smooth muscle resembling either typical leiomyoma or variants outside confines of leiomyoma, if present; subendothelial proliferation of benign smooth muscle may merge with intravascular tumorDiffuse leiomyomatosis peritonealis: Well-defined nodules composed of fascicles of spindled cells with no cytologic atypia or brisk mitotic activity; decidual cells may be admixedBenign metastasizing leiomyoma: Relatively well-defined nodule of spindle cells with fascicular growth and benign cytologic features, most commonly in lung where alveolar spaces may be entrapped",
                      "Dissecting leiomyoma (including cotyledonoid leiomyoma or Sternberg tumor): Swirled growth of spindle cells with prominent vessels and hydropic change separated by delicate fibroblastic matrix with large muscular vessels, often dissecting myometrium and extending into serosa",
                      "Diffuse leiomyomatosis: Poorly defined, closely packed small nodules composed of fascicles of spindled cells with tendency to merge with each other",
                      "Leiomyoma with vascular invasion: Typical leiomyoma or leiomyoma variant with microscopic intravascular growth within tumor",
                      "Intravenous leiomyomatosis: Endothelial covered protrusions of smooth muscle resembling either typical leiomyoma or variants outside confines of leiomyoma, if present; subendothelial proliferation of benign smooth muscle may merge with intravascular tumor",
                      "Diffuse leiomyomatosis peritonealis: Well-defined nodules composed of fascicles of spindled cells with no cytologic atypia or brisk mitotic activity; decidual cells may be admixed",
                      "Benign metastasizing leiomyoma: Relatively well-defined nodule of spindle cells with fascicular growth and benign cytologic features, most commonly in lung where alveolar spaces may be entrapped"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Spindled cells with eosinophilic cytoplasmOften paranuclear vacuole, cigar-shaped nuclei, and fine chromatin with small nucleoli",
                    "sub_points": [
                      "Often paranuclear vacuole, cigar-shaped nuclei, and fine chromatin with small nucleoli"
                    ]
                  },
                  {
                    "text": "Epithelioid cells with eosinophilic or clear cytoplasmUniform round nuclei and small nucleoli",
                    "sub_points": [
                      "Uniform round nuclei and small nucleoli"
                    ]
                  },
                  {
                    "text": "Rhabdoid cells with abundant eosinophilic cytoplasm with rounded/globoid appearance"
                  },
                  {
                    "text": "At most, mild cytologic atypia, except if bizarre nuclei (abundant eosinophilic cytoplasm, mono- or multinucleation, nuclear pseudoinclusions, nucleoli)"
                  },
                  {
                    "text": "Variable mitotic activityUsually low but up to 15/10 HPF if mitotically active leiomyomaIncreased around areas of infarction< 2/10 HPF if epithelioid< 2/10 HPF if myxoid, but any mitoses worrisome",
                    "sub_points": [
                      "Usually low but up to 15/10 HPF if mitotically active leiomyoma",
                      "Increased around areas of infarction",
                      "< 2/10 HPF if epithelioid",
                      "< 2/10 HPF if myxoid, but any mitoses worrisome"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Smooth muscle actin, desmin, caldesmon, smooth muscle myosin, HDAC8, oxytocin positive"
                  },
                  {
                    "text": "Transgelin positivity (limited experience)"
                  },
                  {
                    "text": "Keratin (wide spectrum) and EMA often positive (especially if epithelioid), CD56 positive (closet expression in leiomyomas with bizarre nuclei)"
                  },
                  {
                    "text": "CD10 and IFITM1 variably positive (more often if highly cellular)"
                  },
                  {
                    "text": "WT1 may be positive (cytoplasmic > nuclear)"
                  },
                  {
                    "text": "ER, PR, AR positive (AR ~ 30%)ER and PR may be decreased if treated with GnRHa",
                    "sub_points": [
                      "ER and PR may be decreased if treated with GnRHa"
                    ]
                  },
                  {
                    "text": "p16, p53, and HMGA2 may be positive, especially in leiomyoma with bizarre nuclei (with measured FH expression), p16 may be positive near areas of infarct-type necrosis in apoplectic leiomyoma"
                  },
                  {
                    "text": "Fumarate hydratase loss with S-(2-succino)-cysteine (2SC) positivity in subgroup of leiomyomas with FH somatic or germline mutationsDoes not perfectly correlate with FH mutational status2SC more sensitive to detectFHgene abnormalitiesStaining pattern may be normal in patient with HLRCC",
                    "sub_points": [
                      "Does not perfectly correlate with FH mutational status",
                      "2SC more sensitive to detectFHgene abnormalities",
                      "Staining pattern may be normal in patient with HLRCC"
                    ]
                  },
                  {
                    "text": "Alcian blue and colloidal iron (+) if myxoid leiomyoma but (-) if hydropic leiomyoma"
                  },
                  {
                    "text": "MIB-1 and PHH3 expression typically low except if mitotically active leiomyoma"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Diploid"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Mutations are typically mutually exclusive"
                  },
                  {
                    "text": "MED12mutations in typical leiomyoma (limited knowledge in leiomyoma variants) (~ 70%)Only hot spot mutations in leiomyoma with bizarre nuclei",
                    "sub_points": [
                      "Only hot spot mutations in leiomyoma with bizarre nuclei"
                    ]
                  },
                  {
                    "text": "HGM2/1 aberrations (~ 30%)"
                  },
                  {
                    "text": "COL4A5 and COL4A6 alterations (Alport syndrome) (~ 4%)"
                  },
                  {
                    "text": "FHsomatic > > > > germline mutations"
                  },
                  {
                    "text": "Simple karyotypic abnormalities except leiomyomas with bizarre nuclei"
                  },
                  {
                    "text": "der(14)t(12;14)(q15;q24), among others, in intravenous leiomyomatosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endometrial Stromal Tumor (vs. Highly Cellular Leiomyoma)": [
                  {
                    "text": "No fascicular growth"
                  },
                  {
                    "text": "Small arterioles; if large blood vessels present, typically closer to tumor-myometrium interface"
                  },
                  {
                    "text": "No merging of neoplastic cells with surrounding myometrium"
                  },
                  {
                    "text": "Desmin negative or focally positive; caldesmon negative"
                  }
                ],
                "Endometrial Stromal Tumor (vs. Intravenous Leiomyomatosis)": [
                  {
                    "text": "No thick-walled blood vessels, no cleft-like spaces or hydropic change"
                  },
                  {
                    "text": "Typically no endothelial proliferation"
                  },
                  {
                    "text": "Desmin (-) or focally (+), caldesmon (-)"
                  }
                ],
                "Spindle Leiomyosarcoma (vs. Mitotically Active Leiomyoma)": [
                  {
                    "text": "Destructive myometrial invasion common"
                  },
                  {
                    "text": "High-grade cytologic features and tumor necrosis"
                  },
                  {
                    "text": "Typically p16, often diffuse p53(+) or ATRX loss"
                  }
                ],
                "Smooth Muscle Tumor of Low/Uncertain Malignant Potential (vs. Leiomyoma Variants)": [
                  {
                    "text": "Diffuse atypia and 5-9 mitoses/10 HPF"
                  },
                  {
                    "text": "Tumor cell necrosis or necrosis of uncertain type"
                  },
                  {
                    "text": "If > 15 mitoses/10 HPF, no atypia or necrosis"
                  }
                ],
                "Spindle Leiomyosarcoma (vs. Leiomyoma With Bizarre Nuclei)": [
                  {
                    "text": "True, not degenerative-type, atypia"
                  },
                  {
                    "text": "> 10 mitoses/10 HPF, tumor cell necrosis"
                  },
                  {
                    "text": "Aneuploidy"
                  }
                ],
                "Hydropic Leiomyoma (vs. Intravenous Leiomyomatosis)": [
                  {
                    "text": "Extrusion of watery fluid"
                  },
                  {
                    "text": "Nodularity confined within mass"
                  },
                  {
                    "text": "No protrusion into endothelial-lined spaces outside confines of leiomyoma"
                  },
                  {
                    "text": "CD31(-) as no endothelium"
                  }
                ],
                "Myxoid Leiomyosarcoma (vs. Myxoid Leiomyoma)": [
                  {
                    "text": "Large size and often infiltrative borders"
                  },
                  {
                    "text": "Cytologic atypia &/or tumor cell necrosis"
                  },
                  {
                    "text": "≥ 2 mitoses/10 HPF"
                  }
                ],
                "Epithelioid Leiomyosarcoma (vs. Epithelioid Leiomyoma)": [
                  {
                    "text": "More than mild cytologic atypia"
                  },
                  {
                    "text": "> 4 mitoses/10 HPF"
                  }
                ],
                "Uterine Tumor Resembling Ovarian Sex Cord Tumor": [
                  {
                    "text": "Other characteristic architectural patterns"
                  },
                  {
                    "text": "Inhibin positive and commonNCOA1/NCOA2fusions"
                  }
                ],
                "PEComa (vs. Epithelioid Leiomyoma)": [
                  {
                    "text": "± melanin pigment, prominent capillary network"
                  },
                  {
                    "text": "Melan-A, PNL2, ± TFE3 positive"
                  },
                  {
                    "text": "TSC1/TSC2alterations"
                  }
                ],
                "Placental Trophoblastic Tumors (vs. Epithelioid Leiomyoma)": [
                  {
                    "text": "Infiltrative growth pattern (placental site trophoblastic tumor)"
                  },
                  {
                    "text": "Abundant fibrinoid material with cells growing around vessels (epithelioid trophoblastic tumor)"
                  },
                  {
                    "text": "Scattered multinucleated cells"
                  },
                  {
                    "text": "Inhibin, GATA3 positive"
                  }
                ],
                "Lymphangioleiomyomatosis (vs. Leiomyoma or Benign Metastasizing Leiomyoma)": [
                  {
                    "text": "History of tuberous sclerosis"
                  },
                  {
                    "text": "Nodules with ill-defined borders"
                  },
                  {
                    "text": "Bright eosinophilic appearance of tumor cells"
                  },
                  {
                    "text": "Cleft-like spaces with collagen deposition"
                  },
                  {
                    "text": "Pale, sometimes vacuolated, cytoplasm"
                  },
                  {
                    "text": "Melan-A positive"
                  }
                ],
                "Rhabdomyosarcoma (vs. Leiomyoma With Rhabdoid Features)": [
                  {
                    "text": "Infiltrative borders"
                  },
                  {
                    "text": "Marked nuclear pleomorphism and mitotic activity"
                  },
                  {
                    "text": "Myogenin and MyoD1 positive"
                  }
                ],
                "Metastasizing Leiomyosarcoma (vs. Benign Metastasizing Leiomyoma)": [
                  {
                    "text": "Malignant cytologic features and brisk mitotic activity"
                  }
                ],
                "Inflammatory Myofibroblastic Tumor (vs. Conventional or Myxoid Leiomyoma)": [
                  {
                    "text": "Inflammatory infiltrate common ± ganglion cells"
                  },
                  {
                    "text": "ALK/ROS (+) and associated translocations"
                  }
                ],
                "Leiomyoma With Focal Myxoid Change (vs. Myxoid Leiomyoma)": [
                  {
                    "text": "Typically < 20% of tumor"
                  }
                ],
                "Adenomatoid Tumor": [
                  {
                    "text": "Grossly poorly circumscribed"
                  },
                  {
                    "text": "Epithelial growth with nests, tubules, single cells in between prominent smooth muscle bundles"
                  },
                  {
                    "text": "Calretinin, WT1, D2-40 (+) in mesothelial cells"
                  },
                  {
                    "text": "TRAF7mutations"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Sampling of smooth muscle tumors if unusual gross appearance crucial, especially if epithelioid or myxoid"
                  },
                  {
                    "text": "If typical gross appearance but worrisome microscopic appearance, leiomyoma with bizarre nuclei most likely"
                  },
                  {
                    "text": "If worrisome gross but typical microscopic appearance, most common scenario hydropic, apoplectic, or red degeneration"
                  },
                  {
                    "text": "If worrisome gross and microscopic features, most likely leiomyosarcoma"
                  },
                  {
                    "text": "Leiomyoma variants may coexist (i.e., highly cellular and mitotically active, bizarre nuclei and fat)"
                  },
                  {
                    "text": "If differential diagnosis on gross exam between leiomyoma with hydropic change and myxoid smooth muscle tumor, squeezing of tumor will extrude watery fluid if hydropic change"
                  },
                  {
                    "text": "Important to be aware of margins in partly myxoid leiomyomas, not to misconstrue nonmyxoid areas as myometrium and consider tumor to be infiltrative, and thus malignantIn these tumors, evaluation of nonmyxoid areas helpful in classification",
                    "sub_points": [
                      "In these tumors, evaluation of nonmyxoid areas helpful in classification"
                    ]
                  },
                  {
                    "text": "Collagen bands, although typical of endometrial stromal tumors, may be seen in leiomyomas, including intravenous leiomyomatosis"
                  },
                  {
                    "text": "Evaluation of cytologic atypia should be performed at 10x; helpful to compare with surrounding myometrium"
                  },
                  {
                    "text": "Before counting atypical mitoses as such, consider possibility of karyorrhectic nuclei, especially in leiomyomas with bizarre nuclei if typical mitoses uncommon"
                  },
                  {
                    "text": "If infarct-type necrosis not well developed, may be difficult to be certain about nature of necrosis; in those cases, carefully evaluate cytology and mitotic activity to separate benign from malignant tumors"
                  },
                  {
                    "text": "Important to be aware of \"zonation\" phenomenon in apoplectic leiomyomas as areas close to hemorrhage/infarction may show brisk mitotic activity, myxoid change, and plumper cellsp16 may be extensively (+) and Ki-67 may be increased in next to infarct-type necrosis and may raise concern for leiomyosarcoma",
                    "sub_points": [
                      "p16 may be extensively (+) and Ki-67 may be increased in next to infarct-type necrosis and may raise concern for leiomyosarcoma"
                    ]
                  },
                  {
                    "text": "Vascular leiomyomas may show minimal expression of smooth muscle markers due to dropout of smooth muscle cells"
                  },
                  {
                    "text": "If differential diagnosis between epithelioid smooth muscle tumor and PEComa, do not perform only smooth muscle markers or HMB-45PEComas may be actin, desmin, &/or caldesmon positive, especially if associated with spindle componentSmooth muscle tumors may be HMB-45 and cathepsin positive",
                    "sub_points": [
                      "PEComas may be actin, desmin, &/or caldesmon positive, especially if associated with spindle component",
                      "Smooth muscle tumors may be HMB-45 and cathepsin positive"
                    ]
                  },
                  {
                    "text": "Cleft-like spaces and thick-walled blood vessels are very characteristic of highly cellular leiomyoma and rare in endometrial stromal tumors"
                  },
                  {
                    "text": "Periphery of highly cellular leiomyoma often shows interdigitation with myometrium but typically subtle merging in contrast to sharp outlines of large tongues of low-grade endometrial stromal sarcoma"
                  },
                  {
                    "text": "Highly cellular leiomyomas with small \"seedling\" cellular leiomyomas in adjacent myometrium can be misconstrued as low-grade endometrial stromal sarcoma"
                  },
                  {
                    "text": "In differential diagnosis of highly cellular leiomyoma and endometrial stromal tumor, not recommended to use CD10 or IFITM1 in isolation but as part of panel, including CD10, desmin, and caldesmon, as highly cellular leiomyomas may be CD10 positive"
                  },
                  {
                    "text": "If differential diagnosis between smooth muscle tumor and inflammatory myofibroblastic tumor, ALK/ROS should be part of immunohistochemical panel"
                  },
                  {
                    "text": "FH loss in smooth muscle tumor not necessarily indicative of leiomyomatosis-renal cell carcinoma syndrome; most tumors associated with somatic mutations"
                  },
                  {
                    "text": "Uterine morcellation may be responsible for peritoneal seeding and secondary peritoneal leiomyomatosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Serous Adenocarcinoma": {
            "name": "Serous Adenocarcinoma",
            "url": "https://app.pathprimer.com/document/f77b564b-a68c-4368-8a5c-24e3731e655f/lesson/59688d0c-8e97-4e91-a654-336a1f112412",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "High-grade endometrial carcinoma with nuclear pleomorphism and papillary, glandular, solid growth, or combination thereof, often associated with prominent budding of noncohesive cells"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "May be seen in patients with breast carcinoma (BRCA1/BRCA2mutations)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Postmenopausal women (mean age: 60 years)"
                  },
                  {
                    "text": "Aggressive; 30-40% overall survival rate"
                  },
                  {
                    "text": "Survival up to 90% if confined to endometrium"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "May not be not visible"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Papillary, pseudoglandular, solid growths; slit-like spaces"
                  },
                  {
                    "text": "Irregular, branching papillae with cellular budding"
                  },
                  {
                    "text": "May involve only endometrial polyps or replace preexisting endometrial glands"
                  },
                  {
                    "text": "Prominent nuclear pseudostratification; absent nuclear polarity or luminal border, noncohesive cells"
                  },
                  {
                    "text": "High-grade nuclear atypia and brisk mitotic activity"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p53-mutated staining pattern: Typically diffuse (> 80% of cells strong nuclear), rarely null pattern (deletion mutation) or only cytoplasmic (+); p16 diffusely (+); very high Ki-67 index"
                  },
                  {
                    "text": "WT1(+) in up to 1/3, typically weak/patchy with exceptions"
                  },
                  {
                    "text": "± HER2 overexpression (pattern/intensity correlates with amplification status)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Endometrioid, clear cell, mesonephric-like carcinoma"
                  },
                  {
                    "text": "Secondary serous tumors (ovary, tube, peritoneum)"
                  },
                  {
                    "text": "Syncytial papillary/atypical metaplasia/reactive changes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Serous carcinoma, serous papillary carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Serous carcinoma: High-grade endometrial carcinoma with nuclear pleomorphism and papillary, glandular, solid growth, or combination thereof, often associated with prominent budding of noncohesive cells"
                  },
                  {
                    "text": "Serous endometrial intraepithelial carcinoma: Partial or complete replacement of preexisting endometrial glands &/or surface endometrium by serous carcinomaAlthough proposed as precursor of serous carcinoma, can be associated with extrauterine disease; therefore, terminology may be misleading and is not recommended",
                    "sub_points": [
                      "Although proposed as precursor of serous carcinoma, can be associated with extrauterine disease; therefore, terminology may be misleading and is not recommended"
                    ]
                  },
                  {
                    "text": "Minimal serous carcinoma: Invasion of endometrial stroma but not myometrium (not included in most recent female genital tract tumors WHO)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "May be related to prior radiation or tamoxifen therapy"
                  },
                  {
                    "text": "No association with obesity, hypertension, or hyperestrogenism"
                  }
                ],
                "Hereditary Predisposition": [
                  {
                    "text": "May be seen in patients with breast carcinoma (BRCA1/BRCA2mutations)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Up to 10% of endometrial carcinomas"
                  }
                ],
                "Age": [
                  {
                    "text": "Postmenopausal (mean: 60 years)"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Blacks > Whites"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Postmenopausal bleeding or serosanguineous vaginal discharge"
                  },
                  {
                    "text": "Abnormal Papanicolaou smear"
                  },
                  {
                    "text": "Peritoneal carcinomatosis (with minimal endometrial disease) rare"
                  },
                  {
                    "text": "Signs and symptoms related to extrauterine spread (lung, brain metastases)"
                  },
                  {
                    "text": "Elevated serum CA-125"
                  },
                  {
                    "text": "± paraneoplastic syndrome (cerebellar degeneration, hypercalcemia) rare"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Total abdominal hysterectomy with bilateral adnexectomy and surgical staging"
                  },
                  {
                    "text": "Adjuvant radiation &/or chemotherapy (except for some stage I tumors polyp confined)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tumor confined to endometrium at diagnosis in only ~ 10%"
                  },
                  {
                    "text": "30-40% overall survival rate; 40% of endometrial cancer-related deaths"
                  },
                  {
                    "text": "Survival up to 90% if confined to endometrium"
                  },
                  {
                    "text": "Low survival rates (< 15%) if stage III or IV"
                  },
                  {
                    "text": "Frequent peritoneal and lymph node metastases (up to 45%) without myometrial invasion"
                  },
                  {
                    "text": "High recurrence rate, including stage I and II tumors"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Normal to small-sized or enlarged uterus"
                  },
                  {
                    "text": "May not be visible and confined to endometrial polyp"
                  },
                  {
                    "text": "Irregular polypoid/papillary appearance coating endometrium"
                  },
                  {
                    "text": "Diffuse thickening of myometrial wall"
                  },
                  {
                    "text": "± necrosis &/or hemorrhage"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Papillary growth (most common)Irregularly shaped, medium to large branching papillae, small papillae (less common) ± micropapillary component, and cellular budding (as noncohesive cells) with ragged luminal contours",
                    "sub_points": [
                      "Irregularly shaped, medium to large branching papillae, small papillae (less common) ± micropapillary component, and cellular budding (as noncohesive cells) with ragged luminal contours"
                    ]
                  },
                  {
                    "text": "\"Pseudoglandular\" growthPoorly formed \"thick pseudoglands\" (lack smooth luminal border)Focal early clefting due to noncohesive cells",
                    "sub_points": [
                      "Poorly formed \"thick pseudoglands\" (lack smooth luminal border)",
                      "Focal early clefting due to noncohesive cells"
                    ]
                  },
                  {
                    "text": "Solid growthClosely packed nests and sheets",
                    "sub_points": [
                      "Closely packed nests and sheets"
                    ]
                  },
                  {
                    "text": "Slit-like spaces secondary to compact papillary growth or poorly formed glands"
                  },
                  {
                    "text": "May only involve endometrial polyp(s) or surface endometrium"
                  },
                  {
                    "text": "Prominent nuclear pseudostratification lacking nuclear polarity"
                  },
                  {
                    "text": "± psammoma bodies (much less common than in ovarian/peritoneal counterparts)"
                  },
                  {
                    "text": "Myometrial invasion, gaping gland morphology frequent (no stromal response)"
                  },
                  {
                    "text": "± lymphovascular invasion (often seen as small, round papillae with psammoma bodies) in absence of prominent myometrial invasion"
                  },
                  {
                    "text": "± other high-grade subtype of endometrial carcinoma"
                  },
                  {
                    "text": "May partially or completely replace preexisting endometrial glands (serous intraepithelial carcinoma)"
                  },
                  {
                    "text": "Often background atrophic endometrium"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Noncohesive cells with eosinophilic (focally clear) cytoplasm or hobnail cells"
                  },
                  {
                    "text": "High nuclear:cytoplasmic ratio"
                  },
                  {
                    "text": "High-grade nuclear atypia with hyperchromatic and pleomorphic nuclei, prominent nucleoli ± multinucleated tumor cells"
                  },
                  {
                    "text": "Brisk mitotic activity (> 10/10 HPF) with atypical mitoses common"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "PAX8, CK7, BER-EP4, B72.3, MOC31 (+)"
                  },
                  {
                    "text": "p53-mutated staining patternTypically diffuse (> 80% of cells strong nuclear), rarely null pattern (deletion mutation) or only cytoplasmic (+)",
                    "sub_points": [
                      "Typically diffuse (> 80% of cells strong nuclear), rarely null pattern (deletion mutation) or only cytoplasmic (+)"
                    ]
                  },
                  {
                    "text": "IMP2, IMP3, HMGA2, and p16 (+)"
                  },
                  {
                    "text": "WT1(+) in up to 1/3, typically weak/patchy with exceptions"
                  },
                  {
                    "text": "ER and PR variably (+) or (-)"
                  },
                  {
                    "text": "D2-40, HNF-1-β, and, rarely, napsin A may be (+)"
                  },
                  {
                    "text": "Ki-67(+) in > 75% of cells"
                  },
                  {
                    "text": "PTEN, ARID1A, β-catenin, and MMR expression typically preserved"
                  },
                  {
                    "text": "± HER2 overexpression (pattern and staining intensity correlates with amplification status)0-: No staining1+: Faint incomplete membranous staining in any proportion or weak complete staining in < 10% of tumor cells2+: Strong complete or basolateral/lateral membrane staining in ≤ 30% or weak to moderate staining in ≥ 10% of tumor cells3+: Strong complete or basolateral/lateral membrane staining in > 30% of tumor cells",
                    "sub_points": [
                      "0-: No staining",
                      "1+: Faint incomplete membranous staining in any proportion or weak complete staining in < 10% of tumor cells",
                      "2+: Strong complete or basolateral/lateral membrane staining in ≤ 30% or weak to moderate staining in ≥ 10% of tumor cells",
                      "3+: Strong complete or basolateral/lateral membrane staining in > 30% of tumor cells"
                    ]
                  }
                ],
                "Genetic Alterations": [
                  {
                    "text": "TP53>PPP2R1A>PIK3CA>FBXW7>HER2somatic mutations"
                  },
                  {
                    "text": "Typically with category of copy number high in TCCA"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Endometrioid Carcinoma": [
                  {
                    "text": "Low gradeWell-formed glands/papillae with nuclear polarity and well-defined luminal border (papillary NOS)Slender papillae without branching or budding (villoglandular)Small tufts of cells with eosinophilic &/or mucinous cytoplasm within well-formed glands (mall nonvillous papillae)p53 wild type (most); ER/PR diffusely (+)",
                    "sub_points": [
                      "Well-formed glands/papillae with nuclear polarity and well-defined luminal border (papillary NOS)",
                      "Slender papillae without branching or budding (villoglandular)",
                      "Small tufts of cells with eosinophilic &/or mucinous cytoplasm within well-formed glands (mall nonvillous papillae)",
                      "p53 wild type (most); ER/PR diffusely (+)"
                    ]
                  },
                  {
                    "text": "High grade, includingPOLE-mutated tumorsFocal gland formation or trabecular/nested growthNo striking nuclear pleomorphism (in general exceptPOLEmutated)Squamous or mucinous differentiationER and PR often (+); ± PTEN, ARID1A, and MMR loss",
                    "sub_points": [
                      "Focal gland formation or trabecular/nested growth",
                      "No striking nuclear pleomorphism (in general exceptPOLEmutated)",
                      "Squamous or mucinous differentiation",
                      "ER and PR often (+); ± PTEN, ARID1A, and MMR loss"
                    ]
                  }
                ],
                "Clear Cell Carcinoma": [
                  {
                    "text": "Admixture of tubulocystic and papillary growths"
                  },
                  {
                    "text": "Small, round papillae that may be hyalinized"
                  },
                  {
                    "text": "Atypical, but uniform nuclei with lower mitotic activity"
                  },
                  {
                    "text": "Napsin A and racemase frequently (+); ± ARID1A loss"
                  }
                ],
                "Carcinosarcoma": [
                  {
                    "text": "High-grade mesenchymal component"
                  }
                ],
                "Secondary Involvement by Serous Tumors (Ovary, Fallopian Tube, Peritoneum)": [
                  {
                    "text": "Low-grade serous neoplasmsSmall papillae and low-grade nuclear featuresLow MIB-1 expression; p53 wild typeER, PR, and WT1 diffusely and strongly (+)",
                    "sub_points": [
                      "Small papillae and low-grade nuclear features",
                      "Low MIB-1 expression; p53 wild type",
                      "ER, PR, and WT1 diffusely and strongly (+)"
                    ]
                  },
                  {
                    "text": "High-grade serous carcinomaLarger tumor volume (if synchronous tumors)Presence of tubal serous intraepithelial carcinoma (if synchronous tumors)ER, PR, and WT1 diffusely and strongly (+)",
                    "sub_points": [
                      "Larger tumor volume (if synchronous tumors)",
                      "Presence of tubal serous intraepithelial carcinoma (if synchronous tumors)",
                      "ER, PR, and WT1 diffusely and strongly (+)"
                    ]
                  }
                ],
                "Mesonephric-Like Carcinoma": [
                  {
                    "text": "Ductal &/or tubular architecture common and intraluminal eosinophilic secretions"
                  },
                  {
                    "text": "Overlapping nuclei resembling papillary thyroid carcinoma"
                  },
                  {
                    "text": "GATA3, TTF1 (inverse pattern of staining between GATA3 and TTF-1 in some), CD10 (+)"
                  },
                  {
                    "text": "No abnormal p53 staining and only patchy p16 expression"
                  }
                ],
                "Syncytial Papillary or Atypical Tubal Metaplasia": [
                  {
                    "text": "Syncytial metaplasia: No cytoplasmic borders, rare mitoses in background of stromal breakdown"
                  },
                  {
                    "text": "Tubal metaplasia: Uniform cytologic features with rare mitoses and cilia"
                  }
                ],
                "Reactive Epithelial Changes": [
                  {
                    "text": "Often in background of infarcted polyp"
                  },
                  {
                    "text": "Focal and often on surface lacking mitoses; p53 wild type"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Any serous component should be reported as presence likely has prognostic implications"
                  },
                  {
                    "text": "If unsure about serous component in biopsy/curettage, note should include that possibility, as surgical management may differ from endometrioid carcinoma"
                  },
                  {
                    "text": "Lack of HER2 concordance between endometrial biopsy/curettage and hysterectomy in endometrial serous carcinoma likely due to heterogeneity of staining and fixation issues; testing of multiple specimens may identify larger number of patients eligible for targeted therapy"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Evaluate high-power cytologic features in \"gland-forming\" endometrial carcinoma: Lack of smooth luminal border and nuclear polarity, noncohesive cells, and high-grade nuclear features that do not correlate with glandular architecture favor serous carcinoma"
                  },
                  {
                    "text": "If no tumor grossly seen but polyp identified in hysterectomy specimen of postmenopausal woman with atypical cells suspicious for serous carcinoma on Papanicolaou smear, polyp should be completely submitted for histologic examination"
                  },
                  {
                    "text": "Although serous carcinoma shows mutant p53 and diffuse p16 positivity, these features may be seen in other endometrial carcinoma subtypes; thus, morphologic correlation needed"
                  },
                  {
                    "text": "POLE-mutated endometrioid carcinomas may closely mimic serous carcinomas morphologically as ambiguous and may be p53 mutated, also often scattered giant cells and prominent tumor-infiltrating lymphocytesBefore making diagnosis of serous carcinoma, if most typical morphology not present, consider POLE testing",
                    "sub_points": [
                      "Before making diagnosis of serous carcinoma, if most typical morphology not present, consider POLE testing"
                    ]
                  },
                  {
                    "text": "Always investigate extrauterine origin (ovary, tube, or peritoneum) in any endometrial low-grade papillary serous neoplasm"
                  },
                  {
                    "text": "If synchronous tumors in endometrium and fallopian tube/ovary, evaluate amount of endometrial tumor as well as WT1 and ER profile"
                  },
                  {
                    "text": "When making diagnosis of serous carcinoma, always exclude component of carcinosarcoma"
                  },
                  {
                    "text": "When evaluating omental biopsies for metastatic serous carcinoma, those of tuboovarian origin show more often varied architectural patterns than those arising from endometrium; although immunohistochemical stains not reliable, WT1(-) would favor endometrial primary"
                  },
                  {
                    "text": "Caution in utilization of HNF-1-β and napsin A in differential diagnosis of serous and clear cell carcinomas as former often HNF-1-β(+) and may be napsin A (+)"
                  },
                  {
                    "text": "Although, differential diagnosis between serous carcinomas and melanoma in endometrium typically straightforward, at metastatic sites both may have solid growth; PRAME (preferentially expressed antigen in melanoma) expressed in most serous carcinomas; thus, this marker relatively nonspecific in this differential diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}